SARS-CoV-2-Queries

litHumanCoronaviruses.rq

Ejemplos de código: curl

SPARQL

SELECT ?date ?work ?workLabel ?virus ?virusLabel ?doi ?pubmed WITH {
  SELECT (MAX(?dates) as ?date) ?work ?doi ?virus WHERE {
    VALUES ?virus {
      wd:Q82069695 # SARS-CoV-2
      wd:Q16983360 # HKU1
      wd:Q16991954 # OC43
      wd:Q8351095  # NL63 
      wd:Q16983356 # 229E 
      wd:Q4902157  # MERS-CoV
      wd:Q278567   # SARS-CoV
    }
    ?work wdt:P577 ?dates ;
          wdt:P921 ?virus .
  } GROUP BY ?work ?doi ?virus
    ORDER BY DESC(?date)
    LIMIT 5000
} AS %ARTICLES WHERE {
  INCLUDE %ARTICLES
  OPTIONAL { ?work wdt:P356 ?doi . }
  OPTIONAL { ?work wdt:P698 ?pubmed . }
  SERVICE wikibase:label { bd:serviceParam wikibase:language "es,en". }
}
ORDER BY DESC(?date) ?doi ?pubmed ?virus

ejecutar o editar

Resultados

date work virus doi pubmed
2023-09-01 Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion (edit) SARS-CoV-2 (edit) 10.1016/J.PHYMED.2023.154942
2023-06-01 Head and neck reconstruction in the SARS-CoV-2 pandemic era: outcomes and lessons learned (edit) SARS-CoV-2 (edit) 10.21037/FOMM-21-4
2023-06-01 Uptake and effectiveness of a mobile application for real-time reporting and quality assurance of decentralized SARS-CoV-2 testing in Uganda (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2023.1053544
2023-05-31 Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2 (edit) SARS-CoV-2 (edit) 10.1186/S12967-023-04224-1
2023-05-18 Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2023.1151659
2023-05-08 Excess risk of SARS-CoV-2 infection among in-person nonhealthcare workers in six states, September 2020-June 2021 (edit) SARS-CoV-2 (edit) 10.1002/AJIM.23487
2023-04-19 Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0269104
2023-04-03 Oral Supplementation with AHCC, a Standardized Extract of Cultured Mycelia, Enhances Host Resistance against SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS12040554 37111440
2023-04-01 Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2023.105576
2023-04-01 Lessons learned during COVID-19 pandemic, a worldwide survey: impact of SARS-CoV-2 vaccination on neurosurgeons and neurosurgical practice (edit) SARS-CoV-2 (edit) 10.23736/S0390-5616.22.05885-4
2023-03-31 Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5 (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS11040912 37110335
2023-03-27 Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England (edit) SARS-CoV-2 (edit) 10.1038/S41467-023-36494-0
2023-03-23 New workflow predicts drug targets against SARS-CoV-2 via metabolic changes in infected cells (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010903
2023-03-20 An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition (edit) SARS-CoV-2 (edit) 10.1038/S41467-023-37035-5 36941262
2023-03-17 A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link between Three Residues C22, C44, and K61 Is Frequently Observed in the SARS-CoV-2 Main Protease (edit) SARS-CoV-2 (edit) 10.1021/ACSCHEMBIO.2C00695 36629751
2023-03-17 Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide (edit) SARS-CoV-2 (edit) 10.1080/17425247.2023.2189697
2023-03-17 Assessing suicidality during the SARS-CoV-2 pandemic: Lessons learned from adaptation and implementation of a telephone-based suicide risk assessment and response protocol in Malawi (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0281711
2023-03-17 SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic (edit) SARS-CoV-2 (edit) 10.3390/VACCINES11030682
2023-03-16 Links between Vitamin K, Ferroptosis and SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/ANTIOX12030733
2023-03-14 SARS-CoV-2 receptor-binding domain deep mutational AlphaFold2 structures (edit) SARS-CoV-2 (edit) 10.1038/S41597-023-02035-Z
2023-03-12 Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia (edit) SARS-CoV-2 (edit) 10.1080/10428194.2023.2183730
2023-03-11 Lack of SARS-CoV-2 RNA evidence in the lungs from wild European polecats (Mustela putorius) from Spain (edit) SARS-CoV-2 (edit) 10.1007/S10344-023-01662-6
2023-03-09 Occupational risk factors for SARS-CoV-2 seropositivity in healthcare workers: results of a longitudinal cohort (edit) SARS-CoV-2 (edit) 10.1097/JOM.0000000000002831
2023-03-08 The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1011167
2023-03-04 Transmission of SARS-CoV-2 in the workplace: key findings from a rapid review of the literature (edit) SARS-CoV-2 (edit) 10.1080/02786826.2023.2166394 37213938
2023-03-03 Could the lake ecosystems influence the pathogenicity of the SARS-COV-2 in the air? (edit) SARS-CoV-2 (edit) 10.18388/ABP.2020_6514
2023-03-02 Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU—Practical Recommendations from an Expert Group for CAPA/IAPA Patients (edit) SARS-CoV-2 (edit) 10.3390/JOF9030312
2023-03-01 Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2023.106230
2023-03-01 Sensitivity of wastewater surveillance: What is the minimum COVID-19 cases required in population for SARS-CoV-2 RNA to be detected in wastewater? (edit) SARS-CoV-2 (edit) 10.1016/J.JES.2022.08.020
2023-03-01 Development of a rapid and ultra-sensitive RNA:DNA hybrid immunocapture based biosensor for visual detection of SARS-CoV-2 RNA (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAD031 36909823
2023-03-01 Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAD033 36926220
2023-03-01 Extreme value modelling of SARS-CoV-2 community transmission using discrete generalized Pareto distributions (edit) SARS-CoV-2 (edit) 10.1098/RSOS.220977
2023-02-28 Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial (edit) SARS-CoV-2 (edit) 10.1186/S13104-023-06281-7
2023-02-27 Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-CoV-2 variants of concern in Laikipia, Kenya: institutional and community-based genomic surveillance (edit) SARS-CoV-2 (edit) 10.12688/WELLCOMEOPENRES.18306.2
2023-02-24 SARS-CoV-2 Omicron variant of concern in the Seychelles: Introduction and spread (edit) SARS-CoV-2 (edit) 10.12688/WELLCOMEOPENRES.18908.1
2023-02-23 SARS-CoV-2 Main Protease Targets Host Selenoproteins and Glutathione Biosynthesis for Knockdown via Proteolysis, Potentially Disrupting the Thioredoxin and Glutaredoxin Redox Cycles (edit) SARS-CoV-2 (edit) 10.3390/ANTIOX12030559 36978807
2023-02-22 Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England (edit) SARS-CoV-2 (edit) 10.12688/WELLCOMEOPENRES.17995.1
2023-02-21 SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, 2021 to 2022 (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00522-22
2023-02-16 Optimized workplace risk mitigation measures for SARS-CoV-2 in 2022 (edit) SARS-CoV-2 (edit) 10.1038/S41598-023-29087-W
2023-02-15 Performance of a SARS-CoV-2 RT-PCR Assay with Non-Traditional Specimen Types (edit) SARS-CoV-2 (edit) 10.55504/2473-2869.1260
2023-02-13 Performance of the GeneSoC Rapid PCR System in Detection of SARS-CoV-2 from Saliva Specimens (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.03259-22
2023-02-09 Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens (edit) SARS-CoV-2 (edit) 10.3390/IJMS24043478
2023-02-08 Clinical Validation of GenBody COVID-19 Ag, Nasal and Nasopharyngeal Rapid Antigen Tests for Detection of SARS-CoV-2 in European Adult Population (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES11020493 36831028
2023-02-02 Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen (edit) SARS-CoV-2 (edit) 10.3390/VACCINES11020334
2023-02-01 Inactivation of two SARS-CoV-2 virus surrogates by electron beam irradiation on large yellow croaker slices and their packaging surfaces (edit) SARS-CoV-2 (edit) 10.1016/J.FOODCONT.2022.109340
2023-02-01 Global asymptotic stability, extinction and ergodic stationary distribution in a stochastic model for dual variants of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MATCOM.2022.08.012
2023-02-01 Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients (edit) SARS-CoV-2 (edit) 10.1016/S2666-6367(23)00500-6
2023-02-01 Co-testing a single sputum specimen for TB and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.5588/IJTLD.22.0404
2023-02-01 Indicators of Cardiometabolic Function in Pregnancy and Long-Term Risk of COVID-19: Population-Based Cohort Study (edit) SARS-CoV-2 (edit) 10.7759/CUREUS.35325 36968929
2023-01-31 Reconocimiento de la presencia de sars-cov-2 en pulmones a través de imágenes de radiodiagnóstico haciendo uso de Machine Learning con Python (edit) SARS-CoV-2 (edit) 10.56712/LATAM.V4I1.296
2023-01-30 Performance Evaluation of Different RT-PCR Kits for the Direct Detection of SARS-CoV-2 in Preheated Specimens (edit) SARS-CoV-2 (edit) 10.1055/S-0043-1760752
2023-01-26 Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2023.1092910
2023-01-25 Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS11020312
2023-01-24 PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1016/J.JACC.2022.10.030 36653090
2023-01-13 Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAC796 36196614
2023-01-07 Anti-SARS-CoV-2 IgG ELISA: Replacing the Absorbance Plate Reader by a Regular Scanner with Open-Source Software (edit) SARS-CoV-2 (edit) 10.3390/PR11010194
2023-01-06 Patient Care Satisfaction and Emergency Room Utilization among Young Adult Colorectal Cancer Survivors during the SARS-CoV-2 Pandemic: Lessons Learned (edit) SARS-CoV-2 (edit) 10.3390/JCM12020469
2023-01-03 Assessment of a SARS-CoV-2 wastewater monitoring program in El Paso, Texas, from November 2020 to June 2022 (edit) SARS-CoV-2 (edit) 10.1080/09603123.2022.2159017
2023-01-02 Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave (edit) SARS-CoV-2 (edit) 10.1038/S41591-022-02138-X
2023-01-01 Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5–11 years (edit) SARS-CoV-2 (edit) 10.1016/J.AMJOTO.2022.103669
2023-01-01 PS-C16-11: PREVALENCE AND HOSPITAL OUTCOME OF BACTERIAL CO-INFECTION IN RESPIRATORY TRACT SPECIMEN AMONG COVID 19 PATIENTS WITH SARS-COV-2 PNEUMONIA (edit) SARS-CoV-2 (edit) 10.1097/01.HJH.0000915116.70234.A3
2023-01-01 Postmortem detectability and viability of SARS-COV-2 virus in various biological specimens (edit) SARS-CoV-2 (edit) 10.2298/SARH220118014P
2023-01-01 Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2023.1123724 36845156
2023-01-01 One Health investigation of SARS-CoV-2 in people and animals on multiple mink farms in Utah (edit) SARS-CoV-2 (edit) 10.3390/V15010096
2023-01-01 SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology (edit) SARS-CoV-2 (edit) 10.4103/1673-5374.346486
2022-12-29 LARGE-SCALE SCREENING FOR SARS-COV-2 INFECTION IN ENT PATIENTS DURING THE COVID-19 PANDEMIC (edit) SARS-CoV-2 (edit) 10.17430/JHS.2022.12.4.3
2022-12-23 Rapid Detection of SARS-CoV-2 RNA in Human Nasopharyngeal Specimens Using Surface-Enhanced Raman Spectroscopy and Deep Learning Algorithms (edit) SARS-CoV-2 (edit) 10.1021/ACSSENSORS.2C02194
2022-12-22 The presence of SARS-CoV-2 in multiple clinical specimens of a fatal case of COVID-19: a case report (edit) SARS-CoV-2 (edit) 10.1186/S13256-022-03706-Y
2022-12-21 Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02196-22 36350127
2022-12-14 SARS-CoV-2 infection and persistence in the human body and brain at autopsy (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-05542-Y
2022-12-12 Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-35225-1
2022-12-12 SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City (edit) SARS-CoV-2 (edit) 10.3390/V14122770
2022-12-12 Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs after Vaccination (DANTE-SIRIO 7) Study in a Large Cohort of Healthcare Workers (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10122125 36560536
2022-12-03 Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion (edit) SARS-CoV-2 (edit) 10.3390/IJMS232315264 36499592
2022-12-02 RETRACTED: Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ADD8737
2022-12-01 Zonal modeling of air distribution impact on the long-range airborne transmission risk of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.APM.2022.08.027
2022-12-01 Impedimetric and amperometric genosensors for the highly sensitive quantification of SARS-CoV-2 nucleic acid using an avidin-functionalized multi-walled carbon nanotubes biocapture platform (edit) SARS-CoV-2 (edit) 10.1016/J.BIOSX.2022.100222
2022-12-01 Evaluation of SARS-CoV-2 concentrations in wastewater and river water samples (edit) SARS-CoV-2 (edit) 10.1016/J.CSCEE.2022.100214
2022-12-01 Is the virus-laden standing water change the transmission intensity of SARS-CoV-2 after precipitation? A framework for empirical studies (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2022.114127
2022-12-01 Computational investigation of potent inhibitors against SARS-CoV-2 2′-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2022.108306
2022-12-01 Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents (edit) SARS-CoV-2 (edit) 10.1016/J.JVACX.2022.100211
2022-12-01 Beyond COVID-19: Do biothermodynamic properties allow predicting the future evolution of SARS-CoV-2 variants? (edit) SARS-CoV-2 (edit) 10.1016/J.MRAN.2022.100232
2022-12-01 A standardized instrument quantifying risk factors associated with bi-directional transmission of SARS-CoV-2 and other zoonotic pathogens: The COVID-19 human-animal interactions survey (CHAIS) (edit) SARS-CoV-2 (edit) 10.1016/J.ONEHLT.2022.100422
2022-12-01 Fractal–fractional age-structure study of omicron SARS-CoV-2 variant transmission dynamics (edit) SARS-CoV-2 (edit) 10.1016/J.PADIFF.2022.100455
2022-12-01 Impact of SARS-CoV-2 variants on mobility and air pollution in the United Kingdom (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.158279
2022-12-01 Application of a high-throughput quantitative PCR system for simultaneous monitoring of SARS-CoV-2 variants and other pathogenic viruses in wastewater (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.158659
2022-12-01 Highly valued despite burdens: Qualitative implementation research on rapid tests for hospital-based SARS-CoV-2 screening (edit) SARS-CoV-2 (edit) 10.1016/J.SSMQR.2022.100140
2022-12-01 Protocol to quantify and phenotype SARS-CoV-2-specific T cell response using a rapid flow-cytometry-based whole blood assay (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2022.101771
2022-12-01 Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein (edit) SARS-CoV-2 (edit) 10.1080/13880209.2022.2063341 35594385
2022-12-01 ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/21505594.2021.2019959 34967260
2022-12-01 Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.2008775 34818119
2022-12-01 A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain) (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.2011617 34842496
2022-12-01 A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.2011623 34836485
2022-12-01 Two novel human coronavirus OC43 genotypes circulating in hospitalized children with pneumonia in China (edit) Human coronavirus OC43 (edit) 10.1080/22221751.2021.2019560 34907853
2022-12-01 Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.2022440 34935594
2022-12-01 Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents (edit) SARS-CoV-2 (edit) 10.1080/22221751.2022.2031311 35060426
2022-12-01 Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity (edit) SARS-CoV-2 (edit) 10.1080/22221751.2022.2054369 35293847
2022-12-01 Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS (edit) SARS-CoV-2 (edit) 10.1080/22221751.2022.2081615 35603455
2022-12-01 Comparison of Dose–Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19 (edit) SARS-CoV-2 (edit) 10.1089/JAMP.2022.0043
2022-12-01 The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination—lessons learned from the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1093/CEI/UXAC113
2022-12-01 1880. Detection of Infectious SARS-CoV-2 in Specimens with High CT Values Is More Common for Omicron than for Delta Variants (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAC492.1507
2022-12-01 Next-Day Discharge after Kidney Transplant During the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.6002/ECT.2021.0309
2022-11-30 Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266336
2022-11-30 Detection of Respiratory Viruses in SARS-CoV-2-Negative Specimens from January to March 2020 in Fukuoka, Japan (edit) SARS-CoV-2 (edit) 10.7883/YOKEN.JJID.2022.079
2022-11-26 Optimal control strategies of SARS-CoV-2 Omicron supported by invasive and dynamic models (edit) SARS-CoV-2 (edit) 10.1186/S40249-022-01039-Y
2022-11-26 Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer (edit) SARS-CoV-2 (edit) 10.3390/CIMB44120400
2022-11-23 Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.80329
2022-11-18 Perception of Local COVID-19 Transmission and Use of Preventive Behaviors Among Adults with Recent SARS-CoV-2 Infection - Illinois and Michigan, June 1-July 31, 2022 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7146A2 36395064
2022-11-18 Diagnosis of SARS-CoV-2 during the Pandemic by Multiplex RT-rPCR hCoV Test: Future Perspectives (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS11111378
2022-11-18 Long-term Follow-up Results of Tinnitus and Dizziness Disorders in Patients after SARS-CoV-2 Infection Based on a Questionnaire (edit) SARS-CoV-2 (edit) 10.4274/BALKANMEDJ.GALENOS.2022.2022-7-8
2022-11-15 Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients (edit) SARS-CoV-2 (edit) 10.1182/BLOOD-2022-158716
2022-11-12 Post-Viral Olfactory Loss: What We Learned from the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.3390/LIFE12111868
2022-11-11 Imprinted antibody responses against SARS-CoV-2 Omicron sublineages (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ADC9127
2022-11-10 Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of Escherichia coli (edit) SARS-CoV-2 (edit) 10.3390/BIOENGINEERING9110670
2022-11-03 Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year retrospective cohort study (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-23235-4
2022-11-03 Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021–22: a status-based multi-variant model (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07821-5
2022-11-02 Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0275823
2022-11-01 Virus replication and competition in a cell culture: Application to the SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.AML.2022.108217
2022-11-01 Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2022.09.010
2022-11-01 Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay (edit) SARS-CoV-2 (edit) 10.1016/J.DIAGMICROBIO.2022.115788
2022-11-01 “Ventilator-free days” composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis (edit) SARS-CoV-2 (edit) 10.1016/J.HRTLNG.2022.06.024
2022-11-01 Exploring the anti-SARS-CoV-2 main protease potential of FDA approved marine drugs using integrated machine learning templates as predictive tools (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2022.09.086
2022-11-01 Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.IJCARD.2022.07.018
2022-11-01 Carlina oxide inhibits the interaction of SARS-CoV-2 S glycoprotein with angiotensin-converting enzyme 2 (edit) SARS-CoV-2 (edit) 10.1016/J.INDCROP.2022.115338
2022-11-01 Bioinformatics pipeline unveils genetic variability to synthetic vaccine design for Indian SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1016/J.INTIMP.2022.109224
2022-11-01 Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study (edit) SARS-CoV-2 (edit) 10.1016/J.JINF.2022.09.004
2022-11-01 Macro-level drivers of SARS-CoV-2 transmission: A data-driven analysis of factors contributing to epidemic growth during the first wave of outbreaks in the United States (edit) SARS-CoV-2 (edit) 10.1016/J.SSTE.2022.100539
2022-11-01 Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198915
2022-11-01 The Assessment of the Diagnostic Accuracy of Antigen-Detecting Rapid Diagnostic Test using Nasopharyngeal Swab Specimen in Detecting SARS-CoV-2 among Patients in a Private Hospital in Bulacan, Philippines (edit) SARS-CoV-2 (edit) 10.1093/AJCP/AQAC126.302
2022-11-01 Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept (edit) SARS-CoV-2 (edit) 10.1515/CCLM-2022-0873
2022-11-01 The Absence of Permanent Sensorineural Hearing Loss in a Cohort of Children with SARS-CoV-2 Infection and the Importance of Performing the Audiological “Work-Up” (edit) SARS-CoV-2 (edit) 10.3390/CHILDREN9111681
2022-10-31 Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study (edit) SARS-CoV-2 (edit) 10.3390/V14112416 36366515
2022-10-29 Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay (edit) SARS-CoV-2 (edit) 10.3390/V14112401
2022-10-27 Managing Complexity: The Experience of an Italian Internal Medicine Unit During the SARS-CoV-2 Pandemic, Looking to the Future (edit) SARS-CoV-2 (edit) 10.1007/S42399-022-01320-Z
2022-10-27 Air travel and SARS-CoV-2: many remaining knowledge gaps (edit) SARS-CoV-2 (edit) 10.1093/JTM/TAAC123
2022-10-27 Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes (edit) SARS-CoV-2 (edit) 10.3390/V14112367
2022-10-26 A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-22921-7
2022-10-26 Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01315-22 36121252
2022-10-26 Erratum for Nikiforuk et al., "Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response" (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.03376-22 36214688
2022-10-26 SARS-CoV-2: Searching for the Missing Variants (edit) SARS-CoV-2 (edit) 10.3390/V14112364
2022-10-25 A Timeframe for SARS-CoV-2 Genomes: A Proof of Concept for Postmortem Interval Estimations (edit) SARS-CoV-2 (edit) 10.3390/IJMS232112899
2022-10-24 SARS-CoV-2 Is Not Special, but the Pandemic Is: The Ecology, Evolution, Policy, and Future of the Deadliest Pandemic in Living Memory (edit) SARS-CoV-2 (edit) 10.1146/ANNUREV-ANTHRO-041420-100047
2022-10-22 Targeting an evolutionarily conserved “E-L-L” motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC198 36712339
2022-10-21 Erratum for the Research Article “Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome,” by P. R. Bhatt et al (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ADF3953
2022-10-20 Lack of evidence of viability and infectivity of SARS-CoV-2 in the fecal specimens of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.1030249
2022-10-15 Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-33899-1 36243713
2022-10-15 Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.3390/BIOM12101488 36291697
2022-10-12 SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical-pathologic correlations (edit) SARS-CoV-2 (edit) 10.1016/J.AJOG.2022.10.001 36243041
2022-10-12 Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-33801-Z
2022-10-11 Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2022.17876
2022-10-10 Dysphagia in the Presence of Varicella-Zoster Virus and SARS-CoV-2: A Case Report on the Role of Speech-Language Pathology (edit) SARS-CoV-2 (edit) 10.1044/2022_PERSP-22-00070
2022-10-10 Occupational characteristics associated with SARS-CoV-2 infection in the UK Biobank during August-November 2020: a cohort study (edit) SARS-CoV-2 (edit) 10.1186/S12889-022-14311-5
2022-10-10 Lifestyle changes during the SARS-CoV-2 pandemic confinement in Europe: a systematic review (edit) SARS-CoV-2 (edit) 10.53519/ANALESRANF.2022.88.03.03
2022-10-07 The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-33632-Y
2022-10-06 Risk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC223 36712338
2022-10-05 Diversified Effects of COVID-19 as a Consequence of the Differential Metabolism of Phospholipids and Lipid Peroxidation Evaluated in the Plasma of Survivors and Deceased Patients upon Admission to the Hospital (edit) SARS-CoV-2 (edit) 10.3390/IJMS231911810 36233111
2022-10-04 Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution (edit) SARS-CoV-2 (edit) 10.1101/2022.09.15.507787
2022-10-04 Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.985938
2022-10-01 A fast, ultrasensitive SERS immunoassay to detect SARS-CoV-2 in saliva (edit) SARS-CoV-2 (edit) 10.1016/J.ACA.2022.340290
2022-10-01 Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? (edit) SARS-CoV-2 (edit) 10.1016/J.BIOPHA.2022.113534
2022-10-01 Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.BIOTECHADV.2022.107986
2022-10-01 A geometric deep learning model for display and prediction of potential drug-virus interactions against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CHEMOLAB.2022.104640
2022-10-01 Persistence of SARS-CoV-2 on surfaces and relevance to the food industry (edit) SARS-CoV-2 (edit) 10.1016/J.COFS.2022.100875
2022-10-01 Single-particle detection of native SARS-CoV-2 virions by microfluidic resistive pulse sensing (edit) SARS-CoV-2 (edit) 10.1016/J.COLSURFB.2022.112716
2022-10-01 Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105969
2022-10-01 Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.106035
2022-10-01 Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.DRUDIS.2022.07.015
2022-10-01 Association between long-term exposure to particulate air pollution with SARS-CoV-2 infections and COVID-19 deaths in California, U.S.A (edit) SARS-CoV-2 (edit) 10.1016/J.ENVADV.2022.100270
2022-10-01 Wastewater-based epidemiological surveillance to monitor the prevalence of SARS-CoV-2 in developing countries with onsite sanitation facilities (edit) SARS-CoV-2 (edit) 10.1016/J.ENVPOL.2022.119679
2022-10-01 Genetic sequencing detected the SARS-CoV-2 delta variant in wastewater a month prior to the first COVID-19 case in Ahmedabad (India) (edit) SARS-CoV-2 (edit) 10.1016/J.ENVPOL.2022.119757
2022-10-01 Comment to the article by Pedro Brotons: Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples, IJID 110 (2021) 363–370 (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.08.005
2022-10-01 Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence (edit) SARS-CoV-2 (edit) 10.1016/J.IJSU.2022.106903
2022-10-01 Detecting time-evolving phenotypic components of adverse reactions against BNT162b2 SARS-CoV-2 vaccine via non-negative tensor factorization (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.105237
2022-10-01 SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis (edit) SARS-CoV-2 (edit) 10.1016/J.JAUT.2022.102906
2022-10-01 Docking and molecular dynamics studies of human ezrin protein with a modelled SARS-CoV-2 endodomain and their interaction with potential invasion inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.JKSUS.2022.102277
2022-10-01 SARS-CoV-2 vaccination in haemodialysis patients: Insides from a prospective study comparing mRNA and viral vector vaccines (edit) SARS-CoV-2 (edit) 10.1016/J.LANEPE.2022.100491
2022-10-01 Tailored lipopeptide surfactants as potentially effective drugs to treat SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110948
2022-10-01 Wastewater-based epidemiology in countries with poor wastewater treatment — Epidemiological indicator function of SARS-CoV-2 RNA in surface waters (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.156964
2022-10-01 Good and bad get together: Inactivation of SARS-CoV-2 in particulate matter pollution from different fuels (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.157241
2022-10-01 Eco-friendly stability-indicating HPTLC micro-determination of the first FDA approved SARS-CoV-2 antiviral prodrug Remdesivir: Study of degradation kinetics and structural elucidation of the degradants using HPTLC-MS (edit) SARS-CoV-2 (edit) 10.1016/J.SCP.2022.100744
2022-10-01 Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers (edit) SARS-CoV-2 (edit) 10.1016/J.THROMRES.2022.08.005
2022-10-01 Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors (edit) SARS-CoV-2 (edit) 10.1016/J.THROMRES.2022.08.021
2022-10-01 Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2022.100781
2022-10-01 Ethics and governance challenges related to genomic data sharing in southern Africa: the case of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/S2214-109X(22)00417-X
2022-10-01 Reported exposures among in-person workers with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in 6 states, September 2020-June 2021 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAC486 35717638
2022-10-01 The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010882 36191037
2022-10-01 GPS tracking of free-roaming cats (Felis catus) on SARS-CoV-2-infected mink farms in Utah (edit) SARS-CoV-2 (edit) 10.3390/V14102131 36298686
2022-09-30 Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/IJMS231911589 36232891
2022-09-26 High-yield production in Escherichia coli and convenient purification of a candidate vaccine against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S10529-022-03298-Z
2022-09-24 Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study (edit) SARS-CoV-2 (edit) 10.3390/PHARMACEUTICS14102042
2022-09-22 An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010828
2022-09-21 Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold Values (edit) SARS-CoV-2 (edit) 10.1128/JCM.00501-22
2022-09-20 Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S00449-022-02788-8
2022-09-20 Alterations of the Antioxidant and Inflammatory Response of the Peripheral Blood Granulocytes to SARS-CoV-2 Infection in the Deceased COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.20944/PREPRINTS202209.0298.V1
2022-09-20 Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment (edit) SARS-CoV-2 (edit) 10.3390/V14102087
2022-09-19 'Like building a plane and flying it all in one go': an interview study of infection prevention and control in Australian general practice during the first 2 years of the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2022-061513 36123071
2022-09-19 Barriers to SARS-CoV-2 Testing among U.S. Employers in the COVID-19 Pandemic: A Qualitative Analysis Conducted January through April 2021 (edit) SARS-CoV-2 (edit) 10.3390/IJERPH191811805 36142077
2022-09-17 Predicting onset risk of COVID-19 symptom to support healthy travel route planning in the new normal of long-term coexistence with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1177/23998083221127703
2022-09-16 Outbreak of SARS-CoV-2 B.1.617.2 (Delta Variant) in a Youth Camp Associated With Community Spread, Nebraska, June–July 2021 (edit) SARS-CoV-2 (edit) 10.1177/00333549221123582
2022-09-15 When the Dust Has Settled: Calculation of Binding Affinities from First Principles for SARS-CoV-2 Variants with Quantitative Accuracy (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.2C00604
2022-09-15 Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants (edit) SARS-CoV-2 (edit) 10.1099/MGEN.0.000859
2022-09-15 The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10091537
2022-09-14 Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay (edit) SARS-CoV-2 (edit) 10.1007/S12033-022-00563-4
2022-09-14 Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2209651
2022-09-14 Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1080/22221751.2022.2109515
2022-09-14 Synthesis of Novel N4-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents (edit) SARS-CoV-2 (edit) 10.3390/PH15091144
2022-09-13 Quantum chemical studies on the binding domain of SARS-CoV-2 S-protein: human ACE2 interface complex (edit) SARS-CoV-2 (edit) 10.1080/07391102.2022.2120537
2022-09-13 SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.945317
2022-09-13 Single-cell sequencing of brain tissues reveal the central nervous system’s susceptibility to SARS-CoV-2 and the drug (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2022.971017
2022-09-13 Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/JCM11185369
2022-09-12 Chemoenzymatic Synthesis of SARS-CoV-2 Homogeneous O-Linked Glycopeptides for Exploring Their Inhibition Functions (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.2C00383
2022-09-12 Development of a Deep Learning Generative Neural Network for Computer-Aided Design of Potential SARS-Cov-2 Inhibitors (edit) SARS-CoV-2 (edit) 10.17537/2022.17.188
2022-09-09 IMM-BCP-01, a patient-derived anti–SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2 (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABL9943
2022-09-09 Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19 (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ADD4906
2022-09-09 SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0274509
2022-09-09 Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens — San Francisco Bay Area, California, July 2021—March 2022 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7136A3
2022-09-09 Tracing the trajectories of SARS-CoV-2 variants of concern between December 2020 and September 2021 in the Canary Islands (Spain) (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.919346
2022-09-09 Epidemiological and Serological Analysis of a SARS-CoV-2 Outbreak in a Nursing Home: Impact of SARS-CoV-2 Vaccination and Enhanced Neutralizing Immunity Following Breakthrough Infection (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS10091809
2022-09-09 A Quantitative ELISA to Detect Anti-SARS-CoV-2 Spike IgG Antibodies in Infected Patients and Vaccinated Individuals (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS10091812
2022-09-08 mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.953949
2022-09-08 Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.954093 36159791
2022-09-07 Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-18912-3
2022-09-07 Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2210546
2022-09-07 Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01219-22
2022-09-07 Murine Hepatitis Virus, a Biosafety Level 2 Model for SARS-CoV-2, Can Remain Viable on Meat and Meat Packaging Materials for at Least 48 Hours (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01862-22
2022-09-06 Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.2C04225
2022-09-06 Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-32786-Z
2022-09-06 Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex (edit) SARS-CoV-2 (edit) 10.1161/CIRCULATIONAHA.122.059970
2022-09-05 The Impact of SARS-CoV-2 Variants on the Clinical Phenotype and Severity of Multisystem Inflammatory Syndrome in Children in South Africa (edit) SARS-CoV-2 (edit) 10.1097/INF.0000000000003691
2022-09-05 Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.72896.2
2022-09-05 Levantamento bibliográfico do mecanismo de desenvolvimento de Diabetes Mellitus tipo II após infeção pelo SARS-COV-2 (edit) SARS-CoV-2 (edit) 10.33448/RSD-V11I12.33999
2022-09-05 Benchmark datasets for SARS-CoV-2 surveillance bioinformatics (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.13821
2022-09-02 Impact of SARS-CoV-2 Delta and Omicron variants on viral burden and cycle threshold in BNT162b2-vaccinated 12–18 years group (edit) SARS-CoV-2 (edit) 10.1007/S42770-022-00820-3
2022-09-02 Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.915001
2022-09-02 SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.919958
2022-09-02 Predicting the Kinetic Coordination of Immune Response Dynamics in SARS-CoV-2 Infection: Implications for Disease Pathogenesis (edit) SARS-CoV-2 (edit) 10.3390/MATH10173154
2022-09-02 Łysienie telogenowe jako przejaw zakażenia SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.5603/FD.A2022.0025
2022-09-01 Association of masking policies with mask adherence and distancing during the SARS-COV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.AJIC.2022.04.010
2022-09-01 COVID-19 clusters in a teaching hospital during the second wave of the SARS-CoV-2 pandemic in France: A descriptive study and lessons learned for waves to come (edit) SARS-CoV-2 (edit) 10.1016/J.AJIC.2022.06.018
2022-09-01 Can SARS-CoV-2 positive pregnant women affect the hearing of their newborns: A systematic review (edit) SARS-CoV-2 (edit) 10.1016/J.AMJOTO.2022.103523
2022-09-01 SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations (edit) SARS-CoV-2 (edit) 10.1016/J.ARR.2022.101687
2022-09-01 Depressive symptoms predict antibody titers after a second dose of the SARS-CoV-2 BNT162b2 vaccine among hospital workers in Japan (edit) SARS-CoV-2 (edit) 10.1016/J.BBI.2022.09.004
2022-09-01 Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase (edit) SARS-CoV-2 (edit) 10.1016/J.BBIH.2022.100511
2022-09-01 Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission (edit) SARS-CoV-2 (edit) 10.1016/J.BIOMATERIALS.2022.121671 35953331
2022-09-01 FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances (edit) SARS-CoV-2 (edit) 10.1016/J.BIOSX.2022.100158
2022-09-01 Role of the coronary and non-coronary cardiovascular findings on non-cardiac gated thoracic CT in predicting mortality in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CLINIMAG.2022.06.002
2022-09-01 SARS-CoV-2 infection showing signs of cerebral sinus vein thrombosis in the infantile period (edit) SARS-CoV-2 (edit) 10.1016/J.DSCB.2022.100051
2022-09-01 Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2022.104248
2022-09-01 Lockdowns exert selection pressure on overdispersion of SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.EPIDEM.2022.100613 35939969
2022-09-01 Predicting the dispersal of SARS-CoV-2 RNA from the wastewater treatment plant to the coast (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2022.E10547
2022-09-01 Before blaming SARS-CoV-2 for intra-cerebral aneurysm formation and rupture, alternative mechanisms need to be ruled out (edit) SARS-CoV-2 (edit) 10.1016/J.HEST.2022.09.001
2022-09-01 Considering the precautionary principle and its application to MRSA and SARS-CoV-2 as emerging novel pathogens of their time (edit) SARS-CoV-2 (edit) 10.1016/J.IDH.2022.08.003
2022-09-01 TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.05.051
2022-09-01 SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104959
2022-09-01 Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection? (edit) SARS-CoV-2 (edit) 10.1016/J.NEFRO.2021.09.001
2022-09-01 New insights on circular RNAs and their potential applications as biomarkers, therapeutic agents, and preventive vaccines in viral infections: with a glance at SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.OMTN.2022.08.012
2022-09-01 UV 254 nm is more efficient than UV 222 nm in inactivating SARS-CoV-2 present in human saliva (edit) SARS-CoV-2 (edit) 10.1016/J.PDPDT.2022.103015 35843562
2022-09-01 Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations (edit) SARS-CoV-2 (edit) 10.1016/J.PULMOE.2021.03.003
2022-09-01 Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers (edit) SARS-CoV-2 (edit) 10.1016/J.REC.2021.11.001
2022-09-01 Afección pericárdica y miocárdica tras infección por SARS-CoV-2: estudio descriptivo transversal en trabajadores sanitarios (edit) SARS-CoV-2 (edit) 10.1016/J.RECESP.2021.10.021
2022-09-01 Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(22)00307-3
2022-09-01 Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research (edit) SARS-CoV-2 (edit) 10.1016/S2213-2600(22)00182-5
2022-09-01 Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City (edit) SARS-CoV-2 (edit) 10.1016/S2665-9913(22)00190-4
2022-09-01 Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1038/S41576-022-00483-8 35459859
2022-09-01 Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-05049-6 35798029
2022-09-01 Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-05189-9 35952714
2022-09-01 Probing the mutational landscape of the SARS-CoV-2 spike protein via quantum mechanical modeling of crystallographic structures (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC180 36712320
2022-09-01 Subtyping of major SARS-CoV-2 variants reveals different transmission dynamics based on 10 million genomes (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC181 36714842
2022-09-01 Estimating R0 from early exponential growth: parallels between 1918 influenza and 2020 SARS-CoV-2 pandemics (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC194 36714850
2022-09-01 Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC197 36714870
2022-09-01 Curating a knowledge base for individuals with coinfection of HIV and SARS-CoV-2: a study protocol of EHR-based data mining and clinical implementation (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2022-067204
2022-09-01 Effect of SARS-CoV-2 infection in neonates or in pregnancy on developmental outcomes at 21–24 months (SINEPOST): study protocol for a prospective cohort study (edit) SARS-CoV-2 (edit) 10.1136/BMJPO-2022-001571
2022-09-01 Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases (edit) SARS-CoV-2 (edit) 10.1136/RMDOPEN-2022-002622
2022-09-01 A Study on the Fractal-Fractional Epidemic Probability-Based Model of SARS-CoV-2 Virus along with the Taylor Operational Matrix Method for Its Caputo Version (edit) SARS-CoV-2 (edit) 10.1155/2022/2388557
2022-09-01 SARS-CoV-2 reinfections during the Delta and Omicron waves (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.162007
2022-09-01 Pre-Illness Training And Acute Symptom Clusters Predict Prolonged Return-To-Play In Athletes After Recent SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1249/01.MSS.0000882600.84039.EA
2022-09-01 Mitigation of the biosafety risks of SARS-CoV-2 at BSL-3 laboratories (edit) SARS-CoV-2 (edit) 10.15312/EURASIANJVETSCI.2021.344
2022-09-01 Psychopathological Symptoms Among Chronically Ill Patients During SARS-CoV-2 Pandemic in Poland (edit) SARS-CoV-2 (edit) 10.2147/PRBM.S362918
2022-09-01 TARGETING THE MAIN PROTEASE AND THE SPIKE PROTEIN OF SARS-COV-2 WITH NATURALLY OCCURRING COMPOUNDS FROM SOME CAMEROONIAN MEDICINAL PLANTS: AN IN-SILICO STUDY FOR DRUG DESIGNING (edit) SARS-CoV-2 (edit) 10.4067/S0717-97072022000305602
2022-08-31 Symptomatic and Asymptomatic Transmission of SARS-CoV-2 in K-12 Schools, British Columbia, Canada April to June 2021 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00622-22 35862938
2022-08-31 Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02495-21
2022-08-31 Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0273489 36044431
2022-08-31 The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients (edit) SARS-CoV-2 (edit) 10.3390/JPM12091420
2022-08-30 Author Correction: Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-19152-1
2022-08-30 A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry (edit) SARS-CoV-2 (edit) 10.1128/MBIO.01485-22
2022-08-29 Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.2C02794
2022-08-29 SARS-CoV-2 Surface Swabs in Locations With Public Access—Potential for Improved Source Control (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAC431
2022-08-29 Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2022-062567 36038173
2022-08-29 In Silico Evaluation of Sesquiterpenes and Benzoxazinoids Phytotoxins against Mpro, RNA Replicase and Spike Protein of SARS-CoV-2 by Molecular Dynamics. Inspired by Nature (edit) SARS-CoV-2 (edit) 10.3390/TOXINS14090599
2022-08-28 Ergonomic Factors That Impact Job Satisfaction and Occupational Health during the SARS-CoV-2 Pandemic Based on a Structural Equation Model: A Cross-Sectional Exploratory Analysis of University Workers (edit) SARS-CoV-2 (edit) 10.3390/IJERPH191710714
2022-08-26 The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABP8337 35881005
2022-08-26 Wildlife trade is likely the source of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ADD8384
2022-08-26 Seasonal variation in SARS-CoV-2 transmission in temperate climates: A Bayesian modelling study in 143 European regions (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010435
2022-08-26 SARS-CoV-2 PCR positivity in elementary school classes in Bavaria in the school year 2021/22—initial results from the evaluation of the Bavarian pool test project in elementary and special schools (edit) SARS-CoV-2 (edit) 10.3238/ARZTEBL.M2022.0310
2022-08-26 A bibliometric analysis of the 100 most cited articles describing SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.966847
2022-08-25 Computational Pipeline for Reference-Free Comparative Analysis of RNA 3D Structures Applied to SARS-CoV-2 UTR Models (edit) SARS-CoV-2 (edit) 10.3390/IJMS23179630 36077037
2022-08-24 Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks (edit) SARS-CoV-2 (edit) 10.1080/14760584.2022.2116008
2022-08-24 Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.952916
2022-08-24 Assessment of a Computational Approach to Predict Drug Resistance Mutations for HIV, HBV and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/MOLECULES27175413
2022-08-23 The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1007/S43440-022-00394-9
2022-08-23 Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0273341
2022-08-22 Structure-Based Virtual Screening, Docking, ADMET, Molecular Dynamics, and MM-PBSA Calculations for the Discovery of Potential Natural SARS-CoV-2 Helicase Inhibitors from the Traditional Chinese Medicine (edit) SARS-CoV-2 (edit) 10.1155/2022/7270094
2022-08-21 The Impact of Severe COVID-19 on Plasma Antioxidants (edit) SARS-CoV-2 (edit) 10.3390/MOLECULES27165323 36014561
2022-08-19 Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC159 36111270
2022-08-18 In silico identification of novel SARS-CoV-2 main protease and non-structural protein 13 (nsp13) inhibitors through consensus docking and free binding energy calculations. (edit) SARS-CoV-2 (edit) 10.2174/1386207325666220818141112
2022-08-18 Awake Prone-Positioning in Patients on Non-Invasive Ventilation for Management of SARS-CoV-2 Pneumonia: A Systematic Review (edit) SARS-CoV-2 (edit) 10.3390/ARM90040046
2022-08-17 Multisystem Inflammatory Syndrome in Adults (MIS-A) After COVID-19 Infection and Recent Vaccination with Recombinant Adenoviral Vector Encoding the Spike Protein Antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria) (edit) SARS-CoV-2 (edit) 10.1177/08850666221121589
2022-08-17 Folic acid restricts SARS-CoV-2 invasion by methylating ACE2 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.980903
2022-08-16 Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-17953-Y
2022-08-12 Vaccines against SARS-CoV-2 variants and future pandemics (edit) SARS-CoV-2 (edit) 10.1080/14760584.2022.2110075
2022-08-12 ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABQ2679 35857703
2022-08-12 Leveraging artificial intelligence and data science techniques in harmonizing, sharing, accessing and analyzing SARS-COV-2/COVID-19 data in Rwanda (LAISDAR Project): study design and rationale (edit) SARS-CoV-2 (edit) 10.1186/S12911-022-01965-9
2022-08-12 SARS-CoV-2 Viroporins: A Multi-Omics Insight from Nucleotides to Amino Acids (edit) SARS-CoV-2 (edit) 10.3390/APPLMICROBIOL2030045
2022-08-11 Descriptive analysis of clinical and laboratory findings in relation to changes in SARS-CoV-2 viral dynamics and cyclic threshold: a retrospective, single center observational study in patients treated with Hydroxychloroquine/Azithromycin combinatio (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.28290.1
2022-08-11 Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19 (edit) SARS-CoV-2 (edit) 10.37349/EI.2022.00063
2022-08-10 An exploration on the topologies of SARS-CoV-2/human protein-protein interaction network (edit) SARS-CoV-2 (edit) 10.1080/07391102.2022.2108496
2022-08-10 Impact on Education and Ecological Footprint as a Consequence of SARS-CoV-2 in the Perception of the Quality of Teaching Engineering Students in the Brazilian Amazon (edit) SARS-CoV-2 (edit) 10.3390/SU14169891
2022-08-09 The mechanism of RNA capping by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-05185-Z 35944563
2022-08-09 Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.161045
2022-08-08 SARS-CoV-2 Transmission by Arthropod Vectors: A Scoping Review (edit) SARS-CoV-2 (edit) 10.1155/2022/4329423
2022-08-08 Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.160989
2022-08-08 Roles and functions of SARS-CoV-2 proteins in host immune evasion (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.940756
2022-08-07 Forecasting the spread of SARS-CoV-2 in the campania region using genetic programming (edit) SARS-CoV-2 (edit) 10.1007/S00500-022-07385-1
2022-08-06 Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-32357-2
2022-08-05 Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies (edit) SARS-CoV-2 (edit) 10.1038/S42003-022-03739-5
2022-08-04 SARS-CoV-2 Transmission Potential and Policy Changes in South Carolina, February 2020 – January 2021 (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.212
2022-08-04 Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-17542-Z
2022-08-03 The Microalgal Diatoxanthin Inflects the Cytokine Storm in SARS-CoV-2 Stimulated ACE2 Overexpressing Lung Cells (edit) SARS-CoV-2 (edit) 10.3390/ANTIOX11081515
2022-08-02 Mixed-methods process evaluation of a residence-based SARS-CoV-2 testing participation pilot on a UK university campus during the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1186/S12889-022-13792-8
2022-08-01 Maternal fructose intake reinforces the effects of a Western-type diet in promoting SARS-CoV-2 cell entry factors in male offspring (edit) SARS-CoV-2 (edit) 10.1016/J.ATHEROSCLEROSIS.2022.06.840
2022-08-01 Amphiphilic anti-SARS-CoV-2 drug remdesivir incorporates into the lipid bilayer and nerve terminal membranes influencing excitatory and inhibitory neurotransmission (edit) SARS-CoV-2 (edit) 10.1016/J.BBAMEM.2022.183945
2022-08-01 Persistently positive PCR SARS-CoV-2 at low cycle threshold in an immunosuppressed patient (edit) SARS-CoV-2 (edit) 10.1016/J.BJID.2022.102696
2022-08-01 Elucidation of correlation between SARS-CoV-2 RdRp and N gene cycle threshold (Ct) by RT-PCR with age and gender (edit) SARS-CoV-2 (edit) 10.1016/J.CCA.2022.06.008
2022-08-01 Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.08.024
2022-08-01 Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay (edit) SARS-CoV-2 (edit) 10.1016/J.CELLIN.2022.100046
2022-08-01 Speed and need: twin development challenges in rapid response for a SARS-CoV-2 antibody cocktail (edit) SARS-CoV-2 (edit) 10.1016/J.COPBIO.2022.102715 35447504
2022-08-01 Maintaining safe office spaces to minimise risks of SARS-CoV-2 transmission (edit) SARS-CoV-2 (edit) 10.1016/J.IDH.2022.03.003
2022-08-01 Useful molecular tools for facing next pandemic events: Effective sample preparation and improved RT-PCR for highly sensitive detection of SARS-CoV-2 in wastewater environment (edit) SARS-CoV-2 (edit) 10.1016/J.IJHEH.2022.114017
2022-08-01 Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104685
2022-08-01 A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.JEMERMED.2021.10.005
2022-08-01 A study on the role of aedes mosquitoes in arboviruses and SARS-CoV-2 infection: A new challenge (edit) SARS-CoV-2 (edit) 10.1016/J.JKSUS.2022.102179
2022-08-01 Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2022.05.003
2022-08-01 Simple approximation of sample size for precise estimates of SARS-CoV-2 infection from point-seroprevalence studies (edit) SARS-CoV-2 (edit) 10.1016/J.PUHE.2022.08.008
2022-08-01 Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2022.06.010
2022-08-01 Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice (edit) SARS-CoV-2 (edit) 10.1016/J.VIRS.2022.05.006
2022-08-01 Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(22)00119-0
2022-08-01 Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(22)00420-0
2022-08-01 Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials (edit) SARS-CoV-2 (edit) 10.1016/S2213-2600(22)00131-X
2022-08-01 Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-05053-W 35790190
2022-08-01 Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1080/19490976.2022.2105609
2022-08-01 Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAC349 35937649
2022-08-01 Why do people consent to receiving SARS-CoV-2 vaccinations? A representative survey in Germany (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-060555 35981767
2022-08-01 Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies (edit) SARS-CoV-2 (edit) 10.3201/EID2808.220617
2022-08-01 Pandemic Preparedness: The Potential Advantage of Medicines That Prevent Acute Side Effects of Vaccination, SARS-CoV-2 as an Example (edit) SARS-CoV-2 (edit) 10.3390/FUTUREPHARMACOL2030019
2022-07-31 Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections (edit) SARS-CoV-2 (edit) 10.3390/DIAGNOSTICS12081852
2022-07-30 Regional disparities in SARS-CoV-2 infections by labour market indicators: a spatial panel analysis using nationwide German data on notified infections (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07643-5
2022-07-29 Immune Heterogeneity and Epistasis Explain Punctuated Evolution of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2022.07.27.22278129 35982659
2022-07-29 Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice (edit) SARS-CoV-2 (edit) 10.2147/IJN.S367494 35937077
2022-07-28 Comparing the Psychological Problems Among the Health Care Workers Across Two Waves of SARS-CoV-2 (COVID-19) Pandemic: An Observational Study from India (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.192
2022-07-28 COVID-19 (SARS-CoV-2) in Patients Treated in The Unified Health System (SUS) with Flu and Respiratory Symptoms from Three Brazilian Municipalities in the Border Region (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.195
2022-07-27 Implementation of Multi-level Interventions to Mitigate Risk of SARS-CoV-2 Delta Variant at a PUBLIC UNIVERSITY in Southern United States (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.179
2022-07-27 Low SARS-CoV-2 Antibodies in Blood Donors After the First 6 Months of COVID-19 Epidemic in the Tobruk Region, Eastern Libya (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.180
2022-07-27 Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses (edit) SARS-CoV-2 (edit) 10.1038/S41392-022-01123-7
2022-07-27 Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2203437119
2022-07-27 Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes (edit) SARS-CoV-2 (edit) 10.1128/JVI.00488-22 35758692
2022-07-27 Covariance predicts conserved protein residue interactions important for the emergence and continued evolution of SARS-CoV-2 as a human pathogen (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0270276
2022-07-27 Influencing factors for the persistence of SARS-CoV-2 (COVID-19) exposed in environmental matrices and disinfection methods: systematic review (edit) SARS-CoV-2 (edit) 10.18203/2394-6040.IJCMPH20222040
2022-07-26 Vertical Transmission of SARS-CoV-2 Infection and Miscarriage in the Second Trimester: Report of an Immunohistochemically Proven Case (edit) SARS-CoV-2 (edit) 10.3390/CLINPRACT12040061
2022-07-25 BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.882918
2022-07-23 SARS-ANI: a global open access dataset of reported SARS-CoV-2 events in animals (edit) SARS-CoV-2 (edit) 10.1038/S41597-022-01543-8
2022-07-22 Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1007/S00432-022-04185-W
2022-07-22 Crisis management checklist: lessons learned from the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1007/S44186-022-00033-0
2022-07-22 Evolution of ACE2-Independent SARS-CoV-2 Infection and Mouse Adaption After Passage in Cells Expressing Human and Mouse ACE2 (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAC063
2022-07-22 Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABN8939
2022-07-22 Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABO7896 35762884
2022-07-22 Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7129E1
2022-07-22 Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study) (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.919408
2022-07-22 Resilience and Protection of Health Care and Research Laboratory Workers During the SARS-CoV-2 Pandemic: Analysis and Case Study From an Austrian High Security Laboratory (edit) SARS-CoV-2 (edit) 10.3389/FPSYG.2022.901244
2022-07-22 An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.923815
2022-07-22 Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19158895
2022-07-22 Forecasting the Post-Pandemic Effects of the SARS-CoV-2 Virus Using the Bullwhip Phenomenon Alongside Use of Nanosensors for Disease Containment and Cure (edit) SARS-CoV-2 (edit) 10.3390/MA15145078
2022-07-22 Histopathological and Immunological Findings in the Common Marmoset Following Exposure to Aerosolized SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V14071580
2022-07-22 Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice (edit) SARS-CoV-2 (edit) 10.34133/2022/9864089
2022-07-21 The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41587-022-01382-3
2022-07-21 The importance of effect sizes when comparing cycle threshold values of SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0271808
2022-07-21 Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010686
2022-07-20 LB981 Pandemic associated chilblain-like lesions result from an inducible type 1 interferon response to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JID.2022.05.1004
2022-07-20 Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling (edit) SARS-CoV-2 (edit) 10.1016/J.LANSEA.2022.100046
2022-07-20 COVID-19 infection in patients with chronic myeloid leukemia in the Orenburg region during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.17650/1818-8346-2022-17-3-119-126
2022-07-20 Progress in Electrochemical Biosensing of SARS-CoV-2 Virus for COVID-19 Management (edit) SARS-CoV-2 (edit) 10.3390/CHEMOSENSORS10070287
2022-07-20 Development of Lateral Flow Immunochromatographic Test for Rapid Detection of SARS-CoV-2 Virus Antigens in Clinical Specimens (edit) SARS-CoV-2 (edit) 10.3390/NANO12142477
2022-07-20 The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS11070814
2022-07-19 Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2200592119
2022-07-19 SARS-CoV-2 pandemics and RSV off-season outbreaks (edit) SARS-CoV-2 (edit) 10.23822/EURANNACI.1764-1489.263
2022-07-18 Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies (edit) SARS-CoV-2 (edit) 10.1080/07391102.2022.2098821
2022-07-18 A qualitative process analysis of daily contact testing as an alternative to self-isolation following close contact with a confirmed carrier of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S12889-022-13800-X
2022-07-18 Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010330
2022-07-18 In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010733
2022-07-18 Immunogenicity and protective potential of chimeric virus-like particles containing SARS-CoV-2 spike and H5N1 matrix 1 proteins (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.967493
2022-07-18 Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V14071553
2022-07-16 Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-15930-Z
2022-07-15 Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis (edit) SARS-CoV-2 (edit) 10.1007/S12010-022-04040-1
2022-07-15 Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.910136
2022-07-15 The T Cell Epitope Landscape of SARS-CoV-2 Variants of Concern (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10071123
2022-07-14 Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.2C00404 35731933
2022-07-14 Single vs replicate Real-Time PCR SARS-CoV-2 testing: Lessons learned for effective pandemic management (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0269883
2022-07-14 Immunopathology and pulmonary complications associated with SARS-CoV-2 virus infection. Can plants help us? (edit) SARS-CoV-2 (edit) 10.53301/LW/147770
2022-07-13 Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next? (edit) SARS-CoV-2 (edit) 10.1038/S41577-022-00764-7
2022-07-13 T-cell responses to SARS-CoV-2 in unexposed South African women (edit) SARS-CoV-2 (edit) 10.12688/GATESOPENRES.13373.2
2022-07-12 Tropism of SARS-CoV-2 for human cortical astrocytes (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2122236119
2022-07-12 The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection (edit) SARS-CoV-2 (edit) 10.1128/JVI.00765-22
2022-07-11 Harnessing Natural Products by a Pharmacophore-Oriented Semisynthesis Approach for the Discovery of Potential Anti-SARS-CoV-2 Agents (edit) SARS-CoV-2 (edit) 10.1002/ANIE.202201684 35484726
2022-07-11 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198852
2022-07-11 Air dispersal of respiratory viruses other than severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and the implication on hospital infection control (edit) SARS-CoV-2 (edit) 10.1017/ICE.2022.186
2022-07-11 Neuroinvasion of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2): future risk of epilepsy (edit) SARS-CoV-2 (edit) 10.1080/00207454.2022.2100784
2022-07-11 Analysis of the docking property of host variants of hACE2 for SARS-CoV-2 in a large cohort (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009834
2022-07-09 Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198857
2022-07-09 NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS (edit) SARS-CoV-2 (edit) 10.11134/BTP.2.2022.7
2022-07-08 The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital (edit) SARS-CoV-2 (edit) 10.1016/J.PMEDR.2022.101899
2022-07-08 A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-31721-6
2022-07-08 Consequences of Transplacental Transmission of the SARS-CoV-2 Virus: A Single-Center Experience (edit) SARS-CoV-2 (edit) 10.3390/CHILDREN9071020
2022-07-07 Lack of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a healthcare worker to a cohort of immunosuppressed patients during the SARS-CoV-2 omicron variant surge, California, 2022 (edit) SARS-CoV-2 (edit) 10.1017/ICE.2022.175
2022-07-07 How Reproducible Are QM/MM Simulations? Lessons from Computational Studies of the Covalent Inhibition of the SARS-CoV-2 Main Protease by Carmofur (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.2C00286
2022-07-07 Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology (edit) SARS-CoV-2 (edit) 10.1186/S13054-022-04062-5 35799268
2022-07-07 Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.941009
2022-07-06 Clinical and epidemiological characteristics of SARS-CoV-2 Infection in Los Angeles County youth during the first year of the pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.06.040
2022-07-06 SARS-CoV-2 seroprevalence among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada (edit) SARS-CoV-2 (edit) 10.1101/2022.07.04.22277230
2022-07-06 RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00781-22
2022-07-06 Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.943407
2022-07-05 Hygiene in der Dermatologie: SARS-CoV-2 und weitere Virus-Varianten (edit) SARS-CoV-2 (edit) 10.1055/A-1703-1692
2022-07-05 Saponin and Immune Stimulant Based Gargles and Nasal Rinses: A Potential Virucidal for Preventive Management of SARS-CoV-2 Infection? (edit) SARS-CoV-2 (edit) 10.14218/ERHM.2021.00007
2022-07-04 Investigating the influence of shift work rosters on stress measured as cortisol in hair during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.PSYNEUEN.2022.105858
2022-07-04 Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2022.905197
2022-07-04 Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3390/JPM12071103
2022-07-02 Quantification of SARS-CoV-2 RNA in wastewater treatment plants mirrors the pandemic trend in Hong Kong (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.157121
2022-07-02 Importance score of SARS-CoV-2 genome predicts the death risk of COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41420-022-01100-7
2022-07-01 A surge of pediatric hepatitis: Why SARS-CoV-2 should be considered guilty until proven innocent (edit) SARS-CoV-2 (edit) 10.1016/J.AMSU.2022.103956
2022-07-01 A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.ANNEMERGMED.2022.03.009 35461719
2022-07-01 Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2022.105332
2022-07-01 T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells (edit) SARS-CoV-2 (edit) 10.1016/J.CCA.2022.05.025
2022-07-01 What SARS-CoV-2 does to our brains (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2022.06.013
2022-07-01 Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.INTIMP.2022.108697
2022-07-01 Modeling mutational effects on biochemical phenotypes using convolutional neural networks: application to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104500
2022-07-01 Vocal fold palsy after vaccination against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEDCLE.2021.12.008
2022-07-01 Parálisis de cuerda vocal tras vacunación contra el SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEDCLI.2021.12.013
2022-07-01 An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110903
2022-07-01 Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice (edit) SARS-CoV-2 (edit) 10.1016/J.VACCINE.2022.06.020
2022-07-01 CRISPR-based assays for rapid detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.YMETH.2020.10.003 33045362
2022-07-01 Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(22)01106-0
2022-07-01 Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study (edit) SARS-CoV-2 (edit) 10.1016/S0168-8278(22)01860-8
2022-07-01 Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients (edit) SARS-CoV-2 (edit) 10.1016/S0168-8278(22)01927-4
2022-07-01 Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study (edit) SARS-CoV-2 (edit) 10.1016/S2352-4642(22)00100-6
2022-07-01 Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04778-Y 35447027
2022-07-01 Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04865-0 35584773
2022-07-01 Author Correction: Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-05048-7 35798954
2022-07-01 SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC071 35860600
2022-07-01 Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC096 35799833
2022-07-01 Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19 (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC100 35909795
2022-07-01 Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC105 35899067
2022-07-01 Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study (edit) SARS-CoV-2 (edit) 10.1111/ALL.15206 34986501
2022-07-01 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry (edit) SARS-CoV-2 (edit) 10.1136/RMDOPEN-2022-002322
2022-07-01 Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru (edit) SARS-CoV-2 (edit) 10.12688/GATESOPENRES.13644.1
2022-07-01 Hematological Findings and Alteration of Oxidative Stress Markers in Hospitalized Patients with SARS-COV-2 (edit) SARS-CoV-2 (edit) 10.2478/PRILOZI-2022-0029
2022-07-01 Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021 (edit) SARS-CoV-2 (edit) 10.3201/EID2807.212605
2022-07-01 The Seroprevalence of SARS-CoV-2 IgG Antibodies in Children Hospitalized for Reasons Other Than COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/JCM11133819 35807103
2022-07-01 Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3) (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10071064
2022-06-30 A Topology-Matching Spike Protein-Capping Tetrahedral DNA Nanocrown for SARS-CoV-2 Neutralization (edit) SARS-CoV-2 (edit) 10.31635/CCSCHEM.022.202201945
2022-06-30 An Altered Metabolism in Leukocytes Showing in vitro igG Memory From SARS-CoV-2-Infected Patients (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2022.894207
2022-06-30 Is There a Correlation Between the Cycle Threshold of SARS-CoV-2 RT-PCR and the Clinical Course of COVID-19? (edit) SARS-CoV-2 (edit) 10.4274/ATFM.GALENOS.2022.97658
2022-06-29 Transmission of SARS-CoV-2 on Cold-Chain Food: Precautions Can Effectively Reduce the Risk (edit) SARS-CoV-2 (edit) 10.1007/S12560-022-09521-4
2022-06-29 Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2202092
2022-06-29 Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00913-21
2022-06-29 Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00716-22
2022-06-29 Entorhinal Cortex and Persistent Olfactory Loss in COVID-19 Patients: A Neuroanatomical Hypothesis. Comment on Fiorentino et al. Correlations between Persistent Olfactory and Semantic Memory Disorders after SARS-CoV-2 Infection. Brain Sci. 2022, 12, (edit) SARS-CoV-2 (edit) 10.3390/BRAINSCI12070850
2022-06-29 Global m6A RNA Methylation in SARS-CoV-2 Positive Nasopharyngeal Samples in a Mexican Population: A First Approximation Study (edit) SARS-CoV-2 (edit) 10.3390/EPIGENOMES6030016
2022-06-29 Contrasting Epidemiology and Population Genetics of COVID-19 Infections Defined by Multilocus Genotypes in SARS-CoV-2 Genomes Sampled Globally (edit) SARS-CoV-2 (edit) 10.3390/V14071434
2022-06-28 A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107721
2022-06-28 Putative Host-Derived Insertions in the Genomes of Circulating SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.1128/MSYSTEMS.00179-22
2022-06-27 Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics (edit) SARS-CoV-2 (edit) 10.1007/S11224-022-01999-9
2022-06-27 Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2022.105222
2022-06-27 Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March–April 2021 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAC526 35758873
2022-06-27 Estimating decay curves of neutralizing antibodies to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/IMAMMB/DQAC008
2022-06-26 Evaluation of the DiaSorin LIAISON SARS-CoV-2 antigen assay on nasopharyngeal swabs in two different SARS-CoV-2 pandemic waves in Switzerland: The impact of the Omicron variant on its performance (edit) SARS-CoV-2 (edit) 10.1016/J.JCVP.2022.100095
2022-06-25 Screening of honey bee pollen constituents against COVID-19: an emerging hot spot in targeting SARS-CoV-2-ACE-2 interaction (edit) SARS-CoV-2 (edit) 10.1080/14786419.2022.2092865
2022-06-23 Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2022.105220
2022-06-22 Time of Day of BNT162b2 COVID-19 Immunization Affects Total SARS-CoV-2 Antibody Levels but Not Neutralizing Activity (edit) SARS-CoV-2 (edit) 10.1177/07487304221100951
2022-06-21 In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein (edit) SARS-CoV-2 (edit)
2022-06-21 The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies (edit) SARS-CoV-2 (edit) 10.1128/JVI.00455-22
2022-06-20 SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry—Seattle, July 2021 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAC494
2022-06-20 SARS-CoV-2 infection and seizures: the perfect storm (edit) SARS-CoV-2 (edit) 10.31083/J.JIN2104115
2022-06-19 Cerebral vasospasm after subarachnoid hemorrhage from intracranial aneurysm rupture in SARS-CoV-2 positive patients. A retrospective review from two Bulgarian hospitals (edit) SARS-CoV-2 (edit) 10.1080/13102818.2022.2092421
2022-06-18 Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal (edit) SARS-CoV-2 (edit)
2022-06-17 QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate (edit) SARS-CoV-2 (edit)
2022-06-17 Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts (edit) SARS-CoV-2 (edit) 10.1016/J.JVIROMET.2022.114569
2022-06-17 A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-31097-7
2022-06-17 Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC062 35865361
2022-06-17 An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC091 35873792
2022-06-17 Electrostatic features for the Receptor binding domain of SARS-COV-2 wildtype and its variants. Compass to the severity of the future variants with the charge-rule (edit) SARS-CoV-2 (edit) 10.1101/2022.06.16.496458
2022-06-17 Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABM1208 35608456
2022-06-17 SARS-CoV-2: phenotype, genotype, and characterization of different variants (edit) SARS-CoV-2 (edit) 10.1186/S11658-022-00352-6
2022-06-17 Early Emergence and Dispersal of Delta SARS-CoV-2 Lineage AY.99.2 in Brazil (edit) SARS-CoV-2 (edit) 10.3389/FMED.2022.930380
2022-06-15 De Novo design of potential inhibitors against SARS-CoV-2 Mpro (edit) SARS-CoV-2 (edit)
2022-06-15 Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera (edit) SARS-CoV-2 (edit) 10.1128/JCM.00075-22
2022-06-14 Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABQ1841
2022-06-14 Spatial Sampling Design to Improve the Efficiency of the Estimation of the Critical Parameters of the SARS-CoV-2 Epidemic (edit) SARS-CoV-2 (edit) 10.2478/JOS-2022-0019
2022-06-14 SARS-CoV-2 Risk Quantification Model and Validation Based on Large-Scale Dutch Test Events (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19127238
2022-06-13 RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice (edit) SARS-CoV-2 (edit)
2022-06-13 Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq (edit) SARS-CoV-2 (edit) 10.1007/S11033-022-07545-4 35698014
2022-06-13 SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly (edit) SARS-CoV-2 (edit) 10.36519/IDCM.2022.115
2022-06-12 Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening (edit) SARS-CoV-2 (edit) 10.1007/S11030-022-10468-8 35690957
2022-06-11 Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain a conserved rational immunogenic peptide (edit) SARS-CoV-2 (edit)
2022-06-11 Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis? (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2022.167684 35700770
2022-06-11 Antibody-nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-14263-1 35690632
2022-06-10 Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history (edit) SARS-CoV-2 (edit) 10.1186/S13073-022-01066-2
2022-06-10 High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4+ T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/V14061265
2022-06-09 Seroprevalence of SARS-CoV-2 on health professionals via Bayesian estimation: a Brazilian case study before and after vaccines (edit) SARS-CoV-2 (edit)
2022-06-09 Implementation of Immuno-chemoinformatics Approaches to Construct Multi-epitope for Vaccine Development against Omicron and Delta SARS-CoV-2 Variants Implementación de enfoques inmunoquimioinformáticos para construir múltiples epítopos para la vacun (edit) SARS-CoV-2 (edit)
2022-06-09 A diminished immune response underlies age-related SARS-CoV-2 pathologies (edit) SARS-CoV-2 (edit)
2022-06-09 Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection (edit) SARS-CoV-2 (edit) 10.1016/J.STR.2022.05.020 35716662
2022-06-09 An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice (edit) SARS-CoV-2 (edit) 10.1016/J.VETMIC.2022.109491
2022-06-09 Mitigation of SARS-CoV-2 transmission at a large public university (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-30833-3
2022-06-09 Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy (edit) SARS-CoV-2 (edit) 10.1186/S12929-022-00823-0
2022-06-08 Durability analysis of the highly effective BNT162b2 vaccine against COVID-19 (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC082 35832867
2022-06-08 A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant (edit) SARS-CoV-2 (edit) 10.1128/JVI.00685-22
2022-06-08 Do SNPs in Glutathione S-Transferase-Omega Allow Predictions of the Susceptibility of Vertebrates to SARS-CoV-2? (edit) SARS-CoV-2 (edit) 10.20455/ROS.2022.C805
2022-06-08 SARS-CoV-2 Detection Limits in Swab and Gargle Samples by Comparing Antigen and RT-qPCR Testing (edit) SARS-CoV-2 (edit) 10.3390/COVID2060056
2022-06-08 SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS11060662 35745516
2022-06-07 Clinical Profiles at the Time of Diagnosis of SARS-CoV-2 Infection in Costa Rica During the Pre-vaccination Period Using a Machine Learning Approach (edit) SARS-CoV-2 (edit)
2022-06-07 Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA (edit) SARS-CoV-2 (edit)
2022-06-07 Paradoxes of pandemic infection control: Proximity, pace and care within and beyond SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.SSMQR.2022.100110
2022-06-07 A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine (edit) SARS-CoV-2 (edit) 10.1016/J.TRSL.2022.06.004 35688318
2022-06-07 Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198845
2022-06-07 Metagenomic pipeline for identifying co-infections among distinct SARS-CoV-2 variants of concern: study cases from Alpha to Omicron (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-13113-4 35672431
2022-06-06 Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases (edit) SARS-CoV-2 (edit)
2022-06-06 Classification of SARS-CoV-2 viral genome sequences using Neurochaos Learning (edit) SARS-CoV-2 (edit) 10.1007/S11517-022-02591-3
2022-06-06 Wastewater surveillance of SARS-CoV-2 in dormitories as a part of comprehensive university campus COVID-19 monitoring (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2022.113580 35671797
2022-06-06 Deleterious effects of nervous system in the offspring following maternal SARS-CoV-2 infection during the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1038/S41398-022-01985-Z
2022-06-06 Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-30878-4 35668119
2022-06-06 COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination (edit) SARS-CoV-2 (edit) 10.1098/RSIF.2021.0900 35670221
2022-06-06 Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.74443
2022-06-05 Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y (edit) SARS-CoV-2 (edit) 10.1186/S13062-022-00325-X 35658928
2022-06-05 Development of Nested PCR for SARS-CoV-2 Detection and Its Application for Diagnosis of Active Infection in Cats (edit) SARS-CoV-2 (edit) 10.3390/VETSCI9060272
2022-06-04 In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology (edit) SARS-CoV-2 (edit) 10.1007/S13258-022-01255-8 35665465
2022-06-04 Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus (edit) SARS-CoV-2 (edit) 10.1080/01652176.2022.2086718
2022-06-03 Manufacturer Signal-to-Cutoff Threshold Underestimates Cumulative Incidence of SARS-CoV-2 Infection: Evidence from the Los Angeles Firefighters Study (edit) SARS-CoV-2 (edit) 10.1093/JALM/JFAC034
2022-06-03 Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0268919
2022-06-03 The impact of pre-existing thyroid diseases on susceptibility to respiratory infections or self-reported sickness during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.20945/2359-3997000000436
2022-06-02 Identification of conserved regions from 230,163 SARS-CoV-2 genomes and their use in diagnostic PCR primer design (edit) SARS-CoV-2 (edit) 10.1007/S13258-022-01264-7 35653026
2022-06-02 Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures (edit) SARS-CoV-2 (edit) 10.1183/13993003.01881-2021 34675048
2022-06-02 Emergency SARS-CoV-2 variants of concern: rapidly direct RT-qPCR detection without RNA extraction, clinical comparison, cost-effective, and high-throughput (edit) SARS-CoV-2 (edit) 10.18632/AGING.204095
2022-06-02 A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.889643
2022-06-02 A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein (edit) SARS-CoV-2 (edit) 10.3390/IJMS23116225
2022-06-01 Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1002/IID3.634 35634961
2022-06-01 The Ministry of Religious Congregations to People Affected by the SARS-CoV-2 Coronavirus in Poland: Geographies of Care During the COVID-19 Pandemic (edit) SARS-CoV-2 (edit) 10.1007/S10943-022-01570-0 35484437
2022-06-01 Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling (edit) SARS-CoV-2 (edit) 10.1016/J.BBIOSY.2022.100042
2022-06-01 SARS-CoV-2 triggering autoimmune diseases (edit) SARS-CoV-2 (edit) 10.1016/J.CYTO.2022.155873 35461172
2022-06-01 Decontamination of SARS-CoV-2 from cold-chain food packaging provides no marginal benefit in risk reduction to food workers (edit) SARS-CoV-2 (edit) 10.1016/J.FOODCONT.2022.108845
2022-06-01 Ongoing positive selection drives the evolution of SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1016/J.GPB.2022.05.009
2022-06-01 SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2022.105153
2022-06-01 The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses (edit) SARS-CoV-2 (edit) 10.1016/J.JLR.2022.100208 35436499
2022-06-01 WITHDRAWN: Elevated histamine etiology model for most major vaccine associated adverse events including SARS-CoV-2 spike vaccines (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110893
2022-06-01 Spherical neutralizing aptamer suppresses SARS-CoV-2 Omicron escape (edit) SARS-CoV-2 (edit) 10.1016/J.NANTOD.2022.101499
2022-06-01 Perceptions of the ethical permissibility of strict travel restrictions to mitigate transmission of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.TRIP.2022.100577
2022-06-01 Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(22)00224-9
2022-06-01 IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS (edit) SARS-CoV-2 (edit) 10.1097/01.HJH.0000837180.39534.C1
2022-06-01 Relationship between SARS-CoV-2 and hearing loss: A mini-review (edit) SARS-CoV-2 (edit) 10.1177/20101058221139957
2022-06-01 The level of depressive, anxiety and obsessive-compulsive psychopathological dimensions in symptomatic versus asymptomatic SARS-CoV-2 infected pregnant women (edit) SARS-CoV-2 (edit) 10.1192/J.EURPSY.2022.1372
2022-06-01 Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon (edit) SARS-CoV-2 (edit) 10.3201/EID2806.212580
2022-05-31 In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing (edit) SARS-CoV-2 (edit)
2022-05-31 Amentoflavone derivatives significantly act towards the main protease (3CLPRO/MPRO) of SARS-CoV-2: in silico admet profiling, molecular docking, molecular dynamics simulation, network pharmacology (edit) SARS-CoV-2 (edit) 10.1007/S11030-022-10459-9 35639226
2022-05-31 Atomic-Resolution Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain (edit) SARS-CoV-2 (edit) 10.1021/JACS.2C03320 35638584
2022-05-31 High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-12032-8 35641545
2022-05-31 Mask wearing in community settings reduces SARS-CoV-2 transmission (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2119266119
2022-05-31 Genome Sequencing of Omicron Variants of SARS-CoV-2 Circulating in Bangladesh during the Third Wave of the COVID-19 Pandemic (edit) SARS-CoV-2 (edit) 10.1128/MRA.00381-22
2022-05-31 Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010160
2022-05-31 Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0268909 35639751
2022-05-31 Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0269249 35639708
2022-05-31 Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10060850
2022-05-30 Phytochemistry, biological activities and in silico molecular docking studies of Oxalis pes-caprae L. compounds against SARS-CoV-2 (edit) SARS-CoV-2 (edit)
2022-05-30 Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia (edit) SARS-CoV-2 (edit) 10.1007/S44197-022-00041-9 35635641
2022-05-30 Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104487 35677393
2022-05-30 Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia (edit) SARS-CoV-2 (edit) 10.1038/S41564-022-01135-7 35637329
2022-05-30 Cell response analysis in SARS-CoV-2 infected bronchial organoids (edit) SARS-CoV-2 (edit) 10.1038/S42003-022-03499-2 35637255
2022-05-30 Vaccines Associated Cardiac Adverse Events, Including SARS-Cov-2 Myocarditis, Elevated Histamine Etiology Hypothesis (edit) SARS-CoV-2 (edit) 10.54289/JVVD2200108
2022-05-29 Real-time allelic assays of SARS-CoV-2 variants to enhance sewage surveillance (edit) SARS-CoV-2 (edit)
2022-05-29 A subunit vaccine candidate based on the Spike protein of SARS-CoV-2 prevents infectious virus shedding in cats (edit) SARS-CoV-2 (edit) 10.1016/J.RVSC.2022.05.003
2022-05-29 Could the SARS-CoV-2 Outbreak Cause An Increase In Rickettsia Infection? North Cyprus Observation (edit) SARS-CoV-2 (edit) 10.19127/MBSJOHS.1082154
2022-05-28 GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus (edit) SARS-CoV-2 (edit) 10.1016/J.PHYMED.2022.154215
2022-05-28 Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron (edit) SARS-CoV-2 (edit) 10.1186/S12985-022-01827-W 35643510
2022-05-27 Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds (edit) SARS-CoV-2 (edit)
2022-05-27 Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110952 35675811
2022-05-27 Transmission of SARS-CoV-2 from humans to animals and potential host adaptation (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-30698-6 35624123
2022-05-27 The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABO5083 35622909
2022-05-27 Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: A modelling study (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010158
2022-05-27 Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County—Results from a Population-Based Longitudinal Study in Germany (edit) SARS-CoV-2 (edit) 10.3390/V14061168
2022-05-27 The COVID-19 pandemic: SARS-CoV-2, childhood hepatitis and monkeypox raise five new questions for the global health research community (edit) SARS-CoV-2 (edit) 10.7189/JOGH.12.01002
2022-05-26 Parsing the role of NSP1 in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit)
2022-05-26 Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant (edit) SARS-CoV-2 (edit)
2022-05-26 Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.JVIROMET.2022.114553
2022-05-26 Incidence of SARS-CoV-2 over four epidemic waves in a low-resource community in Rio de Janeiro, Brazil: A prospective cohort study (edit) SARS-CoV-2 (edit) 10.1016/J.LANA.2022.100283
2022-05-26 Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PMED.1003987 35617363
2022-05-26 Excess Mortality on Italian Small Islands during the SARS-CoV-2 Pandemic: An Ecological Study (edit) SARS-CoV-2 (edit) 10.3390/IDR14030043
2022-05-25 Single-cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection (edit) SARS-CoV-2 (edit)
2022-05-25 A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus (edit) SARS-CoV-2 (edit) 10.1007/S00253-022-11988-X 35612630
2022-05-25 SARS-CoV-2 transmission from infected owner to household dogs and cats is associated to food sharing (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.05.049 35643308
2022-05-25 Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABN3481 35613342
2022-05-25 Importance of the Precautionary Principle With Regard to the Risk of Exposure to Aerosols Containing Viral Loads of SARS-CoV-2 Present in Feces: In Perspective (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.892290
2022-05-24 SPIKES: Identification of physicochemical properties of spike proteins across diverse host species of SARS-CoV-2 (edit) SARS-CoV-2 (edit)
2022-05-24 Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro (edit) SARS-CoV-2 (edit) 10.1007/S00705-022-05483-X 35606466
2022-05-24 Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England (edit) SARS-CoV-2 (edit) 10.1017/S0950268822000966 35607808
2022-05-24 Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABQ4411
2022-05-24 The SARS-CoV-2 main protease doesn't induce cell death in human cells in vitro (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266015 35609027
2022-05-24 Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0268389 35609034
2022-05-24 Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000 (edit) SARS-CoV-2 (edit) 10.4081/JPHIA.2022.2142
2022-05-24 SARS-CoV-2 and the Vaccination Hype (edit) SARS-CoV-2 (edit) 10.56098/IJVTPR.V2I1.34
2022-05-23 The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104445 35634575
2022-05-23 AB1163 ATTITUDES AND HESITANCY IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES TOWARDS SARS-CoV-2 VACCINATION: A SINGLE-CENTER STUDY FROM BULGARIA (edit) SARS-CoV-2 (edit) 10.1136/ANNRHEUMDIS-2022-EULAR.4447
2022-05-23 Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study (edit) SARS-CoV-2 (edit) 10.1186/S12889-022-13464-7 35606743
2022-05-23 Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0268093 35604947
2022-05-23 Characterization of the Interaction Between SARS-CoV-2 Membrane Protein (M) and Proliferating Cell Nuclear Antigen (PCNA) as a Potential Therapeutic Target (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.849017 35677658
2022-05-22 E2UbcH5B-derived peptide ligands target HECT E3-E2 binding site and block the Ub-dependent SARS-CoV-2 egression: A computational study (edit) SARS-CoV-2 (edit)
2022-05-22 In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.3390/IJMS23105810 35628622
2022-05-21 Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters (edit) SARS-CoV-2 (edit) 10.1016/J.MSARD.2022.103905 35661563
2022-05-20 Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of COVID-19 in South Kivu, east of the Democratic Republic of the Congo (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.05.041 35598737
2022-05-20 Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine (edit) SARS-CoV-2 (edit) 10.1016/J.JCONREL.2022.05.023 35577151
2022-05-20 A new RT-LAMP-on-a-Chip Instrument for SARS-CoV-2 diagnostics (edit) SARS-CoV-2 (edit) 10.1016/J.MICROC.2022.107600 35620142
2022-05-20 Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity (edit) SARS-CoV-2 (edit) 10.1016/J.STR.2022.04.014 35609600
2022-05-20 Lebanese SARS-CoV-2 genomics: 24 months of the pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198824
2022-05-20 Molecular evolution and structural analyses of the spike glycoprotein from Brazilian SARS-CoV-2 genomes: the impact of selected mutations (edit) SARS-CoV-2 (edit) 10.1080/07391102.2022.2076154
2022-05-20 Twelve-Month Longitudinal Serology in SARS-CoV-2 Naïve and Experienced Vaccine Recipients and Unvaccinated COVID-19-Infected Individuals (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10050813 35632569
2022-05-19 Low expression of TMPRSS2-a SARS-CoV-2 internalization protease-associates with basal subtype of head and neck squamous cell carcinoma (edit) SARS-CoV-2 (edit) 10.1016/J.TRANON.2022.101458 35607455
2022-05-19 SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-12468-Y 35589808
2022-05-19 Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2202012119 35588457
2022-05-19 Clinical Validation of a Rapid Variant-Proof RT-RPA Assay for the Detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/DIAGNOSTICS12051263
2022-05-19 Inactivating SARS-CoV-2 Surrogates on Surfaces Using Engineered Water Nanostructures Incorporated with Nature Derived Antimicrobials (edit) SARS-CoV-2 (edit) 10.3390/NANO12101735 35630957
2022-05-19 Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.75791
2022-05-19 Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.13380 35611169
2022-05-18 Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104431 35607524
2022-05-18 Paving the way to point of care (POC) devices for SARS-CoV-2 detection (edit) SARS-CoV-2 (edit) 10.1016/J.TALANTA.2022.123542 35609482
2022-05-18 Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-30518-X 35585202
2022-05-18 Validation of a COVID-19 Job Exposure Matrix (COVID-19-JEM) for Occupational Risk of a SARS-CoV-2 Infection at Work: Using Data of Dutch Workers (edit) SARS-CoV-2 (edit) 10.1093/ANNWEH/WXAC032 35583140
2022-05-18 Evolutionary Traits and Genomic Surveillance of SARS-CoV-2 in South America (edit) SARS-CoV-2 (edit) 10.1155/2022/8551576
2022-05-18 Distinguishing Admissions Specifically for COVID-19 From Incidental SARS-CoV-2 Admissions: National Retrospective Electronic Health Record Study (edit) SARS-CoV-2 (edit) 10.2196/37931 35476727
2022-05-18 A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.820336 35663966
2022-05-18 Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES10051170 35625907
2022-05-18 Discovery of Natural Lead Compound from Dendrobium sp. against SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/PH15050620 35631446
2022-05-18 Detecting Potentially Adaptive Mutations from the Parallel and Fixed Patterns in SARS-CoV-2 Evolution (edit) SARS-CoV-2 (edit) 10.3390/V14051087 35632828
2022-05-17 The impacts of gradually terminating nonpharmaceutical interventions for SARS-CoV-2: A mathematical modelling analysis (edit) SARS-CoV-2 (edit) 10.1016/J.FMRE.2022.05.007
2022-05-17 Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds (edit) SARS-CoV-2 (edit) 10.1016/J.SAA.2022.121403 35617836
2022-05-17 SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2022.100651 35654046
2022-05-17 Inactivation of SARS-CoV-2 by a chitosan/α-Ag2WO4 composite generated by femtosecond laser irradiation (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-11902-5 35581241
2022-05-17 Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2123000119 35580180
2022-05-17 NGS data vectorization, clustering, and finding key codons in SARS-CoV-2 variations (edit) SARS-CoV-2 (edit) 10.1186/S12859-022-04718-7 35581558
2022-05-17 Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1186/S13578-022-00794-7 35581593
2022-05-17 At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.883612 35655773
2022-05-17 Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19106110
2022-05-17 Molecular Analysis of SARS-CoV-2 Lineages in Armenia (edit) SARS-CoV-2 (edit) 10.3390/V14051074 35632815
2022-05-17 The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10050794 35632550
2022-05-16 IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110904 35617962
2022-05-16 Multifaceted membrane binding head of the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.CRSTBI.2022.05.001 35602928
2022-05-16 Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04856-1
2022-05-16 Development of a new antigen-based microarray platform for screening and detection of human IgG antibodies against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-10823-7 35577791
2022-05-16 SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC) (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-11956-5 35577837
2022-05-16 RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-12179-4
2022-05-16 Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein (edit) SARS-CoV-2 (edit) 10.1186/S12859-022-04724-9 35578172
2022-05-16 Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland (edit) SARS-CoV-2 (edit) 10.12659/MSM.936495
2022-05-16 Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010054
2022-05-16 Six Feet under Microbiota: Microbiologic Contamination and Toxicity Profile in Three Urban Cemeteries from Lisbon, Portugal (edit) SARS-CoV-2 (edit) 10.3390/TOXINS14050348 35622594
2022-05-16 Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10050786 35632541
2022-05-14 Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107692
2022-05-14 Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022? (edit) SARS-CoV-2 (edit) 10.7189/JOGH.12.03023
2022-05-13 How Does Temperature Affect the Dynamics of SARS-CoV-2 M Proteins? Insights from Molecular Dynamics Simulations (edit) SARS-CoV-2 (edit) 10.1007/S00232-022-00244-Y 35552785
2022-05-13 Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study (edit) SARS-CoV-2 (edit) 10.1016/J.NEUROL.2022.03.014 35610098
2022-05-13 Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens (edit) SARS-CoV-2 (edit) 10.1016/S2468-1253(22)00166-2
2022-05-13 Testing Affordable Strategies for the Computational Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2 3CL Protease Inhibition (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.2C00294
2022-05-13 Correction to “Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern” (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.2C00364
2022-05-13 MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine (edit) SARS-CoV-2 (edit) 10.1186/S10020-022-00484-7 35562666
2022-05-12 SARS-CoV-2 RNA and N Antigen Quantification via Wastewater at the Campus Level, Building Cluster Level, and Individual-Building Level (edit) SARS-CoV-2 (edit)
2022-05-12 Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor (edit) SARS-CoV-2 (edit) 10.1007/S00044-022-02903-0 35578732
2022-05-12 Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy (edit) SARS-CoV-2 (edit) 10.1016/J.BBADIS.2022.166432 35568352
2022-05-12 A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells (edit) SARS-CoV-2 (edit) 10.1016/J.CMET.2022.04.009 35561674
2022-05-12 Transmembrane Protease Serine 2 Proteolytic Cleavage of the SARS-CoV-2 Spike Protein: A Mechanistic Quantum Mechanics/Molecular Mechanics Study to Inspire the Design of New Drugs To Fight the COVID-19 Pandemic (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCIM.1C01561 35549216
2022-05-12 Tuaimenal A, a Meroterpene from the Irish Deep-Sea Soft Coral Duva florida, Displays Inhibition of the SARS-CoV-2 3CLpro Enzyme (edit) SARS-CoV-2 (edit) 10.1021/ACS.JNATPROD.2C00054
2022-05-12 The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04835-6 35551511
2022-05-12 Human-to-dog transmission of SARS-CoV-2, Colombia (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-11847-9 35551247
2022-05-12 Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2120976119 35549549
2022-05-12 Structural dynamics of SARS-CoV-2 nucleocapsid protein induced by RNA binding (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010121 35551296
2022-05-12 B-Cell-Epitope-Based Fluorescent Quantum Dot Biosensors for SARS-CoV-2 Enable Highly Sensitive COVID-19 Antibody Detection (edit) SARS-CoV-2 (edit) 10.3390/V14051031 35632772
2022-05-12 Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10050763
2022-05-12 Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10050772 35632528
2022-05-11 Mechanisms underlying inactivation of SARS-CoV-2 by nano-sized electrostatic atomized water particles (edit) SARS-CoV-2 (edit) 10.1007/S11051-022-05485-5 35573750
2022-05-11 Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease (edit) SARS-CoV-2 (edit) 10.1007/S11224-022-01960-W 35571866
2022-05-11 Consensus Receptor-Binding Domain-Targeted Aptamer Selection and Designing of a Photonic Crystal-Decorated Aptasensor for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACS.ANALCHEM.2C00937 35544380
2022-05-11 SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells (edit) SARS-CoV-2 (edit) 10.1128/JVI.00594-22 35543509
2022-05-11 Shared genetic background between SARS-CoV-2 infection and large artery stroke (edit) SARS-CoV-2 (edit) 10.1177/17474930221095696
2022-05-11 Assessing of Humoral Immunity to SARS-COV-2 in Residents of Orenburg During the Epidemic Period (edit) SARS-CoV-2 (edit) 10.31631/20733046-2022-21-2-17-22
2022-05-11 The Biological Interaction of SARS-CoV-2 Infection and Osteoporosis: A Preliminary Study (edit) SARS-CoV-2 (edit) 10.3389/FCELL.2022.917907 35646907
2022-05-11 Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2022.893067
2022-05-11 Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse (edit) SARS-CoV-2 (edit) 10.3390/V14051020
2022-05-11 Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy (edit) SARS-CoV-2 (edit) 10.3390/V14051029 35632769
2022-05-10 Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.05.010 35562044
2022-05-10 Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2022.105300 35552003
2022-05-10 Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-30163-4 35538074
2022-05-10 Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.877813 35620103
2022-05-10 Sample Buffer Containing Guanidine-Hydrochloride Combines Biological Safety and RNA Preservation for SARS-CoV-2 Molecular Diagnostics (edit) SARS-CoV-2 (edit) 10.3390/DIAGNOSTICS12051186
2022-05-09 SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-30195-W 35534483
2022-05-09 A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42255-022-00567-Z
2022-05-09 At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07377-4 35534836
2022-05-09 Robust models of disease heterogeneity and control, with application to the SARS-CoV-2 epidemic (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PGPH.0000412
2022-05-09 Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.876306 35615365
2022-05-09 Insights into the Antimicrobial, Antioxidant, Anti-SARS-CoV-2 and Cytotoxic Activities of Pistacia lentiscus Bark and Phytochemical Profile; In Silico and In Vitro Study (edit) SARS-CoV-2 (edit) 10.3390/ANTIOX11050930 35624793
2022-05-09 The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response (edit) SARS-CoV-2 (edit) 10.7150/THNO.73268 35664076
2022-05-08 Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110864 35594870
2022-05-08 ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion (edit) SARS-CoV-2 (edit) 10.15252/EMBR.202154305 35527514
2022-05-08 SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions (edit) SARS-CoV-2 (edit) 10.3390/V14050999 35632741
2022-05-07 SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07418-Y 35525973
2022-05-07 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS11050551
2022-05-06 Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2022.104025 35533497
2022-05-06 Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen (edit) SARS-CoV-2 (edit) 10.1016/J.YMTHE.2022.04.025 35526097
2022-05-06 Rapid response modeling of SARS-CoV-2 transmission (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABP9498
2022-05-06 RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2'-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION (edit) SARS-CoV-2 (edit) 10.21010/AJID.V16I2.9 35582066
2022-05-06 Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.884433 35603198
2022-05-06 Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FMED.2022.864972
2022-05-06 Determining the Efficacy of Various Governmental Interventions in Stemming the Spread of SARS-CoV-2 in Seven Locations (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.828090
2022-05-06 O efeito do vírus SARS-CoV-2 na audição de pacientes adultos / The effect of the SARS-CoV-2 virus on hearing in adult patients (edit) SARS-CoV-2 (edit) 10.34119/BJHRV5N3-066
2022-05-05 Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development (edit) SARS-CoV-2 (edit) 10.1016/J.REPROTOX.2022.04.011 35525527
2022-05-05 Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines (edit) SARS-CoV-2 (edit) 10.1080/14992027.2022.2056721
2022-05-04 Synthesis, antimicrobial, molecular docking and molecular dynamics studies of lauroyl thymidine analogs against SARS-CoV-2: POM study and identification of the pharmacophore sites (edit) SARS-CoV-2 (edit) 10.1016/J.BIOORG.2022.105850 35533581
2022-05-04 Oral dysbiosis and its linkage with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.MICRES.2022.127055 35597076
2022-05-04 Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-30134-9 35508460
2022-05-04 Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020 (edit) SARS-CoV-2 (edit) 10.12659/MSM.934926 35505583
2022-05-04 A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.855230 35603150
2022-05-04 Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.868724 35603169
2022-05-03 TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2022.100640 35588734
2022-05-03 COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-10987-2 35505068
2022-05-03 Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.807104 35592326
2022-05-02 Intensification of an Essential Tremor by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S12311-022-01409-0
2022-05-02 Reply to “Intensification of an Essential Tremor by SARS-CoV-2” (edit) SARS-CoV-2 (edit) 10.1007/S12311-022-01410-7
2022-05-02 Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.04.035 35568035
2022-05-02 SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination (edit) SARS-CoV-2 (edit) 10.1016/J.CLIM.2022.109027 35513305
2022-05-02 Prediction of binding miRNAs involved with immune genes to the SARS-CoV-2 by using sequence features extraction and One-class SVM (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2022.100958 35528315
2022-05-02 Predictive Ability of the MEWS, REMS, and RAPS in Geriatric Patients With SARS-CoV-2 Infection in the Emergency Department (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.107
2022-05-02 SARS-CoV-2 omicron variant and the future of the pandemic (edit) SARS-CoV-2 (edit) 10.12968/DENU.2022.49.5.432
2022-05-01 Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model (edit) SARS-CoV-2 (edit) 10.1002/JHA2.407 35602246
2022-05-01 Prospective Pilot Study Evaluating SARS-CoV-2 Transmission-Limiting Measures in an On-Site School (edit) SARS-CoV-2 (edit) 10.1016/J.ACAP.2021.11.019
2022-05-01 Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110829
2022-05-01 Vocal cord dysfunction/inducible laryngeal obstruction(s) mimicking anaphylaxis during SARS-CoV-2 (COVID-19) vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.JAIP.2022.02.025
2022-05-01 Calcitonin gene-related peptide: A biomarker for stroke in SARS-CoV-2 infection? (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110807
2022-05-01 Pasteurization, storage conditions and viral concentration methods influence RT-qPCR detection of SARS-CoV-2 RNA in wastewater (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.153228
2022-05-01 Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors (edit) SARS-CoV-2 (edit) 10.1016/J.YMTHE.2022.01.024
2022-05-01 Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS (edit) SARS-CoV-2 (edit) 10.1016/S0016-5085(22)63690-4
2022-05-01 Reducing occupational exposure to SARS-CoV-2: a survey of changes in caseload and controls among medical examiner and coroners' offices in Pennsylvania during 2020 (edit) SARS-CoV-2 (edit) 10.1080/15459624.2022.2050740
2022-05-01 Use of DFT Distance Metrics for Classification of SARS-CoV-2 Genomes (edit) SARS-CoV-2 (edit) 10.1089/CMB.2021.0229
2022-05-01 Unheeded SARS-CoV-2 proteins? A deep look into negative-sense RNA (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAC045 35229157
2022-05-01 Risk of Healthcare-Associated Transmission of Sever Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospitalized Cancer Patients (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB670 34329418
2022-05-01 Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers (edit) SARS-CoV-2 (edit) 10.1093/GIGASCIENCE/GIAC045 35639883
2022-05-01 Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC045 36382127
2022-05-01 Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC049 35783502
2022-05-01 Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19 (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC058 36713311
2022-05-01 Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC067 36713328
2022-05-01 The Effect of Glycosylation Modulators on the Trafficking and Interaction of Spike Protein S1 Subunit and Angiotensin‐Converting Enzyme 2 (edit) SARS-CoV-2 (edit) 10.1096/FASEBJ.2022.36.S1.R3340
2022-05-01 Synthesis of the transmembrane domain of the accessory protein ORF7a of SARS‐CoV‐2 using solid phase peptide synthesis and analyzing the oligomerization state (edit) SARS-CoV-2 (edit) 10.1096/FASEBJ.2022.36.S1.R3870
2022-05-01 Variation in ORF3a Protein of SARS‐CoV‐2 Decreases The Severity of Host Cell Damage (edit) SARS-CoV-2 (edit) 10.1096/FASEBJ.2022.36.S1.R4149
2022-05-01 Recognition and Cleavage of Human tRNA Methyltransferase TRMT1 by the SARS‐CoV‐2 Main Protease (edit) SARS-CoV-2 (edit) 10.1096/FASEBJ.2022.36.S1.R4632
2022-05-01 Source terms for benchmarking models of SARS-CoV-2 transmission via aerosols and droplets (edit) SARS-CoV-2 (edit) 10.1098/RSOS.212022
2022-05-01 Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants (edit) SARS-CoV-2 (edit) 10.15252/MSB.202110823 35579274
2022-05-01 Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2 (edit) SARS-CoV-2 (edit) 10.1530/JME-21-0282 35521990
2022-05-01 In Silico Analysis of Peptide-Based Derivatives Containing Bifunctional Warheads Engaging Prime and Non-Prime Subsites to Covalent Binding SARS-CoV-2 Main Protease (Mpro) (edit) SARS-CoV-2 (edit) 10.3390/COMPUTATION10050069
2022-05-01 Positive effects of the decrease of hydraulic dredging due to the SARS-CoV-2 pandemic on benthic fauna and clam harvesting in the northern Adriatic (Mediterranean Sea) (edit) SARS-CoV-2 (edit) 10.35800/JASM.V10I1.37485
2022-05-01 Development of a multi-epitope spike glycoprotein vaccine to combat SARS-CoV-2 using the bioinformatics approach (edit) SARS-CoV-2 (edit) 10.56499/JPPRES21.1210_10.3.445
2022-04-30 A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107688
2022-04-29 Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107687
2022-04-29 SARS-CoV-2 and other airborne respiratory viruses in outdoor aerosols in three Swiss cities before and during the first wave of the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.ENVINT.2022.107266 35512527
2022-04-29 Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products (edit) SARS-CoV-2 (edit) 10.1016/J.OMTM.2022.04.013 35506060
2022-04-29 In silico evidence of antiviral activity against SARS-CoV-2 main protease of oligosaccharides from Porphyridium sp (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.155580 35500710
2022-04-29 Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models (edit) SARS-CoV-2 (edit) 10.1038/S41421-022-00409-Y 35487885
2022-04-29 Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266958 35486622
2022-04-29 Wpływ pandemii Sars-CoV-2 na postrzeganie idei „Slow Food” przez studentów (edit) SARS-CoV-2 (edit) 10.15199/65.2022.4.6
2022-04-29 Investigation of changes in protein stability and substrate affinity of 3CL-protease of SARS-CoV-2 caused by mutations (edit) SARS-CoV-2 (edit) 10.1590/1678-4685-GMB-2021-0404 35499274
2022-04-29 Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages? (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10050708 35632464
2022-04-28 Comparative Analysis of RNA-Extraction Approaches and Associated Influences on RT-qPCR of the SARS-CoV-2 RNA in a University Residence Hall and Quarantine Location (edit) SARS-CoV-2 (edit)
2022-04-28 In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19 (edit) SARS-CoV-2 (edit) 10.1007/S11224-022-01943-X 35502321
2022-04-28 Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.2C02203 35530749
2022-04-28 Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-10738-3 35484171
2022-04-28 All hands on deck: A multidisciplinary approach to SARS-CoV-2-associated MIS-C (edit) SARS-CoV-2 (edit) 10.1093/PCH/PXAB110 35620558
2022-04-28 Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC042 36713312
2022-04-28 Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABO0718 35482820
2022-04-28 A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010465 35482816
2022-04-28 The determination of haemagglutinin influenza antibodies in the Polish population in the epidemic season 2020/2021 during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.18388/ABP.2020_6015
2022-04-28 EU-Funded Telemedicine Projects – Assessment of, and Lessons Learned From, in the Light of the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.3389/FMED.2022.849998
2022-04-28 Impact of SARS-CoV-2 Mutations on PCR Assay Sequence Alignment (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.889973 35570946
2022-04-28 Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry o (edit) SARS-CoV-2 (edit) 10.3390/JPM12050706
2022-04-27 Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105552 35508082
2022-04-27 Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104309 35502319
2022-04-27 Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination (edit) SARS-CoV-2 (edit) 10.1038/S41392-022-00987-Z 35478188
2022-04-27 Antibody response to double SARS-CoV-2 mRNA vaccination in Japanese kidney transplant recipients (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-10510-7 35477954
2022-04-27 Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00998-21
2022-04-27 Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01405-21 35266818
2022-04-27 First Identification of Reinfection by a Genetically Different Variant of SARS-CoV-2 in a Homeless Person from the Metropolitan Area of Santiago, Chile (edit) SARS-CoV-2 (edit) 10.1155/2022/3859071 35528635
2022-04-27 Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0263316
2022-04-27 ECG Utilization Patterns of Patients With Arrhythmias During COVID-19 Epidemic and Post-SARS-CoV-2 Eras in Shanghai, China (edit) SARS-CoV-2 (edit) 10.3389/FCVM.2022.829679
2022-04-27 Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CLpro Main Protease (edit) SARS-CoV-2 (edit) 10.3390/PH15050539 35631364
2022-04-27 Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold (edit) SARS-CoV-2 (edit) 10.3390/PH15050540 35631367
2022-04-26 SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2022.04.030 35495107
2022-04-26 Detection of SARS-CoV-2 in the air in Indian hospitals and houses of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.JAEROSCI.2022.106002 35495416
2022-04-26 In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells (edit) SARS-CoV-2 (edit) 10.1016/J.JKSUS.2022.102049 35493709
2022-04-26 Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2022.100634 35561673
2022-04-26 Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events (edit) SARS-CoV-2 (edit) 10.1038/S41392-022-00992-2
2022-04-26 Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7117E3 35482574
2022-04-26 Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES10050996 35625733
2022-04-26 Chronic Exposure to the Food Additive tBHQ Modulates Expression of Genes Related to SARS-CoV-2 and Influenza Viruses (edit) SARS-CoV-2 (edit) 10.3390/LIFE12050642 35629310
2022-04-26 SARS-CoV-2 Omicron Variant in Croatia-Rapid Detection of the First Case and Cross-Border Spread (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS11050511 35631032
2022-04-25 Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France (edit) SARS-CoV-2 (edit) 10.1002/JMV.27789 35467028
2022-04-25 Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak (edit) SARS-CoV-2 (edit) 10.1016/J.BSHEAL.2022.04.004 35496653
2022-04-25 Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105443 35533463
2022-04-25 Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-29896-Z 35469023
2022-04-25 A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41541-022-00471-3 35468973
2022-04-25 Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07374-7 35468749
2022-04-25 Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PNTD.0010363 35468133
2022-04-25 Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.863831 35547740
2022-04-25 Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2022.872736 35548336
2022-04-25 Field Evaluation of the New Rapid NG-Test® SARS-CoV-2 Ag for Diagnosis of COVID-19 in the Emergency Department of an Academic Referral Hospital (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.840984
2022-04-25 Shell Disorder Models Detect That Omicron Has Harder Shells with Attenuation but Is Not a Descendant of the Wuhan-Hu-1 SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/BIOM12050631 35625559
2022-04-24 Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19 (edit) SARS-CoV-2 (edit) 10.1007/S00894-022-05117-8 35461388
2022-04-24 Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies (edit) SARS-CoV-2 (edit) 10.1186/S43556-022-00074-3 35461370
2022-04-24 A human coronavirus OC43-derived polypeptide causes neuropathic pain (edit) Human coronavirus OC43 (edit) 10.15252/EMBR.202154069 35466531
2022-04-24 Risk mitigation and disease control challenges of SARS-CoV-2 multidirectional transmission at ski resorts (edit) SARS-CoV-2 (edit) 10.21037/JPHE-21-112
2022-04-24 Phylodynamic Dispersal of SARS-CoV-2 Lineages Circulating across Polish–German Border Provinces (edit) SARS-CoV-2 (edit) 10.3390/V14050884
2022-04-23 SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways (edit) SARS-CoV-2 (edit) 10.1002/JCP.30755 35460571
2022-04-23 SARS-COV-2 as potential microRNA sponge in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1186/S12920-022-01243-7 35461273
2022-04-23 SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility (edit) SARS-CoV-2 (edit) 10.3390/CELLS11091431 35563737
2022-04-22 RT- PCR testing of upper respiratory tract samples for diagnosis of SARS-CoV-2: Between justification and overestimation, a multi-center international study (edit) SARS-CoV-2 (edit) 10.1016/J.TMAID.2022.102334 35470069
2022-04-22 Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2022.101383 35664254
2022-04-22 Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.157597 35290246
2022-04-22 Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.157963 35316213
2022-04-22 Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq (edit) SARS-CoV-2 (edit) 10.1186/S12864-022-08541-5 35459088
2022-04-22 Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by connectivity map-based analysis and in vitro studies (edit) SARS-CoV-2 (edit) 10.1186/S12906-022-03584-3 35459166
2022-04-22 The challenge of SARS-CoV-2 environmental monitoring in schools using floors and portable HEPA filtration units: Fresh or relic RNA? (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0267212
2022-04-21 Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110799 35523172
2022-04-21 SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2022.04.022 35474907
2022-04-21 Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant (edit) SARS-CoV-2 (edit) 10.1016/J.DIAGMICROBIO.2022.115699 35569431
2022-04-21 SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198785
2022-04-21 An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266844 35446879
2022-04-21 Human Wharton's Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses (edit) SARS-CoV-2 (edit) 10.3390/CELLS11091408 35563714
2022-04-20 Visibility, wind speed, and dew point temperature are important factors in SARS-CoV-2 transmissibility (edit) SARS-CoV-2 (edit) 10.1002/PUL2.12081 35514785
2022-04-20 Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2022.04.096 35460753
2022-04-20 Preclinical study of a DNA vaccine targeting SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.RETRAM.2022.103348 35489099
2022-04-20 Development and validation of cost-effective one-step multiplex RT-PCR assay for detecting the SARS-CoV-2 infection using SYBR Green melting curve analysis (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-10413-7 35444203
2022-04-20 Immunoinformatics approach of epitope prediction for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S43141-022-00344-1 35441904
2022-04-20 First Analytical Solution of Intracellular life Cycle of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.14302/ISSN.2643-2811.JMBR-22-4130
2022-04-20 Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review (edit) SARS-CoV-2 (edit) 10.2174/1389450123666220418094853
2022-04-20 SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes (edit) SARS-CoV-2 (edit) 10.3389/FCELL.2022.855340 35517495
2022-04-20 The Endolysosomal System: The Acid Test for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/IJMS23094576 35562967
2022-04-20 Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program (edit) SARS-CoV-2 (edit) 10.3390/V14050847 35632589
2022-04-20 Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10050649 35632405
2022-04-19 Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110786 35477024
2022-04-19 Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.2C00120 35439007
2022-04-19 Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-29731-5 35440562
2022-04-19 First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-09615-W 35440789
2022-04-19 Shifts of SARS-CoV-2 exposure settings in the transmission clusters of 2 epidemic waves in Hong Kong (edit) SARS-CoV-2 (edit) 10.1080/09603123.2022.2064438
2022-04-19 The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.848650 35521219
2022-04-19 Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19094930
2022-04-19 Efficacy of a “stay-at-home” policy on SARS-CoV-2 transmission in Toronto, Canada: a mathematical modelling study (edit) SARS-CoV-2 (edit) 10.9778/CMAJO.20200242
2022-04-18 The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2022.108193 35462185
2022-04-18 Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0264723 35436320
2022-04-18 An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266412 35436306
2022-04-17 Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation (edit) SARS-CoV-2 (edit) 10.1002/1873-3468.14354 35434785
2022-04-17 Identification of Transcription Factors Regulating SARS-CoV-2 Tropism Factor Expression by Inferring Cell-Type-Specific Transcriptional Regulatory Networks in Human Lungs (edit) SARS-CoV-2 (edit) 10.3390/V14040837 35458567
2022-04-16 Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2022.105163
2022-04-16 Electrochemical genosensor for the specific detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.TALANTA.2022.123482 35462140
2022-04-15 ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110757 35477023
2022-04-15 Detection of SARS-CoV-2 with RAPID: A prospective cohort study (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104055 35291265
2022-04-15 Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-10293-X 35440680
2022-04-15 One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABM5016 35427158
2022-04-15 COVID-profiler: a webserver for the analysis of SARS-CoV-2 sequencing data (edit) SARS-CoV-2 (edit) 10.1186/S12859-022-04632-Y 35428185
2022-04-15 MALDI-TOF-MS-Based Identification of Monoclonal Murine Anti-SARS-CoV-2 Antibodies within One Hour (edit) SARS-CoV-2 (edit) 10.3390/ANTIB11020027
2022-04-14 A magnetic bead immunoassay to detect high affinity human IgG reactive to SARS-CoV-2 Spike S1 RBD produced in Escherichia coli (edit) SARS-CoV-2 (edit) 10.1007/S42770-022-00753-X
2022-04-14 Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2022.108194 35453047
2022-04-14 Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-09845-Y 35422113
2022-04-14 Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAC292
2022-04-14 Abnormal global alternative RNA splicing in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PGEN.1010137 35421082
2022-04-14 Wastewater surveillance of SARS-CoV-2 mutational profiles at a university and its surrounding community reveals a 20G outbreak on campus (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266407 35421164
2022-04-14 Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010464 35421191
2022-04-14 Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.822599 35493733
2022-04-14 Identification of Compounds With Antiviral Activity Against SARS-CoV-2 in the MMV Pathogen Box Using a Phenotypic High-Throughput Screening Assay (edit) SARS-CoV-2 (edit) 10.3389/FVIRO.2022.854363
2022-04-14 Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10040614
2022-04-14 Research on COVID-19, SARS-CoV-2 in dermatology journals: A brief bibliometric analysis based on PubMed (edit) SARS-CoV-2 (edit) 10.4103/IJD.IJD_397_21
2022-04-13 Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2022.04.001 35434682
2022-04-13 Molecularly Imprinted Polymer Nanoparticles Enable Rapid, Reliable, and Robust Point-of-Care Thermal Detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSSENSORS.2C00100 35416035
2022-04-13 Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city (edit) SARS-CoV-2 (edit) 10.1038/S43856-022-00108-5 35603276
2022-04-13 Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.14744/NCI.2022.28000 35582503
2022-04-13 Free PoC Testing for SARS-CoV-2 in Germany: Factors Expanding Access to Various Communities in a Medium-Sized City (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19084721
2022-04-13 Comparative Evaluation of Six SARS-CoV-2 Real-Time RT-PCR Diagnostic Approaches Shows Substantial Genomic Variant–Dependent Intra- and Inter-Test Variability, Poor Interchangeability of Cycle Threshold and Complementary Turn-Around Times (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS11040462
2022-04-13 Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice (edit) SARS-CoV-2 (edit) 10.3390/V14040800 35458530
2022-04-13 PipeCoV: a pipeline for SARS-CoV-2 genome assembly, annotation and variant identification (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.13300 35437474
2022-04-12 SARS-CoV-2 monitoring by automated target-driven molecular machine-based engineering (edit) SARS-CoV-2 (edit) 10.1007/S10311-022-01434-9
2022-04-12 Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.04.017 35427785
2022-04-12 Severe Adams-Oliver Syndrome after Maternal COVID-19 Infection Could Be Another Effect of the SARS-CoV-2 Inflammatory Storm? Case Report (edit) SARS-CoV-2 (edit) 10.1080/15513815.2022.2064018
2022-04-12 SARS-CoV-2 spike protein–induced cell fusion activates the cGAS-STING pathway and the interferon response (edit) SARS-CoV-2 (edit) 10.1126/SCISIGNAL.ABG8744 35412852
2022-04-12 Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02167-21 35412356
2022-04-12 [Geospatial models for SARS-CoV-2 outbreak control in Cartagena and Barranquilla, Colombia, 2020Modelos geoespaciais para controle de surtos de SARS-CoV-2 em Cartagena e Barranquilla, Colômbia, 2020] (edit) SARS-CoV-2 (edit) 10.26633/RPSP.2022.26 35432500
2022-04-12 Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors (edit) SARS-CoV-2 (edit) 10.3389/FCHEM.2022.861209 35494659
2022-04-12 Identification of Neutrophil-Related Factor LCN2 for Predicting Severity of Patients With Influenza A Virus and SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.854172 35495713
2022-04-11 Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized Plasma (edit) SARS-CoV-2 (edit) 10.1002/ADVS.202104333 35403837
2022-04-11 Structural and functional impact by SARS-CoV-2 Omicron spike mutations (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110729 35452593
2022-04-11 Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104223 35434541
2022-04-11 Cocktail of REGN Antibodies Binds More Strongly to SARS-CoV-2 Than Its Components, but the Omicron Variant Reduces Its Neutralizing Ability (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.2C00708 35403431
2022-04-11 Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00629 35404564
2022-04-11 Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern (edit) SARS-CoV-2 (edit) 10.1111/ALL.15311 35403221
2022-04-11 Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1010021 35404937
2022-04-11 Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010155 35404959
2022-04-11 Dentist’s Experiences and Perceptions One Year into the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.33140/JODH.05.04.03
2022-04-10 Increased close proximity airborne transmission of the SARS-CoV-2 Delta variant (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.151499 34752865
2022-04-09 Characteristic analysis of Omicron-included SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1002/MCO2.129 35434714
2022-04-09 Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110694 35397208
2022-04-09 MutCov: A pipeline for evaluating the effect of mutations in spike protein on infectivity and antigenicity of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105509 35421792
2022-04-09 Replication of the coronavirus genome: a paradox among positive-strand RNA viruses (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2022.101923 35413290
2022-04-09 Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2 (edit) SARS-CoV-2 (edit) 10.3390/CELLS11081274 35455955
2022-04-08 Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.04.009 35523182
2022-04-08 Unveiling the nature's fruit basket to computationally identify Citrus sinensis csi-mir169-3p as a probable plant miRNA against Reference and Omicron SARS-CoV-2 genome (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105502 35605482
2022-04-08 Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-29579-9 35396511
2022-04-08 Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009990 35395058
2022-04-08 SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells (edit) SARS-CoV-2 (edit) 10.3390/CELLS11081262
2022-04-08 Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements (edit) SARS-CoV-2 (edit) 10.3390/V14040778 35458508
2022-04-07 Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence (edit) SARS-CoV-2 (edit) 10.1007/S00018-022-04246-W 35391601
2022-04-07 Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105478 35421790
2022-04-07 Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2022.04.002 35483354
2022-04-07 Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2022.04.003 35447092
2022-04-07 Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-29413-2 35393402
2022-04-07 Systematic evaluating and modeling of SARS-CoV-2 UVC disinfection (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-09930-2 35393480
2022-04-07 SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog (edit) SARS-CoV-2 (edit) 10.1128/JVI.00037-22 35389264
2022-04-07 The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02240-21 35389245
2022-04-07 Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous acid solution and hydrogen peroxide solution (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0261802 35389997
2022-04-07 Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266124 35390032
2022-04-06 Mathematical modeling and analysis of the SARS-Cov-2 disease with reinfection (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107678
2022-04-06 FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04702-4
2022-04-06 Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-09664-1 35388061
2022-04-06 Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-09731-7 35388072
2022-04-06 Evaluation of a machine learning approach utilizing wearable data for prediction of SARS-CoV-2 infection in healthcare workers (edit) SARS-CoV-2 (edit) 10.1093/JAMIAOPEN/OOAC041
2022-04-06 Hospital Disaster and Emergency Plan in Biological Disasters (HDEP): Coronavirus (SARS-CoV-2) COVID-19 Pandemic System Model Example (edit) SARS-CoV-2 (edit) 10.29333/JCONSEPH/11975
2022-04-06 Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.832223 35464437
2022-04-06 What Do We Know About the Impacts of Novel Coronavirus (SARS-Cov-2) on Freshwater Ecosystems? (edit) SARS-CoV-2 (edit) 10.38125/OAJBS.000357
2022-04-05 Online Hydrophilic Interaction Chromatography (HILIC) Enhanced Top-Down Mass Spectrometry Characterization of the SARS-CoV-2 Spike Receptor-Binding Domain (edit) SARS-CoV-2 (edit) 10.1021/ACS.ANALCHEM.2C00139 35380435
2022-04-05 pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein (edit) SARS-CoV-2 (edit) 10.1021/JACS.2C00973 35380805
2022-04-05 Characterisation and natural progression of SARS-CoV-2 infection in ferrets (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-08431-6
2022-04-05 Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2117142119 35380892
2022-04-05 SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-057846 35383082
2022-04-05 Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.821730 35479098
2022-04-05 Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids (edit) SARS-CoV-2 (edit) 10.3390/CELLS11071235 35406799
2022-04-05 Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey (edit) SARS-CoV-2 (edit) 10.4274/BALKANMEDJ.GALENOS.2022.2021-11-25
2022-04-05 Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study (edit) SARS-CoV-2 (edit) 10.4274/BALKANMEDJ.GALENOS.2022.2021-8-131
2022-04-04 The Effects of Migration and Limited Medical Resources of the Transmission of SARS-CoV-2 Model with Two Patches (edit) SARS-CoV-2 (edit) 10.1007/S11538-022-01010-W
2022-04-04 Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110714 35421379
2022-04-04 Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2022.105279 35390503
2022-04-04 Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates (edit) SARS-CoV-2 (edit) 10.1016/J.VACCINE.2022.03.060
2022-04-04 Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor (edit) SARS-CoV-2 (edit) 10.1021/ACSPTSCI.2C00026 35434531
2022-04-04 Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmission (edit) SARS-CoV-2 (edit) 10.1101/2021.12.21.21268143 35411350
2022-04-04 Meteorological factors and non-pharmaceutical interventions explain local differences in the spread of SARS-CoV-2 in Austria (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009973
2022-04-04 Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0265220 35377884
2022-04-04 Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.814806 35444655
2022-04-04 Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.836454 35444976
2022-04-02 Child transmission of SARS-CoV-2: a systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1186/S12887-022-03175-8 35365104
2022-04-02 mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People (edit) SARS-CoV-2 (edit) 10.3390/V14040748
2022-04-01 Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response (edit) SARS-CoV-2 (edit) 10.1002/CTM2.802 35415890
2022-04-01 The variants of SARS-CoV-2 and the challenges of vaccines (edit) SARS-CoV-2 (edit) 10.1002/JMV.27513 34890492
2022-04-01 Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1002/PUL2.12071 35599981
2022-04-01 Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B receptor antagonism (edit) SARS-CoV-2 (edit) 10.1007/S00109-022-02182-7 35247068
2022-04-01 The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S00239-022-10054-4
2022-04-01 Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1007/S00345-021-03810-6
2022-04-01 Amplification-free detection of SARS-CoV-2 using gold nanotriangles functionalized with oligonucleotides (edit) SARS-CoV-2 (edit) 10.1007/S00604-022-05272-Y 35364748
2022-04-01 Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2022.103944 35465948
2022-04-01 ZERO projects in intensive care units: Challenges during SARS-CoV-2 pandemic and future recommendations (edit) SARS-CoV-2 (edit) 10.1016/J.ENFIE.2022.03.001
2022-04-01 Hygienic assessment of digestate from a high solids anaerobic co-digestion of sewage sludge with biowaste by testing Salmonella Typhimurium, Escherichia coli and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.112585
2022-04-01 Assessment of SARS-CoV-2 airborne infection transmission risk in public buses (edit) SARS-CoV-2 (edit) 10.1016/J.GSF.2022.101398
2022-04-01 Link between SARS-CoV-2 emissions and airborne concentrations: Closing the gap in understanding (edit) SARS-CoV-2 (edit) 10.1016/J.JHAZMAT.2022.128279 35063838
2022-04-01 SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis (edit) SARS-CoV-2 (edit) 10.1016/J.JHEP.2022.03.040 35461912
2022-04-01 l-Methionine may modulate the assembly of SARS-CoV-2 by interfering with the mechanism of RNA polymerase (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110798
2022-04-01 Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110810
2022-04-01 All about that trait: Examining extraversion and state anxiety during the SARS-CoV-2 pandemic using a machine learning approach (edit) SARS-CoV-2 (edit) 10.1016/J.PAID.2021.111461
2022-04-01 CLOTH FACE COVERINGS FOR USE AS FACEMASKS DURING THE CORONAVIRUS (SARS-CoV-2) PANDEMIC: WHAT SCIENCE AND EXPERIENCE HAVE TAUGHT US (edit) SARS-CoV-2 (edit) 10.1017/DMP.2020.354 32921329
2022-04-01 Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines (edit) SARS-CoV-2 (edit) 10.1038/S41565-022-01071-X
2022-04-01 SARS-CoV-2 is associated with changes in brain structure in UK Biobank (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04569-5 35255491
2022-04-01 Antibody evasion properties of SARS-CoV-2 Omicron sublineages (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04594-4 35240676
2022-04-01 Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04653-W 35332335
2022-04-01 Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04708-Y 35396582
2022-04-01 Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2119467119 35363556
2022-04-01 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAC262 35380632
2022-04-01 Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? (edit) SARS-CoV-2 (edit) 10.1093/JPIDS/PIAC024 35394545
2022-04-01 Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAC144 35244721
2022-04-01 Determinants of Immune Response to Anti-SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study (edit) SARS-CoV-2 (edit) 10.1097/TP.0000000000004044 34999659
2022-04-01 Portable air cleaners and residential exposure to SARS-CoV-2 aerosols: a real-world study (edit) SARS-CoV-2 (edit) 10.1111/INA.13029 35481935
2022-04-01 Salivary diagnostics of the novel corona virus SARS-CoV-2 (COVID-19) (edit) SARS-CoV-2 (edit) 10.1111/ODI.13729 33211392
2022-04-01 Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization (edit) SARS-CoV-2 (edit) 10.1134/S0006297922040022 35527370
2022-04-01 Impact of air temperature and containment measures on mitigating the intrahousehold transmission of SARS-CoV-2: a data-based modelling analysis (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-049383
2022-04-01 Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform (edit) SARS-CoV-2 (edit) 10.1177/01926233221090518 35514116
2022-04-01 SARS-CoV-2 detection in multi-sample pools in a real pandemic scenario: A screening strategy of choice for active surveillance (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266408 35363805
2022-04-01 Triamcinolone as a potential inhibitor of SARS-CoV-2 main protease and cytokine storm: An in-silico study (edit) SARS-CoV-2 (edit) 10.2174/1570180819666220401142351
2022-03-31 Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2022.105278 35367360
2022-03-31 Defining the risk of SARS-CoV-2 variants on immune protection (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04690-5 35361968
2022-03-31 Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection (edit) SARS-CoV-2 (edit) 10.1056/NEJMOA2118691
2022-03-31 A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07314-5 35361140
2022-03-31 Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001592 35358182
2022-03-31 Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009964
2022-03-31 Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0266417 35358277
2022-03-31 The Finding of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) in a Wild Eurasian River Otter (Lutra lutra) Highlights the Need for Viral Surveillance in Wild Mustelids (edit) SARS-CoV-2 (edit) 10.3389/FVETS.2022.826991
2022-03-30 Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105468 35390745
2022-03-30 Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00486 35352558
2022-03-30 Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009965
2022-03-30 RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PGEN.1010130 35353808
2022-03-30 Computer-Based Immunoinformatic Analysis to Predict Candidate T-Cell Epitopes for SARS-CoV-2 Vaccine Design (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.847617 35432316
2022-03-29 Detection of SARS-CoV-2 Proteins in Wastewater Samples by Mass Spectrometry (edit) SARS-CoV-2 (edit) 10.1021/ACS.EST.1C04705
2022-03-29 Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals (edit) SARS-CoV-2 (edit) 10.1038/S41423-022-00855-4 35352010
2022-03-29 In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-08320-Y 35351926
2022-03-29 Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution (edit) SARS-CoV-2 (edit) 10.1093/EMPH/EOAC010 35419205
2022-03-29 SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00221-22 35348367
2022-03-29 In vitro Suppression of SARS-CoV-2 Infection by Existing Kampo Formulas and Crude Constituent Drugs Used for Treatment of Common Cold Respiratory Symptoms (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2022.804103
2022-03-29 Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis (edit) SARS-CoV-2 (edit) 10.3390/IDR14020029 35447881
2022-03-28 Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required (edit) SARS-CoV-2 (edit) 10.1007/S11845-022-02984-1
2022-03-28 SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107671 35429835
2022-03-28 NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2022.105506 35358660
2022-03-28 Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England (edit) SARS-CoV-2 (edit) 10.1016/S2352-4642(22)00059-1 35358491
2022-03-28 Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617 (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-29288-3 35347138
2022-03-28 A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04661-W 35344983
2022-03-28 Global landscape of SARS-CoV-2 genomic surveillance and data sharing (edit) SARS-CoV-2 (edit) 10.1038/S41588-022-01033-Y
2022-03-28 Virucidal efficacy of laundry sanitizers against SARS-CoV-2 and other coronaviruses and influenza viruses (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-08259-0 35347149
2022-03-28 Molecular consequences of SARS-CoV-2 liver tropism (edit) SARS-CoV-2 (edit) 10.1038/S42255-022-00552-6 35347318
2022-03-28 SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in Arf6-dependent manner (edit) SARS-CoV-2 (edit) 10.1080/22221751.2022.2059403
2022-03-28 Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity (edit) SARS-CoV-2 (edit) 10.1128/JVI.00128-22 35343766
2022-03-28 Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1. (edit) SARS-CoV-2 (edit) 10.1128/JVI.00249-22 35343765
2022-03-28 Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8 (edit) SARS-CoV-2 (edit) 10.1128/MBIO.00402-22
2022-03-28 Phylogenetic analysis of 17271 Indian SARS-CoV-2 genomes to identify temporal and spatial hotspot mutations (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0265579
2022-03-28 Identification of Potential Semisynthetic Andrographolide Derivatives to Combat COVID-19 by Targeting the SARS-COV-2 Spike Protein and Human ACE2 Receptor– An In-silico Approach (edit) SARS-CoV-2 (edit) 10.33263/BRIAC132.155
2022-03-27 RNA–protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV‐2 studies (edit) SARS-CoV-2 (edit) 10.1002/WRNA.1727 35343064
2022-03-27 What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? (edit) SARS-CoV-2 (edit) 10.3390/IJMS23073673 35409036
2022-03-27 Emergence of Two Distinct SARS-CoV-2 Gamma Variants and the Rapid Spread of P.1-like-II SARS-CoV-2 during the Second Wave of COVID-19 in Santa Catarina, Southern Brazil (edit) SARS-CoV-2 (edit) 10.3390/V14040695 35458424
2022-03-26 Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105452 35364308
2022-03-26 Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients (edit) SARS-CoV-2 (edit) 10.1016/J.EKIR.2022.03.020 35372734
2022-03-26 Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104156 35368908
2022-03-26 BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era (edit) SARS-CoV-2 (edit) 10.7189/JOGH.12.05008 35356660
2022-03-25 Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects (edit) SARS-CoV-2 (edit) 10.1002/EJI.202149785 35312186
2022-03-25 Structural diversity of the SARS-CoV-2 Omicron spike (edit) SARS-CoV-2 (edit) 10.1016/J.MOLCEL.2022.03.028 35447081
2022-03-25 Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABM0220 35333580
2022-03-25 Associations among eHealth literacy, social support, individual resilience, and emotional status in primary care providers during the outbreak of the SARS-CoV-2 Delta variant (edit) SARS-CoV-2 (edit) 10.1177/20552076221089789
2022-03-25 Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009978
2022-03-25 Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010181 35333914
2022-03-25 Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2022.866474 35401674
2022-03-25 The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2022.794960 35463957
2022-03-25 Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES10040774 35453524
2022-03-25 Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm (edit) SARS-CoV-2 (edit) 10.3390/LIFE12040478
2022-03-25 Survival and Fate of Novel Coronavirus (SARS-CoV-2) in Water and Wastewater: Possible Health Concerns (edit) SARS-CoV-2 (edit) 10.5296/JEE.V13I1.19674
2022-03-24 SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2022.02.015 35334213
2022-03-24 An extended conformation of SARS-CoV-2 main protease reveals allosteric targets (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2120913119 35324337
2022-03-24 EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts (edit) SARS-CoV-2 (edit) 10.1093/BIOINFORMATICS/BTAC176
2022-03-24 Plant-based expression and characterization of SARS-CoV-2 virus-like particles presenting a native spike protein (edit) SARS-CoV-2 (edit) 10.1111/PBI.13813 35325498
2022-03-24 Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0264700 35324925
2022-03-24 Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010093 35325013
2022-03-24 Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.824378 35401544
2022-03-24 Cannabidiol and SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.870787
2022-03-24 Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.75433 35323111
2022-03-24 The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.75720 35323112
2022-03-23 A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination (edit) SARS-CoV-2 (edit) 10.1002/CTI2.1380 35356067
2022-03-23 Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107668
2022-03-23 Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? (edit) SARS-CoV-2 (edit) 10.1128/JVI.02077-21 35225672
2022-03-23 High Seroprevalence of SARS-CoV-2 in White-Tailed Deer (Odocoileus virginianus) at One of Three Captive Cervid Facilities in Texas (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00576-22
2022-03-23 Molnupiravir Does Not Induce Mutagenesis in Host Lung Cells during SARS-CoV-2 Treatment (edit) SARS-CoV-2 (edit) 10.1177/11779322221085077 35342288
2022-03-23 Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2022.859162 35402510
2022-03-23 Genomic Epidemiology of SARS-CoV-2 in Tocantins State and the Diffusion of P.1.7 and AY.99.2 Lineages in Brazil (edit) SARS-CoV-2 (edit) 10.3390/V14040659 35458389
2022-03-22 SARS-CoV-2, SARS-CoV and MERS-CoV encode circular RNAs of spliceosome-independent origin (edit) MERS-CoV (edit) 10.1002/JMV.27734 35318674
2022-03-22 SARS-CoV-2, SARS-CoV and MERS-CoV encode circular RNAs of spliceosome-independent origin (edit) SARS-CoV-2 (edit) 10.1002/JMV.27734 35318674
2022-03-22 Generalized Methodology for the Quick Prediction of Variant SARS-CoV-2 Spike Protein Binding Affinities with Human Angiotensin-Converting Enzyme II (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.1C10718 35315274
2022-03-22 SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1 (edit) SARS-CoV-2 (edit) 10.1186/S13578-022-00770-1 35317858
2022-03-22 In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets (edit) SARS-CoV-2 (edit) 10.3390/BIOM12040482 35454070
2022-03-22 E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.13099 35341044
2022-03-22 The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.13132 35341058
2022-03-21 Intra-protein interactions of SARS-CoV-2 and SARS: a bioinformatic analysis for plausible explanation regarding stability, divergency, and severity (edit) SARS-CoV-2 (edit)
2022-03-21 Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCIM.2C00100 35312321
2022-03-21 Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest (edit) SARS-CoV-2 (edit) 10.1038/S41420-022-00914-9 35314694
2022-03-21 The early SARS-CoV-2 epidemic in Senegal was driven by the local emergence of B.1.416 and the introduction of B.1.1.420 from Europe (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAC025 35371561
2022-03-21 Comparison of Saliva and Midturbinate Swabs for Detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00128-22 35311575
2022-03-21 Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00182-22 35311586
2022-03-21 SARS-CoV-2 Lineage Tracking, and Evolving Trends Seen during Three Consecutive Peaks of Infection in Delhi, India: a Clinico-Genomic Study (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02729-21 35311567
2022-03-21 No man is an island: management of the emergency response to the SARS-CoV-2 (COVID-19) outbreak in a large public decentralised service delivery organisation (edit) SARS-CoV-2 (edit) 10.1186/S12913-022-07716-W
2022-03-21 From Deer-to-Deer: SARS-CoV-2 is efficiently transmitted and presents broad tissue tropism and replication sites in white-tailed deer (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010197 35312736
2022-03-21 SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.868414 35386683
2022-03-21 Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.850987
2022-03-21 The Traditional Chinese Medicine Formula Jing Guan Fang for Preventing SARS-CoV-2 Infection: From Clinical Observation to Basic Research (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2022.744439
2022-03-21 HSP90 Inhibitors Modulate SARS-CoV-2 Spike Protein Subunit 1-Induced Human Pulmonary Microvascular Endothelial Activation and Barrier Dysfunction (edit) SARS-CoV-2 (edit) 10.3389/FPHYS.2022.812199 35388292
2022-03-21 Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic (edit) SARS-CoV-2 (edit) 10.3390/GENES13030552
2022-03-19 SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil (edit) SARS-CoV-2 (edit) 10.3201/EID2804.211961
2022-03-18 Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.03.019 35429436
2022-03-18 Both simulation and sequencing data reveal coinfections with multiple SARS-CoV-2 variants in the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2022.03.011 35342534
2022-03-18 Metataxonomic Analysis of Milk Samples From SARS-CoV-2-Positive and SARS-CoV-2-Negative Women (edit) SARS-CoV-2 (edit) 10.3389/FNUT.2022.853576 35369105
2022-03-17 Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish (edit) SARS-CoV-2 (edit) 10.1016/J.BBI.2022.03.006 35307504
2022-03-17 Immunoassay platform with surface-enhanced resonance Raman scattering for detecting trace levels of SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.TALANTA.2022.123381 35364338
2022-03-17 De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-29104-Y 35301314
2022-03-17 Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAC002 35310621
2022-03-17 Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B.1.1.7 in Pakistan through international travelers (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAC020 35462736
2022-03-17 Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22) (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.865401 35371009
2022-03-17 Mutations and Phylogenetic Analyses of SARS-CoV-2 Among Imported COVID-19 From Abroad in Nanjing, China (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.851323 35369437
2022-03-17 The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites (edit) SARS-CoV-2 (edit) 10.3390/MOLECULES27061947 35335311
2022-03-16 SARS-CoV-2: Receptor and Co-receptor Tropism Probability (edit) SARS-CoV-2 (edit) 10.1007/S00284-022-02807-7 35292865
2022-03-16 Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells (edit) SARS-CoV-2 (edit) 10.1016/J.JKSUS.2022.101965 35313445
2022-03-16 The accessible promoter-mediated supplementary effect of host factors provides new insight into the tropism of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.OMTN.2022.03.010 35313658
2022-03-16 Monitoring SARS-CoV-2 in wastewater during New York City's second wave of COVID-19: sewershed-level trends and relationships to publicly available clinical testing data (edit) SARS-CoV-2 (edit) 10.1039/D1EW00747E
2022-03-16 Sensitive, smartphone-based SARS-CoV-2 detection from clinical saline gargle samples (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC028 35450423
2022-03-16 Collaboration between Clinical and Academic Laboratories for Sequencing SARS-CoV-2 Genomes (edit) SARS-CoV-2 (edit) 10.1128/JCM.01288-21
2022-03-16 When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1128/JVI.00136-22 35293770
2022-03-16 Free ISG15 and protein ISGylation emerging in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.2174/1389450123666220316094720 35297347
2022-03-16 SARS-CoV-2 spike E156G/Δ157-158 mutations contribute to increased infectivity and immune escape (edit) SARS-CoV-2 (edit) 10.26508/LSA.202201415 35296517
2022-03-16 SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.71945 35293857
2022-03-16 Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.77444 35294338
2022-03-15 Isolation of Thioinosine and Butenolides from a Terrestrial Actinomycetes sp. GSCW-51 and Their in Silico Studies for Potential against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1002/CBDV.202100843 35213767
2022-03-15 Virus blocking textile for SARS-CoV-2 using human body triboelectric energy harvesting (edit) SARS-CoV-2 (edit) 10.1016/J.XCRP.2022.100813 35309284
2022-03-15 Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.824578 35372134
2022-03-14 When cyclin‐dependent kinases meet viral infections, including SARS‐CoV‐2 (edit) SARS-CoV-2 (edit) 10.1002/JMV.27719 35288942
2022-03-14 SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2022.103940 35301181
2022-03-14 Association of high SARS-CoV-2 RNAemia with diabetes and mortality in critically ill COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104075 35309726
2022-03-14 Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge (edit) SARS-CoV-2 (edit) 10.1038/S41541-022-00451-7 35288576
2022-03-14 Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity (edit) SARS-CoV-2 (edit) 10.1038/S41579-022-00722-Z
2022-03-14 Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics (edit) SARS-CoV-2 (edit) 10.1128/AEM.02289-21 35285246
2022-03-14 Data on Transfer of Human Coronavirus SARS-CoV-2 from Foods and Packaging Materials to Gloves Indicate That Fomite Transmission Is of Minor Importance (edit) SARS-CoV-2 (edit) 10.1128/AEM.02338-21 35285254
2022-03-14 Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2022.799703 35372520
2022-03-13 Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease (edit) SARS-CoV-2 (edit) 10.1002/SMSC.202100124 35600064
2022-03-13 Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2. (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2022.103934 35290827
2022-03-12 Characterization of persons with reported SARS-CoV-2 infection in the Oklahoma City tri-county area: Evidence from the first 12 months of transmission (edit) SARS-CoV-2 (edit) 10.1016/J.AJIC.2022.03.007 35292299
2022-03-12 Risk of SARS-CoV-2 transmission upon return to work in RNA-positive healthcare workers (edit) SARS-CoV-2 (edit) 10.1016/J.JHIN.2022.02.024 35288252
2022-03-11 Persistence of Endogenous SARS-CoV-2 and Pepper Mild Mottle Virus RNA in Wastewater-Settled Solids (edit) SARS-CoV-2 (edit)
2022-03-11 RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.104043 35291264
2022-03-11 Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2022.100583 35480627
2022-03-11 Efficient Identification of Anti-SARS-CoV-2 Compounds Using Chemical Structure- and Biological Activity-Based Modeling (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.1C01372 35275639
2022-03-11 ACE2-independent infection of T lymphocytes by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41392-022-00919-X
2022-03-11 Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-08073-8 35277538
2022-03-11 Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABL4292 35084937
2022-03-11 Indirect protection of children from SARS-CoV-2 infection through parental vaccination (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABM3087 35084938
2022-03-11 The changing epidemiology of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABM4915 35271324
2022-03-11 Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0263671 35275926
2022-03-11 Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7110A3 35271558
2022-03-11 SARS-CoV-2 Incidence in K-12 School Districts with Mask-Required Versus Mask-Optional Policies - Arkansas, August-October 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7110E1 35271560
2022-03-11 Exploring Zebrafish Larvae as a COVID-19 Model: Probable Abortive SARS-CoV-2 Replication in the Swim Bladder (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2022.790851 35360100
2022-03-11 Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10030433 35335065
2022-03-10 SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo (edit) SARS-CoV-2 (edit)
2022-03-10 Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.03.009 35344711
2022-03-10 Structural basis of nanobodies neutralizing SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.STR.2022.02.011 35276082
2022-03-10 Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells (edit) SARS-CoV-2 (edit) 10.1038/S41423-022-00845-6 35273357
2022-03-10 Divergent trajectories of antiviral memory after SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28898-1 35273178
2022-03-10 Anti-SARS-CoV-2 equine F (Ab')2 immunoglobulin as a possible therapy for COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-07793-1 35273234
2022-03-10 Stopping pandemics before they start: Lessons learned from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABN1900
2022-03-10 Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABO0535 35271298
2022-03-10 Unsupervised explainable AI for molecular evolutionary study of forty thousand SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1186/S12866-022-02484-3
2022-03-10 Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant (edit) SARS-CoV-2 (edit) 10.17179/EXCLI2022-4721 35651657
2022-03-10 Overview SARS-CoV-2 Pandemic as January-February 2022: Likely Cometary Origin, Global Spread, Prospects for Future Vaccine Efficacy (edit) SARS-CoV-2 (edit) 10.31038/IDT.2022311
2022-03-10 Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43 (edit) Human coronavirus OC43 (edit) 10.3389/FIMMU.2022.835333 35359936
2022-03-10 Decline in Respiratory Functions in Hospitalized SARS-CoV-2 Infected Cancer Patients Following Cytotoxic Chemotherapy-An Additional Risk for Post-chemotherapy Complications (edit) SARS-CoV-2 (edit) 10.3389/FMED.2022.835098 35360723
2022-03-10 SARS-CoV-2 infection in public hospital medical doctors in an Eastern Cape metro (edit) SARS-CoV-2 (edit) 10.4102/SAJID.V37I1.335 35399560
2022-03-09 Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study (edit) SARS-CoV-2 (edit) 10.1136/BMJ-2021-069761
2022-03-09 In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S43141-022-00314-7 35262828
2022-03-09 Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0261045 35263335
2022-03-09 RespiCoV: Simultaneous identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and 46 respiratory tract viruses and bacteria by amplicon-based Oxford-Nanopore MinION sequencing (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0264855 35263362
2022-03-09 CovDif, a Tool to Visualize the Conservation between SARS-CoV-2 Genomes and Variants (edit) SARS-CoV-2 (edit) 10.3390/V14030561
2022-03-08 RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.OMTN.2022.02.008 35186439
2022-03-08 Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication–transcription complex (edit) SARS-CoV-2 (edit) 10.1038/S41594-022-00734-6
2022-03-08 An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-07867-0 35260703
2022-03-07 Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.BIOMATERIALS.2022.121460 35286852
2022-03-07 Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110558 35303476
2022-03-07 Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110561 35303475
2022-03-07 Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells (edit) SARS-CoV-2 (edit) 10.1016/J.VIRS.2022.03.003 35272059
2022-03-07 HLA-dependent variation in SARS-CoV-2 CD8 + T cell cross-reactivity with human coronaviruses (edit) SARS-CoV-2 (edit) 10.1111/IMM.13451 35143694
2022-03-07 Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02191-21 35254107
2022-03-07 Using genomic epidemiology of SARS-CoV-2 to support contact tracing and public health surveillance in rural Humboldt County, California (edit) SARS-CoV-2 (edit) 10.1186/S12889-022-12790-0 35255849
2022-03-07 Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance (edit) SARS-CoV-2 (edit) 10.15252/EMBR.202154199 35253970
2022-03-06 An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages (edit) SARS-CoV-2 (edit) 10.7150/THNO.66831 35401811
2022-03-05 Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(22)00152-0 35202601
2022-03-04 Transport Safety Concerning a Patient Infected With SARS-CoV-2 and Emergency Service Officers in an Ambulance Accident—A Case Study (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.50
2022-03-04 Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine (edit) SARS-CoV-2 (edit) 10.1093/JTM/TAAC033
2022-03-04 Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity (edit) SARS-CoV-2 (edit) 10.1101/2022.03.01.482592
2022-03-04 Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABN2688 35143256
2022-03-03 CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2 (edit) SARS-CoV-2 (edit)
2022-03-03 Truncating fined-tuned vision-based models to lightweight deployable diagnostic tools for SARS-CoV-2 infected chest X-rays and CT-scans (edit) SARS-CoV-2 (edit) 10.1007/S11042-022-12484-0 35261555
2022-03-03 Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28882-9 35241675
2022-03-03 Viral load of SARS-CoV-2 in droplets and bioaerosols directly captured during breathing, speaking and coughing (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-07301-5 35241703
2022-03-03 SARS-CoV-2 ORF3a induces RETREG1/FAM134B-dependent reticulophagy and triggers sequential ER stress and inflammatory responses during SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1080/15548627.2022.2039992 35239449
2022-03-03 Statewide Evaluation of SARS-CoV-2 Diagnoses and Sexual Orientation and Gender Identity (edit) SARS-CoV-2 (edit) 10.1177/00333549221077073
2022-03-03 Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant (edit) SARS-CoV-2 (edit) 10.1186/S12916-022-02312-5
2022-03-03 Mini-XT, a miniaturized tagmentation-based protocol for efficient sequencing of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S12967-022-03307-9 35241105
2022-03-02 Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28603-2 35236847
2022-03-02 Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009922 35235558
2022-03-02 Travel ban effects on SARS-CoV-2 transmission lineages in the UAE as inferred by genomic epidemiology (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0264682 35235585
2022-03-01 Comparison of anti-peptide and anti-protein antibody-based purification techniques for detection of SARS-CoV-2 by targeted LC-MS/MS (edit) SARS-CoV-2 (edit)
2022-03-01 Elucidating important structural features for the binding affinity of spike - SARS-CoV-2 neutralizing antibody complexes (edit) SARS-CoV-2 (edit) 10.1002/PROT.26277 34761442
2022-03-01 Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α (edit) SARS-CoV-2 (edit) 10.1007/S12024-021-00414-9 34463916
2022-03-01 The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease (edit) SARS-CoV-2 (edit) 10.1016/J.AMJOTO.2021.103320
2022-03-01 SARS-CoV-2 vaccine-associated-tinnitus: A review (edit) SARS-CoV-2 (edit) 10.1016/J.AMSU.2022.103293
2022-03-01 SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110429
2022-03-01 Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine (edit) SARS-CoV-2 (edit) 10.1016/J.CMI.2021.10.006
2022-03-01 Factors Responsible for Emergence of Novel Viruses: An emphasis on SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COESH.2022.100358
2022-03-01 Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105367 35247766
2022-03-01 Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.112092 34562480
2022-03-01 Existing human mobility data sources poorly predicted the spatial spread of SARS-CoV-2 in Madagascar (edit) SARS-CoV-2 (edit) 10.1016/J.EPIDEM.2021.100534
2022-03-01 Vaccine efficacy and SARS-CoV-2 control in California and U.S. during the session 2020–2026: A modeling study (edit) SARS-CoV-2 (edit) 10.1016/J.IDM.2021.11.002
2022-03-01 HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103856
2022-03-01 Experiences of the SARS-CoV-2 pandemic amongst Australian healthcare workers: from stressors to protective factors (edit) SARS-CoV-2 (edit) 10.1016/J.JHIN.2021.12.002 34902500
2022-03-01 Copper acetate aerosols: A possible tool complementary to vaccination in fight against SARS-CoV-2 and variants replication (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110775
2022-03-01 Mitochondrial hijacking: A potential mechanism for SARS-CoV-2 to impair female fertility (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2022.110778
2022-03-01 Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.MTADV.2022.100208
2022-03-01 SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2022.01.003
2022-03-01 T cell responses to SARS-CoV-2 spike cross-recognize Omicron (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04460-3 35102311
2022-03-01 Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04465-Y 35102312
2022-03-01 Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor (edit) SARS-CoV-2 (edit) 10.1038/S42003-022-03084-7
2022-03-01 Laboratory study of physical barrier efficiency for worker protection against SARS-CoV-2 while standing or sitting (edit) SARS-CoV-2 (edit) 10.1080/02786826.2021.2020210
2022-03-01 Feasibility of a high-volume filter sampler for detecting SARS-CoV-2 RNA in COVID-19 patient rooms (edit) SARS-CoV-2 (edit) 10.1093/ANNWEH/WXAB100 34791020
2022-03-01 Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAC120 35234938
2022-03-01 Coupling freedom from disease principles and early warning from wastewater surveillance to improve health security (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC001 36712792
2022-03-01 Continuous genomic diversification of long polynucleotide fragments drives the emergence of new SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1093/PNASNEXUS/PGAC018 36712796
2022-03-01 The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03705-21 35229634
2022-03-01 Impact of residual risk messaging to reduce false reassurance following test-negative results from asymptomatic coronavirus (SARS-CoV-2) testing: an online experimental study of a hypothetical test (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-056533
2022-03-01 Histopathology and localization of SARS-CoV-2 and its host cell entry receptor ACE2 in tissues from naturally infected US-farmed mink (Neovison vison) (edit) SARS-CoV-2 (edit) 10.1177/03009858221079665
2022-03-01 The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression (edit) SARS-CoV-2 (edit) 10.1261/RNA.079086.121
2022-03-01 TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021109622 35178710
2022-03-01 Does SARS-CoV-2 affect cochlear functions in children? (edit) SARS-CoV-2 (edit) 10.15537/SMJ.2022.43.3.20210782
2022-03-01 Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic (edit) SARS-CoV-2 (edit) 10.2217/FMB-2021-0286
2022-03-01 Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications (edit) SARS-CoV-2 (edit) 10.3201/EID2803.211885 35202525
2022-03-01 Impact of SARS-CoV-2 Infection Among Non-Invasive Ventilated ALS Patients (edit) SARS-CoV-2 (edit) 10.3233/JND-210733
2022-02-28 The SARS-CoV-2 Mu variant should not be left aside: It warrants attention for its immuno-escaping ability (edit) SARS-CoV-2 (edit) 10.1002/JMV.27663 35174519
2022-02-28 ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2022.105271 35240221
2022-02-28 Optimizing peptide inhibitors of SARS-Cov-2 nsp10/nsp16 methyltransferase predicted through molecular simulation and machine learning (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2022.100886 35252541
2022-02-28 SARS-CoV-2 nucleocapsid protein targets a conserved surface groove of the NTF2-like domain of G3BP1 (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2022.167516 35240128
2022-02-26 Comparison of analytical sensitivity and efficiency for SARS-CoV-2 primer sets by TaqMan-based and SYBR Green-based RT-qPCR (edit) SARS-CoV-2 (edit) 10.1007/S00253-022-11822-4 35218386
2022-02-26 Machine learning prediction of 3CL SARS-CoV-2 docking scores (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2022.107656
2022-02-25 The first baseline of ALDFG generated by the artisanal fishery during the SARS-CoV-2 pandemic on the north coast of Pernambuco, Brazil (edit) SARS-CoV-2 (edit) 10.1016/J.MARPOLBUL.2022.113470 35245765
2022-02-25 Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay (edit) SARS-CoV-2 (edit) 10.1038/S42003-022-03090-9 35217718
2022-02-25 Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABN8652 35076256
2022-02-25 Index-Based Policy to Guide Mask-Wearing for SARS-CoV-2 and Other Pandemics (edit) SARS-CoV-2 (edit) 10.2139/SSRN.4039299
2022-02-25 Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.3168/JDS.2021-21247 35221061
2022-02-25 Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.835686 35281029
2022-02-25 Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.838985
2022-02-25 A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody (edit) SARS-CoV-2 (edit) 10.3390/IJMS23052558 35269703
2022-02-24 Viroporins: structure, function, and their role in the life cycle of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.BIOCEL.2022.106185 35219876
2022-02-24 Insights into Binding of Single-Stranded Viral RNA Template to the Replication-Transcription Complex of SARS-CoV-2 for the Priming Reaction from Molecular Dynamics Simulations (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOCHEM.1C00755 35199520
2022-02-24 Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.0C01140 33186044
2022-02-24 Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India (edit) SARS-CoV-2 (edit) 10.1038/S41591-022-01736-Z
2022-02-24 Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-06873-6 35210470
2022-02-24 Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination (edit) SARS-CoV-2 (edit) 10.3201/EID2804.211907 35203113
2022-02-23 Neuropilin‐1‐Mediated SARS‐CoV‐2 Infection in Bone Marrow‐Derived Macrophages Inhibits Osteoclast Differentiation (edit) SARS-CoV-2 (edit) 10.1002/ADBI.202200007 35195371
2022-02-23 The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2022.02.068 35245742
2022-02-23 Detection of SARS-CoV-2 RNA throughout wastewater treatment plants and a modeling approach to understand COVID-19 infection dynamics in Winnipeg, Canada (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.153906 35218826
2022-02-23 Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28508-0 35197461
2022-02-23 An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission (edit) SARS-CoV-2 (edit) 10.1038/S41541-022-00450-8 35197485
2022-02-23 Evaluation of Swab-Seq as a scalable, sensitive assay for community surveillance of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-06901-5
2022-02-23 Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01454-21 35196794
2022-02-23 Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections—an Open Observational Study in Lower Saxony, Germany (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01512-21
2022-02-23 Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02366-21 35196783
2022-02-23 Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02513-21
2022-02-23 Limited Recognition of Highly Conserved Regions of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.02780-21 35196796
2022-02-23 Is heparan sulfate a target for inhibition of RNA virus infection? (edit) SARS-CoV-2 (edit) 10.1152/AJPCELL.00028.2022
2022-02-23 Serially passaged, conditionally reprogrammed nasal epithelial cells as a model to study epithelial functions and SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1152/AJPCELL.00363.2021 35196166
2022-02-23 Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.832501 35281023
2022-02-23 Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.829094 35283834
2022-02-23 Stillbirth after COVID-19 in Unvaccinated Mothers Can Result from SARS-CoV-2 Placentitis, Placental Insufficiency, and Hypoxic Ischemic Fetal Demise, Not Direct Fetal Infection: Potential Role of Maternal Vaccination in Pregnancy (edit) SARS-CoV-2 (edit) 10.3390/V14030458 35336864
2022-02-23 IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study (edit) SARS-CoV-2 (edit) 10.5603/CJ.A2021.0148 34787891
2022-02-22 The SARS‐CoV‐2 Spike Glycoprotein Directly Binds Exogeneous Sialic Acids: A NMR View (edit) SARS-CoV-2 (edit) 10.1002/ANIE.202201432
2022-02-22 Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103967 35224468
2022-02-22 A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2022.101229 35287269
2022-02-22 Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture (edit) SARS-CoV-2 (edit) 10.1038/S42003-022-03101-9 35194144
2022-02-22 BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant (edit) SARS-CoV-2 (edit) 10.1038/S43856-022-00083-X 35465056
2022-02-22 Identification of a SARS-CoV-2 host metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 and variants of concern Alpha, Delta, and Omicron (edit) SARS-CoV-2 (edit) 10.1101/2022.02.19.481107
2022-02-22 Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review (edit) SARS-CoV-2 (edit) 10.1186/S40001-022-00647-6 35193695
2022-02-22 Shedding Light on SARS-CoV-2, COVID-19, COVID-19 Vaccination, and Auditory Symptoms: Causality or Spurious Conjunction? (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2022.837513
2022-02-21 Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma (edit) SARS-CoV-2 (edit) 10.1007/S12185-022-03300-4 35190963
2022-02-21 SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110503 35235832
2022-02-21 Limited extent and consequences of pancreatic SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110508 35247306
2022-02-21 Active site prediction of phosphorylated SARS-CoV-2 N-Protein using molecular simulation (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2022.100889 35224174
2022-02-21 Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism (edit) SARS-CoV-2 (edit) 10.1242/JCS.259666 35187564
2022-02-21 Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19042392
2022-02-19 How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17 (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2022.01.038 35063769
2022-02-19 Can spike fragments of SARS-CoV-2 induce genomic instability and DNA damage in the guppy, Poecilia reticulate? An unexpected effect of the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.153988 35192827
2022-02-18 Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein (edit) SARS-CoV-2 (edit) 10.1007/S00705-022-05385-Y 35178586
2022-02-18 SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism (edit) SARS-CoV-2 (edit) 10.1007/S12015-021-10322-8 35181867
2022-02-18 Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2022.105253 35189404
2022-02-18 Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-06752-0 35181735
2022-02-18 Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity (edit) SARS-CoV-2 (edit) 10.1101/2022.02.17.480845
2022-02-18 SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABM5835 35076281
2022-02-18 SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABN7760 35050643
2022-02-17 Synthesis of Dihydrobenzofuro[3,2-b]chromenes as Potential 3CLpro Inhibitors of SARS-CoV-2: A Molecular Docking and Molecular Dynamics Study (edit) SARS-CoV-2 (edit) 10.1002/CMDC.202100782 35112482
2022-02-17 Identification of a Potential mRNA-based Vaccine Candidate against the SARS-CoV-2 Spike Glycoprotein: A Reverse Vaccinology Approach (edit) SARS-CoV-2 (edit) 10.1002/SLCT.202103903 35601809
2022-02-17 Impacts of the SARS-CoV-2 pandemic on the global demand for exotic pets: An expert elicitation approach (edit) SARS-CoV-2 (edit) 10.1016/J.GECCO.2022.E02067
2022-02-17 SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103934 35194575
2022-02-17 Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103939 35194576
2022-02-17 The effect of prostacyclin infusion on markers of endothelial activation and damage in mechanically ventilated patients with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.JCRC.2022.154010 35183892
2022-02-17 Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS-CoV-2 using computational and in vitro approaches (edit) SARS-CoV-2 (edit) 10.1016/J.MOLLIQ.2022.118775 35194277
2022-02-17 Detecting SARS-CoV-2 lineages and mutational load in municipal wastewater and a use-case in the metropolitan area of Thessaloniki, Greece (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-06625-6 35177697
2022-02-17 Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010343 35176124
2022-02-17 Sensitivity and efficiency of RNA sample pooling for real-time quantitative polymerase chain reaction testing for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.21037/JPHE-21-97
2022-02-17 A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pa (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10020314 35214772
2022-02-16 Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions (edit) SARS-CoV-2 (edit) 10.1016/J.LFS.2022.120411 35181310
2022-02-16 Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04532-4
2022-02-16 Reproduction Numbers of SARS-CoV-2 Variants: A Systematic Review and Meta-analysis (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAC137 35171991
2022-02-16 Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00681-21 35170989
2022-02-16 Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01271-21 35171025
2022-02-16 Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S12865-022-00480-W 35172720
2022-02-16 Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.51061.3
2022-02-16 Infection clusters can elevate risk of diagnostic target failure for detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0264008 35171960
2022-02-16 A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.811430 35250984
2022-02-16 Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.828053 35251012
2022-02-16 Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies (edit) SARS-CoV-2 (edit) 10.4049/IMMUNOHORIZONS.2200005 35173021
2022-02-15 Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-06306-4 35169179
2022-02-15 SARS-CoV-2 RNA is enriched by orders of magnitude in primary settled solids relative to liquid wastewater at publicly owned treatment works (edit) SARS-CoV-2 (edit) 10.1039/D1EW00826A 35433013
2022-02-15 Unrecognized introductions of SARS-CoV-2 into the US state of Georgia shaped the early epidemic (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAC011 35317348
2022-02-15 Inhibition of Protein Glycosylation Blocks SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03718-21 35164559
2022-02-15 Assessment of performance and implementation characteristics of rapid point of care SARS-CoV-2 antigen testing (edit) SARS-CoV-2 (edit) 10.12688/AASOPENRES.13323.1
2022-02-15 Operationalizing a routine wastewater monitoring laboratory for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PWAT.0000007
2022-02-15 Rapid SARS-CoV-2 Intra-Host and Within-Household Emergence of Novel Haplotypes (edit) SARS-CoV-2 (edit) 10.3390/V14020399
2022-02-14 Strikingly Different Roles of SARS-CoV-2 Fusion Peptides Uncovered by Neutron Scattering (edit) SARS-CoV-2 (edit) 10.1021/JACS.1C09856 35157798
2022-02-14 Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28446-X 35165285
2022-02-14 Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-04952-2 35165301
2022-02-14 Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2106379119 35165203
2022-02-14 Structural polymorphism of coiled‐coils from the stalk domain of SARS‐CoV‐2 spike protein (edit) SARS-CoV-2 (edit) 10.1096/FJ.202101670R 35157347
2022-02-14 Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study (edit) SARS-CoV-2 (edit) 10.1186/S12933-022-01462-3 35164745
2022-02-14 SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.798813 35237261
2022-02-14 Post SARS-CoV-2 Urban India: Computing Air Quality Health Indicators (AQHI) for Gurugram City to Assess Imminent Threats to Public Health (edit) SARS-CoV-2 (edit) 10.53550/EEC.2022.V28I01S.027
2022-02-13 Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells (edit) SARS-CoV-2 (edit) 10.1016/J.PEP.2022.106071 35172194
2022-02-13 Use of ozonation technology to combat viruses and bacteria in aquatic environments: problems and application perspectives for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/09593330.2022.2034981
2022-02-13 Disposition of PF-07321332 (Nirmatrelvir), an Orally Bioavailable Inhibitor of SARS-CoV-2 3CL Protease, across Animals and Humans (edit) SARS-CoV-2 (edit) 10.1124/DMD.121.000801
2022-02-12 Structure and dynamics of the SARS‐CoV ‐2 envelope protein monomer (edit) SARS-CoV-2 (edit) 10.1002/PROT.26317
2022-02-12 Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations (edit) SARS-CoV-2 (edit) 10.1016/J.YMETH.2022.02.004 35167916
2022-02-12 Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy (edit) SARS-CoV-2 (edit) 10.1016/J.YMTHE.2022.02.013 35167974
2022-02-11 SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2022.101724 35157849
2022-02-11 Evaluation of Interactions between SARS-CoV-2 RBD and Full-Length ACE2 with Coarse-Grained Molecular Dynamics Simulations (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCIM.1C01306 35147419
2022-02-11 Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABN7591 35040667
2022-02-11 Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots (edit) SARS-CoV-2 (edit) 10.3791/63395
2022-02-10 Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform (edit) SARS-CoV-2 (edit) 10.1016/J.YMTHE.2022.02.011 35151843
2022-02-10 Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses (edit) SARS-CoV-2 (edit) 10.1021/JACS.1C08402 35142215
2022-02-10 Plasma Neutralization of the SARS-CoV-2 Omicron Variant (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2119641 35030645
2022-02-10 Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro (edit) SARS-CoV-2 (edit) 10.1080/22221751.2022.2026739
2022-02-10 Factors affecting the transmission of SARS-CoV-2 in school settings (edit) SARS-CoV-2 (edit) 10.1111/IRV.12968 35146922
2022-02-10 Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients (edit) SARS-CoV-2 (edit) 10.1152/JAPPLPHYSIOL.00015.2022 35142560
2022-02-10 Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07102-1 35144550
2022-02-10 Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009726 35143484
2022-02-10 The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009914 35143587
2022-02-10 A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010265 35143592
2022-02-10 Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.820126
2022-02-09 Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development (edit) SARS-CoV-2 (edit) 10.1016/J.CRSTBI.2022.01.002 35156058
2022-02-09 Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2 (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2022.101710 35150743
2022-02-09 Selection of surrogate viruses for process control in detection of SARS-CoV-2 in wastewater (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.153737 35149069
2022-02-09 Monitoring of SARS-CoV-2 seroprevalence among primary healthcare patients in the Barcelona Metropolitan Area: the SeroCAP sentinel network protocol (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-053237 35140153
2022-02-09 The atlas of ACE2 expression in fetal and adult human hearts reveals the potential mechanism of heart-injured patients infected with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1152/AJPCELL.00169.2021 35138176
2022-02-09 Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis (edit) SARS-CoV-2 (edit) 10.1186/S13578-022-00750-5 35139909
2022-02-08 B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients (edit) SARS-CoV-2 (edit) 10.1002/ANA.26309 35067959
2022-02-08 Human SARS-CoV-2 has evolved to increase U content and reduce genome size (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2022.02.034 35149094
2022-02-08 Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury (edit) SARS-CoV-2 (edit) 10.1016/J.PHYPLU.2022.100237 35403090
2022-02-08 Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children? (edit) SARS-CoV-2 (edit) 10.1016/J.PRRV.2022.01.008 35227628
2022-02-08 Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.1C00786
2022-02-08 Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27942-W 35136068
2022-02-08 Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28324-6 35136050
2022-02-08 Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28420-7 35136039
2022-02-08 Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-06091-0 35136154
2022-02-08 An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking (edit) SARS-CoV-2 (edit) 10.1038/S42003-022-03063-Y 35136165
2022-02-08 Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes and Alveolar Macrophages (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03751-21 35130722
2022-02-08 SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021 (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03788-21 35130727
2022-02-08 Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-055474 35135773
2022-02-08 SARS-CoV-2 Spike Glycoprotein Binds Heparan Sulfate Chains and N-Glycans in Psoriatic Keratinocytes: A Hypothesis. (edit) SARS-CoV-2 (edit) 10.33425/2690-537X.1019
2022-02-07 Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CLPro) of SARS-CoV-2: in silico study (edit) SARS-CoV-2 (edit) 10.1007/S11224-022-01887-2 35153452
2022-02-07 Cryo-EM structure of the SARS-CoV-2 Omicron spike (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110428 35172173
2022-02-07 Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study (edit) SARS-CoV-2 (edit) 10.1016/J.EJCA.2022.01.019 35248840
2022-02-07 The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2022.101695 35143839
2022-02-07 Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04482-X
2022-02-07 Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-054271
2022-02-07 Omicron Variant (B.1.1.529) of SARS-CoV-2, A Worldwide Public Health Emergency! (edit) SARS-CoV-2 (edit) 10.24018/CLINICMED.2022.3.1.159
2022-02-07 Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in Pandemics (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.786233
2022-02-06 Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation (edit) SARS-CoV-2 (edit) 10.1111/JFBC.14085 35128681
2022-02-05 Spatiotemporal clustering patterns and sociodemographic determinants of COVID-19 (SARS-CoV-2) infections in Helsinki, Finland (edit) SARS-CoV-2 (edit)
2022-02-05 Tracing the SARS-CoV-2 infection on the ocular surface: Overview and preliminary corneoscleral transcriptome sequencing (edit) SARS-CoV-2 (edit) 10.1016/J.EXER.2022.108975 35134391
2022-02-05 Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103880 35156006
2022-02-05 Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study (edit) SARS-CoV-2 (edit) 10.1016/J.LANA.2022.100195 35156075
2022-02-05 Escherichia coli recombinant expression of SARS-CoV-2 protein fragments (edit) SARS-CoV-2 (edit) 10.1186/S12934-022-01753-0
2022-02-04 SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2022.100873 35136832
2022-02-04 Limited genomic reconstruction of SARS-CoV-2 transmission history within local epidemiological clusters (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAC008 35242361
2022-02-04 Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike (edit) SARS-CoV-2 (edit) 10.1186/S41231-022-00109-5 35136839
2022-02-04 Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.798538 35185890
2022-02-04 Secondary Structure of Subgenomic RNA M of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V14020322 35215915
2022-02-04 Biomimetic Alveolus-on-a-Chip for SARS-CoV-2 Infection Recapitulation (edit) SARS-CoV-2 (edit) 10.34133/2022/9819154 35224503
2022-02-03 Designed SARS-CoV-2 receptor binding domain variants form stable monomers (edit) SARS-CoV-2 (edit) 10.1002/BIOT.202100422 35078277
2022-02-03 Omicron (B.1.1.529) variant of SARS-CoV-2 – Concerns, challenges and recent updates (edit) SARS-CoV-2 (edit) 10.1002/JMV.27633
2022-02-03 A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2022.01.004 35132398
2022-02-03 Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28246-3
2022-02-03 Myeloid cell interferon responses correlate with clearance of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28315-7 35115549
2022-02-03 The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes Is Consistent with Adaptations to the Human Host (edit) SARS-CoV-2 (edit) 10.1093/MOLBEV/MSAC029
2022-02-03 Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations (edit) SARS-CoV-2 (edit) 10.3389/FCELL.2022.768356 35186917
2022-02-03 Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.817905 35185909
2022-02-02 Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples (edit) SARS-CoV-2 (edit)
2022-02-02 Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2 (edit) SARS-CoV-2 (edit) 10.1007/S40199-022-00435-X
2022-02-02 Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.01.027 35202565
2022-02-02 Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2022.01.011 35134624
2022-02-02 A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28113-1 35110538
2022-02-02 Host cellular RNA helicases regulate SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1128/JVI.00002-22
2022-02-01 Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine (edit) SARS-CoV-2 (edit) 10.1001/JAMAINTERNMED.2021.7382
2022-02-01 SARS-CoV-2 Variant Tracking and Mitigation During In-Person Learning at a Midwestern University in the 2020-2021 School Year (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.46805 35113163
2022-02-01 Comparison of SARS-CoV-2 Test Positivity in NCAA Division I Student Athletes vs Nonathletes at 12 Institutions (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.47805 35138397
2022-02-01 Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach (edit) SARS-CoV-2 (edit) 10.1002/OPEN.202100248 35103413
2022-02-01 SARS-CoV-2 Inhibitors from Nigella Sativa (edit) SARS-CoV-2 (edit) 10.1007/S12010-021-03790-8 35102539
2022-02-01 Dysphagia Characteristics of Patients Post SARS-CoV-2 During Inpatient Rehabilitation (edit) SARS-CoV-2 (edit) 10.1016/J.APMR.2021.10.007
2022-02-01 Rapid detection of novel coronavirus SARS-CoV-2 by RT-LAMP coupled solid-state nanopores (edit) SARS-CoV-2 (edit) 10.1016/J.BIOS.2021.113759
2022-02-01 Multi-color super-resolution imaging to study human coronavirus RNA during cellular infection (edit) Human coronavirus 229E (edit) 10.1016/J.CRMETH.2022.100170 35128513
2022-02-01 Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients (edit) SARS-CoV-2 (edit) 10.1016/J.DIAGMICROBIO.2021.115566 34781164
2022-02-01 SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2022.103861
2022-02-01 Corrigendum to “Error rates in SARS-CoV-2 testing examined with Bayes' theorem” [Heliyon 7, (4), (April 2021), Article e06905] (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2022.E08836
2022-02-01 Impaired hearing following SARS-CoV-2 vaccinations (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.12.317
2022-02-01 A Case Report of Pediatric Germinoma With SARS-CoV-2: Lessons Learned From an Academic Tertiary Referral Hospital in Asian COVID Epicentrum (edit) SARS-CoV-2 (edit) 10.1016/J.IJSCR.2022.106774 35070644
2022-02-01 Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article (edit) SARS-CoV-2 (edit) 10.1016/J.IJSU.2022.106233
2022-02-01 A SARS-CoV-2 Delta variant containing mutation in the probe binding region used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result (edit) SARS-CoV-2 (edit) 10.1016/J.JIAC.2022.01.019 35144878
2022-02-01 Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study (edit) SARS-CoV-2 (edit) 10.1016/J.JINF.2021.09.019
2022-02-01 Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110750
2022-02-01 SARS-CoV-2 might transmit through the skin while the skin barrier function could be the mediator (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110752 35002019
2022-02-01 A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110754
2022-02-01 Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2022.01.014 35180394
2022-02-01 The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review (edit) SARS-CoV-2 (edit) 10.1038/S41429-021-00491-6
2022-02-01 SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load (edit) SARS-CoV-2 (edit) 10.1038/S41467-022-28287-8 35105893
2022-02-01 Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04342-0 34937050
2022-02-01 SARS-CoV-2 infection in free-ranging white-tailed deer (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04353-X 34942632
2022-02-01 Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04462-1 35104835
2022-02-01 Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04474-X 35104837
2022-02-01 SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04479-6
2022-02-01 Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach (edit) SARS-CoV-2 (edit) 10.1080/21655979.2022.2027181 35048792
2022-02-01 Expression of recombinant SARS-CoV-2 papain-like protease (SARS-CoV-2 PLpro) in Escherichia coli RIPL (edit) SARS-CoV-2 (edit) 10.1088/1755-1315/976/1/012033
2022-02-01 Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB1297 35048970
2022-02-01 Testing for SARS-CoV-2 in symptomatic vaccinated and unvaccinated health care workers during the Delta variant surge (edit) SARS-CoV-2 (edit) 10.1097/JOM.0000000000002431 34775397
2022-02-01 The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03168-21 35100873
2022-02-01 Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1165/RCMB.2021-0292OC 34731594
2022-02-01 Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019–February 2020 (edit) SARS-CoV-2 (edit) 10.2147/IDR.S344437
2022-02-01 Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3201/EID2802.211938 34852213
2022-02-01 The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS10020342
2022-02-01 Microplastics and Macroplastic Debris as Potential Physical Vectors of SARS-CoV-2: A Hypothetical Overview with Implications for Public Health (edit) SARS-CoV-2 (edit) 10.3390/MICROPLASTICS1010010
2022-02-01 Structural Comparison and Drug Screening of Spike Proteins of Ten SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.34133/2022/9781758 35198984
2022-02-01 Molecular Docking Studies to Identify Promising Natural Inhibitors Targeting SARS-CoV-2 Nsp10-Nsp16 Protein Complex (edit) SARS-CoV-2 (edit) 10.4274/TJPS.GALENOS.2021.56957 35227055
2022-02-01 A COVID-19 T-Cell Response Detection Method Based on a Newly Identified Human CD8+ T Cell Epitope from SARS-CoV-2 - Hubei Province, China, 2021 (edit) SARS-CoV-2 (edit) 10.46234/CCDCW2021.258 35186375
2022-01-31 Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity (edit) SARS-CoV-2 (edit) 10.1002/CMDC.202100732 35099120
2022-01-31 Virus interactions with the actin cytoskeleton—what we know and do not know about SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S00705-022-05366-1 35102456
2022-01-31 SARS-CoV-2 in Egypt: epidemiology, clinical characterization and bioinformatics analysis (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2022.E08864 35128118
2022-01-31 The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates regulatory/inflammatory signals (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103854 35128349
2022-01-31 Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation (edit) SARS-CoV-2 (edit) 10.1016/J.JTCT.2022.01.019 35092892
2022-01-31 In silico, in vitro screening of plant extracts for anti-SARS-CoV-2 activity and evaluation of their acute and sub-acute toxicity (edit) SARS-CoV-2 (edit) 10.1016/J.PHYPLU.2022.100233 35403091
2022-01-31 An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-05597-X 35102208
2022-01-31 SARS-CoV-2 S Protein Subunit 1 Elicits Ca2+ Influx - Dependent Ca2+ Signals in Pancreatic Stellate Cells and Macrophages In Situ (edit) SARS-CoV-2 (edit) 10.1093/FUNCTION/ZQAC002 35284826
2022-01-31 Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1101/2022.01.29.478316
2022-01-31 Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China (edit) SARS-CoV-2 (edit) 10.1186/S12916-022-02243-1
2022-01-31 Sulfated Polysaccharide from Marine Red Microalga Porphyridium against SARS-CoV-2 - A Mini-Review (edit) SARS-CoV-2 (edit) 10.31080/ASMI.2022.05.1012
2022-01-30 Inhibitory efficacy of 2, 4-diacetylphloroglucinol against SARS-COV-2 proteins: in silico study (edit) SARS-CoV-2 (edit) 10.1007/S11756-021-00979-4 35125499
2022-01-29 The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2022.01.106 35123263
2022-01-29 Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2022.01.024 35126884
2022-01-29 Persistence of SARS-CoV-2 RNA in wastewater after the end of the COVID-19 epidemics (edit) SARS-CoV-2 (edit) 10.1016/J.JHAZMAT.2022.128358
2022-01-29 The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro (edit) SARS-CoV-2 (edit) 10.1016/J.VIRS.2022.01.029 35277373
2022-01-29 Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198702 35104582
2022-01-29 Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(22)00017-4 35065011
2022-01-29 SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB394 33949665
2022-01-28 Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift (edit) SARS-CoV-2 (edit) 10.1002/JMV.27596 35032057
2022-01-28 Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103818 35106453
2022-01-28 Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04466-X 35090164
2022-01-28 Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach (edit) SARS-CoV-2 (edit) 10.1039/D1RA08604A 35425367
2022-01-28 Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile (edit) SARS-CoV-2 (edit) 10.1186/S12879-022-07045-7 35090398
2022-01-28 Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, December 2020-January 2022 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7104E4
2022-01-28 SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.732197 35154090
2022-01-27 Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature (edit) SARS-CoV-2 (edit) 10.1007/S12560-022-09509-0
2022-01-27 Identification of potential edible mushroom as SARS-CoV-2 main protease inhibitor using rational drug designing approach (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-05349-X 35087077
2022-01-27 Effect of SARS-CoV-2 spike mutations on its activation by TMPRSS2 and TMPRSS13 (edit) SARS-CoV-2 (edit) 10.1101/2022.01.26.477969
2022-01-27 Clinically Suspected and Biopsy-Proven Myocarditis Temporally Associated with SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1146/ANNUREV-MED-042220-023859
2022-01-27 Genome-scale CRISPR screens identify host factors that promote human coronavirus infection (edit) SARS-CoV-2 (edit) 10.1186/S13073-022-01013-1 35086559
2022-01-27 Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.751705 35154094
2022-01-27 Integrated Analysis Reveals the Characteristics and Effects of SARS-CoV-2 Maternal-Fetal Transmission (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.813187 35154056
2022-01-26 Trypsin enhances SARS-CoV-2 infection by facilitating viral entry (edit) SARS-CoV-2 (edit) 10.1007/S00705-021-05343-0 35079901
2022-01-26 Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2022.105235 35123137
2022-01-26 Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen Presentation (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOMAC.1C01447 35080884
2022-01-26 Despite the odds: formation of the SARS-CoV-2 methylation complex (edit) SARS-CoV-2 (edit) 10.1101/2022.01.25.477673
2022-01-26 A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells (edit) SARS-CoV-2 (edit) 10.1128/JVI.01678-21 34757848
2022-01-26 Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice (edit) SARS-CoV-2 (edit) 10.1128/JVI.02184-21 35080423
2022-01-26 Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen (edit) SARS-CoV-2 (edit) 10.1128/JVI.02216-21 35080424
2022-01-26 Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France (edit) SARS-CoV-2 (edit) 10.1186/S12916-022-02235-1
2022-01-26 End-to-end system for rapid and sensitive early-detection of SARS-CoV-2 for resource-poor and field-test environments using a $51 lab-in-a-backpack (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0259886 35081119
2022-01-25 Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.01.018 35148837
2022-01-25 A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110368 35123652
2022-01-25 Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2022.01.003 35134333
2022-01-25 Characteristics of SARS-CoV-2 transmission in a medium-sized city with traditional communities during the early COVID-19 epidemic in China (edit) SARS-CoV-2 (edit) 10.1016/J.VIRS.2022.01.030
2022-01-25 Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-05342-4 35079083
2022-01-25 Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2113874119 35078919
2022-01-25 N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03662-21 35073761
2022-01-25 Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests (edit) SARS-CoV-2 (edit) 10.2147/IJN.S328090 35115773
2022-01-24 Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection (edit) SARS-CoV-2 (edit)
2022-01-24 SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.01.015 35139340
2022-01-24 Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2022.100527 35233548
2022-01-24 Protocol for structure determination of SARS-CoV-2 main protease at near-physiological-temperature by serial femtosecond crystallography (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2022.101158 35194584
2022-01-24 SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules (edit) SARS-CoV-2 (edit) 10.1038/S41392-022-00878-3 35075101
2022-01-24 Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010255 35073387
2022-01-24 Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.830527 35140714
2022-01-23 Development and Evaluation of Peptidomimetic Compounds Against SARS-CoV-2 Spike Protein: an In Silico and In Vitro Study (edit) SARS-CoV-2 (edit) 10.1002/MINF.202100231 35068079
2022-01-22 Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2022.103818 35078012
2022-01-22 Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2022.112720 35074352
2022-01-22 Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2022.01.121 35077748
2022-01-22 HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy (edit) SARS-CoV-2 (edit) 10.1021/ACSAMI.1C19541 35067058
2022-01-22 An investigation for the interaction of gamma oryzanol with the Mpro of SARS-CoV-2 to combat COVID-19: DFT, molecular docking, ADME and molecular dynamics simulations (edit) SARS-CoV-2 (edit) 10.1080/07391102.2022.2029770
2022-01-21 Operational Constraints of Detecting SARS-CoV-2 on Passive Samplers using Electronegative Filters: A Kinetic and Equilibrium Analysis (edit) SARS-CoV-2 (edit)
2022-01-21 Patients’ perspective about speech, swallowing and hearing status post-SARS-CoV-2 (COVID-19) recovery: E-survey (edit) SARS-CoV-2 (edit) 10.1007/S00405-021-07217-2
2022-01-21 Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2022.01.006 35150638
2022-01-21 Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2022.01.021 35096288
2022-01-21 Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103589 34909610
2022-01-21 ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103720 35005526
2022-01-21 SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04441-6 35062015
2022-01-21 Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04442-5
2022-01-21 Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-04950-4 35064154
2022-01-21 Tracking the circulating SARS-CoV-2 variant of concern in South Africa using wastewater-based epidemiology (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-05110-4 35064174
2022-01-21 The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABM4034 35044811
2022-01-21 SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABM0620 34735261
2022-01-21 Studies reveal dangers of SARS-CoV-2 infection in pregnancy (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ADA0233
2022-01-21 Identification of Marine Fungi-Based Antiviral Agents as Potential Inhibitors of SARS-CoV-2 by Molecular Docking, ADMET and Molecular Dynamic Study (edit) SARS-CoV-2 (edit) 10.1142/S2737416522500065
2022-01-21 Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.811952 35126396
2022-01-20 SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone (edit) SARS-CoV-2 (edit) 10.1007/S12032-021-01628-1 35059896
2022-01-20 SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110336 35090596
2022-01-20 The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.12.011 35063125
2022-01-20 Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase (edit) SARS-CoV-2 (edit) 10.1039/D1RA07447D 35425333
2022-01-20 RNA reference materials with defined viral RNA loads of SARS-CoV-2-A useful tool towards a better PCR assay harmonization (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0262656 35051208
2022-01-20 Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.74153
2022-01-19 Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110344 35093235
2022-01-19 Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110345 35090598
2022-01-19 Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2022.105404 35065253
2022-01-19 The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain (edit) SARS-CoV-2 (edit) 10.1038/S41392-022-00874-7 35046385
2022-01-19 Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41589-021-00965-6 35046611
2022-01-19 An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01678-Y 35046573
2022-01-19 Tissue-level alveolar epithelium model for recapitulating SARS-CoV-2 infection and cellular plasticity (edit) SARS-CoV-2 (edit) 10.1038/S42003-022-03026-3 35046486
2022-01-19 Extended ensemble simulations of a SARS-CoV-2 nsp1-5'-UTR complex (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009804 35045069
2022-01-19 Genomic surveillance of SARS-CoV-2 in the state of Delaware reveals tremendous genomic diversity (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0262573 35045124
2022-01-19 Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.811020 35126395
2022-01-19 Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence (edit) SARS-CoV-2 (edit) 10.3390/V14020187 35215783
2022-01-18 Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.21921 34860253
2022-01-18 Distinct mutations and lineages of SARS-CoV-2 virus in the early phase of COVID-19 pandemic and subsequent 1-year global expansion (edit) SARS-CoV-2 (edit) 10.1002/JMV.27580 35001392
2022-01-18 Sequence analysis for SNP detection and phylogenetic reconstruction of SARS-cov-2 isolated from Nigerian COVID-19 cases (edit) SARS-CoV-2 (edit) 10.1016/J.NMNI.2022.100955 35070322
2022-01-18 Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27745-Z 35042863
2022-01-18 Early-stage spatial disease surveillance of novel SARS-CoV-2 variants of concern in Germany with crowdsourced data (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-04573-1
2022-01-18 Two short low complexity regions (LCRs) are hallmark sequences of the Delta SARS-CoV-2 variant spike protein (edit) SARS-CoV-2 (edit) 10.1038/S41598-022-04976-8 35042962
2022-01-18 JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03377-21 35038906
2022-01-18 Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection In Vitro, despite Eliciting a Prolonged Antiviral Response (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03436-21 35038898
2022-01-18 Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report (edit) SARS-CoV-2 (edit) 10.12659/AJCR.934220
2022-01-18 Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0262657 35041700
2022-01-18 SARS-CoV-2 antibody seroprevalence in healthcare personnel during the pandemics peak: The experience of single hospital (edit) SARS-CoV-2 (edit) 10.5455/MEDSCIENCE.2021.09.294
2022-01-17 Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells (edit) SARS-CoV-2 (edit) 10.1007/S00018-021-04119-8 35039944
2022-01-17 Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1007/S00253-022-11769-6 35037999
2022-01-17 Detection of homologous recombination events in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S10529-021-03218-7 35037234
2022-01-17 Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations (edit) SARS-CoV-2 (edit) 10.1007/S10719-021-10039-3 35037163
2022-01-17 Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2022.01.094 35051498
2022-01-17 Factors associated with SARS-CoV-2 test positivity in long-term care homes: A population-based cohort analysis using machine learning (edit) SARS-CoV-2 (edit) 10.1016/J.LANA.2021.100146 35072145
2022-01-17 Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2022.153171 35051459
2022-01-17 Purifying Selection Determines the Short-Term Time Dependency of Evolutionary Rates in SARS-CoV-2 and pH1N1 Influenza (edit) SARS-CoV-2 (edit) 10.1093/MOLBEV/MSAC009
2022-01-17 Characterization of the SARS-CoV-2 ExoN (nsp14ExoN–nsp10) complex: implications for its role in viral genome stability and inhibitor identification (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB1303 35037045
2022-01-17 Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.785941 35111156
2022-01-17 Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.796094 35111161
2022-01-16 Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction (edit) SARS-CoV-2 (edit) 10.1016/J.DIAGMICROBIO.2022.115636 35219552
2022-01-15 Automatic system for high-throughput and high-sensitivity diagnosis of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S00449-021-02674-9 35031864
2022-01-15 Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.CRVIRO.2022.100019 35072124
2022-01-15 SARS-CoV-2 rapid antigen tests provide benefits for epidemic control – observations from Austrian schools (edit) SARS-CoV-2 (edit) 10.1016/J.JCLINEPI.2022.01.002
2022-01-14 Detection and discrimination of SARS-CoV-2 spike protein-derived peptides using THz metamaterials (edit) SARS-CoV-2 (edit) 10.1016/J.BIOS.2022.113981 35086028
2022-01-14 Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency Use (edit) SARS-CoV-2 (edit) 10.1017/DMP.2022.15
2022-01-14 4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABJ5508 34855509
2022-01-14 Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABM0811
2022-01-14 Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1186/S12916-021-02228-6 35027067
2022-01-14 In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.794780 35095870
2022-01-14 Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.808932 35095897
2022-01-14 Fatal Pneumonia Associated With a Novel Genotype of Human Coronavirus OC43 (edit) Human coronavirus OC43 (edit) 10.3389/FMICB.2021.795449
2022-01-14 Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes (edit) SARS-CoV-2 (edit) 10.3390/V14010144 35062348
2022-01-13 Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2022.114121 35114539
2022-01-13 Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-01113-X
2022-01-13 The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster model (edit) SARS-CoV-2 (edit) 10.1101/2022.01.12.476031
2022-01-13 A short plus long-amplicon based sequencing approach improves genomic coverage and variant detection in the SARS-CoV-2 genome (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0261014 35025877
2022-01-13 Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.812176
2022-01-12 Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.12.004 34953513
2022-01-12 Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains (edit) SARS-CoV-2 (edit) 10.1016/J.NANTOD.2022.101393 35035515
2022-01-12 SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK (edit) SARS-CoV-2 (edit) 10.1038/S41418-022-00928-X 35022571
2022-01-12 SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02983-5 35022513
2022-01-12 Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2113118119
2022-01-12 SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2117576119 35022217
2022-01-12 Wildlife in Cameroon harbor diverse coronaviruses, including many closely related to human coronavirus 229E (edit) Human coronavirus 229E (edit) 10.1093/VE/VEAB110 35233291
2022-01-12 Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases (edit) SARS-CoV-2 (edit) 10.1128/JVI.02186-21 35019723
2022-01-12 Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1152/AJPLUNG.00397.2021
2022-01-12 Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission (edit) SARS-CoV-2 (edit) 10.3390/IJMS23020796 35054983
2022-01-11 Spatially refined time-varying reproduction numbers of SARS-CoV-2 in Arkansas and Kentucky and their relationship to population size and public health policy, March - November 2020 (edit) SARS-CoV-2 (edit) 10.1016/J.ANNEPIDEM.2021.12.012 35031444
2022-01-11 Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2022.110318 35090597
2022-01-11 Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses (edit) SARS-CoV-2 (edit) 10.1016/J.CHEMBIOL.2021.11.006 35021060
2022-01-11 Exploring the Local Determinants of SARS-CoV-2 Transmission and Control via an Exposure-Based Model (edit) SARS-CoV-2 (edit) 10.1021/ACS.EST.1C05633
2022-01-11 Increased immune escape of the new SARS-CoV-2 variant of concern Omicron (edit) SARS-CoV-2 (edit) 10.1038/S41423-021-00836-Z
2022-01-11 Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27881-6 35017512
2022-01-11 Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California (edit) SARS-CoV-2 (edit) 10.1101/2022.01.11.22269045
2022-01-11 Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02443-21
2022-01-11 Variant analysis of SARS-CoV-2 strains with phylogenetic analysis and the Coronavirus Antiviral and Resistance Database (edit) SARS-CoV-2 (edit) 10.2217/CER-2021-0208 35014556
2022-01-11 SARS-CoV-2 Saliva Mass Screening in Primary Schools: A 10-Week Sentinel Surveillance Study in Munich, Germany (edit) SARS-CoV-2 (edit) 10.3390/DIAGNOSTICS12010162
2022-01-10 Phenotypic analysis of the pediatric immune response to SARS-CoV-2 by flow cytometry (edit) SARS-CoV-2 (edit) 10.1002/CYTO.A.24528 34953025
2022-01-10 The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses (edit) SARS-CoV-2 (edit) 10.1007/S00018-021-04085-1 35013790
2022-01-10 The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro (edit) SARS-CoV-2 (edit) 10.1007/S11418-021-01596-W 35006524
2022-01-10 Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study (edit) SARS-CoV-2 (edit) 10.1007/S11756-021-01004-4 35034970
2022-01-10 'All In One' SARS-CoV-2 variant recognition platform: Machine learning-enabled point of care diagnostics (edit) SARS-CoV-2 (edit) 10.1016/J.BIOSX.2022.100105 35036904
2022-01-10 Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia (edit) SARS-CoV-2 (edit) 10.1016/J.CCELL.2021.12.003 34895486
2022-01-10 Evidence of SARS-CoV-2 symptomatic reinfection in four healthcare professionals from the same hospital despite the presence of antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2022.01.006 35017107
2022-01-10 Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media (edit) SARS-CoV-2 (edit) 10.1016/J.JHAZMAT.2022.128251 35032958
2022-01-10 Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2022.198674 35021068
2022-01-10 Robust and durable serological response following pediatric SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27595-9 35013206
2022-01-10 Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27669-8 35013235
2022-01-10 Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27717-3 35013229
2022-01-10 Identification and characterisation of SARS-CoV-2 and Human alphaherpesvirus 1 from a productive coinfection in a fatal COVID-19 case (edit) SARS-CoV-2 (edit) 10.1590/0074-02760210176 35019069
2022-01-10 The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.804387 35082790
2022-01-10 Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2021.801763
2022-01-10 Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10010099 35062760
2022-01-09 Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study (edit) SARS-CoV-2 (edit) 10.1007/S00431-021-04345-Z
2022-01-09 Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization (edit) SARS-CoV-2 (edit) 10.1007/S10875-021-01190-5 35000058
2022-01-09 Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia (edit) SARS-CoV-2 (edit) 10.1186/S13045-021-01219-7
2022-01-09 Tokophobia and Anxiety in Pregnant Women during the SARS-CoV-2 Pandemic in Poland-A Prospective Cross-Sectional Study (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19020714 35055536
2022-01-08 UV and violet light can Neutralize SARS-CoV-2 Infectivity (edit) SARS-CoV-2 (edit) 10.1016/J.JPAP.2021.100107 35036965
2022-01-08 Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structural and molecular insights (edit) SARS-CoV-2 (edit) 10.1016/J.MOLSTRUC.2022.132369 35034979
2022-01-08 SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1 (edit) SARS-CoV-2 (edit) 10.1038/S41418-021-00916-7
2022-01-08 Ferrets are valuable models for SARS-CoV-2 research (edit) SARS-CoV-2 (edit) 10.1177/03009858211071012 35001763
2022-01-07 Point-of-Care Platform for Rapid Multiplexed Detection of SARS-CoV-2 Variants and Respiratory Pathogens (edit) SARS-CoV-2 (edit) 10.1002/ADMT.202101013 35441089
2022-01-07 Predicting SARS-CoV-2 infection duration at hospital admission:a deep learning solution (edit) SARS-CoV-2 (edit) 10.1007/S11517-021-02479-8
2022-01-07 Immunity to SARS-CoV-2 up to 15 months after infection (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2022.103743 35018336
2022-01-07 A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation (edit) SARS-CoV-2 (edit) 10.1016/J.JIM.2022.113216 35007561
2022-01-07 Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (edit) SARS-CoV-2 (edit) 10.1038/D41586-021-03832-5
2022-01-07 Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04411-Y 35042229
2022-01-07 Vulnerability of SARS-CoV-2 and PR8 H1N1 virus to cold atmospheric plasma activated media (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-04360-Y 34997166
2022-01-07 A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABH3827 34995117
2022-01-07 Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABJ4526 34995115
2022-01-07 Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction (edit) SARS-CoV-2 (edit) 10.1186/S12860-021-00403-4 34991443
2022-01-07 Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH (edit) SARS-CoV-2 (edit) 10.26508/LSA.202101124
2022-01-07 Financial Burden and Shortage of Respiratory Rehabilitation for SARS-CoV-2 Survivors: The Next Step of the Pandemic? (edit) SARS-CoV-2 (edit) 10.3390/JRFM15010020
2022-01-07 SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy (edit) SARS-CoV-2 (edit) 10.4049/JIMMUNOL.2100684
2022-01-07 Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.12751 35036106
2022-01-06 Worsening of Essential Tremor After SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1007/S12311-022-01366-8
2022-01-06 Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context (edit) SARS-CoV-2 (edit) 10.1007/S13167-021-00267-W 35013687
2022-01-06 Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2022.01.001 35093192
2022-01-06 Palindromic target site identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by adopting CRISPR-Cas technique (edit) SARS-CoV-2 (edit) 10.1016/J.GENE.2021.146136 34999179
2022-01-06 Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCIM.1C01451
2022-01-06 Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02946-W 34992214
2022-01-05 Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants (edit) SARS-CoV-2 (edit) 10.1101/2022.01.04.474958
2022-01-05 Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01438-21 34985323
2022-01-05 Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01504-21 34985303
2022-01-05 UV-4B potently inhibits replication of multiple SARS-CoV-2 strains in clinically relevant human cell lines (edit) SARS-CoV-2 (edit) 10.31083/J.FBL2701003
2022-01-04 Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach (edit) SARS-CoV-2 (edit) 10.1007/S12033-021-00432-6 34981440
2022-01-04 SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.12.046 35081335
2022-01-04 SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2111199119 34930824
2022-01-04 SARS-CoV-2 spreads through cell-to-cell transmission (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2111400119 34937699
2022-01-04 IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0262162
2022-01-04 A Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study (edit) SARS-CoV-2 (edit) 10.2196/32564 34803022
2022-01-04 Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10010075
2022-01-03 Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy (edit) SARS-CoV-2 (edit) 10.1007/S00520-021-06667-Y 34977981
2022-01-03 Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus (edit) SARS-CoV-2 (edit) 10.1007/S10989-021-10357-Y 35002586
2022-01-03 Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure (edit) SARS-CoV-2 (edit) 10.1016/J.JKSUS.2021.101810 35002180
2022-01-03 A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice (edit) SARS-CoV-2 (edit) 10.1084/JEM.20211818 34757384
2022-01-03 Sequencing SARS-CoV-2 genomes from saliva (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAB098 35542310
2022-01-03 The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism (edit) SARS-CoV-2 (edit) 10.1101/2022.01.03.21268111
2022-01-03 Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.775420 35046939
2022-01-03 Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10010072
2022-01-02 A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry (edit) SARS-CoV-2 (edit) 10.1016/J.SLASD.2021.12.005 35086793
2022-01-02 Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles (edit) SARS-CoV-2 (edit) 10.1101/2021.12.20.21268048 34981067
2022-01-02 The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V14010078
2022-01-01 Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit)
2022-01-01 Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection (edit) SARS-CoV-2 (edit)
2022-01-01 SARS-CoV-2 productively infects human brain microvascular endothelial cells (edit) SARS-CoV-2 (edit)
2022-01-01 Prediction of SARS-CoV-2-positivity from million-scale complete blood counts using machine learning (edit) SARS-CoV-2 (edit)
2022-01-01 High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencing (edit) SARS-CoV-2 (edit)
2022-01-01 Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance (edit) SARS-CoV-2 (edit)
2022-01-01 Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients (edit) SARS-CoV-2 (edit)
2022-01-01 Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses (edit) SARS-CoV-2 (edit)
2022-01-01 A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing (edit) SARS-CoV-2 (edit)
2022-01-01 Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam (edit) SARS-CoV-2 (edit)
2022-01-01 A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant (edit) SARS-CoV-2 (edit)
2022-01-01 Characteristics of 24 SARS-CoV-2-Sequenced Reinfection Cases in a Tertiary Hospital in Spain (edit) SARS-CoV-2 (edit)
2022-01-01 Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins—A Possible Signature of Adaptive Selection (edit) SARS-CoV-2 (edit)
2022-01-01 Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit)
2022-01-01 Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine (edit) SARS-CoV-2 (edit)
2022-01-01 Saliva molecular testing bypassing RNA extraction is suitable for monitoring and diagnosing SARS-CoV-2 infection in children (edit) SARS-CoV-2 (edit)
2022-01-01 Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination (edit) SARS-CoV-2 (edit)
2022-01-01 Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins [version 2; peer review: 2 approved] (edit) SARS-CoV-2 (edit)
2022-01-01 Sequencing SARS-CoV-2 from antigen tests (edit) SARS-CoV-2 (edit)
2022-01-01 Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine (edit) SARS-CoV-2 (edit)
2022-01-01 Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies (edit) SARS-CoV-2 (edit)
2022-01-01 Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease (edit) SARS-CoV-2 (edit)
2022-01-01 Influence of atmospheric environment on SARS-CoV-2 transmission: A review (edit) SARS-CoV-2 (edit)
2022-01-01 Research progress and intervention strategies against SARS-CoV-2 viral entry (edit) SARS-CoV-2 (edit)
2022-01-01 Application of Nanotechnology for Virus Inactivation in Water: Implications for Transmission-Blocking of the Novel Coronavirus SARS-CoV-2 (edit) SARS-CoV-2 (edit)
2022-01-01 Research Progress on Nano Photonics Technology-based SARS-CoV-2 Detection (edit) SARS-CoV-2 (edit)
2022-01-01 Inorganic-based Surface Materials with Anti-SARS-CoV-2 Properties and Their Mechanisms of Action (edit) SARS-CoV-2 (edit)
2022-01-01 Reduced Requests for Medical Rehabilitation Because of the SARS-CoV-2 Pandemic: A Difference-in-Differences Analysis (edit) SARS-CoV-2 (edit) 10.1016/J.APMR.2021.07.791 34371015
2022-01-01 Pathophysiological and molecular considerations of viral and bacterial infections during maternal-fetal and –neonatal interactions of SARS-CoV-2, Zika, and Mycoplasma infectious diseases (edit) SARS-CoV-2 (edit) 10.1016/J.BBADIS.2021.166285 34624499
2022-01-01 D155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1 (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2022.01.017 35126886
2022-01-01 Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2022.07.019
2022-01-01 Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.11.040 34863925
2022-01-01 SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103722 35005527
2022-01-01 First evidence of SARS-CoV-2 genome detection in zebra mussel (Dreissena polymorpha) (edit) SARS-CoV-2 (edit) 10.1016/J.JENVMAN.2021.113866
2022-01-01 Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden (edit) SARS-CoV-2 (edit) 10.1016/J.JINF.2021.08.043 34474056
2022-01-01 An easy pipeline for one-step purification of SARS-CoV-2 nucleocapsid protein from insect cell suspension culture (edit) SARS-CoV-2 (edit) 10.1016/J.JVIROMET.2021.114341 34699776
2022-01-01 Are there medium to short-term multifaceted effects of the airborne pollutant PM2.5 determining the emergence of SARS-CoV-2 variants? (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110718
2022-01-01 Nicotinic receptors as SARS-CoV-2 spike co-receptors? (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110741
2022-01-01 Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection (edit) SARS-CoV-2 (edit) 10.1016/J.VACCINE.2021.11.051
2022-01-01 Air exchanges, climate change, and severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Results from a survey of the Society of Healthcare Epidemiology of America Research Network (SRN) (edit) SARS-CoV-2 (edit) 10.1017/ASH.2021.256
2022-01-01 Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04186-8 34758478
2022-01-01 Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16 (edit) SARS-CoV-2 (edit) 10.1039/D1CB00135C 35128408
2022-01-01 Structure of the 5′ untranslated region in SARS-CoV-2 genome and its specific recognition by innate immune system via the human oligoadenylate synthase 1 (edit) SARS-CoV-2 (edit) 10.1039/D1CC07006A
2022-01-01 Grammatical evolution-based design of SARS-CoV-2 main protease inhibitors (edit) SARS-CoV-2 (edit) 10.1039/D1CP04159B
2022-01-01 Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods (edit) SARS-CoV-2 (edit) 10.1039/D1RA06532G 35425433
2022-01-01 Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors (edit) SARS-CoV-2 (edit) 10.1039/D2CC00121G 35380569
2022-01-01 Targeting proteases involved in the viral replication of SARS-CoV-2 by sesquiterpene lactones from chicory (Cichorium intybus L.) (edit) SARS-CoV-2 (edit) 10.1039/D2FO00933A
2022-01-01 Ångstrom-scale silver particles potently combat SARS-CoV-2 infection by suppressing the ACE2 expression and inflammatory responses (edit) SARS-CoV-2 (edit) 10.1039/D2TB00336H
2022-01-01 Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19 (edit) SARS-CoV-2 (edit) 10.1080/19420862.2022.2047144 35289719
2022-01-01 A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/19490976.2022.2073131 35574937
2022-01-01 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB380 33906227
2022-01-01 Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart (edit) SARS-CoV-2 (edit) 10.1093/CVR/CVAB322 34647998
2022-01-01 The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB459 34514500
2022-01-01 Proteolytic activation of SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1111/1348-0421.12945 34561887
2022-01-01 Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID (edit) SARS-CoV-2 (edit) 10.1111/ALL.14907 33993490
2022-01-01 SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study (edit) SARS-CoV-2 (edit) 10.1111/ANAE.15563 34428858
2022-01-01 COVID-19 in children: I. Epidemiology, prevention and indirect impacts (edit) SARS-CoV-2 (edit) 10.1111/JPC.15791 34643307
2022-01-01 COVID-19 in children. II: Pathogenesis, disease spectrum and management (edit) SARS-CoV-2 (edit) 10.1111/JPC.15811 34694037
2022-01-01 Study protocol for monitoring SARS-CoV-2 infection and its determinants in Catalonia (Spain): an observational and participatory research approach in a Sentinel Network of Schools (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-055649
2022-01-01 Short- and Long-Term Self-Reported Audiovestibular Symptoms of SARS-CoV-2 Infection in Hospitalized and Nonhospitalized Patients (edit) SARS-CoV-2 (edit) 10.1159/000521963
2022-01-01 Assessment of SARS-CoV-2 seroprevalence by community survey and residual specimens, Denver, Colorado, July-August 2020 (edit) SARS-CoV-2 (edit) 10.1177/00333549211055137 34752156
2022-01-01 Computational Structural and Functional Analyses of ORF10 in Novel Coronavirus SARS-CoV-2 Variants to Understand Evolutionary Dynamics (edit) SARS-CoV-2 (edit) 10.1177/11769343221108218
2022-01-01 A case of sudden mixed hearing loss in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1177/2050313X221080642
2022-01-01 How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0262114 35061758
2022-01-01 Are We Hearing Right? The Negative Impact of New SARS-CoV-2 Preventive Measures and Prolonged Use of Treatment Modalities during Orthodontic Treatment (edit) SARS-CoV-2 (edit) 10.1590/PBOCI.2022.023
2022-01-01 Detecting Time-Evolving Phenotypic Components of Adverse Reactions Against BNT162b2 mRNA SARS-CoV-2 Vaccine Via Non-Negative Tensor Factorization (edit) SARS-CoV-2 (edit) 10.2139/SSRN.4041409
2022-01-01 Pre-Clinical Testing of Two Serologically Distinct Chimpanzee-Origin Adenovirus Vectors Expressing Spike of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.2139/SSRN.4059223
2022-01-01 Thromboembolic Events in Deceased Patients with Proven SARS-CoV-2 Infection: Frequency, Characteristics and Risk Factors (edit) SARS-CoV-2 (edit) 10.2139/SSRN.4075484
2022-01-01 SARS-CoV-2 Disease in Cameroon:& Theoretical and Computational Analysis of a Delayed SIQR Model with Optimal Control (edit) SARS-CoV-2 (edit) 10.2139/SSRN.4229706
2022-01-01 Impact of a Non-Invasive Respiratory Support Strategy and Switches in Therapy During Acute Respiratory Failure Due to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.2139/SSRN.4313559
2022-01-01 Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach (edit) SARS-CoV-2 (edit) 10.2196/32401 35506029
2022-01-01 SARS-CoV-2 antibody screening in healthcare workers: lessons learned from the first months of COVID-19 outbreak in Europe. Significance of serology testing for effective pandemic management and reduction of the occupational risk (edit) SARS-CoV-2 (edit) 10.2478/PJPH-2022-0001
2022-01-01 Using Open-Source Bioinformatics and Visualization Tools to Explore the Structure and Function of SARS-CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.24918/CS.2022.5
2022-01-01 SARS-CoV-2 and Environment: Transmission and Green Combat (edit) SARS-CoV-2 (edit) 10.31632/IJALSR.2022.V05I02.001
2022-01-01 Multistate outbreak of SARS-CoV-2 infections, including vaccine breakthrough infections, associated with large public gatherings, United States (edit) SARS-CoV-2 (edit) 10.3201/EID2801.212220 34793690
2022-01-01 Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.821595 35154139
2022-01-01 Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2022.842740 35265086
2022-01-01 Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2022.854567 35356515
2022-01-01 Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2022.804109 35495619
2022-01-01 Persisting, unilateral tinnitus 22 days after first dose of an mRNA-based SARS-CoV-2 vaccine (edit) SARS-CoV-2 (edit) 10.4103/JFMPC.JFMPC_1927_21
2022-01-01 CHANGES IN CARDIO-PHYSIOLOGICAL PARAMETERS ANALYZED WITH BRUCE PROTOCOL FOLLOWING SARS-COV-2 INFECTION IN SOCCER PLAYERS (edit) SARS-CoV-2 (edit) 10.53582/AMJ2222025M
2022-01-01 SARS-Cov-2 and hearing loss: Two sibling cases (edit) SARS-CoV-2 (edit) 10.5455/MEDSCIENCE.2021.09.295
2022-01-01 Assessment of cochlear functions in hospitalized patients with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.5455/MEDSCIENCE.2022.07.154
2022-01-01 Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis (edit) SARS-CoV-2 (edit) 10.5603/CJ.A2021.0122 34642923
2022-01-01 Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.7150/THNO.65563 34987630
2022-01-01 Seroprevalence of SARS-CoV-2 antibodies among Jordanian citizens: A cross-sectional study of the demographic and clinical factors that ameliorate serum IgG concentration (edit) SARS-CoV-2 (edit) 10.7324/JAPS.2022.121116
2021-12-31 Modelling policy combinations of vaccination and transmission suppression of SARS-CoV-2 in Rio de Janeiro, Brazil (edit) SARS-CoV-2 (edit) 10.1016/J.IDM.2021.12.007 35005325
2021-12-31 SARS-CoV-2 causes a significant stress response mediated by small RNAs in the blood of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.OMTN.2021.12.034 35003892
2021-12-31 Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron (edit) SARS-CoV-2 (edit) 10.1038/S41586-022-04399-5
2021-12-31 In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.2023048
2021-12-31 Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene (edit) SARS-CoV-2 (edit) 10.1080/15476286.2021.2010959 34904915
2021-12-31 Active environmental surveillance of SARS-CoV-2 in Midwestern United States meatpacking plants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0261704
2021-12-31 Evaluation of test to stay strategy on secondary and tertiary transmission of SARS-CoV-2 in K-12 schools - Lake County, Illinois, August 9-October 29, 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM705152E2 34968375
2021-12-31 AB035. Comparative sensitivity of different self-sampling methods for SARS-CoV-2 RT-PCR testing (edit) SARS-CoV-2 (edit) 10.21037/JPHE-21-AB035
2021-12-31 Microsecond molecular dynamics simulations revealed the inhibitory potency of amiloride analogs against SARS-CoV-2 E viroporin (edit) SARS-CoV-2 (edit) 10.5808/GI.21040 35172476
2021-12-31 High-performance computing for SARS-CoV-2 RNAs clustering: a data science‒based genomics approach (edit) SARS-CoV-2 (edit) 10.5808/GI.21056 35012291
2021-12-30 Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-04108-8
2021-12-30 A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAB526
2021-12-30 Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1093/CLINCHEM/HVAB148 34358289
2021-12-30 Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling (edit) SARS-CoV-2 (edit) 10.1093/JMCB/MJAB068 34687317
2021-12-30 Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19010406 35010666
2021-12-29 Kinetics and persistence of anti-SARS-CoV-2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort (edit) SARS-CoV-2 (edit) 10.1002/IID3.583 34965032
2021-12-29 Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529 (edit) SARS-CoV-2 (edit) 10.1101/2021.12.27.474288
2021-12-29 Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010203 34965282
2021-12-29 Hypothetical Immunological and Immunogenetic Model of Heterogenous Effects of BCG Vaccination in SARS-CoV-2 Infections: BCG-induced Trained and Heterologous Immunity (edit) SARS-CoV-2 (edit) 10.20883/MEDICAL.E551
2021-12-28 A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (edit) Human coronavirus 229E (edit) 10.1371/JOURNAL.PBIO.3001490
2021-12-28 A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (edit) MERS-CoV (edit) 10.1371/JOURNAL.PBIO.3001490
2021-12-28 A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001490
2021-12-28 Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-1196079/V1
2021-12-28 Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints (edit) SARS-CoV-2 (edit) 10.3389/FCHEM.2021.757826 35028304
2021-12-28 DETECTION OF SARS-COV-2 FROM SURFACE OF PATIENTS’ LEFTOVER FOOD PACKAGES AT A COVID-19 QUARANTINE CENTRE (edit) SARS-CoV-2 (edit) 10.37268/MJPHM/VOL.21/NO.3/ART.1205
2021-12-27 Development of SARS-CoV-2 packaged RNA reference material for nucleic acid testing (edit) SARS-CoV-2 (edit) 10.1007/S00216-021-03846-Y 34958396
2021-12-27 Spatial and temporal effects on severe acute respiratory coronavirus virus 2 (SARS-CoV-2) contamination of the healthcare environment (edit) SARS-CoV-2 (edit) 10.1017/ICE.2021.530 34955111
2021-12-27 Disease severity related to VOC dominance in unvaccinated SARS-CoV-2 positive adults without risk factors in Sweden (edit) SARS-CoV-2 (edit) 10.1101/2021.12.23.21268040
2021-12-27 SARS-CoV-2 Omicron VOC Transmission in Danish Households (edit) SARS-CoV-2 (edit) 10.1101/2021.12.27.21268278
2021-12-27 The interactions of ZDHHC5/GOLGA7 with SARS-CoV-2 spike (S) protein and their effects on S protein's subcellular localization, palmitoylation and pseudovirus entry (edit) SARS-CoV-2 (edit) 10.1186/S12985-021-01722-W 34961524
2021-12-27 An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-1175516/V1 34981042
2021-12-25 SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids (edit) SARS-CoV-2 (edit) 10.1016/J.STEM.2021.12.010 35032430
2021-12-24 Evidence for a mouse origin of the SARS-CoV-2 Omicron variant (edit) SARS-CoV-2 (edit) 10.1016/J.JGG.2021.12.003 34954396
2021-12-24 Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-04133-7 34952919
2021-12-24 Molecular interactions of the M and E integral membrane proteins of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1039/D1FD00031D 34543372
2021-12-24 SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with delta variant in TMPRSS2-expressed cells (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.2023329
2021-12-24 An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABL4784 34726479
2021-12-24 Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABL6184
2021-12-24 Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABL8506
2021-12-24 Learning From Biological and Computational Machines: Importance of SARS-CoV-2 Genomic Surveillance, Mutations and Risk Stratification (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.783961 35047415
2021-12-24 Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.810047 35003140
2021-12-24 Stress and Coping Strategies of Nurses Working with Patients Infected with and Not Infected with SARS-CoV-2 Virus (edit) SARS-CoV-2 (edit) 10.3390/IJERPH19010195 35010454
2021-12-24 SARS-CoV-2 Post Vaccinated Adverse Effects and Efficacy in the Egyptian Population (edit) SARS-CoV-2 (edit) 10.3390/VACCINES10010018 35062679
2021-12-23 SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.12.026 35026152
2021-12-23 Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.LANWPC.2021.100360 34961854
2021-12-23 A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105195 34954105
2021-12-23 Comprehensive serologic profile and specificity of maternal and neonatal cord blood SARS-CoV-2 antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.XAGR.2021.100046 34961853
2021-12-23 Evolution of enhanced innate immune evasion by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04352-Y 34942634
2021-12-23 Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04385-3 35016194
2021-12-23 Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04386-2 35016195
2021-12-23 Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04388-0
2021-12-23 Considerable escape of SARS-CoV-2 Omicron to antibody neutralization (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04389-Z
2021-12-23 Efficacy of antiviral drugs against the omicron variant of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.12.21.473268
2021-12-23 Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice (edit) SARS-CoV-2 (edit) 10.1101/2021.12.22.473914 34981061
2021-12-23 Spatially distributed infection increases viral load in a computational model of SARS-CoV-2 lung infection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009735
2021-12-23 Critical Role of the Subways in the Initial Spread of SARS-CoV-2 in New York City (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2021.754767 35004575
2021-12-23 Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus (edit) SARS-CoV-2 (edit) 10.3390/V14010017 35062221
2021-12-22 SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.110242 34998467
2021-12-22 Local and systemic responses to SARS-CoV-2 infection in children and adults (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04345-X 34937051
2021-12-22 The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease (edit) SARS-CoV-2 (edit) 10.1042/CS20210735 34807265
2021-12-22 Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice (edit) SARS-CoV-2 (edit) 10.1128/JVI.01969-21 34935438
2021-12-21 Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.BIOORG.2021.105574 34971947
2021-12-21 Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health? (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.152345 34942250
2021-12-21 Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-03731-9 34934117
2021-12-21 Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02756-21
2021-12-21 Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02975-21 34781736
2021-12-21 The Impact of the SARS-CoV-2 (COVID-19) Coronavirus Pandemic on Ecological Security and the Development of International Environmental Policy (edit) SARS-CoV-2 (edit) 10.5604/01.3001.0015.6476
2021-12-20 Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101518 34942146
2021-12-20 Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor (edit) SARS-CoV-2 (edit) 10.1016/J.JKSUS.2021.101773 34955621
2021-12-20 Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach (edit) SARS-CoV-2 (edit) 10.1186/S10020-021-00424-X 34930105
2021-12-20 SARS-CoV-2 infection and persistence throughout the human body and brain (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-1139035/V1
2021-12-20 METHYLENE BLUE INHIBITS THE INTERACTION BETWEEN HEPARAN SULFATE AND SARS-COV-2 SPIKE PROTEIN; A REVIEW OF EVIDENCE FOR A HYPOTHESIS. (edit) SARS-CoV-2 (edit) 10.31674/MJMR.2021.V05I04.002
2021-12-20 Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.12595
2021-12-18 Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition (edit) SARS-CoV-2 (edit) 10.1016/J.CPLETT.2021.139294 34961797
2021-12-18 Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105192 34933126
2021-12-18 SARS-CoV-2 and COVID-19: revisiting the most important research questions (edit) SARS-CoV-2 (edit) 10.1186/S13578-021-00730-1
2021-12-18 The experience of the ethics committee in research in human beings in times of pandemic COVID-19 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.54448/MDNT21634
2021-12-17 Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.105155 34942397
2021-12-17 The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101507 34929169
2021-12-17 Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105191 34923158
2021-12-17 SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00849-0 34921131
2021-12-17 QTQTN motif upstream of the furin-cleavage site plays key role in SARS-CoV-2 infection and pathogenesis (edit) SARS-CoV-2 (edit) 10.1101/2021.12.15.472450
2021-12-17 An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S40001-021-00609-4 34920753
2021-12-17 Geographical Landscape and Transmission Dynamics of SARS-CoV-2 Variants Across India: A Longitudinal Perspective (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.753648
2021-12-16 SARS-CoV-2 loads in urine, sera and stool specimens in association with clinical features of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.JCVP.2021.100059 35262032
2021-12-16 Modeling the number of people infected with SARS-COV-2 from wastewater viral load in Northwest Spain (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.152334 34921882
2021-12-16 Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27611-Y 34916516
2021-12-16 Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2114706 34731554
2021-12-16 COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) (edit) SARS-CoV-2 (edit) 10.1177/09612033211062523
2021-12-16 Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009629
2021-12-16 A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection (edit) SARS-CoV-2 (edit) 10.15252/EMBR.202154341 34914162
2021-12-16 Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.50.2101146
2021-12-16 Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.50.2101147 34915975
2021-12-15 Transmission of SARS-CoV-2 from humans to a 16-year-old domestic cat with comorbidities in Pennsylvania, USA (edit) SARS-CoV-2 (edit) 10.1002/VMS3.695 34910368
2021-12-15 Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.110210 34971573
2021-12-15 Genomic characterization of SARS-CoV-2 and its association with clinical outcomes: a 1-year longitudinal study of the pandemic in Colombia (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.12.326 34920122
2021-12-15 Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB1226 34908151
2021-12-15 Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAB091 35039782
2021-12-15 Heptad stereotypy, S/Q layering, and remote origin of the SARS-CoV-2 fusion core (edit) SARS-CoV-2 (edit) 10.1093/VE/VEAB097 35039783
2021-12-15 Metalloproteinase-dependent and TMPRSS2-independnt cell surface entry pathway of SARS-CoV-2 requires the furin-cleavage site and the S2 domain of spike protein (edit) SARS-CoV-2 (edit) 10.1101/2021.12.14.472513
2021-12-15 Spatial epidemiology and genetic diversity of SARS-CoV-2 and related coronaviruses in domestic and wild animals (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0260635 34910734
2021-12-15 Reconstructing SARS-CoV-2 infection dynamics through the phylogenetic inference of unsampled sources of infection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0261422 34910769
2021-12-15 Comment on “Comparison of two pandemics: H1N1 and SARS-CoV-2” (edit) SARS-CoV-2 (edit) 10.1590/1806-9282.20210756
2021-12-15 Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.724936 34975833
2021-12-15 Cryptocurrency as Epidemiologically Safe Means of Transactions: Diminishing Risk of SARS-CoV-2 Spread (edit) SARS-CoV-2 (edit) 10.3390/MATH9243263
2021-12-14 The atomic portrait of SARS‐CoV‐2 as captured by cryo‐electron microscopy (edit) SARS-CoV-2 (edit) 10.1111/JCMM.17103 34904376
2021-12-14 Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0260850 34905589
2021-12-14 Inflammasomes and SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/V13122513 34960782
2021-12-13 Host Manipulation Mechanisms of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S10441-021-09425-Z 34902063
2021-12-13 Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations (edit) SARS-CoV-2 (edit) 10.1016/J.JTCME.2021.12.002 34926189
2021-12-13 Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27202-X 34903718
2021-12-13 Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples (edit) SARS-CoV-2 (edit) 10.15252/EMMM.202115290 34862752
2021-12-13 Seroprevalence of SARS-CoV-2 (COVID-19) among Health Care Workers in Three Health Facilities of Yaounde, Center Region of Cameroon (edit) SARS-CoV-2 (edit) 10.24018/EJMED.2021.3.6.1109
2021-12-13 A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.766821 34966387
2021-12-11 Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)02758-6 34871545
2021-12-11 Combination of cycle threshold time, absolute lymphocyte count and neutrophil:lymphocyte ratio is predictive of hypoxia in patients with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/TRSTMH/TRAB182 34894631
2021-12-11 Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression (edit) SARS-CoV-2 (edit) 10.1186/S13072-021-00428-1 34895312
2021-12-10 Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103748 34902788
2021-12-10 Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.MOLIMM.2021.12.006 34915268
2021-12-10 Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases (edit) SARS-CoV-2 (edit) 10.1039/D1RA07504G 35492479
2021-12-10 Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABL9463
2021-12-09 Numbers of close contacts of individuals infected with SARS-CoV-2 and their association with government intervention strategies (edit) SARS-CoV-2 (edit) 10.1186/S12889-021-12318-Y 34886842
2021-12-09 Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010085
2021-12-09 Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.779026 34956207
2021-12-09 SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.798859 34956236
2021-12-09 Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2021.784303 34957216
2021-12-09 SARS-CoV-2 ORF3a Induces Incomplete Autophagy via the Unfolded Protein Response (edit) SARS-CoV-2 (edit) 10.3390/V13122467 34960736
2021-12-08 SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.110143 34919799
2021-12-08 Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing (MeRIP-Seq) (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.101067 34901888
2021-12-08 Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.1C00882 34878788
2021-12-08 Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-01655-Y 34880279
2021-12-08 TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABI6802 34878838
2021-12-08 Possibilities for the Entrance of SARS-Cov-2 as an Archaeal Vi-rus into the Ecosystem (edit) SARS-CoV-2 (edit) 10.18502/IJPH.V50I12.7948
2021-12-08 B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-1148985/V1
2021-12-07 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.12.005 34965382
2021-12-07 VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.105119 34902608
2021-12-07 Structure-guided design of multi-epitopes vaccine against variants of concern (VOCs) of SARS-CoV-2 and validation through In silico cloning and immune simulations (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.105122 34896886
2021-12-07 Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh (edit) SARS-CoV-2 (edit) 10.1016/J.JIPH.2021.12.002 34952247
2021-12-07 Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27318-0 34876592
2021-12-07 A single-cell transcriptomic landscape of the lungs of patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41556-021-00796-6 34876692
2021-12-07 Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04280-X 34875673
2021-12-07 N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-02904-W 34876606
2021-12-07 Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.12.04.471200
2021-12-07 Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant (edit) SARS-CoV-2 (edit) 10.1101/2021.12.06.471389
2021-12-07 Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects (edit) SARS-CoV-2 (edit) 10.18632/ONCOTARGET.28088 34917266
2021-12-07 IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.781352 34950146
2021-12-07 Production of SARS-CoV-2 N Protein-Specific Monoclonal Antibody and Its Application in an ELISA-Based Detection System and Targeting the Interaction Between the Spike C-Terminal Domain and N Protein (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.726231 34950112
2021-12-06 Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses (edit) SARS-CoV-2 (edit) 10.1002/CMDC.202100483 34382337
2021-12-06 Modelling the spreading of the SARS-CoV-2 in presence of the lockdown and quarantine measures by a kinetic-type reactions approach (edit) SARS-CoV-2 (edit) 10.1093/IMAMMB/DQAB017
2021-12-06 A Cross-Disciplinary View of Testing and Bioinformatic Analysis of SARS-CoV-2 and Other Human Respiratory Viruses in Pandemic Settings (edit) SARS-CoV-2 (edit) 10.1109/ACCESS.2021.3133417 35582017
2021-12-06 Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0260438 34871297
2021-12-06 Forced association of SARS-CoV-2 proteins with the yeast proteome perturb vesicle trafficking (edit) SARS-CoV-2 (edit) 10.15698/MIC2021.12.766 34909432
2021-12-06 Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.773198 34938188
2021-12-06 SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kB pathway (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.68563 34866574
2021-12-05 Extracellular Vimentin as a Target Against SARS‐CoV‐2 Host Cell Invasion (edit) SARS-CoV-2 (edit) 10.1002/SMLL.202105640 34866333
2021-12-04 A structural view of the SARS-CoV-2 virus and its assembly (edit) SARS-CoV-2 (edit) 10.1016/J.COVIRO.2021.11.011 34915287
2021-12-04 SARS-CoV-2 Nucleocapsid protein attenuates stress granules and interacts with mRNAs to impair host stress response (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103562 34901782
2021-12-04 Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers (edit) SARS-CoV-2 (edit) 10.1177/07487304211059315
2021-12-03 Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103553 34877479
2021-12-03 Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.1C00965
2021-12-03 Investigating the mutational landscape of the SARS-CoV-2 Omicron variant via ab initio quantum mechanical modeling (edit) SARS-CoV-2 (edit) 10.1101/2021.12.01.470748
2021-12-03 Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010118 34860860
2021-12-03 Exosomes/microvesicles target SARS-CoV-2 via innate and RNA-induced immunity with PIWI-piRNA system (edit) SARS-CoV-2 (edit) 10.26508/LSA.202101240
2021-12-03 SARS-CoV-2 Nsp5 Protein Causes Acute Lung Inflammation, A Dynamical Mathematical Model (edit) SARS-CoV-2 (edit) 10.3389/FSYSB.2021.764155
2021-12-02 Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat (edit) SARS-CoV-2 (edit) 10.1007/S11356-021-16356-2
2021-12-02 Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.11.151 34863825
2021-12-02 Contrasting SARS-CoV-2 epidemics in Singapore: cohort studies in migrant workers and the general population (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.11.043
2021-12-02 Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02885-6 34857854
2021-12-02 Patient health records and whole viral genomes from an early SARS-CoV-2 outbreak in a Quebec hospital reveal features associated with favorable outcomes (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0260714 34855869
2021-12-02 Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.795741 34925381
2021-12-02 The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression (edit) SARS-CoV-2 (edit) 10.3390/BIOM11121812 34944456
2021-12-02 The Correlation between Nurses' COVID-19 Infections and Their Emotional State and Work Conditions during the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.3390/IJERPH182312715 34886440
2021-12-01 Highly accurate whole-genome imputation of SARS-CoV-2 from partial or low-quality sequences (edit) SARS-CoV-2 (edit) 34865008
2021-12-01 Millisecond dynamic of SARS-CoV-2 spike and its interaction with ACE2 receptor and small extracellular vesicles (edit) SARS-CoV-2 (edit) 10.1002/JEV2.12170 34874124
2021-12-01 SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems (edit) SARS-CoV-2 (edit) 10.1002/JMV.27244 34324210
2021-12-01 Modeling SARS-CoV-2 proteins in the CASP-commons experiment (edit) SARS-CoV-2 (edit) 10.1002/PROT.26231 34462960
2021-12-01 D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity (edit) SARS-CoV-2 (edit) 10.1007/S00253-021-11676-2 34755213
2021-12-01 Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series (edit) SARS-CoV-2 (edit) 10.1007/S40121-021-00493-9 34302258
2021-12-01 SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality (edit) SARS-CoV-2 (edit) 10.1016/J.AJOG.2021.08.020 34454898
2021-12-01 Computational screening and biochemical analysis of Pistacia integerrima and Pandanus odorifer plants to find effective inhibitors against Receptor-Binding domain (RBD) of the spike protein of SARS-Cov-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ARABJC.2021.103600 34909068
2021-12-01 SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases (edit) SARS-CoV-2 (edit) 10.1016/J.BBADIS.2021.166264 34481867
2021-12-01 The spike protein of SARS-CoV-2 virus induces heme oxygenase-1: Pathophysiologic implications (edit) SARS-CoV-2 (edit) 10.1016/J.BBADIS.2021.166322 34920080
2021-12-01 Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107613
2021-12-01 Impact of cobas PCR Media freezing on SARS-CoV-2 viral RNA integrity and whole genome sequencing analyses (edit) SARS-CoV-2 (edit) 10.1016/J.DIAGMICROBIO.2021.115521
2021-12-01 Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2021.114030 34883292
2021-12-01 Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.03.060
2021-12-01 Pannexin-1 channel opening is critical for COVID-19 pathogenesis (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103478 34841222
2021-12-01 A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2021.105050 34883405
2021-12-01 Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells (edit) SARS-CoV-2 (edit) 10.1016/J.JTBI.2021.110895 34499915
2021-12-01 Models for SARS-CoV-2 associated thrombocytopenia associated with hemophagocytic histiocytes (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110700
2021-12-01 Molecular docking of SARS-COV-2 Spike epitope sequences identifies heterodimeric peptide-protein complex formation with human Zo-1, TLR8 and brain specific glial proteins (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110706
2021-12-01 SARS-CoV-2 mutational cascades and the risk of hyper-exponential growth (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2021.105237
2021-12-01 Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ONEHLT.2021.100352
2021-12-01 Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection (edit) SARS-CoV-2 (edit) 10.1016/J.TALANTA.2021.122691
2021-12-01 Normalization of SARS-CoV-2 viral load via RT-qPCR provides higher-resolution data for comparison across time and between patients (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198604
2021-12-01 UnCovid: A versatile, low-cost, and open-source protocol for SARS-CoV-2 RNA detection (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.100878
2021-12-01 SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00357-Z 34903715
2021-12-01 SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells (edit) SARS-CoV-2 (edit) 10.1038/S41423-021-00794-6 34782760
2021-12-01 The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27431-0 34893599
2021-12-01 Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27511-1 34907161
2021-12-01 Genomic reconstruction of the SARS-CoV-2 epidemic in England (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04069-Y 34649268
2021-12-01 Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04117-7 34670266
2021-12-01 Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02866-9 34853399
2021-12-01 SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications (edit) SARS-CoV-2 (edit) 10.1080/01652176.2021.1921311 33892621
2021-12-01 Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis (edit) SARS-CoV-2 (edit) 10.1080/21505594.2021.1911477 34030593
2021-12-01 The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells (edit) SARS-CoV-2 (edit) 10.1080/21505594.2021.1964329 34494942
2021-12-01 The antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1888660 33560940
2021-12-01 Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1898291 33666147
2021-12-01 The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1899770 33691601
2021-12-01 Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1902755 33704002
2021-12-01 Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1931465 34003073
2021-12-01 Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1932607 34013835
2021-12-01 Lentil lectin derived from exhibit broad antiviral activities against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1957720 34278967
2021-12-01 A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1964925 34348599
2021-12-01 Host-dependent editing of SARS-CoV-2 in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1080/22221751.2021.1969868 34402744
2021-12-01 A Daily-Updated Database and Tools for Comprehensive SARS-CoV-2 Mutation-Annotated Trees (edit) SARS-CoV-2 (edit) 10.1093/MOLBEV/MSAB264 34469548
2021-12-01 Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children (edit) SARS-CoV-2 (edit) 10.1097/MOP.0000000000001061 34534994
2021-12-01 Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABJ1476 34851667
2021-12-01 Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00711-21 34851166
2021-12-01 Sampling for SARS-CoV-2 aerosols in hospital patient rooms (edit) SARS-CoV-2 (edit) 10.3390/V13122347 34960615
2021-12-01 Future medico-legal implications on Obstetrics and Gynaecology practice in the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.36129/JOG.33.04.07
2021-12-01 Deploying a rapid point-of-care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety (edit) SARS-CoV-2 (edit) 10.4155/BIO-2021-0079
2021-11-30 Dynamics of spreading of SARS-CoV-2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains (edit) SARS-CoV-2 (edit) 10.1002/JMV.27471 34811754
2021-11-30 Severity of SARS-CoV-2 infection is linked to double-negative (CD27- IgD-) B cell subset numbers (edit) SARS-CoV-2 (edit) 10.1007/S00011-021-01525-3 34850243
2021-11-30 Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27325-1 34848718
2021-11-30 A hydrated 2,3-diaminophenazinium chloride as a promising building block against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-02280-5 34848758
2021-11-30 Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02858-9
2021-11-30 Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease? (edit) SARS-CoV-2 (edit) 10.1080/20477724.2021.1995657
2021-11-30 Multiplex Gene Tagging with CRISPR-Cas9 for Live-Cell Microscopy and Application to Study the Role of SARS-CoV-2 Proteins in Autophagy, Mitochondrial Dynamics, and Cell Growth (edit) SARS-CoV-2 (edit) 10.1089/CRISPR.2021.0041 34847745
2021-11-30 A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB938 34849655
2021-11-30 Is cardiac involvement prevalent in highly trained athletes after SARS-CoV-2 infection? A cardiac magnetic resonance study using sex-matched and age-matched controls (edit) SARS-CoV-2 (edit) 10.1136/BJSPORTS-2021-104576 34848398
2021-11-30 EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.12548 34909278
2021-11-29 Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2021.101190 34870134
2021-11-29 Mechanistic Insights into SARS-CoV-2 Main Protease Inhibition Reveals Hotspot Residues (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCIM.1C00928
2021-11-29 SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy (edit) SARS-CoV-2 (edit) 10.1038/S41423-021-00807-4 34845370
2021-11-29 Immune response against SARS-CoV-2 variants: the role of neutralization assays (edit) SARS-CoV-2 (edit) 10.1038/S41541-021-00404-6 34845231
2021-11-29 A 3D structural SARS-CoV-2-human interactome to explore genetic and drug perturbations (edit) SARS-CoV-2 (edit) 10.1038/S41592-021-01318-W 34845387
2021-11-29 The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB1160 34850141
2021-11-29 Crystal structure of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) frameshifting pseudoknot (edit) SARS-CoV-2 (edit) 10.1261/RNA.078825.121
2021-11-29 Intra-Familial Transmission Patterns of COVID-19 Infection among the Rural Residents of Ahmedabad, Gujarat, during an Epidemic of SARS-CoV-2 in India (edit) SARS-CoV-2 (edit) 10.7883/YOKEN.JJID.2021.267
2021-11-27 SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.11.033 34914922
2021-11-27 The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.11.013 34921776
2021-11-27 A colorimetric sandwich-type bioassay for SARS-CoV-2 using a hACE2-based affinity peptide pair (edit) SARS-CoV-2 (edit) 10.1016/J.JHAZMAT.2021.127923 34906876
2021-11-27 Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2021.11.008 34871905
2021-11-27 The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose-Study in Healthcare Workers Group in Poland (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9121402 34960148
2021-11-26 Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking (edit) SARS-CoV-2 (edit) 10.1007/S10822-021-00432-3 34825285
2021-11-26 Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective (edit) SARS-CoV-2 (edit) 10.1016/J.GENREP.2021.101452 34849425
2021-11-26 Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1016/J.REDOX.2021.102199 34847508
2021-11-26 Development of a Rapid and Sensitive CasRx-Based Diagnostic Assay for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSSENSORS.1C01088 34714054
2021-11-26 Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00595-6 34837059
2021-11-26 Epidemiological associations with genomic variation in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-02548-W 34837008
2021-11-26 Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABL6096 34826236
2021-11-26 The vaccination threshold for SARS-CoV-2 depends on the indoor setting and room ventilation (edit) SARS-CoV-2 (edit) 10.1186/S12879-021-06884-0 34836502
2021-11-26 Major Complex Trait for Early De Novo Programming ‘CoV-MAC-TED’ Detected in Human Nasal Epithelial Cells Infected by Two SARS-CoV-2 Variants Is Promising to Help in Designing Therapeutic Strategies (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9121399
2021-11-25 Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 Mpro and its evolutionary mutations as a case study (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.11.016 34849191
2021-11-25 Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103712 34839261
2021-11-25 Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage (edit) SARS-CoV-2 (edit) 10.1016/J.VPH.2021.106946 34838735
2021-11-25 Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04266-9 34823256
2021-11-25 Epidemic size, trend and spatiotemporal mapping of SARS-CoV-2 using geographical information system in Alborz Province, Iran (edit) SARS-CoV-2 (edit) 10.1186/S12879-021-06870-6 34823478
2021-11-25 Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.733539 34899693
2021-11-24 A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.110112 34863353
2021-11-24 Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.110114 34883043
2021-11-24 A comparison of precipitation and filtration-based SARS-CoV-2 recovery methods and the influence of temperature, turbidity, and surfactant load in urban wastewater (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.151916 34826466
2021-11-24 The N501Y spike substitution enhances SARS-CoV-2 infection and transmission (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04245-0 34818667
2021-11-24 Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein (edit) SARS-CoV-2 (edit) 10.1128/JVI.01626-21 34817202
2021-11-24 Whole-Genome Sequences of SARS-CoV-2 Isolates from the Dominican Republic (edit) SARS-CoV-2 (edit) 10.1128/MRA.00952-21 34817214
2021-11-24 Data-driven multi-scale mathematical modeling of SARS-CoV-2 infection reveals heterogeneity among COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009587
2021-11-23 SARS‐CoV‐2 N Protein Induces Acute Kidney Injury via Smad3‐Dependent G1 Cell Cycle Arrest Mechanism (edit) SARS-CoV-2 (edit) 10.1002/ADVS.202103248 34813685
2021-11-23 COVID-19 and Gynecologic Oncology: What Have We Learned? (edit) SARS-CoV-2 (edit) 10.1007/S11864-021-00905-5 34812973
2021-11-23 Performance of a computer aided diagnosis system for SARS-CoV-2 pneumonia based on ultrasound images (edit) SARS-CoV-2 (edit) 10.1016/J.EJRAD.2021.110066 34902668
2021-11-23 Low-Cost Optodiagnostic for Minute-Time Scale Detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSNANO.1C03236 34669371
2021-11-23 A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-04232-5 34814158
2021-11-23 An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-02266-3 34815498
2021-11-23 Spatiotemporal interactions of a novel mesocarnivore community in an urban environment before and during SARS-CoV-2 lockdown (edit) SARS-CoV-2 (edit) 10.1111/1365-2656.13635 34775595
2021-11-23 Comprehensive occupational health services for healthcare workers in Zimbabwe during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0260261 34813627
2021-11-23 Methodological problems of SARS-CoV-2 rapid point-of-care tests when used in mass testing (edit) SARS-CoV-2 (edit) 10.3934/PUBLICHEALTH.2022007 35071670
2021-11-22 SARS-CoV-2 Infection Fatality Rates in India: Systematic Review, Meta-analysis and Model-based Estimation (edit) SARS-CoV-2 (edit) 10.1177/23210222211054324
2021-11-22 Towards a COVID-19 symptom triad: The importance of symptom constellations in the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0258649 34807925
2021-11-22 TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009820 34807954
2021-11-20 SARS-CoV-2: Can sunlight exposure reduce the risk of developing severe consequences of COVID-19? (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107602
2021-11-20 Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.105049 34823857
2021-11-20 Symptomatic and asymptomatic transmission of SARS-CoV-2 in K-12 schools, British Columbia, April to June 2021 (edit) SARS-CoV-2 (edit) 10.1101/2021.11.15.21266284
2021-11-19 SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021 (edit) SARS-CoV-2 (edit)
2021-11-19 In silico validation of anti-viral drugs obtained from marine sources as a potential target against SARS-CoV-2 Mpro (edit) SARS-CoV-2 (edit)
2021-11-19 SARS-CoV-2 triggers DNA damage response in Vero E6 cells (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.09.024 34600299
2021-11-19 Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.11.026 34910927
2021-11-19 Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26498-Z 34799561
2021-11-19 SARS-CoV-2 infection generates tissue-localized immunological memory in humans (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABL9105 34618554
2021-11-19 Association between ambient air pollutants and meteorological factors with SARS-CoV-2 transmission and mortality in India: an exploratory study (edit) SARS-CoV-2 (edit) 10.1186/S12940-021-00804-0 34794454
2021-11-19 Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.748291
2021-11-18 Backbone and Ile, Leu, Val methyl group resonance assignment of CoV-Y domain of SARS-CoV-2 non-structural protein 3 (edit) SARS-CoV-2 (edit) 10.1007/S12104-021-10059-Y 34792756
2021-11-18 Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.11.024
2021-11-18 Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100798 34812411
2021-11-18 Fluvastatin mitigates SARS-CoV-2 infection in human lung cells (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103469 34812415
2021-11-18 Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105153 34801754
2021-11-18 Metaviromic identification of discriminative genomic features in SARS-CoV-2 using machine learning (edit) SARS-CoV-2 (edit) 10.1016/J.PATTER.2021.100407 34812427
2021-11-18 Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein (edit) SARS-CoV-2 (edit) 10.1021/ACSCHEMBIO.1C00756 34792325
2021-11-18 Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-27040-X 34795285
2021-11-18 The role of cell surface sialic acids for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/GLYCOB/CWAB032 33909065
2021-11-18 COVID-19 and vertical transmission: assessing the expression of ACE2/TMPRSS2 in the human fetus and placenta to assess the risk of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1111/1471-0528.16974 34735736
2021-11-18 Dissecting the early COVID-19 cases in Wuhan (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABM4454 34793199
2021-11-18 Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0259712 34793508
2021-11-18 Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0260283 34793553
2021-11-18 Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.753444 34869063
2021-11-18 Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.768993 34869070
2021-11-17 Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis (edit) SARS-CoV-2 (edit) 10.1007/S10528-021-10144-W 34787756
2021-11-17 SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1. (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105144 34798321
2021-11-17 SARS-CoV-2–Associated New Dysphagia in Parkinson’s Disease Requires Exclusion of Differentials (edit) SARS-CoV-2 (edit) 10.1097/PHM.0000000000001927
2021-11-17 Response to the Letter to the Editor “SARS-CoV-2–Associated New Dysphagia in Parkinson’s Disease Requires Exclusion of Differentials” (edit) SARS-CoV-2 (edit) 10.1097/PHM.0000000000001928
2021-11-17 Tunneling nanotubes provide a novel route for SARS-CoV-2 spreading between permissive cells and to non-permissive neuronal cells (edit) SARS-CoV-2 (edit) 10.1101/2021.11.15.468633
2021-11-17 The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells (edit) SARS-CoV-2 (edit) 10.1101/2021.11.16.468777
2021-11-17 A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01131-21 34787485
2021-11-17 Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody (edit) SARS-CoV-2 (edit) 10.15252/EMMM.202114544
2021-11-17 A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19 (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.747816 34869058
2021-11-16 Sustained Delivery of SARS-CoV-2 RBD Subunit Vaccine Using a High Affinity Injectable Hydrogel Scaffold (edit) SARS-CoV-2 (edit) 10.1002/ADHM.202101714 34755476
2021-11-16 SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.110020 34762851
2021-11-16 SARS-CoV-2 infection and replication in human gastric organoids (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26762-2 34785679
2021-11-16 Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02315-21 34781748
2021-11-16 A Bacterial Cell-Based Assay To Study SARS-CoV-2 Protein-Protein Interactions (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02936-21 34781739
2021-11-16 Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals (edit) SARS-CoV-2 (edit) 10.3390/CELLS10113187
2021-11-16 A Comparative Study between Spanish and British SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3390/CIMB43030140 34889898
2021-11-15 Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs (edit) SARS-CoV-2 (edit) 10.1002/BIT.27945 34585736
2021-11-15 SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids (edit) SARS-CoV-2 (edit) 10.1016/J.JCIS.2021.06.056 34157514
2021-11-15 The existence, spread, and strategies for environmental monitoring and control of SARS-CoV-2 in environmental media (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.148949 34252782
2021-11-15 Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis (edit) SARS-CoV-2 (edit) 10.1016/S2666-5247(21)00267-6
2021-11-15 Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.1C00613 34779632
2021-11-15 The glycosylation in SARS-CoV-2 and its receptor ACE2 (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00809-8 34782609
2021-11-15 SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26910-8 34782627
2021-11-15 Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2112703118 34782481
2021-11-15 Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients (edit) SARS-CoV-2 (edit) 10.3390/CANCERS13225718 34830872
2021-11-14 Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.3748/WJG.V27.I42.7271
2021-11-13 Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.11.005 34822776
2021-11-13 A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features (edit) SARS-CoV-2 (edit) 10.1016/J.CRSTBI.2021.11.002 34806033
2021-11-13 SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.NBD.2021.105561 34780863
2021-11-13 Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1093/BJS/ZNAB336
2021-11-13 In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches (edit) SARS-CoV-2 (edit) 10.1186/S12863-021-01007-9 34773976
2021-11-13 Identification of Cellular Factors Required for SARS-CoV-2 Replication (edit) SARS-CoV-2 (edit) 10.3390/CELLS10113159 34831382
2021-11-12 Assessing the efficacy of interventions to control indoor SARS-Cov-2 transmission: An agent-based modeling approach (edit) SARS-CoV-2 (edit) 10.1016/J.EPIDEM.2021.100524 34798545
2021-11-12 Disulfide bonds play a critical role in the structure and function of the receptor-binding domain of the SARS-CoV-2 Spike antigen (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167357 34780781
2021-11-12 Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00278 34658235
2021-11-12 SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26803-W 34772941
2021-11-12 Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-00684-X 34772947
2021-11-12 The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/MOLBEV/MSAB327 34788836
2021-11-12 Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1 (edit) SARS-CoV-2 (edit) 10.3390/NU13114047
2021-11-11 Dresdner Kinder und Corona - kein schöne(s)r Land zu dieser Zeit: Eine Beobachtung aus Prohlis (edit) SARS-CoV-2 (edit)
2021-11-11 Meine Kindheit mit Corona: Bericht einer Zehnjährigen (edit) SARS-CoV-2 (edit)
2021-11-11 Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103426 34786539
2021-11-11 Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)-Molecular dynamics, molecular mechanics, and density functional theory investigations (edit) SARS-CoV-2 (edit) 10.1016/J.MOLSTRUC.2021.131879 34785822
2021-11-11 Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda (edit) SARS-CoV-2 (edit) 10.1101/2021.06.30.450632 34230931
2021-11-11 Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0259165 34762662
2021-11-11 Evolutionary and Antigenic Profiling of the Tendentious D614G Mutation of SARS-CoV-2 in Gujarat, India (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.764927 34858480
2021-11-11 Research progress of human coronaviruses and associated eye diseases (edit) SARS-CoV-2 (edit) 10.3760/CMA.J.CN112142-20210426-00190 34743475
2021-11-10 Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.11.004 34838159
2021-11-10 Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103412 34786537
2021-11-10 Close proximity risk assessment for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.148749 34225157
2021-11-10 The P681H mutation in the Spike glycoprotein confers Type I interferon resistance in the SARS-CoV-2 alpha (B.1.1.7) variant (edit) SARS-CoV-2 (edit) 10.1101/2021.11.09.467693
2021-11-10 High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00965-21 34756082
2021-11-09 Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.105025 34772510
2021-11-09 Discovery of Camellia sinensis catechins as SARS-CoV-2 3CL protease inhibitors through molecular docking, intra and extra cellular assays (edit) SARS-CoV-2 (edit) 10.1016/J.PHYMED.2021.153853 34799184
2021-11-09 Transparent Polymeric Formulations Effective against SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1021/ACSAMI.1C10404 34752084
2021-11-09 A novel SARS-CoV-2 related coronavirus in bats from Cambodia (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26809-4
2021-11-09 Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41589-021-00924-1 34754101
2021-11-09 Candidate genes of SARS-CoV-2 gender susceptibility (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-01131-7 34753980
2021-11-09 CCR2 Signaling Restricts SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02749-21
2021-11-09 Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16) (edit) SARS-CoV-2 (edit) 10.1186/S43141-021-00273-5 34751829
2021-11-08 Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.11.007 34777716
2021-11-08 Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-01410-3 34750486
2021-11-08 Correction: Collaboration in the time of COVID: a scientometric analysis of multidisciplinary SARS-CoV-2 research (edit) SARS-CoV-2 (edit) 10.1057/S41599-021-00957-W
2021-11-08 Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1010053 34748603
2021-11-08 Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections (edit) SARS-CoV-2 (edit) 10.3390/V13112239 34835045
2021-11-07 Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103675 34758415
2021-11-06 Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations (edit) SARS-CoV-2 (edit) 10.1007/S00109-021-02161-4 34741638
2021-11-06 Genomic diversity and molecular dynamics interaction on mutational variances among RB domains of SARS-CoV-2 interplay drug inactivation (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105128 34752930
2021-11-06 Surveillance and control of SARS-CoV-2 in mustelids: An evolutionary perspective (edit) SARS-CoV-2 (edit) 10.1111/EVA.13310 34899977
2021-11-06 Strategy to Develop and Evaluate a Multiplex RT-ddPCR in Response to SARS-CoV-2 Genomic Evolution (edit) SARS-CoV-2 (edit) 10.3390/CIMB43030134 34889894
2021-11-05 In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrum (edit) SARS-CoV-2 (edit) 10.1007/S00216-021-03721-W 34739558
2021-11-05 Phylogenetic and Ancestral Sequence Reconstruction of SARS-CoV-2 Reveals Latent Capacity to Bind Human ACE2 Receptor (edit) SARS-CoV-2 (edit) 10.1007/S00239-021-10034-0 34739551
2021-11-05 Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S13337-021-00747-7 34754886
2021-11-05 Predicting COVID-19 cases in diverse population groups using SARS-CoV-2 wastewater monitoring across Oklahoma City (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.151431 34748841
2021-11-05 Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26760-4 34741049
2021-11-05 Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-01081-0 34741079
2021-11-05 Diosmectite inhibits the interaction between SARS-CoV-2 and human enterocytes by trapping viral particles, thereby preventing NF-kappaB activation and CXCL10 secretion (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-01217-2 34741071
2021-11-05 Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma (edit) SARS-CoV-2 (edit) 10.1182/BLOOD-2021-153901
2021-11-04 CTD of SARS‐CoV‐2 N protein is a cryptic domain for binding ATP and nucleic acid that interplay in modulating phase separation (edit) SARS-CoV-2 (edit) 10.1002/PRO.4221 34734665
2021-11-04 Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2021.105024 34781240
2021-11-04 SARS-CoV-2 can infect and propagate in human placenta explants (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100456 34751258
2021-11-04 In Silico End-to-End Protein-Ligand Interaction Characterization Pipeline: The Case of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSSYNBIO.1C00368 34736321
2021-11-04 Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26602-3 34737266
2021-11-04 Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001284 34735434
2021-11-03 Risk of chlorine dioxide as emerging contaminant during SARS-CoV-2 pandemic: enzyme, cardiac, and behavior effects on amphibian tadpoles (edit) SARS-CoV-2 (edit)
2021-11-03 Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.10.027 34798069
2021-11-03 Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.105017 34758907
2021-11-03 Comprehensive investigation of SARS-CoV-2 fate in wastewater and finding the virus transfer and destruction route through conventional activated sludge and sequencing batch reactor (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.151391 34740662
2021-11-03 Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study (edit) SARS-CoV-2 (edit) 10.1016/S1470-2045(21)00573-8
2021-11-03 Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.1C01494 34730959
2021-11-03 A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00810-1 34732694
2021-11-03 Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2109905118 34732583
2021-11-03 Insights on the SARS-CoV-2 genome variability: the lesson learned in Brazil and its impacts on the future of pandemics (edit) SARS-CoV-2 (edit) 10.1099/MGEN.0.000656
2021-11-03 SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism (edit) SARS-CoV-2 (edit) 10.3390/V13112209 34835015
2021-11-02 RNA-extraction-free diagnostic method to detect SARS-CoV-2: an assessment from two states, India (edit) SARS-CoV-2 (edit)
2021-11-02 Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109928 34706271
2021-11-02 A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.10.038 34745450
2021-11-02 Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E08308 34746476
2021-11-02 Bilateral giant cell arteritis with skin necrosis following SARS‐CoV‐2 vaccination (edit) SARS-CoV-2 (edit) 10.1111/BJD.20824
2021-11-01 SARS-CoV-2 Antibodies in Breast Milk After Vaccination (edit) SARS-CoV-2 (edit) 34408089
2021-11-01 The evaluation of potential global impact of the N501Y mutation in SARS-COV-2 positive patients (edit) SARS-CoV-2 (edit) 10.1002/JMV.27413 34676574
2021-11-01 In response to the letter to the editor regarding SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.1002/LARY.29723 34216142
2021-11-01 In Reference to "SARS-CoV-2 presence in the saliva, tears and cerumen of COVID-19 patients" (edit) SARS-CoV-2 (edit) 10.1002/LARY.29727 34216143
2021-11-01 Zn‐Induced Interactions Between SARS‐CoV‐2 orf7a and BST2/Tetherin (edit) SARS-CoV-2 (edit) 10.1002/OPEN.202100217 34791819
2021-11-01 SARS-CoV-2 research using human pluripotent stem cells and organoids (edit) SARS-CoV-2 (edit) 10.1002/SCTM.21-0183 34302450
2021-11-01 Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1007/S00296-021-04932-1 34259880
2021-11-01 Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations (edit) SARS-CoV-2 (edit) 10.1007/S12031-020-01767-6 33464535
2021-11-01 High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors (edit) SARS-CoV-2 (edit) 10.1007/S13238-021-00836-9 33864621
2021-11-01 Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays (edit) SARS-CoV-2 (edit) 10.1016/J.APSB.2021.10.026 34745850
2021-11-01 Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain (edit) SARS-CoV-2 (edit) 10.1016/J.BBAMEM.2021.183697 34274319
2021-11-01 Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant (edit) SARS-CoV-2 (edit) 10.1016/J.BIOMATERIALS.2021.121159
2021-11-01 Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.110049 34788596
2021-11-01 Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.10.003
2021-11-01 Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors (edit) SARS-CoV-2 (edit) 10.1016/J.CLIM.2021.108871
2021-11-01 Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real (edit) SARS-CoV-2 (edit) 10.1016/J.CLNU.2021.11.018
2021-11-01 Emerging SARS-CoV-2 variants expand species tropism to murines (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103643 34689086
2021-11-01 Water-sanitation-health nexus in the Indus-Ganga-Brahmaputra River Basin: need for wastewater surveillance of SARS-CoV-2 for preparedness during the future waves of pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.ECOHYD.2021.11.001
2021-11-01 Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2021.113966 34749200
2021-11-01 The impact of viral mutations on recognition by SARS-CoV-2 specific T cells (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103353 34729465
2021-11-01 In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice (edit) SARS-CoV-2 (edit) 10.1016/J.LFS.2021.119881 34389403
2021-11-01 Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105038 34403832
2021-11-01 Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110681
2021-11-01 Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity (edit) SARS-CoV-2 (edit) 10.1016/J.SAA.2021.120595 34815178
2021-11-01 Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2021.09.001 34536797
2021-11-01 Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00289-9
2021-11-01 High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort (edit) SARS-CoV-2 (edit) 10.1016/S2214-109X(21)00355-7 34678195
2021-11-01 Virus detective: searching for Zika, dengue and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/D41586-021-03001-8
2021-11-01 Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00570-1 34584244
2021-11-01 Structural biology of SARS-CoV-2 and implications for therapeutic development (edit) SARS-CoV-2 (edit) 10.1038/S41579-021-00630-8 34535791
2021-11-01 SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03944-Y 34488225
2021-11-01 Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01540-1 34588689
2021-11-01 Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins (edit) SARS-CoV-2 (edit) 10.1039/D1RA05327B 35493250
2021-11-01 In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors (edit) SARS-CoV-2 (edit) 10.1039/D1RA07845C 35493238
2021-11-01 Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2114390118 34702736
2021-11-01 347. SARS-CoV-2 and Acute Otitis Media in Children: A Case Series (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAB466.548
2021-11-01 A hybrid PDE–ABM model for viral dynamics with application to SARS-CoV-2 and influenza (edit) SARS-CoV-2 (edit) 10.1098/RSOS.210787
2021-11-01 Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography (edit) SARS-CoV-2 (edit) 10.1107/S2052252521010113 34804549
2021-11-01 Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine (edit) SARS-CoV-2 (edit) 10.1111/TRF.16672 34549821
2021-11-01 Spectra of Photobiological Inactivation of SARS-CoV-2 by Solar UVB Radiation (280–320 nm) (edit) SARS-CoV-2 (edit) 10.1134/S1024856021060191
2021-11-01 NK cell receptor and ligand composition influences the clearance of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1172/JCI146408
2021-11-01 Interplay between the Genetics of Personality Traits, severe Psychiatric Disorders, and COVID-19 Host Genetics in the Susceptibility to SARS-CoV-2 Infection - ADDENDUM (edit) SARS-CoV-2 (edit) 10.1192/BJO.2021.1037
2021-11-01 Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets (edit) SARS-CoV-2 (edit) 10.15252/MSB.202110260 34709707
2021-11-01 SARS-CoV-2-host proteome interactions for antiviral drug discovery (edit) SARS-CoV-2 (edit) 10.15252/MSB.202110396 34709727
2021-11-01 Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.2217/FVL-2021-0050
2021-11-01 The high diversity of SARS-CoV-2-related coronaviruses in pangolins alerts potential ecological risks (edit) SARS-CoV-2 (edit) 10.24272/J.ISSN.2095-8137.2021.334 34766482
2021-10-31 Structural basis for the interaction of SARS‐CoV‐2 virulence factor nsp1 with DNA Polymerase a ‐ Primase (edit) SARS-CoV-2 (edit) 10.1002/PRO.4220 34719824
2021-10-31 Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01416-21 34704808
2021-10-30 Analysis on genome variation of SARS-CoV-2 circulating in the world (edit) SARS-CoV-2 (edit)
2021-10-30 Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection (edit) SARS-CoV-2 (edit) 10.1007/S10875-021-01142-Z 34716845
2021-10-30 Clinical and Epidemiological Characteristics of 1283 Pediatric Patients with Coronavirus Disease 2019 during the First and Second Waves of the Pandemic-Results of the Pediatric Part of a Multicenter Polish Register SARSTer (edit) SARS-CoV-2 (edit) 10.3390/JCM10215098 34768620
2021-10-29 Evaluation of virucidal activity of residual quaternary ammonium-treated surfaces on SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.AJIC.2021.10.021 34756967
2021-10-29 SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.10.112 34743814
2021-10-29 Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.10.019 34788600
2021-10-29 SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101371 34756892
2021-10-29 BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals (edit) SARS-CoV-2 (edit) 10.1016/J.JCLINEPI.2021.10.011 34715314
2021-10-29 In silico identification of potential inhibitors against main protease of SARS-CoV-2 6LU7 from Andrographis panniculata via molecular docking, binding energy calculations and molecular dynamics simulation studies (edit) SARS-CoV-2 (edit) 10.1016/J.SJBS.2021.10.060 34729030
2021-10-29 Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00648-4
2021-10-29 Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-01068-Z 34716452
2021-10-29 Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7043E1 34710076
2021-10-28 A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101362 34756886
2021-10-28 RT-qPCR assays for SARS-CoV-2 variants of concern in wastewater reveals compromised vaccination-induced immunity (edit) SARS-CoV-2 (edit) 10.1016/J.WATRES.2021.117808 34753092
2021-10-28 Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy (edit) SARS-CoV-2 (edit) 10.1016/J.YGENO.2021.10.015 34718131
2021-10-28 Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)02276-5
2021-10-28 Quantification of airborne SARS-CoV-2 genomic particles in different hospital settings (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-00761-1 34711888
2021-10-28 The intersection of COVID-19 and autoimmunity (edit) SARS-CoV-2 (edit) 10.1172/JCI154886 34710063
2021-10-28 Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.770066
2021-10-27 Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100452
2021-10-27 The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100453 34723226
2021-10-27 Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.1C01475
2021-10-27 Nanodiagnostics to Face SARS-CoV-2 and Future Pandemics: From an Idea to the Market and Beyond (edit) SARS-CoV-2 (edit) 10.1021/ACSNANO.1C06839
2021-10-27 Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study (edit) SARS-CoV-2 (edit) 10.1038/S43018-021-00274-W 34950880
2021-10-27 qNMR characterization of potential peptide calibrators for isotope dilution LC–MS quantification of a SARS-CoV-2 IgG monoclonal antibody (edit) SARS-CoV-2 (edit) 10.1088/1361-6501/AC2FE9
2021-10-27 Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality (edit) SARS-CoV-2 (edit) 10.3390/JPM11111098 34834450
2021-10-26 Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation (edit) SARS-CoV-2 (edit) 10.1002/PTR.7315 34697842
2021-10-26 Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109881 34655519
2021-10-26 Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL substrate degradome (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109892 34672947
2021-10-26 Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107594 34736125
2021-10-26 Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104981 34735950
2021-10-26 SARS-CoV-2 exploits host DGAT and ADRP for efficient replication (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00338-2 34702802
2021-10-26 Detailed phylogenetic analysis tracks transmission of distinct SARS-COV-2 variants from China and Europe to West Africa (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-00267-W 34702899
2021-10-26 Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02371-21 34579570
2021-10-26 Diurnal Variation in SARS-CoV-2 PCR Test Results: Test Accuracy May Vary by Time of Day (edit) SARS-CoV-2 (edit) 10.1177/07487304211051841
2021-10-26 Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.750386 34764961
2021-10-26 OM-85 Broncho-Vaxom, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES9111544 34829773
2021-10-25 De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104967 34739968
2021-10-25 Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100450
2021-10-25 Structure-Based Primer Design Minimizes the Risk of PCR Failure Caused by SARS-CoV-2 Mutations (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.741147 34760717
2021-10-24 Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103341 34723159
2021-10-23 SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation (edit) SARS-CoV-2 (edit) 10.1007/S11481-021-10029-0 34687399
2021-10-23 DCcov: Repositioning of drugs and drug combinations for SARS-CoV-2 infected lung through constraint-based modeling (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103331 34723158
2021-10-23 SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults (edit) SARS-CoV-2 (edit) 10.1016/J.JACI.2021.10.014 34695490
2021-10-22 COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-bi (edit) SARS-CoV-2 (edit) 10.1002/BIES.202100158 34677872
2021-10-22 Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332 (edit) SARS-CoV-2 (edit) 10.1007/S13238-021-00883-2 34687004
2021-10-22 Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India (edit) SARS-CoV-2 (edit) 10.1016/J.CRPHAR.2021.100065 34870160
2021-10-22 Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 spike glycoprotein (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101329 34688668
2021-10-22 Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021 (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2021.10.005 34700068
2021-10-22 Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data (edit) SARS-CoV-2 (edit) 10.1016/S2214-109X(21)00434-4 34695371
2021-10-22 De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis (edit) SARS-CoV-2 (edit) 10.1155/2021/8400842
2021-10-22 Evolutionary Perspective and Theories on the Possible Origin of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.7759/CUREUS.18981 34820236
2021-10-21 Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19 (edit) SARS-CoV-2 (edit) 10.1002/JMV.27405 34672376
2021-10-21 Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity (edit) SARS-CoV-2 (edit) 10.1016/J.MOLSTRUC.2021.131782 34697505
2021-10-21 The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells (edit) SARS-CoV-2 (edit) 10.1038/S41593-021-00926-1 34675436
2021-10-21 SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2113468
2021-10-21 Are antigen tests useful as screening for the identification of SARS-CoV-2 in emergency rooms? (edit) SARS-CoV-2 (edit) 10.1093/EURPUB/CKAB164.813
2021-10-21 Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1186/S13062-021-00305-7 34674770
2021-10-21 Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PMED.1003807
2021-10-21 Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.750229 34745122
2021-10-21 The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis (edit) SARS-CoV-2 (edit) 10.3390/CANCERS13215276
2021-10-21 A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/PHARMACEUTICS13111759 34834174
2021-10-20 Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound (edit) SARS-CoV-2 (edit) 10.1002/FSN3.2576 34900242
2021-10-20 Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas (edit) SARS-CoV-2 (edit) 10.1007/S40618-021-01693-3 34669152
2021-10-20 An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity (edit) SARS-CoV-2 (edit) 10.1016/J.CHEMBIOL.2021.10.008 34672954
2021-10-20 Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101290 34678315
2021-10-20 COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26354-0
2021-10-20 Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26401-W 34671049
2021-10-20 An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats (edit) SARS-CoV-2 (edit) 10.1038/S41541-021-00390-9 34671047
2021-10-20 An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2110817118 34670842
2021-10-20 Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects (edit) SARS-CoV-2 (edit) 10.1128/JVI.01110-21 34668774
2021-10-20 SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.01298-21 34668728
2021-10-20 Mechanisms of Immunothrombosis by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/BIOM11111550 34827548
2021-10-20 Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents (edit) SARS-CoV-2 (edit) 10.3390/NU13113680 34835935
2021-10-20 Direct RNA Sequencing Reveals SARS-CoV-2 m6A Sites and Possible Differential DRACH Motif Methylation among Variants (edit) SARS-CoV-2 (edit) 10.3390/V13112108 34834915
2021-10-19 Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109778 34686343
2021-10-19 Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103637 34678613
2021-10-19 Evaluation of SARS-CoV-2 main protease and inhibitor interactions using dihedral angle distributions and radial distribution function (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E08220 34693066
2021-10-19 Collaboration in the time of COVID: a scientometric analysis of multidisciplinary SARS-CoV-2 research (edit) SARS-CoV-2 (edit) 10.1057/S41599-021-00922-7
2021-10-19 Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.1128/JCM.00921-21 34379531
2021-10-19 Computational Analysis of Missense Variants in the Human Transmembrane Protease Serine 2 (TMPRSS2) and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1155/2021/9982729 34692848
2021-10-19 Factors affecting aerosol SARS-CoV-2 transmission via HVAC systems; a modeling study (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009474
2021-10-19 COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms (edit) SARS-CoV-2 (edit) 10.15252/MSB.202110387 34664389
2021-10-18 SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00578-7 34663909
2021-10-18 Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-01035-8 34663977
2021-10-15 Sequence complementarity between human noncoding RNAs and SARS-CoV-2 genes: What are the implications for human health? (edit) SARS-CoV-2 (edit) 10.1016/J.BBADIS.2021.166291 34662705
2021-10-15 Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.08.036 34425281
2021-10-15 An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109920 34731648
2021-10-15 Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/JACS.1C06778
2021-10-15 Attenuated activation of pulmonary immune cells in mRNA-1273–vaccinated hamsters after SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1172/JCI148036
2021-10-14 Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26267-Y 34650062
2021-10-14 Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99642-W 34650130
2021-10-14 Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assay (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99661-7
2021-10-14 Integrin activation is an essential component of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99893-7 34650161
2021-10-14 Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants (edit) SARS-CoV-2 (edit) 10.1186/S13073-021-00985-W 34649620
2021-10-13 The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape (edit) SARS-CoV-2 (edit) 10.1002/JMV.27376
2021-10-13 Host genetic factors determining COVID-19 susceptibility and severity (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103629 34655949
2021-10-13 The effect of glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103272 34661088
2021-10-13 Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02728-4 34645933
2021-10-13 Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve (edit) SARS-CoV-2 (edit) 10.1038/S43856-021-00039-7 35602204
2021-10-13 Thermodynamics and kinetics in antibody resistance of the 501Y.V2 SARS-CoV-2 variant (edit) SARS-CoV-2 (edit) 10.1039/D1RA04134G 35497518
2021-10-13 Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABI6533 34644111
2021-10-13 Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00055-21 34643448
2021-10-13 Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PNTD.0009835 34644287
2021-10-13 Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.765039 34722346
2021-10-13 Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.741639 34721408
2021-10-13 Strategy and Performance Evaluation of Low-Frequency Variant Calling for SARS-CoV-2 Using Targeted Deep Illumina Sequencing (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.747458 34721349
2021-10-13 SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro (edit) SARS-CoV-2 (edit) 10.3390/V13102056 34696485
2021-10-12 Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line (edit) SARS-CoV-2 (edit) 10.1002/PTR.7302 34643000
2021-10-12 B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109825 34614392
2021-10-12 Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh (edit) SARS-CoV-2 (edit) 10.1016/J.HPOPEN.2021.100054
2021-10-12 A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.08.016 34481543
2021-10-12 Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease (edit) SARS-CoV-2 (edit) 10.1016/J.PHYTOCHEM.2021.112984 34757253
2021-10-12 Computational Study on the Function of Palmitoylation on the Envelope Protein in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.1C00359 34516136
2021-10-12 Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening (edit) SARS-CoV-2 (edit) 10.1039/D1RA05976A 35497510
2021-10-12 Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.2147/IJGM.S335162 34675627
2021-10-12 Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin (edit) SARS-CoV-2 (edit) 10.3389/FENDO.2021.714909 34712201
2021-10-11 ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress (edit) SARS-CoV-2 (edit) 10.1016/J.DEVCEL.2021.10.006 34706264
2021-10-11 Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2021.108028 34649146
2021-10-11 A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2108728118
2021-10-11 The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus (edit) SARS-CoV-2 (edit) 10.1093/JTM/TAAB124 34369565
2021-10-11 SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001425 34634033
2021-10-11 Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9101120
2021-10-09 A student led computational screening of peptide inhibitors against main protease of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1002/BMB.21580 34626436
2021-10-09 Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1002/PROT.26250 34580920
2021-10-08 Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans (edit) SARS-CoV-2 (edit) 10.1002/EJI.202149535 34580856
2021-10-08 SARS-CoV-2 spike protein harnesses SNX27-mediated endocytic recycling pathway (edit) SARS-CoV-2 (edit) 10.1002/MCO2.92 34909756
2021-10-08 Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109882 34653416
2021-10-08 Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.10.006 34628021
2021-10-08 SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99404-8 34625610
2021-10-08 Compelling Evidence Suggesting the Codon Usage of SARS-CoV-2 Adapts to Human After the Split From RaTG13 (edit) SARS-CoV-2 (edit) 10.1177/11769343211052013 34646060
2021-10-08 Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy) (edit) SARS-CoV-2 (edit) 10.2196/27739 34533472
2021-10-08 Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study (edit) SARS-CoV-2 (edit) 10.3389/FCHEM.2021.744376 34692642
2021-10-08 Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.693462 34691016
2021-10-08 Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.753435 34691072
2021-10-07 A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2021.105183 34626674
2021-10-07 Airborne microplastics and SARS-CoV-2 in total suspended particles in the area surrounding the largest medical centre in Latin America (edit) SARS-CoV-2 (edit) 10.1016/J.ENVPOL.2021.118299 34626707
2021-10-07 A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.NBT.2021.10.002 34628049
2021-10-07 Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.100906 34642671
2021-10-07 Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine (edit) SARS-CoV-2 (edit) 10.1021/ACSNANO.1C01243 34618423
2021-10-07 SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26117-X 34620860
2021-10-07 ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26178-Y 34620866
2021-10-07 Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99431-5 34620951
2021-10-07 Nutritional behaviors of women and men in Poland during confinement related to the SARS-CoV-2 epidemic (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99561-W 34620981
2021-10-07 Genome Sequences of Community SARS-CoV-2 B.1.526 and P.1 Variants Circulating in the Dominican Republic (edit) SARS-CoV-2 (edit) 10.1128/MRA.00744-21 34617785
2021-10-07 Interplay between the genetics of personality traits, severe psychiatric disorders and COVID-19 host genetics in the susceptibility to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1192/BJO.2021.1030
2021-10-07 Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.750725 34691002
2021-10-07 l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells (edit) SARS-CoV-2 (edit) 10.3390/MOLECULES26196062 34641606
2021-10-07 Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening Program (edit) SARS-CoV-2 (edit) 10.3390/V13102014
2021-10-07 Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.70968 34617885
2021-10-06 Superspreading events of SARS-CoV-2 in Paris: A retrospective analysis of data from the first wave of COVID-19 in 2020 (edit) SARS-CoV-2 (edit) 10.1016/J.JIPH.2021.10.001 34715427
2021-10-06 SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25946-0 34615863
2021-10-06 Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99344-3 34615949
2021-10-06 Sex differences in electrolyte imbalances caused by SARS-CoV-2: A cross-sectional study (edit) SARS-CoV-2 (edit) 10.1111/IJCP.14882 34529866
2021-10-06 Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition (edit) SARS-CoV-2 (edit) 10.1128/JVI.01368-21 34613786
2021-10-06 Rapid and High-Throughput Reverse Transcriptase Quantitative PCR (RT-qPCR) Assay for Identification and Differentiation between SARS-CoV-2 Variants B.1.1.7 and B.1.351 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00506-21 34612692
2021-10-06 Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00792-21
2021-10-06 Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation (edit) SARS-CoV-2 (edit) 10.3390/DIAGNOSTICS11101843
2021-10-05 Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109771 34587480
2021-10-05 Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109784 34592170
2021-10-05 In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109838 34648735
2021-10-05 Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication (edit) SARS-CoV-2 (edit) 10.1016/J.MCPRO.2021.100159 34619366
2021-10-05 Mechanisms of SARS-CoV-2 entry into cells (edit) SARS-CoV-2 (edit) 10.1038/S41580-021-00418-X 34611326
2021-10-05 A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02473-21 34607456
2021-10-05 UK Research Ethics Committee’s review of the global first SARS-CoV-2 human infection challenge studies (edit) SARS-CoV-2 (edit) 10.1136/MEDETHICS-2021-107709
2021-10-05 A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein (edit) SARS-CoV-2 (edit) 10.1155/2021/7251119 34651048
2021-10-05 Tailoring Our Approach in Response to the SARS-CoV-2 Pandemic and Transcending Science Outreach Modalities for Native American Students in a Cancer Research Education Program (edit) SARS-CoV-2 (edit) 10.15695/JSTEM/V4I4.08
2021-10-05 Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.746203 34675930
2021-10-04 The acid sphingomyelinase/ceramide system in COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41380-021-01309-5 34608263
2021-10-04 Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs (edit) SARS-CoV-2 (edit) 10.1084/JEM.20211211 34357402
2021-10-04 The early interferon catches the SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1084/JEM.20211667 34424267
2021-10-04 Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.741502 34671355
2021-10-02 Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID (edit) SARS-CoV-2 (edit) 10.1007/S11481-021-10015-6 34599743
2021-10-02 The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103215 34632327
2021-10-02 Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review (edit) SARS-CoV-2 (edit) 10.1093/RHEUMATOLOGY/KEAB026
2021-10-02 SARS‐CoV‐2 Alpha, Beta and Delta variants display enhanced Spike‐mediated Syncytia Formation (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021108944 34601723
2021-10-01 Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.15125 34459863
2021-10-01 Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.28568 34643720
2021-10-01 SARS-CoV-2 Delta variant infects ACE2 primary human bronchial epithelial cells more efficiently than other variants (edit) SARS-CoV-2 (edit) 10.1002/JMV.27372 34596249
2021-10-01 SARS-CoV-2 infects an upper airway model derived from induced pluripotent stem cells (edit) SARS-CoV-2 (edit) 10.1002/STEM.3422 34152044
2021-10-01 Lesson by SARS-CoV-2 disease (COVID-19): whole-body CT angiography detection of "relevant" and "other/incidental" systemic vascular findings (edit) SARS-CoV-2 (edit) 10.1007/S00330-021-07904-Y 33864140
2021-10-01 Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations (edit) SARS-CoV-2 (edit) 10.1007/S00403-020-02156-0 33159236
2021-10-01 H, C and N Backbone chemical shift assignments of the n-terminal and central intrinsically disordered domains of SARS-CoV-2 nucleoprotein (edit) SARS-CoV-2 (edit) 10.1007/S12104-021-10014-X 33730325
2021-10-01 H, C and N assignment of stem-loop SL1 from the 5'-UTR of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S12104-021-10047-2 34453696
2021-10-01 A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery (edit) SARS-CoV-2 (edit) 10.1007/S12250-021-00385-9 33999369
2021-10-01 Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2021.105167 34450201
2021-10-01 Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus (edit) SARS-CoV-2 (edit) 10.1016/J.BBADIS.2021.166198
2021-10-01 Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome (edit) SARS-CoV-2 (edit) 10.1016/J.CJCA.2021.05.014
2021-10-01 Proteases and variants: context matters for SARS-CoV-2 entry assays (edit) SARS-CoV-2 (edit) 10.1016/J.COVIRO.2021.07.004 34365113
2021-10-01 S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity (edit) SARS-CoV-2 (edit) 10.1016/J.DEVCEL.2021.09.016 34599882
2021-10-01 Modeling viral dynamics in SARS-CoV-2 infection based on differential equations and numerical analysis (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E08207
2021-10-01 SARS-CoV-2 and dengue virus coinfection in an adult with beta-thalassemia (trait): A case report from Bangladesh with literature review (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E08229
2021-10-01 APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.10.004
2021-10-01 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103213 34632326
2021-10-01 Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101202 34537245
2021-10-01 The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167280 34606831
2021-10-01 Application of a novel mathematical model to identify intermediate hosts of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JTBI.2021.110761
2021-10-01 Complementation of contact tracing by mass testing for successful containment of beta COVID-19 variant (SARS-CoV-2 VOC B.1.351) epidemic in Hong Kong (edit) SARS-CoV-2 (edit) 10.1016/J.LANWPC.2021.100281 34611629
2021-10-01 High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110677
2021-10-01 OntoRepliCov: an Ontology-Based Approach for Modeling the SARS-CoV-2 Replication Process (edit) SARS-CoV-2 (edit) 10.1016/J.PROCS.2021.08.050 34630741
2021-10-01 [SARS-CoV-2 infection and ischemic stroke] (edit) SARS-CoV-2 (edit) 10.1016/J.SEMERG.2020.09.007 33218946
2021-10-01 Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198522
2021-10-01 Weather, air pollution, and SARS-CoV-2 transmission: a global analysis (edit) SARS-CoV-2 (edit) 10.1016/S2542-5196(21)00202-3
2021-10-01 Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study (edit) SARS-CoV-2 (edit) 10.1016/S2666-5247(21)00129-4 34258603
2021-10-01 Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study (edit) SARS-CoV-2 (edit) 10.1016/S2666-5247(21)00146-4
2021-10-01 Will prenatal exposure to SARS-CoV-2 define a birth cohort with accelerated aging in the century ahead? (edit) SARS-CoV-2 (edit) 10.1017/S204017442000104X 33168125
2021-10-01 An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner (edit) SARS-CoV-2 (edit) 10.1038/S41375-021-01332-Z 34163002
2021-10-01 SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse (edit) SARS-CoV-2 (edit) 10.1038/S41418-021-00846-4 34389814
2021-10-01 O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00545-2 34341488
2021-10-01 Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00555-0 34433900
2021-10-01 Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-26055-8 34599175
2021-10-01 β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization (edit) SARS-CoV-2 (edit) 10.1039/D1RA04820A 35493159
2021-10-01 Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/07391102.2020.1802345 32752944
2021-10-01 Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts (edit) SARS-CoV-2 (edit) 10.1111/BJH.17629 34101171
2021-10-01 Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe (edit) SARS-CoV-2 (edit) 10.1183/23120541.00411-2021
2021-10-01 Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections (edit) SARS-CoV-2 (edit) 10.1186/S12916-021-02103-4 34593004
2021-10-01 The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009412 34597346
2021-10-01 Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021108375 34375000
2021-10-01 Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021 (edit) SARS-CoV-2 (edit) 10.3201/EID2710.211427 34289335
2021-10-01 The Emergence of the New P.4 Lineage of SARS-CoV-2 With Spike L452R Mutation in Brazil (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2021.745310 34660520
2021-10-01 The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/IJMS221910636
2021-10-01 High-dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS-CoV-2 infection: A case-based review of the literature (Review) (edit) SARS-CoV-2 (edit) 10.3892/ETM.2021.10616 34475972
2021-10-01 Estimating the effect of timetabling decisions on the spread of SARS-CoV-2 in medium-to-large engineering schools in Canada: an agent-based modelling study (edit) SARS-CoV-2 (edit) 10.9778/CMAJO.20200280 34933883
2021-09-30 No increase in anti-A isohemagglutinin titer after SARS-CoV-2 infection: A retrospective cohort analysis of group O apheresis platelet donors (edit) SARS-CoV-2 (edit) 10.1002/JCA.21942 34590725
2021-09-30 Cell death mechanisms involved in cell injury caused by SARS‐CoV‐2 (edit) SARS-CoV-2 (edit) 10.1002/RMV.2292 34590761
2021-09-30 The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.09.003 34537136
2021-09-30 Role of miR-2392 in driving SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109839 34624208
2021-09-30 The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109841 34624207
2021-09-30 Theoretical and experimental study of interaction of macroheterocyclic compounds with ORF3a of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-99072-8 34593970
2021-09-30 Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2113401118 34593624
2021-09-30 Identification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1980109 34590967
2021-09-30 Analysis of SARS-CoV-2 haplotypes and genomic sequences during 2020 in Victoria, Australia, in the context of putative deficits in innate immune deaminase anti-viral responses (edit) SARS-CoV-2 (edit) 10.1111/SJI.13100 34940992
2021-09-30 Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0258151
2021-09-30 Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing ORF7a, ORF7b and ORF8, Poland, July to August 2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.39.2100902 34596017
2021-09-29 SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103185 34604721
2021-09-29 The roles of lipids in SARS-CoV-2 viral replication and the host immune response (edit) SARS-CoV-2 (edit) 10.1016/J.JLR.2021.100129 34599996
2021-09-29 Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.PHYPLU.2021.100135 35403085
2021-09-29 Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25985-7 34588460
2021-09-29 Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2 (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2106480118
2021-09-29 Metabolic snapshot of plasma samples reveals new pathways implicated in SARS-CoV-2 pathogenesis (edit) SARS-CoV-2 (edit) 10.1101/2021.09.29.462326
2021-09-29 Critical Capability Needs for Reduction of Transmission of SARS-CoV-2 Indoors (edit) SARS-CoV-2 (edit) 10.3389/FBIOE.2021.641599 34660544
2021-09-29 Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses (edit) SARS-CoV-2 (edit) 10.3390/JCM10194493
2021-09-29 Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury (edit) SARS-CoV-2 (edit) 10.5455/JAVAR.2021.H544 35106293
2021-09-29 mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.69375
2021-09-28 Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100421 34604819
2021-09-28 In vivo structure and dynamics of the SARS-CoV-2 RNA genome (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25999-1
2021-09-28 Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1182/BLOODADVANCES.2021004977
2021-09-28 Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0257784 34582497
2021-09-28 Representing COVID-19 information in collaborative knowledge graphs: the case of Wikidata (edit) SARS-CoV-2 (edit) 10.3233/SW-210444
2021-09-28 ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.752597 34650546
2021-09-28 Autoimmune Disorders & COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/MEDICINES8100055 34677484
2021-09-27 High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples (edit) SARS-CoV-2 (edit) 34631911
2021-09-27 Identifying Distinct Structural Features of the SARS-CoV-2 Spike Protein Fusion Domain Essential for Membrane Interaction (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOCHEM.1C00543
2021-09-27 Machine Learning Models Identify Inhibitors of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCIM.1C00683 34387990
2021-09-27 Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25903-X 34580297
2021-09-27 Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25997-3 34580306
2021-09-27 AGO CLIP-based imputation of potent siRNA sequences targeting SARS-CoV-2 with antifibrotic miRNA-like activity (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-98708-Z 34580386
2021-09-27 Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-98709-Y 34580409
2021-09-27 Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1038/S42255-021-00479-4 34580494
2021-09-27 SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study (edit) SARS-CoV-2 (edit) 10.1093/BJS/ZNAB101 33761533
2021-09-27 Characterization of SARS2 Nsp15 nuclease activity reveals it's mad about U (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB719 34403466
2021-09-27 Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia (edit) SARS-CoV-2 (edit) 10.1186/S13048-021-00872-3 34579761
2021-09-27 Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0249254 34570776
2021-09-27 Characterization of Phytochemicals in Ulva intestinalis L. and Their Action Against SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain (edit) SARS-CoV-2 (edit) 10.3389/FCHEM.2021.735768 34650958
2021-09-27 New Tetramic Acid Derivatives From the Deep-Sea-Derived Fungus Penicillium sp. SCSIO06868 With SARS-CoV-2 Mpro Inhibitory Activity Evaluation (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.730807 34646250
2021-09-27 A meta-analysis for the risk and prevalence of preeclampsia among pregnant women with COVID-19 (edit) SARS-CoV-2 (edit) 10.4274/TJOD.GALENOS.2021.66750 34580872
2021-09-27 Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19 (edit) SARS-CoV-2 (edit) 10.4274/TJOD.GALENOS.2021.74829 34580931
2021-09-25 Reinfection cases by closely related SARS-CoV-2 lineages in Southern Brazil (edit) SARS-CoV-2 (edit) 10.1007/S42770-021-00621-0 34562232
2021-09-25 Role of microRNAs in COVID-19 with implications for therapeutics (edit) SARS-CoV-2 (edit) 10.1016/J.BIOPHA.2021.112247 34601190
2021-09-25 Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109822 34610292
2021-09-25 The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103172 34604720
2021-09-25 Analytical performance comparison of four SARS-CoV-2 RT-qPCR primer-probe sets for wastewater samples (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.150572 34582851
2021-09-25 CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00760-8 34564690
2021-09-25 Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and thrombosis (edit) SARS-CoV-2 (edit) 10.1101/2021.09.24.461743
2021-09-25 Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas (edit) SARS-CoV-2 (edit) 10.3390/V13101927 34696358
2021-09-24 Implications derived from S-protein variants of SARS-CoV-2 from six continents (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.09.080 34571123
2021-09-24 Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102941 34368648
2021-09-24 D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101238 34563540
2021-09-24 Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00562-1 34561618
2021-09-24 Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants (edit) SARS-CoV-2 (edit) 10.1093/GLYCOB/CWAB102
2021-09-24 Azithromycin: characteristics and clinical indications for bacterial and virus infections, including SARS-CoV-2 infections (edit) SARS-CoV-2 (edit) 10.33448/RSD-V10I12.19864
2021-09-24 A Linkage-specific Sialic Acid Labeling Strategy Reveals Different Site-specific Glycosylation Patterns in SARS-CoV-2 Spike Protein Produced in CHO and HEK Cell Substrates (edit) SARS-CoV-2 (edit) 10.3389/FCHEM.2021.735558 34631661
2021-09-24 Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.725240 34630400
2021-09-24 α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.757691 34630436
2021-09-23 Palmitoylation of SARS‐CoV‐2 S protein is critical for S‐mediated syncytia formation and virus entry (edit) SARS-CoV-2 (edit) 10.1002/JMV.27339 34528721
2021-09-23 SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.09.053 34592572
2021-09-23 A robust high-throughput fluorescent polarization assay for the evaluation and screening of SARS-CoV-2 fusion inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.BIOORG.2021.105362 34598089
2021-09-23 SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25949-X 34556667
2021-09-22 In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds (edit) SARS-CoV-2 (edit) 10.1007/S11756-021-00881-Z 34565804
2021-09-22 "SARS-CoV-2 is transmitted by particulate air pollution": Misinterpretations of statistical data, skewed citation practices, and misuse of specific terminology spreading the misconception (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.112116 34562486
2021-09-22 Mechanisms of Antiviral Immune Evasion of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167265 34562466
2021-09-22 Identification of SARS-CoV-2 S RBD escape mutants using yeast screening and deep mutational scanning (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.100869 34568839
2021-09-22 SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00749-3
2021-09-22 Destruction mechanisms of ozone over SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-97860-W 34552128
2021-09-22 Changes in severity, mortality, and virus genome among a Spanish cohort of patients hospitalized with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-98308-X 34552127
2021-09-22 Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants (edit) SARS-CoV-2 (edit) 10.1039/D1RA04107J 35496863
2021-09-22 Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors (edit) SARS-CoV-2 (edit) 10.1039/D1RA05817G 35496831
2021-09-22 Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase (edit) SARS-CoV-2 (edit) 10.1056/NEJMOA2113017 34551225
2021-09-22 Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes (edit) SARS-CoV-2 (edit) 10.1111/ALL.15066 34453317
2021-09-22 Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABH2848 34550739
2021-09-22 RNA Viromics of Southern California Wastewater and Detection of SARS-CoV-2 Single-Nucleotide Variants (edit) SARS-CoV-2 (edit) 10.1128/AEM.01448-21 34550753
2021-09-22 Whole-Genome Sequencing of SARS-CoV-2: Assessment of the Ion Torrent AmpliSeq Panel and Comparison with the Illumina MiSeq ARTIC Protocol (edit) SARS-CoV-2 (edit) 10.1128/JCM.00649-21 34550806
2021-09-22 Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin (edit) SARS-CoV-2 (edit) 10.1128/JVI.01396-21 34549987
2021-09-22 Good Cholesterol Gone Bad? HDL and COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/IJMS221910182 34638523
2021-09-22 Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination (edit) SARS-CoV-2 (edit) 10.3390/IJMS221910188 34638527
2021-09-22 Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/NCRNA7040060 34698261
2021-09-21 A highly potent antibody effective against SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109814 34599871
2021-09-21 mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.09.011 34614412
2021-09-21 Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25796-W 34548480
2021-09-21 Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail (edit) SARS-CoV-2 (edit) 10.1038/S41564-021-00972-2 34548634
2021-09-21 SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02335-21 34544279
2021-09-21 Cohort profile: a national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA—the CHASING COVID Cohort study (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-048778
2021-09-21 Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.707977 34621266
2021-09-21 Impact of Two Different Recruitment Procedures (Random vs. Volunteer Selection) on the Results of Seroepidemiological Study (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.3390/IJERPH18189928
2021-09-21 Intent to Vaccinate SARS-CoV-2 Infected Children in US Households: A Survey (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9091049 34579286
2021-09-20 On the weak binding and spectroscopic signature of SARS‐CoV‐2 nsp14 interaction with RNA (edit) SARS-CoV-2 (edit) 10.1002/CBIC.202100486
2021-09-20 SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection (edit) SARS-CoV-2 (edit) 10.1007/S10719-021-10021-Z 34542788
2021-09-20 Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02640-X 34545191
2021-09-20 The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants (edit) SARS-CoV-2 (edit) 10.1128/AAC.00772-21 34543092
2021-09-20 Mathematical models of the spread and consequences of the SARS-CoV-2 pandemics (edit) SARS-CoV-2 (edit) 10.1186/S13362-021-00111-W
2021-09-20 Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009436 34543264
2021-09-20 SAS: A Platform of Spike Antigenicity for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FCELL.2021.713188 34616728
2021-09-19 SARS-CoV-2 pandemic and its threats to humans and animals (edit) SARS-CoV-2 (edit) 10.21521/MW.6593
2021-09-17 Inhibition of the RNA-dependent RNA Polymerase of the SARS-CoV-2 by Short Peptide Inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.EJPS.2021.106012 34543728
2021-09-17 Complete genome sequencing and molecular characterization of SARS-COV-2 from COVID-19 cases in Alborz province in Iran (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E08027 34549097
2021-09-17 Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101207 34537241
2021-09-17 Spatial and temporal variability and data bias in wastewater surveillance of SARS-CoV-2 in a sewer system (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.150390 34818797
2021-09-17 A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25729-7
2021-09-17 The biological and clinical significance of emerging SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41576-021-00408-X 34535792
2021-09-17 Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-97667-9
2021-09-17 Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-97972-3 34535740
2021-09-17 Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1970627 34533107
2021-09-17 SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB368 34260717
2021-09-17 SARS-CoV-2 Epidemiology on a Public University Campus in Washington State (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAB464
2021-09-17 Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a two-arm crossover randomised controlled trial protocol (edit) SARS-CoV-2 (edit) 10.1186/S12879-021-06659-7 34535091
2021-09-17 Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing (edit) SARS-CoV-2 (edit) 10.1186/S12920-021-01079-7 34535131
2021-09-17 In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009929 34534263
2021-09-17 Enisamium Inhibits SARS-CoV-2 RNA Synthesis (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES9091254 34572438
2021-09-16 Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.07.025 34332650
2021-09-16 Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants (edit) SARS-CoV-2 (edit) 10.1016/J.JPHA.2021.09.006 34545316
2021-09-16 Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay (edit) SARS-CoV-2 (edit) 10.1016/J.JTCME.2021.09.002 34549024
2021-09-16 Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India) (edit) SARS-CoV-2 (edit) 10.1016/J.JVE.2021.100054 34548928
2021-09-16 Dynamic Interactions of Fully Glycosylated SARS-CoV-2 Spike Protein with Various Antibodies (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.1C00552
2021-09-16 S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00756-4 34531369
2021-09-16 In silico approach to design a multi-epitopic vaccine candidate targeting the non-mutational immunogenic regions in envelope protein and surface glycoprotein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1977702 34528491
2021-09-16 Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19 (edit) SARS-CoV-2 (edit) 10.1186/S40001-021-00560-4 34530915
2021-09-16 Ozone Treatment Is Insufficient to Inactivate SARS-CoV-2 Surrogate under Field Conditions (edit) SARS-CoV-2 (edit) 10.3390/ANTIOX10091480 34573110
2021-09-16 Technical Data of Heterologous Expression and Purification of SARS-CoV-2 Proteases Using Escherichia coli System (edit) SARS-CoV-2 (edit) 10.3390/DATA6090099
2021-09-16 In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta) (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS9091967
2021-09-15 Case-control study evaluating risk factors for SARS-CoV-2 outbreak amongst healthcare personnel at a tertiary care center (edit) SARS-CoV-2 (edit) 10.1016/J.AJIC.2021.09.004 34536502
2021-09-15 First reported nosocomial SARS-CoV-2 outbreak in a hospital-based laundry facility (edit) SARS-CoV-2 (edit) 10.1017/S0950268821002016 34521489
2021-09-15 Nanopore Dwell Time Analysis Permits Sequencing and Conformational Assignment of Pseudouridine in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.1C00788 34729414
2021-09-15 The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication (edit) SARS-CoV-2 (edit) 10.1128/JVI.01257-21 34523966
2021-09-15 SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021108249 34296442
2021-09-14 Characteristics and outcomes of pregnant women with SARS-CoV-2 infection and other severe acute respiratory infections (SARI) in Brazil from January to November 2020 (edit) SARS-CoV-2 (edit) 10.1016/J.BJID.2021.101620 34563490
2021-09-14 Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.08.015 34453881
2021-09-14 Honey bee (Apis mellifera L.) colonies as bioindicators of environmental SARS-CoV-2 occurrence (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.150327
2021-09-14 Rapid Detection of SARS-CoV-2 Antigens and Antibodies Using OFET Biosensors Based on a Soft and Stretchable Semiconducting Polymer (edit) SARS-CoV-2 (edit) 10.1021/ACSBIOMATERIALS.1C00727
2021-09-14 Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01507-2 34522051
2021-09-14 MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity (edit) MERS-CoV (edit) 10.1128/MBIO.01316-21 34517762
2021-09-14 MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity (edit) SARS-CoV-2 (edit) 10.1128/MBIO.01316-21 34517762
2021-09-14 High-Frequency, High-Throughput Quantification of SARS-CoV-2 RNA in Wastewater Settled Solids at Eight Publicly Owned Treatment Works in Northern California Shows Strong Association with COVID-19 Incidence (edit) SARS-CoV-2 (edit) 10.1128/MSYSTEMS.00829-21 34519528
2021-09-13 SARS-COV-2 Mpro conformational changes induced by covalently bound ligands (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1970626
2021-09-13 On the timing of interventions to preserve hospital capacity: lessons to be learned from the Belgian SARS-CoV-2 pandemic in 2020 (edit) SARS-CoV-2 (edit) 10.1186/S13690-021-00685-2
2021-09-13 Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009384 34516563
2021-09-12 Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective (edit) SARS-CoV-2 (edit) 10.1007/S11239-021-02558-5 34510337
2021-09-12 Discovery of a Natural Product with Potent Efficacy Against SARS-CoV-2 by Drug Screening (edit) SARS-CoV-2 (edit) 10.1007/S12539-021-00477-W 34510373
2021-09-12 A nanoenzyme linked immunochromatographic sensor for rapid and quantitative detection of SARS-CoV-2 nucleocapsid protein in human blood (edit) SARS-CoV-2 (edit) 10.1016/J.SNB.2021.130718 34539081
2021-09-12 Infection and transmission of SARS‐CoV‐2 depends on heparan sulfate proteoglycans (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2020106765 34510494
2021-09-11 5-Hydroxymethyltubercidin exhibits potent antiviral activity against flaviviruses and coronaviruses, including SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103120 34541466
2021-09-11 The Challenge of Using an Antigen Test as a Screening Tool for SARS-CoV-2 Infection in an Emergency Department: Experience of a Tertiary Care Hospital in Southern Italy (edit) SARS-CoV-2 (edit) 10.1155/2021/3893733 34527736
2021-09-10 Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.09.018 34517025
2021-09-10 Monitoring SARS-CoV-2 in sewage: Toward sentinels with analytical accuracy (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.150244 34798752
2021-09-10 Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOCHEM.1C00414 34506130
2021-09-10 Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-97658-W 34508172
2021-09-10 Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABG7996 34516768
2021-09-10 Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data (edit) SARS-CoV-2 (edit) 10.1186/S12916-021-02107-0 34503493
2021-09-09 Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue (edit) SARS-CoV-2 (edit) 10.1016/J.CLIM.2021.108850 34506944
2021-09-09 Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25589-1 34504087
2021-09-09 Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.1128/JVI.00685-21 34287040
2021-09-09 Interleukin-1RA Mitigates SARS-CoV-2–Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice (edit) SARS-CoV-2 (edit) 10.1161/ATVBAHA.121.316925
2021-09-09 Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1172/JCI150613 34499051
2021-09-09 Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry (edit) SARS-CoV-2 (edit) 10.1186/S10020-021-00356-6 34503440
2021-09-09 Machine Learning augmented docking studies of aminothioureas at the SARS-CoV-2-ACE2 interface (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0256834 34499662
2021-09-08 A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109754 34547223
2021-09-08 Structure of SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.COVIRO.2021.08.010 34534731
2021-09-08 The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins (edit) SARS-CoV-2 (edit) 10.1016/J.JTCME.2021.09.001 34513611
2021-09-08 Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach (edit) SARS-CoV-2 (edit) 10.1016/J.SJBS.2021.09.002 34518755
2021-09-08 Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics (edit) SARS-CoV-2 (edit) 10.1038/S41374-021-00663-W
2021-09-08 SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes (edit) SARS-CoV-2 (edit) 10.1101/2021.09.08.459464
2021-09-08 A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABH1547 34516878
2021-09-08 Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00596-21 34494886
2021-09-08 In vitro efficacy of Artemisia extracts against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S12985-021-01651-8 34496903
2021-09-08 SARS-CoV-2, Trait Anxiety, and the Microbiome (edit) SARS-CoV-2 (edit) 10.3389/FPSYT.2021.720082
2021-09-08 Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS10091155 34578187
2021-09-07 Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-97267-7 34493762
2021-09-07 SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2103154118 34417349
2021-09-07 Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19 (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2105815118 34413211
2021-09-07 Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009380 34491988
2021-09-07 Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009883 34492088
2021-09-07 Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis (edit) SARS-CoV-2 (edit) 10.2174/1389450122666210120142746
2021-09-07 Evaluation of Capillary Blood Gases in Medical Personnel Caring for Patients Isolated Due to SARS-CoV-2 in Intensive Care Units before and after Using Enhanced Filtration Masks: A Prospective Cohort Study (edit) SARS-CoV-2 (edit) 10.3390/IJERPH18189425 34574350
2021-09-06 Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101175 34499924
2021-09-06 SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00719-9 34489403
2021-09-06 Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design (edit) SARS-CoV-2 (edit) 10.1039/D1SC02775A 34777769
2021-09-06 Featuring ACE2 binding SARS-CoV and SARS-CoV-2 through a conserved evolutionary pattern of amino acid residues (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1965028 34486937
2021-09-06 In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1968497 34486935
2021-09-06 Emotional Control among Nurses against Work Conditions and the Support Received during the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.3390/IJERPH18179415 34502006
2021-09-05 Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production (edit) SARS-CoV-2 (edit) 10.1002/1873-3468.14180 34409594
2021-09-05 Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant (edit) SARS-CoV-2 (edit) 10.1101/2021.08.12.456173 34462752
2021-09-05 How Informative Were Early SARS-CoV-2 Treatment and Prevention Trials? A longitudinal cohort analysis of trials registered on clinicaltrials.gov (edit) SARS-CoV-2 (edit) 10.1101/2021.08.25.21262155
2021-09-04 Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients (edit) SARS-CoV-2 (edit) 10.1002/JMV.27285 34415583
2021-09-04 Exploration of In-silico screening of therapeutic agents against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CHEMPHYS.2021.111354 34511699
2021-09-04 The epidemiology of hospital inpatient exposure to SARS-CoV-2: A cohort study (edit) SARS-CoV-2 (edit) 10.1016/J.INFPIP.2021.100173 34514365
2021-09-04 The dominant strain of SARS-CoV-2 is a mosaicism (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198553
2021-09-04 Analysis of Intermediate Hosts and Susceptible Animals of SARS-CoV-2 by Computational Methods (edit) SARS-CoV-2 (edit) 10.15212/ZOONOSES-2021-0010
2021-09-03 A Proposed Functional Analysis of Transmission Prevention Behaviors for a Respiratory Virus (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.1007/S42822-021-00055-1
2021-09-03 Computational insights into the membrane fusion mechanism of SARS-CoV-2 at the cellular level (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.08.053 34540146
2021-09-03 SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3 (edit) SARS-CoV-2 (edit) 10.1016/J.CYTO.2021.155697 34509038
2021-09-03 Inhibition of SARS-CoV-2 infection by human defensin HNP1 and retrocyclin RC-101 (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167225 34487793
2021-09-03 Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.1C00349 34379411
2021-09-03 Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00312-21
2021-09-03 SARS-CoV-2 Initiates Programmed Cell Death in Platelets (edit) SARS-CoV-2 (edit) 10.1161/CIRCRESAHA.121.319117 34293929
2021-09-03 Ethacridine inhibits SARS-CoV-2 by inactivating viral particles (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009898
2021-09-03 Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.7150/IJBS.53312 34671200
2021-09-02 SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19 (edit) SARS-CoV-2 (edit) 10.1002/14651858.CD013825.PUB2
2021-09-02 Potential Achilles heels of SARS-CoV-2 are best displayed by the base order-dependent component of RNA folding energy (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107570
2021-09-02 Predicted pH-dependent stability of SARS-CoV-2 spike protein trimer from interfacial acidic groups (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.08.049 34490059
2021-09-02 High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.08.062 34481966
2021-09-02 Activation Pathways and Free Energy Landscapes of the SARS-CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.1C03384 34514271
2021-09-02 Effectiveness of an Inactivated SARS-CoV-2 Vaccine (edit) SARS-CoV-2 (edit) 10.1056/NEJME2111165 34469651
2021-09-02 Comparative phylogenetic analysis of SARS-CoV-2 spike protein-possibility effect on virus spillover (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAB144 33885726
2021-09-02 Modeling transmission dynamics and effectiveness of worker screening programs for SARS-CoV-2 in pork processing plants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0249143
2021-09-02 Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0256877
2021-09-01 Bioinformatics analysis of SARS-CoV-2 infection-associated immune injury and therapeutic prediction for COVID-19 (edit) SARS-CoV-2 (edit)
2021-09-01 SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy (edit) SARS-CoV-2 (edit) 10.1001/JAMAOPHTHALMOL.2020.5464 33662099
2021-09-01 SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers (edit) SARS-CoV-2 (edit) 10.1002/JMV.27300 34449894
2021-09-01 Lipid-based therapies against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1002/RMV.2214 34546604
2021-09-01 Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation (edit) SARS-CoV-2 (edit) 10.1007/S00439-021-02305-Z 34155559
2021-09-01 The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance (edit) SARS-CoV-2 (edit) 10.1007/S12275-021-1348-5 34449057
2021-09-01 Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies? (edit) SARS-CoV-2 (edit) 10.1007/S40268-021-00349-0 34106430
2021-09-01 Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2021.105142 34303749
2021-09-01 The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103544 34419925
2021-09-01 Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2021.101064 34401689
2021-09-01 Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2021.101069 34377969
2021-09-01 Wastewater monitoring as a supplementary surveillance tool for capturing SARS-COV-2 community spread. A case study in two Greek municipalities (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.111749 34310965
2021-09-01 Approximative He Hamiltonian in descriptive multidimensional scaling statistics of RNA contained information with application to SARS-CoV-2 Spike mRNA and 7SLRNA, RN7SL2 and RN7SL3 (edit) SARS-CoV-2 (edit) 10.1016/J.GENREP.2021.101203
2021-09-01 Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.06.019
2021-09-01 The Relationship Between GI symptoms, State and Trait Anxiety, and Lifestyle Factors in Males and Females During the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.JAND.2021.06.101
2021-09-01 The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101041 34358560
2021-09-01 SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2021.104914 34304088
2021-09-01 Comparison of approaches to quantify SARS-CoV-2 in wastewater using RT-qPCR: Results and implications from a collaborative inter-laboratory study in Canada (edit) SARS-CoV-2 (edit) 10.1016/J.JES.2021.01.029 34412784
2021-09-01 Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine (edit) SARS-CoV-2 (edit) 10.1016/J.KINT.2021.06.033
2021-09-01 The emergence of novel SARS-CoV-2 variant P.1 in Amazonas (Brazil) was temporally associated with a change in the age and sex profile of COVID-19 mortality: A population based ecological study (edit) SARS-CoV-2 (edit) 10.1016/J.LANA.2021.100021
2021-09-01 Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105057 34481060
2021-09-01 A scoping review of the experience of implementing population testing for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.PUHE.2021.06.012 34352612
2021-09-01 Citizen volunteers detect SARS-CoV-2 RNA from outdoor urban fomites (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.147719
2021-09-01 Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.08.018 34525378
2021-09-01 Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study) (edit) SARS-CoV-2 (edit) 10.1016/J.VACCINE.2021.07.093 34393019
2021-09-01 Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198473 34118360
2021-09-01 Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study (edit) SARS-CoV-2 (edit) 10.1016/S2589-7500(21)00115-1 34305035
2021-09-01 SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCIM.1C00857 34468141
2021-09-01 Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00734-W 34471088
2021-09-01 A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00742-W 34471099
2021-09-01 Cellular host factors for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41564-021-00958-0 34471255
2021-09-01 Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-01028-7 34471264
2021-09-01 A human three-dimensional neural-perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01443-1 34244682
2021-09-01 Manipulation of autophagy by SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1080/15548627.2021.1953847 34281462
2021-09-01 Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB281 33857303
2021-09-01 Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium (edit) SARS-CoV-2 (edit) 10.1093/HUMREP/DEAB183 34329437
2021-09-01 SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses (edit) SARS-CoV-2 (edit) 10.1093/JALM/JFAB080 34170314
2021-09-01 Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice (edit) SARS-CoV-2 (edit) 10.1096/FJ.202002742RR 34365657
2021-09-01 Targeting neuropilins as a viable SARS-CoV-2 treatment (edit) SARS-CoV-2 (edit) 10.1111/FEBS.16096 34185437
2021-09-01 Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva (edit) SARS-CoV-2 (edit) 10.1111/IMM.13349 33932228
2021-09-01 Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions (edit) SARS-CoV-2 (edit) 10.1681/ASN.2020111546 34112705
2021-09-01 Is Environmental Pollen Concentration a Risk Factor for SARS-CoV-2 Infection? (edit) SARS-CoV-2 (edit) 10.18176/JIACI.0743
2021-09-01 An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.2144/FSOA-2021-0064
2021-09-01 Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.2147/JIR.S322430 34511970
2021-09-01 Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease (edit) SARS-CoV-2 (edit) 10.22092/ARI.2020.351202.1517 34824739
2021-09-01 SARS-CoV-2 Wastewater Surveillance for Public Health Action (edit) SARS-CoV-2 (edit) 10.3201/EID2709.210753 34424162
2021-09-01 Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.728960 34539756
2021-09-01 Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria (edit) SARS-CoV-2 (edit) 10.3390/IJMS22179518 34502431
2021-09-01 Direct detection of SARS-CoV-2 RNA using high-contrast pH-sensitive dyes (edit) SARS-CoV-2 (edit) 10.7171/JBT.21-3203-007 35027870
2021-09-01 Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications (edit) SARS-CoV-2 (edit) 10.7171/JBT.21-3203-017 35136384
2021-08-31 The nucleotide addition cycle of the SARS-CoV-2 polymerase (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109650 34433083
2021-08-31 Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2 (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101151 34478710
2021-08-31 Genome-wide association study of COVID-19 severity among the Chinese population (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00318-6
2021-08-31 Mechanical activation of spike fosters SARS-CoV-2 viral infection (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00558-X 34465913
2021-08-31 Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03925-1
2021-08-31 Trans-ethnic genome-wide association study of severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02549-5
2021-08-31 Correction for Benton et al., The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2112850118 34426505
2021-08-31 D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage (edit) SARS-CoV-2 (edit) 10.1128/MBIO.00587-21 34311586
2021-08-31 The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19 (edit) SARS-CoV-2 (edit) 10.1128/MBIO.00970-21 34340553
2021-08-31 Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication (edit) SARS-CoV-2 (edit) 10.1128/MBIO.01067-21 34225491
2021-08-31 Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.1128/MBIO.01140-21 34465019
2021-08-31 Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains (edit) SARS-CoV-2 (edit) 10.1128/MBIO.01590-21 34340537
2021-08-31 Origin of imported SARS-CoV-2 strains in The Gambia identified from whole genome sequences (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0241942 34464385
2021-08-31 Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0251114 34460832
2021-08-31 Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0256451 34464419
2021-08-31 SARS-CoV-2 Lambda Variant: Spatiotemporal Distribution and Potential Public Health Impact (edit) SARS-CoV-2 (edit) 10.15212/ZOONOSES-2021-0009
2021-08-31 The Clinical Impact and Cost Effectiveness of Intervention Policies Against the SARS-CoV-2 Pandemic: A Mathematical Modelling Analysis (edit) SARS-CoV-2 (edit) 10.2139/SSRN.3911364
2021-08-31 Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions (edit) SARS-CoV-2 (edit) 10.3390/NCRNA7030054 34564316
2021-08-31 Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.70362
2021-08-30 Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor (edit) SARS-CoV-2 (edit) 10.1186/S13578-021-00680-8 34461999
2021-08-30 SARS-CoV-2: Origin, Intermediate Host and Allergenicity Features and Hypotheses (edit) SARS-CoV-2 (edit) 10.3390/HEALTHCARE9091132
2021-08-30 Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase (edit) SARS-CoV-2 (edit) 10.3390/V13091722 34578302
2021-08-30 In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry (edit) SARS-CoV-2 (edit) 10.3906/BIY-2012-52 34803446
2021-08-30 Genomic chronicle of SARS-CoV-2: a mutational analysis with over 1 million genome sequences (edit) SARS-CoV-2 (edit) 10.3906/BIY-2106-8 34803444
2021-08-30 Epidemiology, virology, clinical features, diagnosis, and treatment of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.52142/OMUJECM.38.4.44
2021-08-28 Ultrasensitive Detection of Dopamine, IL-6 and SARS-CoV-2 Proteins on Crumpled Graphene FET Biosensor (edit) SARS-CoV-2 (edit) 10.1002/ADMT.202100712 34901384
2021-08-28 In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104818 34481181
2021-08-28 Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2021.101101 34476394
2021-08-28 In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct (edit) SARS-CoV-2 (edit) 10.1016/J.IMBIO.2021.152134 34474252
2021-08-28 SARS-CoV-2 in residential rooms of two self-isolating persons with COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.JAEROSCI.2021.105870 34483358
2021-08-28 SARS-CoV-2 infection of the central nervous system in a 14-month-old child: A case report of a complete autopsy (edit) SARS-CoV-2 (edit) 10.1016/J.LANA.2021.100046 34485969
2021-08-28 Assessing the extent of community spread caused by mink-derived SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.XINN.2021.100128 34124706
2021-08-28 Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1970024
2021-08-28 Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications (edit) SARS-CoV-2 (edit) 10.1093/PCMEDI/PBAB022 34993416
2021-08-28 Development of a Web GIS for small-scale detection and analysis of COVID-19 (SARS-CoV-2) cases based on volunteered geographic information for the city of Cologne, Germany, in July/August 2020 (edit) SARS-CoV-2 (edit) 10.1186/S12942-021-00290-0 34454536
2021-08-28 Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung (edit) SARS-CoV-2 (edit) 10.7150/IJBS.61320 34671199
2021-08-27 SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling (edit) SARS-CoV-2 (edit) 10.1016/J.BBADIS.2021.166260 34461258
2021-08-27 Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109708 34506741
2021-08-27 Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00475-8 34461056
2021-08-27 Host ADP-ribosylation and the SARS-CoV-2 macrodomain (edit) SARS-CoV-2 (edit) 10.1042/BST20201212 34351418
2021-08-27 A Dedicated SARS-CoV-2 Testing Center for Public Service Agency Personnel: Implementation, Results, and Impact on Human Resources (edit) SARS-CoV-2 (edit) 10.1080/10903127.2021.1973627
2021-08-27 Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.731828 34512357
2021-08-27 Anti-clustering in the national SARS-CoV-2 daily infection counts (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.11856
2021-08-26 Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00237 34437808
2021-08-26 Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25479-6 34446720
2021-08-26 5α-Reductase Inhibitors are Associated with Reduced Risk of SARS-COV-2 Infection: A Matched-Pair, Registry-Based Analysis (edit) SARS-CoV-2 (edit) 10.1097/JU.0000000000002180
2021-08-26 A Remote Control System for Emergency Ventilators During SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1109/LES.2021.3107837 35582518
2021-08-26 Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System (edit) SARS-CoV-2 (edit) 10.1186/S12575-021-00153-9 34433426
2021-08-26 Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020 (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.72914.1
2021-08-26 Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding Sites in TOM70 and Recruitment of Hsp90 (edit) SARS-CoV-2 (edit) 10.3390/IJMS22179233 34502139
2021-08-26 Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study (edit) SARS-CoV-2 (edit) 10.7759/CUREUS.17455 34513523
2021-08-25 In silico molecular docking of SARS-CoV-2 surface proteins with microbial non-ribosomal peptides: identification of potential drugs (edit) SARS-CoV-2 (edit) 10.1007/S42485-021-00072-Z 34456530
2021-08-25 Distinct weather conditions and human mobility impacts on the SARS-CoV-2 outbreak in Colombia: Application of an artificial neural network approach (edit) SARS-CoV-2 (edit) 10.1016/J.IJHEH.2021.113833 34461424
2021-08-25 The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.08.036 34454120
2021-08-25 Extraction-Free Rapid Cycle Quantitative RT-PCR and Extreme RT-PCR for SARS-CoV-2 Virus Detection (edit) SARS-CoV-2 (edit) 10.1016/J.JMOLDX.2021.08.004 34454108
2021-08-25 Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25357-1
2021-08-25 A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25361-5
2021-08-25 Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00275-21 34431693
2021-08-25 Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0244468 34432798
2021-08-25 Spatial scales, patterns, and positivity trends of SARS-CoV-2 pandemics in mass rapid antigen testing in Slovakia (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0256669
2021-08-25 SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.706252 34513728
2021-08-25 Preliminary Findings on the Association of the Lipid Peroxidation Product 4-Hydroxynonenal with the Lethal Outcome of Aggressive COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/ANTIOX10091341 34572973
2021-08-25 Molecular Pathology Demonstration of SARS-CoV-2 in Cytotrophoblast from Placental Tissue with Chronic Histiocytic Intervillositis, Trophoblast Necrosis and COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/JDB9030033 34449643
2021-08-24 Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies (edit) SARS-CoV-2 (edit) 10.1002/ARDP.202100160 34427335
2021-08-24 Autoimmune Complications of COVID‐19 (edit) SARS-CoV-2 (edit) 10.1002/JMV.27292 34427929
2021-08-24 A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia (edit) SARS-CoV-2 (edit) 10.1016/J.CRMICR.2021.100065 34841355
2021-08-24 A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.08.025 34508662
2021-08-24 Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00310-0 34429403
2021-08-24 Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2103554118 34373319
2021-08-24 Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB425 34427670
2021-08-23 Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) - A computational study (edit) SARS-CoV-2 (edit) 10.1016/J.ARABJC.2021.103393 34909061
2021-08-23 Multiple Roles of SARS-CoV-2 N Protein Facilitated by Proteoform-Specific Interactions with RNA, Host Proteins, and Convalescent Antibodies (edit) SARS-CoV-2 (edit) 10.1021/JACSAU.1C00139 34462738
2021-08-23 Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome (edit) SARS-CoV-2 (edit) 10.1038/S41594-021-00653-Y
2021-08-23 Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations (edit) SARS-CoV-2 (edit) 10.1101/2021.08.20.21262389 34462757
2021-08-23 Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus (edit) SARS-CoV-2 (edit) 10.1186/S13059-021-02454-4
2021-08-23 Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009849 34424945
2021-08-23 Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.692937 34497604
2021-08-22 Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells (edit) SARS-CoV-2 (edit) 10.3390/IJMS22169041 34445747
2021-08-21 Molecular characterization of SARS-CoV-2 from Bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E07866 34458642
2021-08-21 HLA repertoire of 115 UAE nationals infected with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.HUMIMM.2021.08.012 34462158
2021-08-21 Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types (edit) SARS-CoV-2 (edit) 10.1016/J.MICINF.2021.104880 34425246
2021-08-21 Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells (edit) SARS-CoV-2 (edit) 10.1038/S41385-021-00437-Z 34420043
2021-08-21 Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein (edit) SARS-CoV-2 (edit) 10.1186/S40249-021-00895-4
2021-08-21 SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites (edit) SARS-CoV-2 (edit) 10.3390/IJMS22169035 34445741
2021-08-20 Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry (edit) SARS-CoV-2 (edit) 10.1007/S11427-021-1990-5 34431042
2021-08-20 Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany (edit) SARS-CoV-2 (edit) 10.1007/S12519-021-00447-8 34415560
2021-08-20 CovidPhy: A tool for phylogeographic analysis of SARS-CoV-2 variation (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.111909 34419470
2021-08-20 Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.103006 34430803
2021-08-20 The Prevention of Common Respiratory Virus Epidemics in 2020-21 during the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: An Unexpected Benefit of the Implementation of Public Health Measures (edit) SARS-CoV-2 (edit) 10.1016/J.LANA.2021.100043
2021-08-20 Enumerating asymptomatic COVID-19 cases and estimating SARS-CoV-2 fecal shedding rates via wastewater-based epidemiology (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.149794 34467933
2021-08-20 mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-01021-0
2021-08-20 Management of SARS-CoV-2 in the Military and Lessons for Future Pandemics (edit) SARS-CoV-2 (edit) 10.1093/MILMED/USAB337
2021-08-20 Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level (edit) SARS-CoV-2 (edit) 10.20411/PAI.V6I2.460 34541432
2021-08-20 Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker (edit) SARS-CoV-2 (edit) 10.3389/FMED.2021.737007 34490316
2021-08-20 N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.69091 34414884
2021-08-19 Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach (edit) SARS-CoV-2 (edit) 10.1016/J.BPC.2021.106677 34428682
2021-08-19 Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103519 34419923
2021-08-19 Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.111901
2021-08-19 Association of Apolipoprotein e polymorphism with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.105043 34419671
2021-08-19 Wastewater SARS-CoV-2 monitoring as a community-level COVID-19 trend tracker and variants in Ohio, United States (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.149757 34467932
2021-08-19 A glycan gate controls opening of the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1038/S41557-021-00758-3 34413500
2021-08-19 SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-96110-3 34413339
2021-08-19 A Community-Adapted Approach to SARS-CoV-2 Testing for Medically Underserved Populations, Rhode Island, USA (edit) SARS-CoV-2 (edit) 10.3201/EID2709.204874
2021-08-18 Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.IJPHARM.2021.121023 34416332
2021-08-18 Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age (edit) SARS-CoV-2 (edit) 10.1016/J.YGENO.2021.08.012 34418496
2021-08-18 HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00726-W 34408131
2021-08-18 Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children (edit) SARS-CoV-2 (edit) 10.1038/S41587-021-01037-9
2021-08-18 Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABH0755
2021-08-18 Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease (edit) SARS-CoV-2 (edit) 10.1128/JVI.00975-21 34406858
2021-08-18 Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage (edit) SARS-CoV-2 (edit) 10.1128/JVI.01357-21 34406867
2021-08-18 A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S12879-021-06528-3 34407759
2021-08-18 Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0256141 34407143
2021-08-18 Wide Application of Minimally Processed Saliva on Multiple RT-qPCR Kits for SARS-CoV-2 Detection in Indonesia (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.691538 34485174
2021-08-18 SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer (edit) SARS-CoV-2 (edit) 10.3389/FONC.2021.715794 34490115
2021-08-18 Group Testing for SARS-CoV-2 Allows for Up to 10-Fold Efficiency Increase Across Realistic Scenarios and Testing Strategies (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2021.583377
2021-08-17 Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations (edit) SARS-CoV-2 (edit) 10.1007/S11756-021-00866-Y 34421121
2021-08-17 Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.08.014 34499854
2021-08-17 A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.08.013 34464596
2021-08-17 “Armed for the future Coronavirus pandemic”: a promising use of the multimeric SARS-CoV-2 receptor binding domain nanoparticle as a new Pan-Coronavirus vaccine (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00721-1
2021-08-17 Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00306-W 34400613
2021-08-17 SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25156-8 34404778
2021-08-17 A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25331-X 34404805
2021-08-17 No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2109066118 34344759
2021-08-17 Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02094-21 34399606
2021-08-17 Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19 (edit) SARS-CoV-2 (edit) 10.1136/THORAXJNL-2021-217561
2021-08-17 Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact (edit) SARS-CoV-2 (edit) 10.15212/ZOONOSES-2021-0005
2021-08-17 A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.69719 34402426
2021-08-16 Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1001/JAMAPEDIATRICS.2021.2770 34398179
2021-08-16 Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2 (edit) SARS-CoV-2 (edit) 10.1007/S12250-021-00431-6 34398430
2021-08-16 Trends in Pediatric Viral Symptoms, Influenza Testing, and SARS-CoV-2 Testing From a Statewide Electronic Health Record Consortium, January 2017 to July 2021 (edit) SARS-CoV-2 (edit) 10.1016/J.ACAP.2021.08.008 34411765
2021-08-16 Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing (edit) SARS-CoV-2 (edit) 10.1016/J.STR.2021.07.007 34403647
2021-08-16 SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020 (edit) SARS-CoV-2 (edit) 10.1016/J.TRANSPROCEED.2021.08.019 34551880
2021-08-16 An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity (edit) SARS-CoV-2 (edit) 10.1016/J.VACCINE.2021.07.034 34304928
2021-08-16 Ultrarapid detection of SARS-CoV-2 RNA using a reverse transcription–free exponential amplification reaction, RTF-EXPAR (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2100347118
2021-08-16 Molecular docking and dynamic simulation of conserved B cell epitope of SARS-CoV-2 glycoprotein Indonesian isolates: an immunoinformatic approach (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.54258.1
2021-08-16 Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria (edit) SARS-CoV-2 (edit) 10.20944/PREPRINTS202108.0329.V1
2021-08-16 Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.722027 34489971
2021-08-15 EVOLUTION OF THE INFECTION OF THE SARS-COV-2 IN ITALY, GENERAL EPIDEMIOLOGICAL RESULTS AND NEW STRADEGIC HYPOTHESES RELATED TO TERRESTRIAL CLIMATE (edit) SARS-CoV-2 (edit) 10.26821/IJSRC.9.8.2021.9822
2021-08-14 Comparison of positive SARS-CoV-2 incidence rate with environmental and socioeconomic factors in northern Illinois (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E07806 34414309
2021-08-14 Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx (edit) SARS-CoV-2 (edit) 10.1016/J.MCPRO.2021.100134 34400346
2021-08-14 A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2021.08.002 34414385
2021-08-14 Does face mask use elicit risk-compensation? Quasi-experimental evidence from Denmark during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1093/EURPUB/CKAB136
2021-08-14 Recovery of Deleted Deep Sequencing Data Sheds More Light on the Early Wuhan SARS-CoV-2 Epidemic (edit) SARS-CoV-2 (edit) 10.1093/MOLBEV/MSAB246
2021-08-14 An overview of the COVID-19 related content of Wikimedia projects (edit) SARS-CoV-2 (edit) 10.5281/ZENODO.5201623
2021-08-13 A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1002/PROT.26205 34369011
2021-08-13 The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor (edit) SARS-CoV-2 (edit) 10.1007/S00216-021-03601-3 34389878
2021-08-13 Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.08.001 34453880
2021-08-13 The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00131 34152728
2021-08-13 Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABH1139 34016740
2021-08-13 The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses (edit) SARS-CoV-2 (edit) 10.1515/REVNEURO-2021-0041 34388333
2021-08-13 Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.706901 34483914
2021-08-13 Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence (edit) SARS-CoV-2 (edit) 10.4049/JIMMUNOL.2100465 34389625
2021-08-12 Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies (edit) SARS-CoV-2 (edit) 10.1007/S12192-021-01230-4 34382151
2021-08-12 Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside (edit) SARS-CoV-2 (edit) 10.1016/J.CRPHAR.2021.100045 34870151
2021-08-12 Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103524 34391096
2021-08-12 Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study (edit) SARS-CoV-2 (edit) 10.1016/J.GENREP.2021.101312 34401607
2021-08-12 Dynamics of SARS-CoV-2 in wastewater in three districts of the Buenos Aires metropolitan region, Argentina, throughout nine months of surveillance: A pilot study (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.149578 34426365
2021-08-12 Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.1C00325
2021-08-12 Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.1C04528 34328740
2021-08-12 The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) (edit) SARS-CoV-2 (edit) 10.1038/S41375-021-01374-3 34385593
2021-08-12 Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function (edit) SARS-CoV-2 (edit) 10.1038/S41594-021-00652-Z
2021-08-12 Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2107799 34233096
2021-08-12 Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1101/2021.08.11.455956 34401880
2021-08-12 Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABJ4176 34385356
2021-08-12 SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study (edit) SARS-CoV-2 (edit) 10.1186/S12916-021-02072-8 34384441
2021-08-12 Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.730288 34458164
2021-08-11 Distinct Lipid Metabolic Dysregulation in Asymptomatic COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102974 34396083
2021-08-11 Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.RETRAM.2021.103309 34418758
2021-08-11 Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry (edit) SARS-CoV-2 (edit) 10.1021/JACS.1C02713 34328324
2021-08-11 Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00716-Y 34381015
2021-08-11 Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25166-6 34381037
2021-08-11 Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis (edit) SARS-CoV-2 (edit) 10.1038/S41594-021-00651-0
2021-08-11 A computational study of cooperative binding to multiple SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-95826-6 34381116
2021-08-11 Multiplexed detection of SARS-CoV-2 genomic and subgenomic RNA using hybridization (edit) SARS-CoV-2 (edit) 10.1101/2021.08.11.455959 34401878
2021-08-11 SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples (edit) SARS-CoV-2 (edit) 10.1128/JCM.01046-21 34379527
2021-08-11 A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters (edit) SARS-CoV-2 (edit) 10.1128/JVI.00592-21 34379509
2021-08-11 TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351) (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00472-21 34378968
2021-08-11 Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00536-21 34378965
2021-08-11 Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0253574 34379620
2021-08-11 Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/V13081593 34452458
2021-08-11 Public Health Leadership in a VUCA World Environment: Lessons Learned during the Regional Emergency Rollout of SARS-CoV-2 Vaccinations in Heidelberg, Germany, during the COVID-19 Pandemic (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9080887
2021-08-10 Determination of vulnerable regions of SARS-CoV-2 in Malaysia using meteorology and air quality data (edit) SARS-CoV-2 (edit) 10.1007/S10668-021-01719-Z 34393622
2021-08-10 Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104759 34403938
2021-08-10 Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.06.015 34246326
2021-08-10 Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101065 34384783
2021-08-10 Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25137-X 34376689
2021-08-10 Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-95733-W 34376762
2021-08-10 Cold atmospheric plasma: A non-negligible strategy for viral RNA inactivation to prevent SARS-CoV-2 environmental transmission (edit) SARS-CoV-2 (edit) 10.1063/5.0060530 34413992
2021-08-10 Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2109229118
2021-08-10 Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice (edit) SARS-CoV-2 (edit) 10.1128/JVI.00402-21 34133899
2021-08-10 Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress (edit) SARS-CoV-2 (edit) 10.3390/CELLS10082047 34440816
2021-08-10 Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS9081700 34442779
2021-08-09 Online bioinformatics teaching practice: Comparison of popular docking programs using SARS-CoV-2 spike RBD-ACE2 complex as a benchmark (edit) SARS-CoV-2 (edit) 10.1002/BMB.21566 34369638
2021-08-09 Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.1C00323 34369795
2021-08-09 Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25168-4 34373458
2021-08-09 Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection and Escherichia coli Sepsis (edit) SARS-CoV-2 (edit) 10.1097/RHU.0000000000001783
2021-08-09 Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021107985 34302370
2021-08-09 A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.707194 34434902
2021-08-07 HD5 and LL-37 Inhibit SARS-CoV and SARS-CoV-2 Binding to Human ACE2 by Molecular Simulation (edit) SARS-CoV-2 (edit) 10.1007/S12539-021-00462-3 34363600
2021-08-06 Structural dynamics of single SARS-CoV-2 pseudoknot molecules reveal topologically distinct conformers (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25085-6 34362921
2021-08-06 Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI6226 34168071
2021-08-06 Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI9745
2021-08-06 Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S13073-021-00943-6 34362430
2021-08-06 Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing (edit) SARS-CoV-2 (edit) 10.1186/S40001-021-00558-Y
2021-08-06 Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings - Barnstable County, Massachusetts, July 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7031E2 34351882
2021-08-06 The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.660490 34421587
2021-08-05 Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CCA.2021.08.003 34364853
2021-08-05 Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.06.020 34242578
2021-08-05 Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JPHA.2021.08.003 34377564
2021-08-05 Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease (edit) SARS-CoV-2 (edit) 10.1016/J.STR.2021.06.002 34161756
2021-08-05 Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021 (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198532 34363852
2021-08-05 SARS-CoV-2 Unrevealed: Ultrastructural and Nanomechanical Analysis (edit) SARS-CoV-2 (edit) 10.1021/ACS.LANGMUIR.1C01488 34351770
2021-08-05 Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-95563-W 34354202
2021-08-05 NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB677 34352100
2021-08-05 Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1009286
2021-08-04 Par ici la sortie ! Le SARS-CoV-2 utilise les lysosomes pour sortir de la cellule infectée (edit) SARS-CoV-2 (edit) 10.1051/MEDSCI/2021100
2021-08-04 Overlapping of Independent SARS-CoV-2 Nosocomial Transmissions in a Complex Outbreak (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00389-21 34346709
2021-08-04 Auditory Disturbances and SARS-CoV-2 Infection: Brain Inflammation or Cochlear Affection? Systematic Review and Discussion of Potential Pathogenesis (edit) SARS-CoV-2 (edit) 10.3389/FNEUR.2021.707207
2021-08-03 Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications (edit) SARS-CoV-2 (edit)
2021-08-03 Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.06.006 34197805
2021-08-03 Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109479 34320401
2021-08-03 Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2103272118 34312227
2021-08-03 Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase (edit) SARS-CoV-2 (edit) 10.1080/17460441.2021.1909566
2021-08-03 SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice (edit) SARS-CoV-2 (edit) 10.1080/21645515.2021.1901545 33847226
2021-08-03 Catching SARS-CoV-2 by Sequence Hybridization: a Comparative Analysis (edit) SARS-CoV-2 (edit) 10.1128/MSYSTEMS.00392-21 34342536
2021-08-03 N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation (edit) SARS-CoV-2 (edit) 10.3389/FCELL.2021.697035 34414185
2021-08-03 Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9080848 34451973
2021-08-03 SARS-COV-2 invasion in lakes: A rare transferability of the dreaded virus by nature or manmade (edit) SARS-CoV-2 (edit) 10.4314/JAS.V36I1.3
2021-08-02 Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics (edit) SARS-CoV-2 (edit) 34128960
2021-08-02 Quantification of Specific Antibodies Against SARS-CoV-2 in Breast Milk of Lactating Women Vaccinated With an mRNA Vaccine (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.20575 34379127
2021-08-02 An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.100755 34368787
2021-08-02 Why All the Fury over Furin? (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.1C00518 34340303
2021-08-02 SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-25015-6 34341353
2021-08-02 β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB247 33961695
2021-08-02 Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0255622 34339474
2021-08-02 SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021107826 34101213
2021-08-02 The Emergence and Spread of Novel SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2021.696664 34409009
2021-08-01 MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 33832550
2021-08-01 Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics (edit) SARS-CoV-2 (edit) 10.1002/BAB.2033 32970352
2021-08-01 Predictable fold switching by the SARS-CoV-2 protein ORF9b (edit) SARS-CoV-2 (edit) 10.1002/PRO.4097 33934422
2021-08-01 p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein (edit) SARS-CoV-2 (edit) 10.1002/PRP2.798 34128351
2021-08-01 Air pollution particulate matter as a potential carrier of SARS-CoV-2 to the nervous system and/or neurological symptom enhancer: arguments in favor (edit) SARS-CoV-2 (edit) 10.1007/S11356-020-11183-3 33051841
2021-08-01 Mortality after surgery with SARS-CoV-2 infection in England: a population-wide epidemiological study (edit) SARS-CoV-2 (edit) 10.1016/J.BJA.2021.05.018 34148733
2021-08-01 ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors (edit) SARS-CoV-2 (edit) 10.1016/J.CCA.2021.04.024 33957095
2021-08-01 In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.06.021 34242577
2021-08-01 The Origins of SARS-CoV-2: A Critical Review (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.08.017
2021-08-01 Novel SARS-CoV-2 variants: the pandemics within the pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.CMI.2021.05.022 34015535
2021-08-01 The conundrum of current anti-SARS-CoV-2 vaccines (edit) SARS-CoV-2 (edit) 10.1016/J.CYTOGFR.2021.03.001
2021-08-01 Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2021.101028 34308321
2021-08-01 Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients (edit) SARS-CoV-2 (edit) 10.1016/J.HEALUN.2021.05.004
2021-08-01 Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.100925 34214498
2021-08-01 S-acylation of SARS-CoV-2 Spike Protein: Mechanistic Dissection, In Vitro Reconstitution and Role in Viral Infectivity (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.101112
2021-08-01 Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2021.104906 34273860
2021-08-01 Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence (edit) SARS-CoV-2 (edit) 10.1016/J.JPSYCHIRES.2021.05.080 34174556
2021-08-01 Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control (edit) SARS-CoV-2 (edit) 10.1016/J.JVIROMET.2021.114174 33984396
2021-08-01 Development and validation of a new triplex real-time quantitative reverse Transcriptase-PCR assay for the clinical detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MCP.2021.101744 34089805
2021-08-01 One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104869 33915216
2021-08-01 Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110622
2021-08-01 Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link? (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110638
2021-08-01 B cell receptor (BCR) guided mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110640
2021-08-01 Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110641
2021-08-01 Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.PBIOMOLBIO.2021.02.002 33636189
2021-08-01 Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00287-5 34051887
2021-08-01 Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01410-W 34108716
2021-08-01 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01413-7 34127854
2021-08-01 Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters (edit) SARS-CoV-2 (edit) 10.1089/VBZ.2021.0032
2021-08-01 Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB256 33978762
2021-08-01 On the Sensitivity and Specificity of Postmortem Upper Respiratory Tract Testing for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB270 33999152
2021-08-01 Proposed framework for considering SARS-CoV-2 antigen testing of unexposed asymptomatic workers in selected workplaces (edit) SARS-CoV-2 (edit) 10.1097/JOM.0000000000002269 34016912
2021-08-01 SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009800 34437657
2021-08-01 Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches (edit) SARS-CoV-2 (edit) 10.17305/BJBMS.2020.5381 33577445
2021-08-01 In Silico Identification of Potential Inhibitors of SARS-CoV-2 Papain-like Protease From Natural Sources: A Natural Weapon to Fight COVID-19 (edit) SARS-CoV-2 (edit) 10.2174/2666796701999201203211330
2021-08-01 Why Are Physicists Involved in the Studies on the Origin of SARS-CoV-2? (edit) SARS-CoV-2 (edit) 10.31661/JBPE.V0I0.2106-1361
2021-08-01 Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic (edit) SARS-CoV-2 (edit) 10.4155/BIO-2021-0100
2021-07-31 Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.04.148 33915212
2021-07-31 An Oral SARS-CoV-2 Mpro Inhibitor Clinical Candidate for the Treatment of COVID-19 (edit) SARS-CoV-2 (edit) 10.1101/2021.07.28.21261232
2021-07-31 Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Measure SARS-CoV-2 Humoral Immunogenicity (edit) SARS-CoV-2 (edit) 10.1101/2021.07.29.21261156
2021-07-31 Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination (edit) SARS-CoV-2 (edit) 10.3390/CELLS10081952 34440721
2021-07-30 Quantum simulations of SARS-CoV-2 main protease M enable high-quality scoring of diverse ligands (edit) SARS-CoV-2 (edit) 10.1007/S10822-021-00412-7 34328586
2021-07-30 "Bucket brigade" using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.07.026 34339634
2021-07-30 An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104703 34352457
2021-07-30 JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102928 34345808
2021-07-30 Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2021.105114 34333072
2021-07-30 Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198526
2021-07-30 Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24887-Y 34330917
2021-07-30 A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24905-Z
2021-07-30 SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 (edit) SARS-CoV-2 (edit) 10.1042/BSR20210611 34328172
2021-07-30 The household secondary attack rate of SARS-CoV-2: A rapid review (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAA1558 33045075
2021-07-30 Synthesis of Hetaryl-Substituted Asymmetric Porphyrins and Their Affinity to SARS-CoV-2 Helicase (edit) SARS-CoV-2 (edit) 10.1134/S1070363221060098 34345157
2021-07-30 Occupational and environmental exposure to SARS-CoV-2 in and around infected mink farms (edit) SARS-CoV-2 (edit) 10.1136/OEMED-2021-107443 34330815
2021-07-29 The genetic structure of SARS‐CoV‐2 is consistent with both natural or laboratory origin: Response to Tyshkovskiy and Panchin (10.1002/bies.202000325) (edit) SARS-CoV-2 (edit) 10.1002/BIES.202100137
2021-07-29 Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00712-2 34326308
2021-07-29 Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-94951-6 34326429
2021-07-29 Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02453-Y 34326460
2021-07-29 Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1111/FEBS.16114 34228902
2021-07-29 Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABJ0299
2021-07-29 SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase (edit) SARS-CoV-2 (edit) 10.1182/BLOOD.2021010685 34075401
2021-07-29 Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0255438
2021-07-29 Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.30.2100673
2021-07-29 Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.719077 34394127
2021-07-29 Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit (edit) SARS-CoV-2 (edit) 10.3390/V13081487 34452352
2021-07-29 Detection of IFNγ-Secreting CD4 and CD8 Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V13081490 34452355
2021-07-28 Structure-based study of immune receptors as eligible binding targets of coronavirus SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2021.107997 34343818
2021-07-28 CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.0C01537 34341769
2021-07-28 IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24817-Y 34321474
2021-07-28 Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03841-4
2021-07-28 Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1128/JVI.01010-21 34319784
2021-07-28 Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets (edit) SARS-CoV-2 (edit) 10.1182/BLOOD.2021011871 34315173
2021-07-28 poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.711437 34394197
2021-07-28 Sewage Systems Surveillance for SARS-CoV-2: Identification of Knowledge Gaps, Emerging Threats, and Future Research Needs (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS10080946 34451410
2021-07-27 An intranasal vaccine durably protects against SARS-CoV-2 variants in mice (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109452 34289385
2021-07-27 SARS-CoV-2 airborne transmission: A validated sampling and analytical method (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.111783 34324848
2021-07-27 Emerging mutations in envelope protein of SARS-CoV-2 and their effect on thermodynamic properties (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100675 34337139
2021-07-27 N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00704-2 34315847
2021-07-27 Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00295-W 34315862
2021-07-27 Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24807-0 34315893
2021-07-27 Determination of the characteristic inactivation fluence for SARS-CoV-2 under UV-C radiation considering light absorption in culture media (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-94648-W 34315976
2021-07-27 Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2106724118 34244421
2021-07-27 Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI9310 34315827
2021-07-27 Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABI4547
2021-07-27 B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies (edit) SARS-CoV-2 (edit) 10.1128/MBIO.01386-21
2021-07-27 COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.147472
2021-07-27 SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block (edit) SARS-CoV-2 (edit) 10.1261/RNA.078923.121 34315815
2021-07-27 Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2021.614443 34386518
2021-07-27 Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES9080899 34440103
2021-07-26 A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102908 34337354
2021-07-26 Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping' (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24730-4 34312385
2021-07-26 Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24909-9 34312390
2021-07-26 S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-94602-W 34312429
2021-07-26 N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry (edit) SARS-CoV-2 (edit) 10.1101/2021.07.26.453787
2021-07-25 Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S12539-021-00461-4 34308530
2021-07-24 Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air (edit) SARS-CoV-2 (edit) 10.3390/IJMS22157919 34360686
2021-07-23 Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.07.023 34352228
2021-07-23 Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109504 34352226
2021-07-23 Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104668 34340124
2021-07-23 Target capture sequencing of SARS-CoV-2 genomes using the ONETest Coronaviruses Plus (edit) SARS-CoV-2 (edit) 10.1016/J.DIAGMICROBIO.2021.115508 34391075
2021-07-23 ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102770 34189428
2021-07-23 Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167058 34023401
2021-07-23 The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167108 34161778
2021-07-23 RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes (edit) SARS-CoV-2 (edit) 10.1038/S41419-021-04012-Z 34301919
2021-07-23 Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues (edit) SARS-CoV-2 (edit) 10.1093/EHJCVP/PVAA105 33155016
2021-07-23 Lung Ultrasound Examination in Patients with SARS-CoV-2 Infection: Multicenter Study (edit) SARS-CoV-2 (edit) 10.3390/JCM10153255 34362039
2021-07-23 SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity (edit) SARS-CoV-2 (edit) 10.3390/V13081439 34452305
2021-07-23 SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain (edit) SARS-CoV-2 (edit) 10.4049/JIMMUNOL.2100272
2021-07-22 SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.06.005 34192529
2021-07-22 SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway (edit) SARS-CoV-2 (edit) 10.1016/J.EJPHAR.2021.174374 34303662
2021-07-22 Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection (edit) SARS-CoV-2 (edit) 10.1016/J.JARE.2021.07.007 35116175
2021-07-22 Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.1C04176 34255499
2021-07-22 Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates (edit) SARS-CoV-2 (edit) 10.1038/S41401-021-00732-2 34294887
2021-07-22 Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization (edit) SARS-CoV-2 (edit) 10.1038/S41522-021-00232-5 34294722
2021-07-22 A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41541-021-00352-1
2021-07-22 Influenza-like illness among personnel responding to U.S. quarantine of cruise ship passengers exposed to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1097/JOM.0000000000002335
2021-07-22 Increasing SARS-CoV-2 antibody prevalence in England at the start of the second wave: REACT-2 Round 4 cross-sectional study in 160,000 adults (edit) SARS-CoV-2 (edit) 10.1101/2021.07.21.21260926
2021-07-22 L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.148999 34291736
2021-07-22 Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1186/S13578-021-00644-Y 34294141
2021-07-21 Classification of SARS-CoV-2 and non-SARS-CoV-2 using machine learning algorithms (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104650 34329865
2021-07-21 Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104669 34320442
2021-07-21 Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104671 34332348
2021-07-21 In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1 (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100670 34307830
2021-07-21 A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102892 34308277
2021-07-21 Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.1C00596
2021-07-21 Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41423-021-00728-2 34290398
2021-07-21 Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93996-X 34290262
2021-07-21 The virological impacts of SARS-CoV-2 D614G mutation (edit) SARS-CoV-2 (edit) 10.1093/JMCB/MJAB045 34289053
2021-07-20 Ultrasensitive, high-throughput, and rapid simultaneous detection of SARS-CoV-2 antigens and IgG/IgM antibodies within 10 min through an immunoassay biochip (edit) SARS-CoV-2 (edit) 10.1007/S00604-021-04896-W 34282508
2021-07-20 Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication (edit) SARS-CoV-2 (edit) 10.1007/S43450-021-00162-5 34305198
2021-07-20 SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109415 34270919
2021-07-20 Shedding light on toxicity of SARS-CoV-2 peptides in aquatic biota: A study involving neotropical mosquito larvae (Diptera: Culicidae) (edit) SARS-CoV-2 (edit) 10.1016/J.ENVPOL.2021.117818
2021-07-20 Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials (edit) SARS-CoV-2 (edit) 10.1021/ACS.ANALCHEM.0C04634
2021-07-20 To Knot or Not to Knot: Multiple Conformations of the SARS-CoV-2 Frameshifting RNA Element (edit) SARS-CoV-2 (edit) 10.1021/JACS.1C03003 34283611
2021-07-20 SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity (edit) SARS-CoV-2 (edit) 10.1136/ANNRHEUMDIS-2021-220781 34285048
2021-07-20 Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.647693
2021-07-20 SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS9071542 34361977
2021-07-19 Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay (edit) SARS-CoV-2 (edit) 10.1002/CTI2.1312 34295471
2021-07-19 Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3'UTR region: A computational genomics assessment (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104662 34311261
2021-07-19 Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1089/OMI.2021.0068 34280038
2021-07-19 Using a household-structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1098/RSTB.2020.0267
2021-07-19 SARS-CoV-2: from its discovery to genome structure, transcription, and replication (edit) SARS-CoV-2 (edit) 10.1186/S13578-021-00643-Z 34281608
2021-07-19 Whole-genome sequencing of SARS-CoV-2 in Uganda: implementation of the low-cost ARTIC protocol in resource-limited settings (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.53567.1 34457243
2021-07-19 Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.669357 34349756
2021-07-19 Role of Laboratory Medicine in SARS-CoV-2 Diagnostics. Lessons Learned from a Pandemic (edit) SARS-CoV-2 (edit) 10.3390/HEALTHCARE9070915
2021-07-18 Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies (edit) SARS-CoV-2 (edit) 10.1002/ADMA.202101707 34278613
2021-07-18 The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis (edit) SARS-CoV-2 (edit) 10.1016/J.KINT.2021.07.005 34284044
2021-07-18 Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation (edit) SARS-CoV-2 (edit) 10.1016/J.MOLSTRUC.2021.131124 34305175
2021-07-18 Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study (edit) SARS-CoV-2 (edit) 10.1053/J.GASTRO.2021.07.010 34284037
2021-07-18 Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study (edit) SARS-CoV-2 (edit) 10.1101/2021.07.14.21260497
2021-07-17 HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences (edit) SARS-CoV-2 (edit) 10.1186/S12859-021-04294-2 34273961
2021-07-17 SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling (edit) SARS-CoV-2 (edit) 10.3390/CELLS10071814 34359983
2021-07-16 Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins (edit) SARS-CoV-2 (edit) 10.1002/JMV.27188 34241906
2021-07-16 Updated SARS-CoV-2 single nucleotide variants and mortality association (edit) SARS-CoV-2 (edit) 10.1002/JMV.27191 34245452
2021-07-16 Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104654 34346317
2021-07-16 Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JCV.2021.104897 34304089
2021-07-16 Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations (edit) SARS-CoV-2 (edit) 10.1016/J.MOLSTRUC.2021.131113 34305174
2021-07-16 Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.1C03055 34337269
2021-07-16 SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24521-X 34272374
2021-07-16 In vitro efficacy of artemisinin-based treatments against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93361-Y 34272426
2021-07-16 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease (edit) SARS-CoV-2 (edit) 10.1042/BCJ20210199 34198324
2021-07-16 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase (edit) SARS-CoV-2 (edit) 10.1042/BCJ20210201 34198322
2021-07-16 Patterns of SARS-CoV-2 exposure and mortality suggest endemic infections, in addition to space and population factors, shape dynamics across countries (edit) SARS-CoV-2 (edit) 10.1101/2021.07.12.21260394
2021-07-16 Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1128/AAC.00491-21 34001511
2021-07-16 Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0253364 34270554
2021-07-16 Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009715 34270613
2021-07-16 High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.694243 34335605
2021-07-15 Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S13337-021-00715-1
2021-07-15 Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach (edit) SARS-CoV-2 (edit) 10.1007/S13337-021-00720-4 34307771
2021-07-15 Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00531-8 34267349
2021-07-15 A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93757-W 34267263
2021-07-15 Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93855-9 34267262
2021-07-14 Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study (edit) SARS-CoV-2 (edit) 10.1016/J.ARABJC.2021.103315 34909064
2021-07-14 Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.05.004 34022154
2021-07-14 SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.06.006 34171266
2021-07-14 Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.07.014 34273511
2021-07-14 The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102857 34278249
2021-07-14 Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany (edit) SARS-CoV-2 (edit) 10.1016/J.LANEPE.2021.100164 34278371
2021-07-14 SARS-CoV-2 detection in wastewater using multiplex quantitative PCR (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.148890 34298359
2021-07-14 Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00689-Y
2021-07-14 Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24467-0 34262047
2021-07-14 SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03807-6
2021-07-14 Rapid Base-Specific Calling of SARS-CoV-2 Variants of Concern Using Combined RT-PCR Melting Curve Screening and SIRPH Technology (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAB364 34409122
2021-07-14 SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway (edit) SARS-CoV-2 (edit) 10.1128/JVI.00862-21
2021-07-14 Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0252509
2021-07-13 A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.BMCL.2021.128263 34271072
2021-07-13 Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109364 34214467
2021-07-13 Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.PHYPLU.2021.100095 35399824
2021-07-13 SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States (edit) SARS-CoV-2 (edit) 10.1038/S41370-021-00366-W
2021-07-13 Placental response to maternal SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93931-0 34257394
2021-07-13 A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABI8452
2021-07-13 RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection (edit) SARS-CoV-2 (edit) 10.1128/MSYSTEMS.00643-21 34254825
2021-07-13 What Impact Have SARS-CoV-2/Covid-19 Pandemic induced lockdown on the number of OPD patients of Diabetes, Hypertension, Stroke (CVA), Acute Heart Disease, Mental Illness, Epilepsy, Ophthalmic, Dental and oncology in India during the lockdown months ( (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-708392/V1
2021-07-13 What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) SARS-CoV-2 (edit) 10.32388/KWXMBG
2021-07-12 Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93608-8 34253751
2021-07-12 Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections (edit) SARS-CoV-2 (edit) 10.1101/2021.06.28.21258780 34268529
2021-07-12 Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual (edit) SARS-CoV-2 (edit) 10.1128/JVI.00294-21 33980601
2021-07-12 ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1128/JVI.00327-21 33963054
2021-07-12 Emerging SARS-CoV-2 variants of concern and potential intervention approaches (edit) SARS-CoV-2 (edit) 10.1186/S13054-021-03662-X 34253247
2021-07-12 Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009706
2021-07-12 Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin (edit) SARS-CoV-2 (edit) 10.15252/EMMM.202114122 34170074
2021-07-12 What Impact Have SARS-CoV-2/Covid-19 Pandemic induced lockdown on the number of OPD patients of Diabetes, Hypertension, Stroke (CVA), Acute Heart Disease, Mental Illness, Epilepsy, Ophthalmic, Dental and oncology in India during the lockdown months ( (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/ENAFH
2021-07-12 SARS-CoV-2 Crisis Management With a Wastewater Early-Warning System in the Bavarian District of Berchtesgadener Land, Germany (edit) SARS-CoV-2 (edit) 10.3238/ARZTEBL.M2021.0261
2021-07-12 What Impact Have SARS-CoV-2/Covid-19 Pandemic induced lockdown on the number of OPD patients of Diabetes, Hypertension, Stroke (CVA), Acute Heart Disease, Mental Illness, Epilepsy, Ophthalmic, Dental and oncology in India during the lockdown months ( (edit) SARS-CoV-2 (edit) 10.32388/8I2HH5
2021-07-12 Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19 (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2021.648232 34322517
2021-07-12 Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells (edit) SARS-CoV-2 (edit) 10.3390/CELLS10071762 34359932
2021-07-12 Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain (edit) SARS-CoV-2 (edit) 10.3390/IJMS22147469 34299089
2021-07-10 Investigations into the origin of SARS-CoV-2: an update (edit) SARS-CoV-2 (edit)
2021-07-10 Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.07.002 34306570
2021-07-10 RAAS, ACE2 and COVID-19; a mechanistic review (edit) SARS-CoV-2 (edit) 10.1016/J.SJBS.2021.07.003 34305426
2021-07-10 Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion (edit) SARS-CoV-2 (edit) 10.3390/IJMS22147425
2021-07-09 Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.1C00616 34242027
2021-07-09 Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19 (edit) SARS-CoV-2 (edit) 10.1111/JTH.15455 34242469
2021-07-09 Estimating infectiousness throughout SARS-CoV-2 infection course (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI5273
2021-07-09 Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols - United States, 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7027E1 34237047
2021-07-09 COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) SARS-CoV-2 (edit) 10.21203/RS.3.PEX-1338/V3
2021-07-09 Evaluation of Screening Tests in Bavarian Healthcare Facilities during the Second Wave of the SARS-CoV-2 Pandemic (edit) SARS-CoV-2 (edit) 10.3390/IJERPH18147371
2021-07-09 SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review (edit) SARS-CoV-2 (edit) 10.5492/WJCCM.V10.I4.132
2021-07-08 Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening (edit) SARS-CoV-2 (edit) 10.1016/J.JTEMB.2021.126818 34274845
2021-07-08 First detection and molecular analysis of SARS-CoV-2 from a naturally infected cat from Argentina (edit) SARS-CoV-2 (edit) 10.1016/J.VETMIC.2021.109179 34271305
2021-07-08 Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity (edit) SARS-CoV-2 (edit) 10.1038/S41556-021-00710-0 34239064
2021-07-08 Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03777-9
2021-07-08 SARS-CoV-2 Variants and Vaccines (edit) SARS-CoV-2 (edit) 10.1056/NEJMSR2105280 34161052
2021-07-08 REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021 (edit) SARS-CoV-2 (edit) 10.1101/2021.07.08.21260185
2021-07-08 Autoimmunity to Annexin A2 predicts mortality among hospitalised COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1183/13993003.00918-2021
2021-07-08 Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India (edit) SARS-CoV-2 (edit) 10.1186/S13104-021-05652-2 34238344
2021-07-08 Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.1186/S40794-021-00147-1 34238372
2021-07-07 Glycosylation of SARS-CoV-2: structural and functional insights (edit) SARS-CoV-2 (edit) 10.1007/S00216-021-03499-X 34235568
2021-07-07 A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.07.007 34289344
2021-07-07 Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109432 34270918
2021-07-07 A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109433 34273271
2021-07-07 Low-cost biosensor for rapid detection of SARS-CoV-2 at the point of care (edit) SARS-CoV-2 (edit) 10.1016/J.MATT.2021.05.003 33997767
2021-07-07 SARS-CoV-2-specific immune response in COVID-19 convalescent individuals (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00686-1 34234102
2021-07-07 Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24435-8 34234131
2021-07-07 Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy (edit) SARS-CoV-2 (edit) 10.1039/D1SC00244A 34276947
2021-07-07 Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2024302118
2021-07-07 SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB571 34232992
2021-07-07 Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021107776 34232536
2021-07-07 ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.673692 34305903
2021-07-07 Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.710778 34305617
2021-07-06 Prevalence of SARS-CoV-2 genes in water reclamation facilities: From influent to anaerobic digester (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.148905 34271386
2021-07-06 Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.1C03639 34228472
2021-07-06 Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis (edit) SARS-CoV-2 (edit) 10.1038/S41418-021-00817-9 34230615
2021-07-06 SARS-CoV-2 infection in the mouse olfactory system (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00290-1 34230457
2021-07-06 First molecular-based detection of SARS-CoV-2 virus in the field-collected houseflies (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93439-7 34230585
2021-07-06 Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants (edit) SARS-CoV-2 (edit) 10.1080/21645515.2021.1940652 34228597
2021-07-06 Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score (edit) SARS-CoV-2 (edit) 10.1093/BJS/ZNAB183 34227657
2021-07-06 Kidney injury molecule-1 is a potential receptor for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/JMCB/MJAB003 33493263
2021-07-06 Entry, egress and vertical transmission of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/JMCB/MJAB013 33677567
2021-07-06 What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology (edit) SARS-CoV-2 (edit) 10.1093/JMCB/MJAB016 33693723
2021-07-06 Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAB358
2021-07-06 Mechanisms of immunothrombosis in COVID-19 (edit) SARS-CoV-2 (edit) 10.1097/MOH.0000000000000666 34232139
2021-07-06 Lockdowns exert selection pressure on overdispersion of SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1101/2021.06.30.21259771
2021-07-06 SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PMED.1003656 34228725
2021-07-06 Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.64188 34227468
2021-07-05 SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation (edit) SARS-CoV-2 (edit) 10.1002/CTI2.1306 34257967
2021-07-05 Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs (edit) SARS-CoV-2 (edit) 10.1007/S00018-021-03889-5 34223911
2021-07-05 Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1007/S00395-021-00882-8 34224022
2021-07-05 In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies (edit) SARS-CoV-2 (edit) 10.1016/J.BBAPAP.2021.140693 34237472
2021-07-05 Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.100940 34237302
2021-07-05 SARS-COV-2 seroprevalence among employees of a University Hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study) (edit) SARS-CoV-2 (edit) 10.1017/S0950268821001540 34219629
2021-07-05 SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry (edit) SARS-CoV-2 (edit) 10.1038/S41409-021-01379-7 34226667
2021-07-05 COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance (edit) SARS-CoV-2 (edit) 10.1101/2021.07.01.21259833
2021-07-05 Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2. (edit) SARS-CoV-2 (edit) 10.1590/S1678-9946202163058 34231823
2021-07-05 Personal protective equipment waste potentially infected with SARS-CoV-2 – a new global challenge for biological safety (edit) SARS-CoV-2 (edit) 10.17816/PHF71586
2021-07-05 Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.714511 34290717
2021-07-04 SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies (edit) SARS-CoV-2 (edit) 10.1021/ACSCHEMBIO.1C00272
2021-07-03 Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease (edit) SARS-CoV-2 (edit) 10.1016/J.CYTO.2021.155637 34242899
2021-07-03 A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103465 34229274
2021-07-03 The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigen (edit) SARS-CoV-2 (edit) 10.1101/2021.06.29.21259605
2021-07-03 SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum (edit) SARS-CoV-2 (edit) 10.1101/2021.07.02.450959
2021-07-03 SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS9071438 34361874
2021-07-02 Recent advances in developing small-molecule inhibitors against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.APSB.2021.06.016 34249607
2021-07-02 Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOCHEM.1C00279 34213308
2021-07-02 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease (edit) SARS-CoV-2 (edit) 10.1042/BCJ20210198 34198326
2021-07-02 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase (edit) SARS-CoV-2 (edit) 10.1042/BCJ20210219
2021-07-02 An all-out assault on SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1042/BCJ20210256
2021-07-02 Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2’ by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.07.02.450896
2021-07-02 ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009723 34214142
2021-07-01 A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization (edit) SARS-CoV-2 (edit) 10.1002/1873-3468.14109 33991349
2021-07-01 SARS-CoV-2's claimed natural origin is undermined by issues with genome sequences of its relative strains: Coronavirus sequences RaTG13, MP789 and RmYN02 raise multiple questions to be critically addressed by the scientific community (edit) SARS-CoV-2 (edit) 10.1002/BIES.202100015 34046923
2021-07-01 Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure (edit) SARS-CoV-2 (edit) 10.1002/JMV.26791 33433004
2021-07-01 Fetal and placental infection with SARS-CoV-2 in early pregnancy (edit) SARS-CoV-2 (edit) 10.1002/JMV.26965 33764543
2021-07-01 Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target (edit) SARS-CoV-2 (edit) 10.1002/JMV.27009 33837972
2021-07-01 Salivary glands are a target for SARS-CoV-2: a source for saliva contamination (edit) SARS-CoV-2 (edit) 10.1002/PATH.5679 33834497
2021-07-01 Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment (edit) SARS-CoV-2 (edit) 10.1002/RMV.2194 33205496
2021-07-01 Neurological manifestations temporally associated with SARS-CoV-2 infection in pediatric patients in Mexico (edit) SARS-CoV-2 (edit) 10.1007/S00381-021-05104-Z 33751228
2021-07-01 The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19 (edit) SARS-CoV-2 (edit) 10.1007/S10741-020-10066-6 33404999
2021-07-01 Decontamination of respirators amid shortages due to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S43630-021-00064-4
2021-07-01 Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators (edit) SARS-CoV-2 (edit) 10.1016/J.AJPATH.2021.04.006 33894177
2021-07-01 Evaluation of cochlear functions in infants exposed to SARS-CoV-2 intrauterine (edit) SARS-CoV-2 (edit) 10.1016/J.AMJOTO.2021.102982
2021-07-01 The SARS-CoV-2 envelope (E) protein has evolved towards membrane topology robustness (edit) SARS-CoV-2 (edit) 10.1016/J.BBAMEM.2021.183608 33771486
2021-07-01 SARS-Cov-2 spike protein fragment 674–685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.05.018 34000512
2021-07-01 Variations in Orf3a protein of SARS-CoV-2 alter its structure and function (edit) SARS-CoV-2 (edit) 10.1016/J.BBREP.2021.100933 33527091
2021-07-01 Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics (edit) SARS-CoV-2 (edit) 10.1016/J.BCP.2021.114424 33482149
2021-07-01 Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109482 34297909
2021-07-01 The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.CUB.2021.06.049
2021-07-01 Evolution and spread of SARS-CoV-2 likely to be affected by climate (edit) SARS-CoV-2 (edit) 10.1016/J.ECOCHG.2021.100005
2021-07-01 How to study SARS-CoV-2 in soils? (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2020.110464 33188764
2021-07-01 Hearing screening outcomes in neonates of SARS-CoV-2 positive pregnant women (edit) SARS-CoV-2 (edit) 10.1016/J.IJPORL.2021.110754
2021-07-01 Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.06.002 34174183
2021-07-01 Role of host factors in SARS-CoV-2 entry (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.100847 34058196
2021-07-01 Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients (edit) SARS-CoV-2 (edit) 10.1016/J.JIM.2021.113046 33775672
2021-07-01 Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - A high risk community-hospital interface (edit) SARS-CoV-2 (edit) 10.1016/J.JINF.2021.04.020 33895226
2021-07-01 SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients (edit) SARS-CoV-2 (edit) 10.1016/J.JOTO.2021.01.005
2021-07-01 Inflammatory cytokine storms severity may be fueled by interactions of micronuclei and RNA viruses such as COVID-19 virus SARS-CoV-2. A hypothesis (edit) SARS-CoV-2 (edit) 10.1016/J.MRREV.2021.108395
2021-07-01 Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study (edit) SARS-CoV-2 (edit) 10.1016/J.MSARD.2021.102947 33979771
2021-07-01 SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on 18F-FDG PET/CT study for vasculitis diagnosis (edit) SARS-CoV-2 (edit) 10.1016/J.REMNIE.2020.08.004
2021-07-01 Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.STR.2021.05.014 34111408
2021-07-01 Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.THROMRES.2021.05.010
2021-07-01 The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2021.03.009 33774551
2021-07-01 Sputnik V Vaccine Elicits Seroconversion and Neutralizing Capacity to SARS CoV-2 after a Single Dose (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100359
2021-07-01 Science, not speculation, is essential to determine how SARS-CoV-2 reached humans (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)01419-7
2021-07-01 Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00224-3 33930320
2021-07-01 Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2 (edit) SARS-CoV-2 (edit) 10.1016/S2666-5247(21)00082-3 33870240
2021-07-01 SARS-CoV-2 variants, spike mutations and immune escape (edit) SARS-CoV-2 (edit) 10.1038/S41579-021-00573-0 34075212
2021-07-01 COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03570-8 33915569
2021-07-01 Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03676-Z 34098567
2021-07-01 Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-91662-W 34210996
2021-07-01 The RNA sensor MDA5 detects SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-92940-3 34211037
2021-07-01 An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic (edit) SARS-CoV-2 (edit) 10.1093/MOLBEV/MSAB118 33942847
2021-07-01 Potential zoonotic sources of SARS-CoV-2 infections (edit) SARS-CoV-2 (edit) 10.1111/TBED.13872 33034151
2021-07-01 The role of the SARS-CoV-2 envelope protein as a pH-dependent cation channel (edit) SARS-CoV-2 (edit) 10.1113/JP281785 34089533
2021-07-01 SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI7994
2021-07-01 SARS-CoV-2 transmission during rugby league matches: do players become infected after participating with SARS-CoV-2 positive players? (edit) SARS-CoV-2 (edit) 10.1136/BJSPORTS-2020-103714 33574043
2021-07-01 Clinical efficacy and security of glycyrrhizic acid preparation in the treatment of anti-SARS-CoV-2 drug-induced liver injury: a protocol of systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1136/BMJOPEN-2021-051484
2021-07-01 Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19 (edit) SARS-CoV-2 (edit) 10.1172/JCI148517 34003804
2021-07-01 SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes (edit) SARS-CoV-2 (edit) 10.1172/JCI148635 34196300
2021-07-01 Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors (edit) SARS-CoV-2 (edit) 10.1177/24725552211026261 34192965
2021-07-01 Intranasal gene therapy to prevent infection by SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009544 34265018
2021-07-01 Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009759 34320031
2021-07-01 Assessment of weather and atmospheric pollution as a co-factor in the spread of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.23750/ABM.V92I3.11354 34212907
2021-07-01 SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.27.2100568 34240697
2021-07-01 Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.27.2100570 34240695
2021-07-01 What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational & statistical analysis of Bihar-version 2 (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/63WJ5
2021-07-01 AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.651151 34276587
2021-07-01 Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.4038/SLJM.V30I1.273
2021-07-01 SARS-CoV-2 transmission in kindergarten to grade 12 schools in the Vancouver Coastal Health region: a descriptive epidemiologic study (edit) SARS-CoV-2 (edit) 10.9778/CMAJO.20210106 34429325
2021-06-30 Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement (edit) SARS-CoV-2 (edit) 10.1016/J.MOLIMM.2021.06.021 34242919
2021-06-30 Binding of the SARS-CoV-2 spike protein to glycans (edit) SARS-CoV-2 (edit) 10.1016/J.SCIB.2021.01.010 33495714
2021-06-30 SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24377-1 34193870
2021-06-30 Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-93046-6 34193945
2021-06-30 Exploitation of the Secretory Pathway by SARS-CoV-2 Envelope (edit) SARS-CoV-2 (edit) 10.1101/2021.06.30.450614
2021-06-30 Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABI9915 34103407
2021-06-30 Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020 (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00180-21 34190583
2021-06-30 Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models (edit) SARS-CoV-2 (edit) 10.1128/MSPHERE.00270-21 34160239
2021-06-30 Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.658519 34276652
2021-06-30 Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.686462 34276672
2021-06-30 Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M and Its Antiviral Activity in Cells against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/IJMS22137048 34208928
2021-06-29 Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109292 34166617
2021-06-29 Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109414 34260965
2021-06-29 Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.1C01797 34235330
2021-06-29 Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-92941-2 34188167
2021-06-29 Absolute quantitation of individual SARS-CoV-2 RNA molecules: a new paradigm for infection dynamics and variant differences (edit) SARS-CoV-2 (edit) 10.1101/2021.06.29.450133
2021-06-29 Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects (edit) SARS-CoV-2 (edit) 10.1128/MBIO.00788-21
2021-06-29 Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides (edit) SARS-CoV-2 (edit) 10.1128/MBIO.01423-21 34154407
2021-06-29 Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring (edit) SARS-CoV-2 (edit) 10.1155/2021/5553173 34258267
2021-06-29 IL-13 is a driver of COVID-19 severity (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.150107 34185704
2021-06-29 Production of SARS-CoV-2 Specific IFN-γ/IL-10 Co-producing CD4 T Cells from Convalescent Donors to Treat COVID-19: A Hypothesis (edit) SARS-CoV-2 (edit) 10.14218/ERHM.2021.00008
2021-06-29 Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.676314 34267735
2021-06-29 Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 (edit) SARS-CoV-2 (edit) 10.3390/V13071263
2021-06-28 SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19 (edit) SARS-CoV-2 (edit) 34181169
2021-06-28 Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.06.003 34197802
2021-06-28 Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2021.06.009 34217923
2021-06-28 Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00319-4 34197764
2021-06-28 COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24285-4 34183681
2021-06-28 A STING in the tail for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-00971-9
2021-06-28 One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2 (edit) SARS-CoV-2 (edit) 10.1111/ALL.14991 34180546
2021-06-28 The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009687 34181691
2021-06-28 What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-635528/V2
2021-06-27 Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2021.100993
2021-06-27 Variants in SARS-CoV-2 associated with mild or severe outcome (edit) SARS-CoV-2 (edit) 10.1093/EMPH/EOAB019 34447577
2021-06-26 Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109391 34242574
2021-06-26 Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection (edit) SARS-CoV-2 (edit) 10.1016/J.FREERADBIOMED.2021.06.018 34186206
2021-06-26 SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)01358-1 34139198
2021-06-25 SARS-CoV-2–Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease (edit) SARS-CoV-2 (edit) 10.1007/S10875-021-01063-X
2021-06-25 An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor (edit) SARS-CoV-2 (edit) 10.1016/J.CHEMBIOL.2021.05.018 34174194
2021-06-25 Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102523 33997662
2021-06-25 Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102681 34095780
2021-06-25 Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-92740-9 34172783
2021-06-25 Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/ABT/TBAB013 34286216
2021-06-25 Averting an outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a university residence hall through wastewater surveillance (edit) SARS-CoV-2 (edit) 10.1101/2021.06.23.21259176
2021-06-25 Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus and Viral RNA in Relation to Surface Type and Contamination Concentration (edit) SARS-CoV-2 (edit) 10.1128/AEM.00526-21 33962986
2021-06-25 Quantification of SARS-CoV-2 variant mutations (HV69-70 and E484K/N501Y) in settled solids using digital RT-PCR v1 (edit) SARS-CoV-2 (edit) 10.17504/PROTOCOLS.IO.BV5BN82N
2021-06-24 Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective (edit) SARS-CoV-2 (edit) 10.1007/S43440-021-00300-9 34165771
2021-06-24 Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.04.025 33991487
2021-06-24 An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.05.032 34139176
2021-06-24 Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.06.037 34188776
2021-06-24 In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100645 34189252
2021-06-24 A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.OMTN.2021.06.014 34188971
2021-06-24 The architecture of the SARS-CoV-2 RNA genome inside virion (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22785-X
2021-06-24 Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19 (edit) SARS-CoV-2 (edit) 10.1101/2021.06.15.448419 34159331
2021-06-24 Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1101/2021.06.21.21258528
2021-06-24 Targeting the m6A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication (edit) SARS-CoV-2 (edit) 10.1101/GAD.348320.121 34168039
2021-06-24 Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract (edit) SARS-CoV-2 (edit) 10.1128/JVI.00130-21 33893170
2021-06-24 Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome (edit) SARS-CoV-2 (edit) 10.1128/JVI.00663-21 33963053
2021-06-24 Autoantibodies stabilize neutrophil extracellular traps in COVID-19 (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.150111
2021-06-24 The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review (edit) SARS-CoV-2 (edit) 10.3390/JCM10132772 34202613
2021-06-23 In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104591 34216889
2021-06-23 Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.1C00010 34235261
2021-06-23 COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24078-9 34162869
2021-06-23 Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-92641-X 34162970
2021-06-23 Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins (edit) SARS-CoV-2 (edit) 10.1093/ABBS/GMAB088
2021-06-23 SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesion in endothelial cells (edit) SARS-CoV-2 (edit) 10.1128/JVI.00794-21
2021-06-23 Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell–cell fusion (edit) SARS-CoV-2 (edit) 10.1186/S13578-021-00626-0
2021-06-23 TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2021107821 34159616
2021-06-23 Interfering Reactive Cysteine Proteome in Covid-19 Disease (edit) SARS-CoV-2 (edit) 10.2174/0929867328666210623142811
2021-06-23 Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells (edit) SARS-CoV-2 (edit) 10.3389/FCIMB.2021.678482 34282405
2021-06-23 Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? (edit) SARS-CoV-2 (edit) 10.3389/FENDO.2021.665134 34248841
2021-06-22 Genome‐wide association analysis of COVID‐19 mortality risk in SARS‐CoV‐2 genomes identifies mutation in the SARS‐CoV‐2 spike protein that colocalizes with P.1 of the Brazilian strain (edit) SARS-CoV-2 (edit) 10.1002/GEPI.22421
2021-06-22 Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.1C01785 34179644
2021-06-22 Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs (edit) SARS-CoV-2 (edit) 10.1038/S41594-021-00619-0 34158638
2021-06-22 The total number and mass of SARS-CoV-2 virions (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2024815118 34083352
2021-06-22 Factors affecting the transmission of SARS-CoV-2 in school settings (edit) SARS-CoV-2 (edit) 10.1101/2021.06.18.21259156 34189533
2021-06-22 Interplay between SARS-CoV-2-derived miRNAs, immune system, vitamin D pathway and respiratory system (edit) SARS-CoV-2 (edit) 10.1111/JCMM.16694 34159729
2021-06-22 Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI4708
2021-06-22 The SARS-CoV-2 Spike Protein Subunit 1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells (edit) SARS-CoV-2 (edit) 10.1152/AJPLUNG.00223.2021
2021-06-21 Transmission of SARS-CoV-2 in Inpatient and Outpatient Settings in a Veterans Affairs Health Care System (edit) SARS-CoV-2 (edit)
2021-06-21 Simultaneous enrichment and separation of neutral and sialyl glycopeptides of SARS-CoV-2 spike protein enabled by dual-functionalized Ti-IMAC material (edit) SARS-CoV-2 (edit) 10.1007/S00216-021-03433-1
2021-06-21 On the airborne transmission of SARS-CoV-2 and relationship with indoor conditions at a hospital (edit) SARS-CoV-2 (edit) 10.1016/J.ATMOSENV.2021.118563 34177342
2021-06-21 Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals (edit) SARS-CoV-2 (edit) 10.1016/J.JAUT.2021.102682
2021-06-21 SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24007-W 34155207
2021-06-21 Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-24013-Y 34155214
2021-06-21 Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-92206-Y
2021-06-21 Quantifying SARS-CoV-2 Infection Risk Within the Google/Apple Exposure Notification Framework to Inform Quarantine Recommendations (edit) SARS-CoV-2 (edit) 10.1111/RISA.13768 34155669
2021-06-21 Ingestion of Cyanogens from Cassava Generates Disinfectant Hypothiocyanite That May Decrease the Transmissibility of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.20935/AL1211
2021-06-21 What impacts have geographical locations on the cases and deaths from COVID-19/SARS-CoV-2 pandemic in 36 states and union territories of India:-observational analysis in India (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-640243/V1
2021-06-21 A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.665041 34234758
2021-06-21 Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern (edit) SARS-CoV-2 (edit) 10.5802/CRBIOL.53
2021-06-20 Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.100902 34157282
2021-06-20 SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance (edit) SARS-CoV-2 (edit) 10.1111/TRF.16555 34121205
2021-06-19 Methods to Identify Immunogenic Peptides in SARS-CoV-2 Spike and Protective Monoclonal Antibodies in COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.1002/SMTD.202100058 34514088
2021-06-19 Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2021.105115 34157321
2021-06-19 Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2021.105051 34153417
2021-06-19 What impacts have geographical locations on the cases and deaths from COVID-19/SARS-CoV-2 pandemic in 36 states and union territories of India:-observational analysis in India (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/GR6VU
2021-06-18 Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107533
2021-06-18 Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2-infected COPD airway epithelium (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.100663 34250510
2021-06-18 Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.1C00519 34341772
2021-06-18 In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19 (edit) SARS-CoV-2 (edit) 10.1093/JAC/DKAB072 33880524
2021-06-18 SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada (edit) SARS-CoV-2 (edit) 10.1101/2021.06.16.21258861
2021-06-18 A Computational-Based Drug Repurposing Method Targeting SARS-CoV-2 and its Neurological Manifestations Genes and Signaling Pathways (edit) SARS-CoV-2 (edit) 10.1177/11779322211026728 34211268
2021-06-18 Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.51061.2
2021-06-18 The landscape of antibody binding in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001265 34143766
2021-06-18 What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-635528/V1
2021-06-18 The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.691154 34220784
2021-06-18 COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FNINS.2021.674204
2021-06-18 Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/IJMS22126574 34207476
2021-06-17 Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide (edit) SARS-CoV-2 (edit) 10.1016/J.ACTATROPICA.2021.106013 34146538
2021-06-17 Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CHEMBIOL.2021.04.020 33979649
2021-06-17 Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ETI.2021.101696 34250217
2021-06-17 Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E07284 34179538
2021-06-17 Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2021.107970 34242876
2021-06-17 Functional landscape of SARS-CoV-2 cellular restriction (edit) SARS-CoV-2 (edit) 10.1016/J.MOLCEL.2021.04.008 33930332
2021-06-17 Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.1C00372
2021-06-17 A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells (edit) SARS-CoV-2 (edit) 10.1038/S41541-021-00346-Z
2021-06-17 Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-91798-9 34140557
2021-06-17 ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-92293-X 34140611
2021-06-17 Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2103740 33826819
2021-06-17 Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication (edit) SARS-CoV-2 (edit) 10.1128/AAC.00097-21 33903110
2021-06-17 What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/SH97Q
2021-06-17 The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.687869 34220844
2021-06-17 Immunological Response to SARS-CoV-2 Is Sustained by Vitamin D: A Case Presentation of One-Year Follow-Up (edit) SARS-CoV-2 (edit) 10.3390/REPORTS4020018
2021-06-16 Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23825-2 34135340
2021-06-16 SARS-CoV-2 NSP12 protein is not an IFN-β antagonist (edit) SARS-CoV-2 (edit) 10.1128/JVI.00747-21 34133897
2021-06-16 Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1 (edit) SARS-CoV-2 (edit) 10.1128/SPECTRUM.00169-21 34132580
2021-06-16 Low Acyl Gellan as an Excipient to Improve the Sprayability and Mucoadhesion of Iota Carrageenan in a Nasal Spray to Prevent Infection With SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FMEDT.2021.687681 35047933
2021-06-16 Serology in COVID-19: Comparison of Two Methods (edit) SARS-CoV-2 (edit) 10.3390/IJERPH18126497 34208607
2021-06-16 Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V13061149 34208484
2021-06-15 Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2'--methyl transfer by SARS-CoV-2 nsp16 (edit) SARS-CoV-2 (edit) 34131072
2021-06-15 Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00017
2021-06-15 The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article (edit) SARS-CoV-2 (edit) 10.1038/S41429-021-00430-5 34127807
2021-06-15 Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23751-3 34131140
2021-06-15 Molecular benchmarks of a SARS-CoV-2 epidemic (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23883-6 34131116
2021-06-15 Design and in silico validation of polymerase chain reaction primers to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-91817-9 34131209
2021-06-15 COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials (edit) SARS-CoV-2 (edit) 10.1080/14760584.2021.1938550 34078215
2021-06-15 Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19 (edit) SARS-CoV-2 (edit) 10.1084/JEM.20210582
2021-06-15 Discovery of pan-ErbB inhibitors protecting from SARS-CoV-2 replication, inflammation, and lung injury by a drug repurposing screen (edit) SARS-CoV-2 (edit) 10.1101/2021.05.15.444128 34159337
2021-06-15 Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABJ1031
2021-06-15 Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021 (edit) SARS-CoV-2 (edit) 10.1128/MSYSTEMS.00353-21 34128696
2021-06-15 Neurotropism of SARS-CoV-2 in idiopathic hearing disorders (edit) SARS-CoV-2 (edit) 10.26444/JPCCR/136055
2021-06-14 Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge (edit) SARS-CoV-2 (edit) 10.1002/JMV.27132 34125455
2021-06-14 Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics (edit) SARS-CoV-2 (edit) 10.1021/JASMS.1C00086 34121407
2021-06-14 SARS-CoV-2 infection and transmission in the North American deer mouse (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23848-9 34127676
2021-06-14 Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03696-9 34126625
2021-06-14 Restriction of SARS-CoV-2 replication by targeting programmed −1 ribosomal frameshifting (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2023051118 34185680
2021-06-14 Landscape and selection of vaccine epitopes in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S13073-021-00910-1 34127050
2021-06-14 Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein (edit) SARS-CoV-2 (edit) 10.1261/RNA.078661.120 34127534
2021-06-12 Emerging Infection, Vaccination, and Guillain–Barré Syndrome: A Review (edit) SARS-CoV-2 (edit) 10.1007/S40120-021-00261-4 34117994
2021-06-12 Review: SARS-CoV-2 infection in farmed minks – an overview of current knowledge on occurrence, disease and epidemiology (edit) SARS-CoV-2 (edit) 10.1016/J.ANIMAL.2021.100272
2021-06-12 Rational optimization of a human neutralizing antibody of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104550 34147856
2021-06-12 Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104570 34157472
2021-06-12 Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing (edit) SARS-CoV-2 (edit) 10.1016/J.ENG.2021.05.009 34150352
2021-06-12 Technical framework for wastewater-based epidemiology of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.148271 34130001
2021-06-11 Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.06.017 34126235
2021-06-11 Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.JAUT.2021.102683
2021-06-11 Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.0C00478 33352056
2021-06-11 Recent Insights into Emerging Coronavirus: SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.0C00646 33296169
2021-06-11 Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19 (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.0C00815 33570381
2021-06-11 Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00070 33979123
2021-06-11 Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00651-Y 34117209
2021-06-11 Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00653-W 34117216
2021-06-11 Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23267-W 34117221
2021-06-11 Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02250-7 34117354
2021-06-11 Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19 (edit) SARS-CoV-2 (edit) 10.7150/IJBS.57810 34239361
2021-06-10 Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104560 34147855
2021-06-10 Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2021.113622 34147744
2021-06-10 Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2021.105041 34119626
2021-06-10 Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and Ebola Viruses by Remdesivir (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOCHEM.1C00292
2021-06-10 Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCLETT.1C00831 34110168
2021-06-10 SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00519-4 34112954
2021-06-10 BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03693-Y
2021-06-10 Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-91794-Z 34112906
2021-06-10 Genome-wide analysis in 756,646 individuals provides first genetic evidence that expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease (edit) SARS-CoV-2 (edit) 10.1101/2020.12.14.20248176 33619501
2021-06-10 SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors (edit) SARS-CoV-2 (edit) 10.1128/JVI.00266-21 34110264
2021-06-10 Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate (edit) SARS-CoV-2 (edit) 10.1128/JVI.02232-20 33827954
2021-06-10 Comparative analysis of viral infection outcomes in human seminal fluid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications (edit) SARS-CoV-2 (edit) 10.1186/S12978-021-01172-1
2021-06-10 Simulated sunlight decreases the viability of SARS-CoV-2 in mucus (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0253068 34111204
2021-06-10 Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.645713 34177827
2021-06-10 The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation (edit) SARS-CoV-2 (edit) 10.3390/V13061115 34200602
2021-06-10 Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020 (edit) SARS-CoV-2 (edit) 10.3390/V13061118
2021-06-10 Discovery of Antivirals Using Phage Display (edit) SARS-CoV-2 (edit) 10.3390/V13061120 34200959
2021-06-10 SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains-A Molecular and Clinical Approach (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9060639 34200951
2021-06-09 Viral and host transcriptomes in SARS-CoV-2 infected human lung cells (edit) SARS-CoV-2 (edit) 34106002
2021-06-09 (4-Hydroxyphenyl) retinamide suppresses SARS-CoV-2 spike protein-mediated cell-cell fusion by a dihydroceramide Δ4-desaturase 1-independent mechanism (edit) SARS-CoV-2 (edit) 34106748
2021-06-09 Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies (edit) SARS-CoV-2 (edit) 10.1007/S42485-021-00067-W 34121824
2021-06-09 Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.100635 34124695
2021-06-09 Extraction of Viral Nucleic Acids with Carbon Nanotubes Increases SARS-CoV-2 Quantitative Reverse Transcription Polymerase Chain Reaction Detection Sensitivity (edit) SARS-CoV-2 (edit) 10.1021/ACSNANO.1C02494 34105936
2021-06-09 Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.1C02336 34179666
2021-06-09 Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir (edit) SARS-CoV-2 (edit) 10.1021/ACSPTSCI.1C00099 34414360
2021-06-09 Conformational Ensembles of Noncoding Elements in the SARS-CoV-2 Genome from Molecular Dynamics Simulations (edit) SARS-CoV-2 (edit) 10.1021/JACS.1C01094 34039006
2021-06-09 Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00644-X 34108440
2021-06-09 SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse (edit) SARS-CoV-2 (edit) 10.1038/S41564-021-00932-W
2021-06-09 Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-91231-1
2021-06-09 Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment (edit) SARS-CoV-2 (edit) 10.1186/S13195-021-00850-3 34108016
2021-06-09 SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0251955
2021-06-09 What’s in the Pipeline? Evidence on the Transmission of SARS-CoV-2 via Building Wastewater Plumbing Systems (edit) SARS-CoV-2 (edit) 10.3389/FBUIL.2021.641745
2021-06-09 Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.681586 34177926
2021-06-09 Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.631206 34177566
2021-06-08 Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109305 34166618
2021-06-08 Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104538 34116362
2021-06-08 A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104555 34144270
2021-06-08 Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.03.023 33836142
2021-06-08 SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2 (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.05.006 34048708
2021-06-08 Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.06.003 34166623
2021-06-08 Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23533-X 34103506
2021-06-08 Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23688-7 34103497
2021-06-08 A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23779-5 34103499
2021-06-08 SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB289
2021-06-08 Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules (edit) SARS-CoV-2 (edit) 10.1101/2021.06.07.21258350
2021-06-08 Senolytics reduce coronavirus-related mortality in old mice (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABE4832
2021-06-08 SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment (edit) SARS-CoV-2 (edit) 10.1186/S40168-021-01083-0
2021-06-08 Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? (edit) SARS-CoV-2 (edit) 10.3390/BIOM11060855 34201172
2021-06-07 Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 34097489
2021-06-07 A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2) (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.06.017 34111482
2021-06-07 Cell entry by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.TIBS.2021.06.001 34187722
2021-06-07 SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23494-1 34099652
2021-06-07 B.1.1.7 and B.1.351 variants are highly virulent in K18-ACE2 transgenic mice and show different pathogenic patterns from early SARS-CoV-2 strains (edit) SARS-CoV-2 (edit) 10.1101/2021.06.05.447221
2021-06-07 Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant (edit) SARS-CoV-2 (edit) 10.1101/2021.06.06.446826 34127972
2021-06-07 A comparison of five epidemiological models for transmission of SARS-CoV-2 in India (edit) SARS-CoV-2 (edit) 10.1186/S12879-021-06077-9 34098885
2021-06-07 ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin (edit) SARS-CoV-2 (edit) 10.3390/CELLS10061419 34200372
2021-06-05 Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s) (edit) SARS-CoV-2 (edit) 10.1007/S13337-021-00696-1
2021-06-05 The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.06.002 34161776
2021-06-05 Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components (edit) SARS-CoV-2 (edit) 10.1016/J.CRPHAR.2021.100038 34870149
2021-06-04 A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.06.001 34133950
2021-06-04 Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-91371-4 34088957
2021-06-04 Two novel oxetane containing lignans and a new megastigmane from Paronychia arabica and in silico analysis of them as prospective SARS-CoV-2 inhibitors (edit) SARS-CoV-2 (edit) 10.1039/D1RA02486H 35479905
2021-06-04 Evidence-based approach to early outpatient treatment of SARS-CoV-2 (COVID-19) infection (edit) SARS-CoV-2 (edit) 10.1080/08998280.2021.1925049 34211257
2021-06-04 Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model (edit) SARS-CoV-2 (edit) 10.15252/EMBR.202152744 33908688
2021-06-04 High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome (edit) SARS-CoV-2 (edit) 10.1681/ASN.2021010059
2021-06-04 Engineering of Chinese Hamster Ovary Cells With NDPK-A to Enhance DNA Nuclear Delivery Combined With EBNA1 Plasmid Maintenance Gives Improved Exogenous Transient Reporter, mAb and SARS-CoV-2 Spike Protein Expression (edit) SARS-CoV-2 (edit) 10.3389/FBIOE.2021.679448 34150735
2021-06-04 Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.691715 34149735
2021-06-04 The Many Faces of Innate Immunity in SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9060596 34199761
2021-06-03 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)01290-3 34090624
2021-06-03 Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03673-2 34082438
2021-06-03 SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02220-Z
2021-06-03 Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward (edit) SARS-CoV-2 (edit) 10.1080/21645515.2020.1845524 33270478
2021-06-03 Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1101/2021.06.01.21257759
2021-06-03 Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI5224 34083449
2021-06-03 The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner (edit) SARS-CoV-2 (edit) 10.3390/V13061062 34205098
2021-06-02 COVID-19 disrupts spermatogenesis through the oxidative stress pathway following induction of apoptosis (edit) SARS-CoV-2 (edit) 10.1007/S10495-021-01680-2 34076792
2021-06-02 Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device (edit) SARS-CoV-2 (edit) 10.1016/J.BIOS.2021.113390 34171821
2021-06-02 Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity (edit) SARS-CoV-2 (edit) 10.1016/J.INTIMP.2021.107825 34116286
2021-06-02 Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104951 34089909
2021-06-02 Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry (edit) SARS-CoV-2 (edit) 10.1016/J.YMTHE.2021.02.007 33578036
2021-06-02 Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings-ten Emerging Infections Program sites, April-November 2020 (edit) SARS-CoV-2 (edit) 10.1017/ICE.2021.262 34075869
2021-06-02 Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain (edit) SARS-CoV-2 (edit) 10.1021/ACS.JAFC.1C02050 34015930
2021-06-02 A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2′-O methylation of its first nucleotide (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23594-Y 34078893
2021-06-02 High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABF8654 33979301
2021-06-02 Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1155/2021/6696012
2021-06-02 Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation (edit) SARS-CoV-2 (edit) 10.4049/JIMMUNOL.2001407 34078711
2021-06-01 Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.15985 34097044
2021-06-01 Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies (edit) SARS-CoV-2 (edit) 10.1002/ANIE.202100543 33709491
2021-06-01 Upregulation of CCR4 in activated CD8 T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1002/EJI.202049135 33784417
2021-06-01 Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1002/JEV2.12112 34188786
2021-06-01 Inhibitory effect on SARS‐CoV‐2 infection of neferine by blocking Ca 2+ ‐dependent membrane fusion (edit) SARS-CoV-2 (edit) 10.1002/JMV.27117
2021-06-01 Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V (edit) SARS-CoV-2 (edit) 10.1002/PRO.4073 33786919
2021-06-01 Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors (edit) SARS-CoV-2 (edit) 10.1002/PRO.4075 33813796
2021-06-01 Why do SARS-CoV-2 NSPs rush to the ER? (edit) SARS-CoV-2 (edit) 10.1007/S00415-020-10197-8 32870373
2021-06-01 Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020 (edit) SARS-CoV-2 (edit) 10.1007/S00520-020-05908-W 33242162
2021-06-01 Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications (edit) SARS-CoV-2 (edit) 10.1007/S10557-020-07070-1 32918656
2021-06-01 Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? (edit) SARS-CoV-2 (edit) 10.1007/S11481-021-09986-3 33534108
2021-06-01 Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex (edit) SARS-CoV-2 (edit) 10.1007/S12013-021-00977-Y 33792836
2021-06-01 SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism (edit) SARS-CoV-2 (edit) 10.1007/S12035-020-02245-1 33439437
2021-06-01 SARS-CoV-2 therapeutics: how far do we stand from a remedy? (edit) SARS-CoV-2 (edit) 10.1007/S43440-020-00204-0 33389724
2021-06-01 Human Type II Taste Cells Express ACE2 and are Infected by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.AJPATH.2021.05.010 34102107
2021-06-01 SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut (edit) SARS-CoV-2 (edit) 10.1016/J.AMJMED.2021.01.020
2021-06-01 Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2021.105064 33781803
2021-06-01 Transport mechanisms of SARS-CoV-E viroporin in calcium solutions: Lipid-dependent Anomalous Mole Fraction Effect and regulation of pore conductance (edit) SARS-CoV-2 (edit) 10.1016/J.BBAMEM.2021.183590 33621516
2021-06-01 Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2 (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.05.026 34087218
2021-06-01 Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.06.008
2021-06-01 SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109197 34043946
2021-06-01 Structure and function of SARS-CoV-2 polymerase (edit) SARS-CoV-2 (edit) 10.1016/J.COVIRO.2021.03.010 33945951
2021-06-01 Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication (edit) SARS-CoV-2 (edit) 10.1016/J.CYTO.2021.155496 33773396
2021-06-01 COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2021.100924
2021-06-01 Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2021.113390
2021-06-01 Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.EJMG.2021.104227 33872774
2021-06-01 Mutational analysis of SARS-CoV-2 during six months of COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.GENREP.2021.101024 33490718
2021-06-01 An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.JAUT.2021.102644 33971585
2021-06-01 A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167118 34174328
2021-06-01 Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2021.107836 33588349
2021-06-01 Asymptomatic SARS-CoV-2 infection: Incidental findings on FDG PET/CT (edit) SARS-CoV-2 (edit) 10.1016/J.JMIR.2021.03.002 33820742
2021-06-01 The zoonotic and natural foci characteristics of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JOBB.2021.06.002 34189426
2021-06-01 The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection (edit) SARS-CoV-2 (edit) 10.1016/J.JVS.2020.12.056 33348007
2021-06-01 A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy (edit) SARS-CoV-2 (edit) 10.1016/J.LANEPE.2021.100092 34104904
2021-06-01 Proteomics-based Insights into the SARS-CoV-2 Mediated COVID-19 Pandemic: A Review of the First Year of Research (edit) SARS-CoV-2 (edit) 10.1016/J.MCPRO.2021.100103 34089862
2021-06-01 The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant (edit) SARS-CoV-2 (edit) 10.1016/J.MEDIDD.2021.100086 33681755
2021-06-01 SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104760 33556558
2021-06-01 Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients? (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110570
2021-06-01 Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1016/J.MGENE.2021.100873 33619452
2021-06-01 The fate of SARS-COV-2 in WWTPS points out the sludge line as a suitable spot for detection of COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.145268
2021-06-01 Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2021.02.013 33774510
2021-06-01 Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198401 33781798
2021-06-01 The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198469
2021-06-01 Fine-Scale Temporal Dynamics of SARS-CoV-2 RNA Abundance in Wastewater during A COVID-19 Lockdown (edit) SARS-CoV-2 (edit) 10.1016/J.WATRES.2021.117093 33826985
2021-06-01 First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00007-4 33450180
2021-06-01 Saliva as a gold-standard sample for SARS-CoV-2 detection (edit) SARS-CoV-2 (edit) 10.1016/S2213-2600(21)00178-8 33887248
2021-06-01 Understanding Viral Shedding of SARS-CoV-2: Review of Current Literature (edit) SARS-CoV-2 (edit) 10.1017/ICE.2020.1273 33077007
2021-06-01 Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 M (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00639-8 34075025
2021-06-01 Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes (edit) SARS-CoV-2 (edit) 10.1038/S41418-021-00795-Y 33981020
2021-06-01 The basis of a more contagious 501Y.V1 variant of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00496-8 33893398
2021-06-01 Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03491-6 33827113
2021-06-01 The SARS-CoV-2 pandemic: the race to trace: contact tracing scale-up in San Francisco—early lessons learned (edit) SARS-CoV-2 (edit) 10.1057/S41271-021-00285-Y
2021-06-01 JAK-STAT pathway inhibition and their implications in COVID-19 therapy (edit) SARS-CoV-2 (edit) 10.1080/00325481.2020.1855921 33245005
2021-06-01 Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/MOLBEV/MSAB060 33674876
2021-06-01 A map of the SARS-CoV-2 RNA structurome (edit) SARS-CoV-2 (edit) 10.1093/NARGAB/LQAB043 34046592
2021-06-01 SARS-CoV-2 Spreads through Cell-to-Cell Transmission (edit) SARS-CoV-2 (edit) 10.1101/2021.06.01.446579 34100011
2021-06-01 The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7) (edit) SARS-CoV-2 (edit) 10.1111/ADD.15276 33007104
2021-06-01 Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study (edit) SARS-CoV-2 (edit) 10.1111/ANAE.15458 33690889
2021-06-01 Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening (edit) SARS-CoV-2 (edit) 10.1111/AOR.13880 33264436
2021-06-01 Comparison of Infection Risks and Clinical Outcomes in Patients with and without SARS-CoV-2 Lung Infection under Renin-Angiotensin-Aldosterone-System Blockade - Systematic Review and Meta-Analysis (edit) SARS-CoV-2 (edit) 10.1111/BCP.14660 33217033
2021-06-01 Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro (edit) SARS-CoV-2 (edit) 10.1111/BPH.15418 33825201
2021-06-01 Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan (edit) SARS-CoV-2 (edit) 10.1111/JOG.14748 33754418
2021-06-01 The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH (edit) SARS-CoV-2 (edit) 10.1113/JP281037 33709461
2021-06-01 Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11 (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABF5632 33958322
2021-06-01 Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes (edit) SARS-CoV-2 (edit) 10.1128/MBIO.00696-21 34060334
2021-06-01 A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19 (edit) SARS-CoV-2 (edit) 10.1177/2472555220985040 33423577
2021-06-01 Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients (edit) SARS-CoV-2 (edit) 10.1186/S12575-021-00148-6 34058978
2021-06-01 Construction of a Human Cell Landscape of COVID-19 Infection at Single-cell Level (edit) SARS-CoV-2 (edit) 10.14336/AD.2021.0301 34094635
2021-06-01 The WHO mission report struggles to trace the origins of the SARS-CoV-2 epidemic (edit) SARS-CoV-2 (edit) 10.1684/VIR.2021.0902
2021-06-01 Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.24.2100509 34142653
2021-06-01 Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada (edit) SARS-CoV-2 (edit) 10.3201/EID2706.210532 33784237
2021-06-01 Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan (edit) SARS-CoV-2 (edit) 10.3201/EID2706.210728 33821784
2021-06-01 Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis (edit) SARS-CoV-2 (edit) 10.3310/HTA25390
2021-06-01 Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications (edit) SARS-CoV-2 (edit) 10.3390/IJMS22115980 34205975
2021-06-01 Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses (edit) SARS-CoV-2 (edit) 10.3390/IJMS22115992 34206057
2021-06-01 Expectations of Young People Towards Their Future Work and Career After the SARS-CoV-2 Pandemic Outbreak in Poland (edit) SARS-CoV-2 (edit) 10.35808/ERSJ/2188
2021-06-01 Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination (edit) SARS-CoV-2 (edit) 10.4049/JIMMUNOL.2100195 33972373
2021-06-01 MuSK Antibody-Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report (edit) SARS-CoV-2 (edit) 10.7326/L20-1298 33428437
2021-05-31 Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants (edit) SARS-CoV-2 (edit) 34057039
2021-05-31 Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2 (edit) SARS-CoV-2 (edit) 10.1002/ADMA.202008304 34060150
2021-05-31 Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E07200 34095559
2021-05-31 Revealing the host antiviral protein ZAP-S as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting (edit) SARS-CoV-2 (edit) 10.1101/2021.05.31.445667
2021-05-31 Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.666163 34135895
2021-05-31 The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis-A Literature Review (edit) SARS-CoV-2 (edit) 10.3390/IJMS22115894 34072715
2021-05-31 Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital (edit) SARS-CoV-2 (edit) 10.3390/JOF7060440
2021-05-30 Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2021.113584 34118724
2021-05-29 Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2021.104955 34058304
2021-05-28 Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1002/JMV.27093 34009691
2021-05-28 ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.03.096 33813272
2021-05-28 Broad Auto-Reactive IgM Responses are Common in Critically Ill Patients Including Those with COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100321 34075365
2021-05-28 S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB082 33580259
2021-05-28 Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 and Spike Protein Subunit 1 (edit) SARS-CoV-2 (edit) 10.1101/2021.05.27.445991
2021-05-28 The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin (edit) SARS-CoV-2 (edit) 10.1101/2021.05.28.446163
2021-05-28 Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium (edit) SARS-CoV-2 (edit) 10.1101/2021.05.28.446179
2021-05-28 Resurgence of SARS-CoV-2: Detection by community viral surveillance (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF0874 33893241
2021-05-28 A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABI9002 34010139
2021-05-28 Pharmacological activation of STING blocks SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABI9007
2021-05-28 A review of the Cochrane COVID-19 Study Register reveals inconsistency in the choice and measurement of SARS-CoV-2 infection outcomes in prevention trials (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.52491.1
2021-05-28 Outbreak investigation of SARS-CoV-2 transmission in an emergency childcare centre (edit) SARS-CoV-2 (edit) 10.17269/S41997-021-00544-1
2021-05-28 A Computational Framework for Pattern Detection on Unaligned Sequences: An Application on SARS-CoV-2 Data (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.618170 34122498
2021-05-28 Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-Phenotype (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.653399 34122366
2021-05-28 Modeling the Consequences of Social Distancing Over Epidemics Spreading in Complex Social Networks: From Link Removal Analysis to SARS-CoV-2 Prevention (edit) SARS-CoV-2 (edit) 10.3389/FPHY.2021.681343
2021-05-28 Correlating qRT-PCR, dPCR and Viral Titration for the Identification and Quantification of SARS-CoV-2: A New Approach for Infection Management (edit) SARS-CoV-2 (edit) 10.3390/V13061022 34071726
2021-05-27 Evolution and spread of SARS-CoV-2 likely to be affected by climate (edit) SARS-CoV-2 (edit)
2021-05-27 NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry (edit) SARS-CoV-2 (edit) 10.1007/S11427-021-1929-Y 34047913
2021-05-27 Antibody evasion by the P.1 strain of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.055 33852911
2021-05-27 Molecular Biology Clues Portray SARS-CoV-2 as a Gain-of-Function Laboratory Manipulation of Bat CoV RaTG13 (edit) SARS-CoV-2 (edit) 10.1021/ACSMEDCHEMLETT.1C00274 34141073
2021-05-27 SARS-CoV-2 variants of concern are emerging in India (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01397-4
2021-05-27 Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-90556-1 34045524
2021-05-27 Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2101161118 34045361
2021-05-27 SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease (edit) SARS-CoV-2 (edit) 10.1093/QJMED/HCAB157
2021-05-27 Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals (edit) SARS-CoV-2 (edit) 10.1101/2021.05.26.445838
2021-05-27 TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009599
2021-05-27 Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.15252/EMMM.202114045 33961735
2021-05-27 Breakthrough infection after COVID-19 vaccination: A threat for Nepal due to SARS-CoV-2 variants circulating in 2nd wave ravaging India (edit) SARS-CoV-2 (edit) 10.3126/JPAHS.V8I2.37287
2021-05-27 SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES9060611
2021-05-27 Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries (edit) SARS-CoV-2 (edit) 10.3390/MOLECULES26113213 34072087
2021-05-26 Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.05.074 34062392
2021-05-26 Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1924265 34038700
2021-05-26 Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study (edit) SARS-CoV-2 (edit) 10.1101/2021.05.24.21257738
2021-05-26 The effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in different socioeconomic populations in Kuwait: a modeling study (edit) SARS-CoV-2 (edit) 10.1186/S12889-021-10984-6 34039289
2021-05-26 SARS-CoV-2 a public health emergency: challenges in vaccination in Indian setup (edit) SARS-CoV-2 (edit) 10.18203/2394-6040.IJCMPH20212029
2021-05-26 COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) SARS-CoV-2 (edit) 10.21203/RS.3.PEX-1338/V2
2021-05-26 “Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-558954/V1
2021-05-26 How to understand and manage Mucormycosis infections during Covid-19/ SARS-CoV-2/ novel coronavirus pandemic era in India & developing countries? (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/J3R7B
2021-05-26 SARS-CoV-2 Epidemics in Retirement and Nursing Homes in Italy: A New Preparedness Assessment Model after the First Epidemic Wave (edit) SARS-CoV-2 (edit) 10.3390/IJERPH18115712
2021-05-26 Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? (edit) SARS-CoV-2 (edit) 10.3390/IJMS22115672 34073529
2021-05-25 Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 (edit) SARS-CoV-2 (edit) 34052578
2021-05-25 E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104941 34044192
2021-05-25 Existence of SARS-CoV-2 RNA on ambient particulate matter samples: A nationwide study in Turkey (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.147976 34058581
2021-05-25 SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00275-0 34035218
2021-05-25 Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22664-5 34035246
2021-05-25 Immune response to SARS-CoV-2 variants of concern in vaccinated individuals (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23473-6 34035301
2021-05-25 2'-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2100170118 33972410
2021-05-25 Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2105968118
2021-05-25 Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression (edit) SARS-CoV-2 (edit) 10.1093/CVR/CVAB082 33705542
2021-05-25 SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0251368 34033650
2021-05-25 Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study (edit) SARS-CoV-2 (edit) 10.3389/FMED.2021.644715 34113632
2021-05-25 Correction: Bueckert et al. Infectivity of SARS-CoV-2 and Other Coronaviruses on Dry Surfaces: Potential for Indirect Transmission. Materials 2020, 13, 5211 (edit) SARS-CoV-2 (edit) 10.3390/MA14112816
2021-05-24 Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.05.033 34143953
2021-05-24 Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00279-W 34031383
2021-05-24 Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23313-7 34031399
2021-05-24 Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41540-021-00181-X
2021-05-24 SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome (edit) SARS-CoV-2 (edit) 10.1038/S41557-021-00707-0
2021-05-24 Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-89578-6 34031435
2021-05-24 Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease (edit) SARS-CoV-2 (edit) 10.1186/S12920-021-00970-7 34030677
2021-05-24 Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wave of the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1186/S12941-021-00445-8 34030702
2021-05-24 Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.641447 34108961
2021-05-23 Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review (edit) SARS-CoV-2 (edit) 10.3390/MEDICINA57060523 34070998
2021-05-22 Comparative protein structure network analysis on 3CLpro from SARS-CoV-1 and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1002/PROT.26143 33983654
2021-05-22 Glycosylation is a key in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1007/S00109-021-02092-0 34023935
2021-05-22 SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00623-2
2021-05-22 SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions (edit) SARS-CoV-2 (edit) 10.1111/TBED.14104 33835709
2021-05-21 The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.05.043 34029705
2021-05-21 Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102420 33898942
2021-05-21 Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis (edit) SARS-CoV-2 (edit) 10.1016/J.JAIM.2021.05.003 34054246
2021-05-21 Modelling the SARS-CoV-2 outbreak: Assessing the usefulness of protective measures to reduce the pandemic at population level (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.147816 34052482
2021-05-21 SARS-CoV-2 variant from India to Marseille: The still active role of ports in the introduction of epidemics (edit) SARS-CoV-2 (edit) 10.1016/J.TMAID.2021.102085
2021-05-21 Addressing personal protective equipment (PPE) decontamination: methylene blue and light inactivates SARS-CoV-2 on N95 respirators and medical masks with maintenance of integrity and fit (edit) SARS-CoV-2 (edit) 10.1017/ICE.2021.230 34016200
2021-05-21 The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.0C00866 34019767
2021-05-21 Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00514-9 34021265
2021-05-21 SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-90278-4 34021237
2021-05-21 The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2024202118 34021074
2021-05-21 Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB320 33956156
2021-05-21 Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit) Human coronavirus 229E (edit) 10.1101/2021.05.19.444823 34031654
2021-05-21 Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit) MERS-CoV (edit) 10.1101/2021.05.19.444823 34031654
2021-05-21 Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit) SARS-CoV-2 (edit) 10.1101/2021.05.19.444823 34031654
2021-05-21 Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit) Coronavirus Humana NL63 (edit) 10.1101/2021.05.19.444823 34031654
2021-05-21 Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABH2644 33853970
2021-05-21 Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility (edit) SARS-CoV-2 (edit) 10.3390/BIOLOGY10060454 34064163
2021-05-21 Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS10060634
2021-05-20 Exploration of hosts and transmission traits for SARS-CoV-2 based on the k-mer natural vector (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104933 34023511
2021-05-20 The SARS-CoV-2 subgenome landscape and its novel regulatory features (edit) SARS-CoV-2 (edit) 10.1016/J.MOLCEL.2021.02.036 33713597
2021-05-20 SARS-CoV-2 in the environment-Non-droplet spreading routes (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.145260 33513500
2021-05-20 Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-90243-1 34017039
2021-05-20 Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1921032 34014150
2021-05-20 Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB465 34015087
2021-05-20 Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil (edit) SARS-CoV-2 (edit) 10.1186/S12864-021-07708-W 34016042
2021-05-20 Does prior treatment with anti-PD 1 immune check point inhibitors (ICIs) mitigate infection with herpes and SARS-CoV-2 viruses: Clinical evidence supporting basic hypotheses (edit) SARS-CoV-2 (edit) 10.1200/JCO.2021.39.15_SUPPL.E24045
2021-05-19 Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.BBI.2021.05.012 34022369
2021-05-19 SARS-CoV-2 infection induces beta cell transdifferentiation (edit) SARS-CoV-2 (edit) 10.1016/J.CMET.2021.05.015 34081913
2021-05-19 Diverse Functional Autoantibodies in Patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03631-Y
2021-05-19 Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02128-8 34011948
2021-05-19 Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells (edit) SARS-CoV-2 (edit) 10.1091/MBC.E21-02-0074
2021-05-19 What Impact has SARS-CoV-2/Covid-19 Pandemic on Healthcare Workers (HCWs) Mortality & Infections across 36 states & union territories of India? How to prevent mortality & morbidity of HCWs? (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-538781/V1
2021-05-19 Research Article What Impact has SARS-CoV-2/Covid-19 Pandemic on Healthcare Workers (HCWs) Mortality & Infections across 36 states & union territories of India? How to prevent mortality & morbidity of HCWs? (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/TK4F3
2021-05-19 Contribution of Syndecans to the Cellular Entry of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/IJMS22105336 34069441
2021-05-19 COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents (edit) SARS-CoV-2 (edit) 10.3390/NU13051714 34069412
2021-05-18 Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109126 33974846
2021-05-18 Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109133 33984267
2021-05-18 SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment (edit) SARS-CoV-2 (edit) 10.1016/J.CMET.2021.05.013 34081912
2021-05-18 Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells (edit) SARS-CoV-2 (edit) 10.1038/S41420-021-00487-Z 34006825
2021-05-18 Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs (edit) SARS-CoV-2 (edit) 10.1096/FJ.202100560R 34004056
2021-05-18 Fast SARS-CoV-2 virus detection using disposable cartridge strips and a semiconductor-based biosensor platform (edit) SARS-CoV-2 (edit) 10.1116/6.0001060 34055475
2021-05-18 ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial Plasminogen Activator Inhibitor-1 (edit) SARS-CoV-2 (edit) 10.1165/RCMB.2020-0544OC 34003736
2021-05-18 Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009519
2021-05-18 Avoiding culture shock with the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.69496 34003114
2021-05-17 Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies (edit) SARS-CoV-2 (edit) 10.1016/J.JTCME.2021.05.001 34026584
2021-05-17 SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium (edit) SARS-CoV-2 (edit) 10.1016/J.STEM.2021.04.028 34022129
2021-05-17 Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00610-7 34001847
2021-05-17 Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01377-8
2021-05-17 Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02095-0 34002013
2021-05-17 A large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1921034 33998954
2021-05-17 Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB370 33999154
2021-05-17 A glycan gate controls opening of the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1101/2021.02.15.431212 33619492
2021-05-17 Verification of SARS-CoV-2-Encoded small RNAs and contribution to Infection-Associated lung inflammation (edit) SARS-CoV-2 (edit) 10.1101/2021.05.16.444324
2021-05-17 Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells (edit) SARS-CoV-2 (edit) 10.1101/2021.05.17.444467
2021-05-17 First Description of SARS-CoV-2 Infection in Two Feral American Mink (Neovison vison) Caught in the Wild (edit) SARS-CoV-2 (edit) 10.3390/ANI11051422
2021-05-16 Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment (edit) SARS-CoV-2 (edit) 10.1016/J.IDENTJ.2021.05.002 34172261
2021-05-16 Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1101/2021.05.13.444010 34031659
2021-05-15 Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.BMCL.2021.127906 33689873
2021-05-15 Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus (edit) SARS-CoV-2 (edit) 10.1016/J.CARBPOL.2021.117797 33712145
2021-05-15 The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play (edit) MERS-CoV (edit) 10.1016/J.IJBIOMAC.2021.02.203 33667553
2021-05-15 The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.02.203 33667553
2021-05-15 Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104923 34004360
2021-05-14 Modeling the binding of protoporphyrin IX, verteporfin, and chlorin e6 to SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1007/S10593-021-02920-8 34007082
2021-05-14 A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.03.016 33773139
2021-05-14 SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.166946 33744314
2021-05-14 Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2021.04.016 33969332
2021-05-14 Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23118-8 33990585
2021-05-14 Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1922095 33988079
2021-05-14 ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19 (edit) SARS-CoV-2 (edit) 10.1097/FPC.0000000000000436
2021-05-14 Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses (edit) SARS-CoV-2 (edit) 10.1101/2021.05.11.443572
2021-05-14 Glucosidase inhibitors suppress SARS-CoV-2 in tissue culture and may potentiate (edit) SARS-CoV-2 (edit) 10.1101/2021.05.14.444190
2021-05-13 Citizen volunteers detect SARS-CoV-2 RNA from outdoor urban fomites (edit) SARS-CoV-2 (edit)
2021-05-13 Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.052 33861950
2021-05-13 Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109179 34004174
2021-05-13 In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-89605-6 33986351
2021-05-13 Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-89724-0 33986405
2021-05-13 New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2100362 33761203
2021-05-13 Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein (edit) SARS-CoV-2 (edit) 10.1093/GLYCOB/CWAB044 33997890
2021-05-13 Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain (edit) SARS-CoV-2 (edit) 10.1111/CBDD.13847 33894099
2021-05-13 Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF3546 34029205
2021-05-13 Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABH2259 34446527
2021-05-13 IPD 2.0: To derive insights from an evolving SARS-CoV-2 genome (edit) SARS-CoV-2 (edit) 10.1186/S12859-021-04172-X 33985433
2021-05-13 SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0251587 33984048
2021-05-13 Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates (edit) SARS-CoV-2 (edit) 10.3389/FPLS.2021.682953 34054909
2021-05-13 Studies of Melody Efficacy Vaccine Against SARS-CoV-2 are Closing COVID-19 Pandemic Doors? Single Dose is Recommended as Therapeutic Drug and Two Doses Application as Preventive Vaccine (edit) SARS-CoV-2 (edit) 10.47485/2693-2504.1042
2021-05-12 A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1002/IID3.446 33979020
2021-05-12 Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.04.007 33887205
2021-05-12 SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03610-3 33979833
2021-05-12 The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABF1906 33820835
2021-05-12 Sources of SARS-CoV-2 and Other Microorganisms in Dental Aerosols (edit) SARS-CoV-2 (edit) 10.1177/00220345211015948 33977764
2021-05-12 Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0251585 33979391
2021-05-11 Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection (edit) SARS-CoV-2 (edit)
2021-05-11 Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.4388 33739374
2021-05-11 METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109091 33961823
2021-05-11 Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.04.003 33891889
2021-05-11 Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.100770 33989635
2021-05-11 SARS-CoV-2 targets glial cells in human cortical organoids (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.01.016 33979600
2021-05-11 Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.04.001 33979601
2021-05-11 Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review (edit) SARS-CoV-2 (edit) 10.1016/J.TRAC.2021.116328 33994605
2021-05-11 Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12 (edit) SARS-CoV-2 (edit) 10.1016/J.YMTHE.2021.05.005 33984520
2021-05-11 SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22905-7 33976134
2021-05-11 A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22926-2 33976198
2021-05-11 Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22958-8 33976165
2021-05-11 A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-23036-9 33976229
2021-05-11 RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-00942-0
2021-05-11 Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2100425118 33903171
2021-05-11 Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2102516118 33883267
2021-05-10 The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104464 34020130
2021-05-10 A review of the impact of weather and climate variables to COVID-19: In the absence of public health measures high temperatures cannot probably mitigate outbreaks (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2020.144578 33450689
2021-05-10 Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2104547118
2021-05-10 A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1924271 33970798
2021-05-10 Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant (edit) SARS-CoV-2 (edit) 10.1101/2021.05.09.443299 34013272
2021-05-10 Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation (edit) SARS-CoV-2 (edit) 10.1111/ALL.14850 33837568
2021-05-10 A comprehensive library of fluorescent constructs of SARS‐CoV‐2 proteins and their initial characterisation in different cell types (edit) SARS-CoV-2 (edit) 10.1111/BOC.202000158 33666950
2021-05-10 Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays (edit) SARS-CoV-2 (edit) 10.1128/JVI.00044-21
2021-05-10 Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.51061.1
2021-05-10 Predictors for inpatient mortality during the first wave of the SARS-CoV-2 pandemic: A retrospective analysis (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0251262 33970955
2021-05-10 What are the factors responsible for increase in SARS-CoV-2/Covid-19 Pandemic related cases and death in India in 2021? How does environmental, host & agent factors of epidemiological triad do influence & can be utilised to manage ongoing pandemic ca (edit) SARS-CoV-2 (edit) 10.22541/AU.162066514.40049074/V1
2021-05-10 Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.4049/JIMMUNOL.2100054
2021-05-10 Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation (edit) SARS-CoV-2 (edit) 10.7150/IJBS.57802 34131396
2021-05-09 Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.05.002 34051147
2021-05-09 SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough (edit) SARS-CoV-2 (edit) 10.1101/2021.05.08.443253
2021-05-08 A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis (edit) SARS-CoV-2 (edit) 10.1002/CLC.23622 33964035
2021-05-08 Image processing unravels the evolutionary pattern of SARS-CoV-2 against SARS and MERS through position-based pattern recognition (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104471 34004573
2021-05-08 Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China (edit) SARS-CoV-2 (edit) 10.1016/J.JVE.2021.100040
2021-05-08 Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study (edit) SARS-CoV-2 (edit) 10.1016/J.MOLLIQ.2021.116440 33994607
2021-05-08 SARS-CoV-2 promote autophagy to suppress type I interferon response (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00574-8 33966045
2021-05-08 Illness duration and symptom profile in a large cohort of symptomatic UK school-aged children tested for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.05.05.21256649
2021-05-08 Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide (edit) SARS-CoV-2 (edit) 10.3390/BIOMEDICINES9050525 34066729
2021-05-07 Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.0C00758 33666082
2021-05-07 TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-00937-X 33963333
2021-05-07 Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19 (edit) SARS-CoV-2 (edit) 10.1093/BRAIN/AWAB009 33822001
2021-05-07 Mutation Rates and Selection on Synonymous Mutations in SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/GBE/EVAB087 33895815
2021-05-07 Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques (edit) SARS-CoV-2 (edit) 10.1101/2021.05.07.443115 34382034
2021-05-07 X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF7945 33811162
2021-05-07 The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF9648 33758017
2021-05-07 Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001209 33961621
2021-05-07 Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics (edit) SARS-CoV-2 (edit) 10.3390/ANTIBIOTICS10050542 34066998
2021-05-06 Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109164 33991511
2021-05-06 Designing potential siRNA molecule for the nucleocapsid(N) gene silencing of different SARS-CoV-2 strains of Bangladesh: Computational approach (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107486
2021-05-06 Detection of SARS-CoV-2 RNA in bivalve mollusks and marine sediments (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.147534 33984699
2021-05-06 Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100291 33977279
2021-05-06 Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-88809-0 33958613
2021-05-06 Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB406 33956935
2021-05-06 SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany - a cross sectional study (edit) SARS-CoV-2 (edit) 10.1093/EURPUB/CKAB079 33956945
2021-05-06 Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster (edit) SARS-CoV-2 (edit) 10.1101/2021.05.05.21256716
2021-05-06 Structure-based design of a highly stable, covalently-linked SARS-CoV-2 spike trimer with improved structural properties and immunogenicity (edit) SARS-CoV-2 (edit) 10.1101/2021.05.06.441046
2021-05-06 SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases (edit) SARS-CoV-2 (edit) 10.1136/ANNRHEUMDIS-2021-220461 33958324
2021-05-05 Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia (edit) SARS-CoV-2 (edit) 10.1007/S10875-021-01045-Z 33950324
2021-05-05 A cyclic peptide inhibitor of the SARS-CoV-2 main protease (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2021.113530 34023738
2021-05-05 Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100290 33969322
2021-05-05 Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1920464 33949286
2021-05-05 SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB398
2021-05-05 SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination (edit) SARS-CoV-2 (edit) 10.1101/2021.05.04.442663
2021-05-05 SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.05.04.442701
2021-05-04 High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.04.045 34010620
2021-05-04 Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells (edit) SARS-CoV-2 (edit) 10.1021/ACS.ANALCHEM.1C00893 33871970
2021-05-04 The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00268-Z 33947832
2021-05-04 A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice (edit) SARS-CoV-2 (edit) 10.1101/2021.05.03.442520 33972944
2021-05-04 Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG5268
2021-05-04 Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1128/MBIO.00384-21 33947753
2021-05-04 Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor (edit) SARS-CoV-2 (edit) 10.3389/FCHEM.2021.661230 34017819
2021-05-04 Decontamination of Food Packages from SARS-CoV-2 RNA with a Cold Plasma-Assisted System (edit) SARS-CoV-2 (edit) 10.3390/APP11094177
2021-05-03 Evidence of the presence of SARS-CoV-2 virus in atmospheric air and surfaces of a dedicated COVID hospital (edit) SARS-CoV-2 (edit) 10.1002/JMV.27029 33913527
2021-05-03 The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104892 33957338
2021-05-03 Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1084/JEM.20202617 33646265
2021-05-03 The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children (edit) SARS-CoV-2 (edit) 10.1097/INF.0000000000003195
2021-05-03 The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function (edit) SARS-CoV-2 (edit) 10.1186/S12859-021-04148-X 33941085
2021-05-03 SARS-CoV-2—Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis (edit) SARS-CoV-2 (edit) 10.3390/JCM10091962 34063654
2021-05-02 Virtual screening FDA approved drugs against multiple targets of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1111/CTS.13007 33606912
2021-05-01 Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations (edit) SARS-CoV-2 (edit) 10.1002/1873-3468.14076 33728680
2021-05-01 There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (DOI: 10.1002/bies.202000240) (edit) SARS-CoV-2 (edit) 10.1002/BIES.202000325 33751609
2021-05-01 Extrapulmonary Manifestations of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection (edit) SARS-CoV-2 (edit) 10.1002/JMV.26595 33090515
2021-05-01 Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission (edit) SARS-CoV-2 (edit) 10.1002/JMV.26855 33554363
2021-05-01 Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches (edit) SARS-CoV-2 (edit) 10.1002/PMIC.202000279 33860983
2021-05-01 Human SARS CoV-2 spike protein mutations (edit) SARS-CoV-2 (edit) 10.1002/PROT.26042 33423311
2021-05-01 [Coercive measures and the SARS-CoV-2 pandemic] (edit) SARS-CoV-2 (edit) 10.1007/S00115-020-01002-Y 33001264
2021-05-01 Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1007/S00415-020-10149-2 32804279
2021-05-01 SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment (edit) SARS-CoV-2 (edit) 10.1007/S00431-021-03935-1 33452570
2021-05-01 COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1007/S10096-020-04138-6 33389262
2021-05-01 COVID-19: time to flatten the infodemic curve (edit) SARS-CoV-2 (edit) 10.1007/S10238-020-00680-X 33417084
2021-05-01 Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration (edit) SARS-CoV-2 (edit) 10.1007/S12035-020-02236-2 33417221
2021-05-01 Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous (edit) SARS-CoV-2 (edit) 10.1016/J.AMJMED.2021.01.009 33962709
2021-05-01 Sudden sensorineural hearing loss and SARS-CoV-2: Don’t forget the standard work-up! (edit) SARS-CoV-2 (edit) 10.1016/J.ANORL.2021.02.010
2021-05-01 Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines (edit) SARS-CoV-2 (edit) 10.1016/J.BIOPHA.2021.111330 33550043
2021-05-01 Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.03.005 33789084
2021-05-01 Coronavirus-induced autoimmunity (edit) SARS-CoV-2 (edit) 10.1016/J.CLIM.2021.108694 33610741
2021-05-01 From genomes to molecular dynamics - A bottom up approach in extrication of SARS CoV-2 main protease inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.COMTOX.2021.100156 33532671
2021-05-01 Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests (edit) SARS-CoV-2 (edit) 10.1016/J.EJCA.2021.02.024 33773276
2021-05-01 Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections (edit) SARS-CoV-2 (edit) 10.1016/J.JARE.2020.11.013 33282419
2021-05-01 Arginine Methylation of SARS-Cov-2 Nucleocapsid Protein Regulates RNA Binding, its Ability to Suppress Stress Granule Formation and Viral Replication (edit) SARS-CoV-2 (edit) 10.1016/J.JBC.2021.100821 34029587
2021-05-01 Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico (edit) SARS-CoV-2 (edit) 10.1016/J.JINF.2021.01.015 33493496
2021-05-01 Pediatric urology amidst SARS-CoV-2 pandemic: Building the future with current knowledge (edit) SARS-CoV-2 (edit) 10.1016/J.JPEDSURG.2021.01.017
2021-05-01 Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives (edit) SARS-CoV-2 (edit) 10.1016/J.LFS.2021.119251
2021-05-01 Aminoglycosides and their potential as SARS-CoV-2 antivirals (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110559
2021-05-01 Anticholinergic drugs versus preprocedural mouth rinses for reduction of SARS-CoV-2 load in dental aerosols (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110577
2021-05-01 Testicles, adipose organ and heart: A new axis in the management of SARS-CoV-2? (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110587
2021-05-01 Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection (edit) SARS-CoV-2 (edit) 10.1016/J.MOLCEL.2021.05.023 34118193
2021-05-01 The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.REDOX.2021.101902 33662873
2021-05-01 Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00947-8
2021-05-01 Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(20)30942-7 33485468
2021-05-01 CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00078-5 33571446
2021-05-01 SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00262-0 34022142
2021-05-01 Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial (edit) SARS-CoV-2 (edit) 10.1016/S2213-2600(20)30566-X 33556319
2021-05-01 Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (edit) SARS-CoV-2 (edit) 10.1016/S2468-2667(21)00055-4 33857453
2021-05-01 Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics (edit) SARS-CoV-2 (edit) 10.1016/S2666-5247(21)00027-6 33969329
2021-05-01 Type I and III interferon responses in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S12276-021-00592-0 33953323
2021-05-01 Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00487-9 33731853
2021-05-01 Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm (edit) SARS-CoV-2 (edit) 10.1038/S41423-021-00665-0 33742186
2021-05-01 SARS-CoV-2 infection of the oral cavity and saliva (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01296-8 33767405
2021-05-01 Disinfectants Used in Stomatology and SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1055/S-0041-1724154 33694135
2021-05-01 O‐glycosylation of the novel SARS‐CoV‐2 coronavirus spike protein influences furin cleavage (edit) SARS-CoV-2 (edit) 10.1096/FASEBJ.2021.35.S1.00261
2021-05-01 The SARS-CoV-2 pandemic: real-time training and service for Preventive Medicine residents (edit) SARS-CoV-2 (edit) 10.1097/PHH.0000000000001304
2021-05-01 SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done (edit) SARS-CoV-2 (edit) 10.1111/1462-2920.15487 33769683
2021-05-01 Dental Education in the Time of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1111/EJE.12608 33015929
2021-05-01 Host PDZ‐containing proteins targeted by SARS‐CoV‐2 (edit) SARS-CoV-2 (edit) 10.1111/FEBS.15881
2021-05-01 Animal coronaviruses and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1111/TBED.13791 32799433
2021-05-01 SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABG7607 33888467
2021-05-01 Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review (edit) SARS-CoV-2 (edit) 10.1136/RMDOPEN-2021-001580 33958439
2021-05-01 DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009576 34015061
2021-05-01 SARS-CoV-2-related Multisystem Inflammatory Syndrome in Children: A case series (edit) SARS-CoV-2 (edit) 10.18295/SQUMJ.2021.21.02.021 34221480
2021-05-01 Angiotensin System Polymorphisms’ in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study (edit) SARS-CoV-2 (edit) 10.2147/PGPM.S303666 34079337
2021-05-01 Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium (edit) SARS-CoV-2 (edit) 10.3201/EID2705.204410 33900177
2021-05-01 Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China (edit) SARS-CoV-2 (edit) 10.3201/EID2705.210015 33900193
2021-05-01 Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses (edit) SARS-CoV-2 (edit) 10.3201/EID2705.210023 33900165
2021-05-01 Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom (edit) SARS-CoV-2 (edit) 10.3201/EID2705.210050 33760727
2021-05-01 Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil (edit) SARS-CoV-2 (edit) 10.3201/EID2705.210191 33605869
2021-05-01 Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.4062/BIOMOLTHER.2020.226 33504682
2021-05-01 Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins (edit) SARS-CoV-2 (edit) 10.4062/BIOMOLTHER.2021.048
2021-05-01 Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test (edit) SARS-CoV-2 (edit) 10.4103/IJMR.IJMR_3806_20 34145085
2021-05-01 Transmission of SARS-CoV-2 on cold-chain food overpacks: A new challenge (edit) SARS-CoV-2 (edit) 10.7189/JOGH.11.03071 33981410
2021-05-01 Immunological Features and Hypotheses: Do SARS-CoV and MERS-CoV-Reported Individuals have Immunity against SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.9734/JPRI/2021/V33I26B31480
2021-04-30 Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CRIMMU.2021.04.001 33969287
2021-04-30 Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198441 33940003
2021-04-30 Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00634-6 33939953
2021-04-30 Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.1C00395 33929853
2021-04-30 Standard blood laboratory values as a clinical support tool to distinguish between SARS-CoV-2 positive and negative patients (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-88844-X 33931692
2021-04-30 Structural impact on SARS-CoV-2 spike protein by D614G substitution (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF2303 33727252
2021-04-30 SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 (edit) SARS-CoV-2 (edit) 10.1161/CIRCRESAHA.121.318902 33784827
2021-04-30 Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine (edit) SARS-CoV-2 (edit) 10.2471/BLT.20.255752 34248221
2021-04-30 Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V13050808 33946304
2021-04-30 Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience (edit) SARS-CoV-2 (edit) 10.5603/PJNNS.A2021.0031
2021-04-29 SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways (edit) SARS-CoV-2 (edit) 10.1002/JMV.27050 33913550
2021-04-29 SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.042 33735608
2021-04-29 Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.012 33743211
2021-04-29 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.013 33743213
2021-04-29 Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.029 33773105
2021-04-29 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.036 33794143
2021-04-29 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.04.006 33930298
2021-04-29 Reconstitution and functional characterization of SARS-CoV-2 proofreading complex (edit) SARS-CoV-2 (edit) 10.1016/J.PEP.2021.105894 33933612
2021-04-29 Towards computer-aided severity assessment via deep neural networks for geographic and opacity extent scoring of SARS-CoV-2 chest X-rays (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-88538-4
2021-04-29 The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-88630-9 33927258
2021-04-29 Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August–September, 2020 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB321
2021-04-29 Molecular interactions of the M and E integral membrane proteins of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.04.29.442018 33948595
2021-04-29 How SARS-CoV-2 first adapted in humans (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABI4711
2021-04-29 SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism (edit) SARS-CoV-2 (edit) 10.1186/S13045-021-01082-6 33926500
2021-04-29 Hospitalization and interventional procedures in cardiology departments covering a region with 2.5 million inhabitants during the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.33963/KP.15984
2021-04-28 SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00978-8 33932328
2021-04-28 Nutritional status, diet and viral respiratory infections: perspectives for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1017/S0007114520003311 32843118
2021-04-28 Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.1C00058 34056088
2021-04-28 Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.1C00080 34056089
2021-04-28 Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-88315-3 33911109
2021-04-28 Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1914170
2021-04-28 Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.148494
2021-04-28 Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening" (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0250319 33909646
2021-04-28 Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0250780 33909660
2021-04-27 Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104451 34020131
2021-04-27 Assessment of basic reproduction number (R0), spatial and temporal epidemiological determinants, and genetic characterization of SARS-CoV-2 in Bangladesh (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104884 33930563
2021-04-27 The SARS-CoV-2 RNA interactome (edit) SARS-CoV-2 (edit) 10.1016/J.MOLCEL.2021.04.022 33989516
2021-04-27 A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro (edit) SARS-CoV-2 (edit) 10.1016/J.STR.2021.04.005 33930306
2021-04-27 Overview of SARS-CoV-2 infection in adults living with HIV (edit) SARS-CoV-2 (edit) 10.1016/S2352-3018(21)00070-9
2021-04-27 The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets (edit) SARS-CoV-2 (edit) 10.1038/S41564-021-00908-W
2021-04-27 ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2023157118 33827988
2021-04-27 NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies (edit) SARS-CoV-2 (edit) 10.15252/EMBR.202052325 33904225
2021-04-27 Humoral immunity to SARS-CoV-2 among the population of Murmansk region amid COVID-19 epidemic (edit) SARS-CoV-2 (edit) 10.22328/2077-9828-2021-13-1-17-27
2021-04-27 A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9050431 33925446
2021-04-26 Can tweets be used to detect problems early with scientific papers? A case study of three retracted COVID-19/SARS-CoV-2 papers (edit) SARS-CoV-2 (edit) 10.1007/S11192-021-03962-7 33935330
2021-04-26 Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102477 33937724
2021-04-26 Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102479 33937725
2021-04-26 Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOCHEM.1C00139 33900725
2021-04-26 Analysis and forecasting of global real time RT-PCR primers and probes for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-88532-W 33903676
2021-04-26 Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAA1249 33029620
2021-04-26 Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera‐hosted coronaviruses: SARS‐CoV, MERS‐CoV and SARS‐CoV‐2 (edit) SARS-CoV-2 (edit) 10.1111/CLA.12454
2021-04-26 Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PNTD.0008879
2021-04-25 SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/IJMS22094472 33922918
2021-04-24 B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.04.032 34015271
2021-04-24 Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109109 33932326
2021-04-24 Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.04.129 33901557
2021-04-24 Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.04.063 33901650
2021-04-24 In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins (edit) SARS-CoV-2 (edit) 10.1016/J.SJBS.2021.04.051 33942008
2021-04-24 RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00575-7 33895773
2021-04-24 The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00591-7 33895780
2021-04-24 Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India (edit) SARS-CoV-2 (edit) 10.1101/2021.04.22.440932
2021-04-24 Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9050428
2021-04-23 SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.02.080 33676232
2021-04-23 Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109108 33961822
2021-04-23 ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102293 33723527
2021-04-23 Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.1C00509 33891389
2021-04-23 Rational Engineering of the DNA Walker Amplification Strategy by Using a Au@Ti3C2@PEI-Ru(dcbpy)32+ Nanocomposite Biosensor for Detection of the SARS-CoV-2 RdRp Gene (edit) SARS-CoV-2 (edit) 10.1021/ACSAMI.1C04453
2021-04-23 Structure and function analysis of a potent human neutralizing antibody CA521 against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02029-W 33893388
2021-04-23 Genome-wide, bidirectional CRISPR screens identify mucins as critical host factors modulating SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1101/2021.04.22.440848
2021-04-23 Online biophysical predictions for SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1186/S12860-021-00362-W 33892639
2021-04-23 Laboratory modeling of SARS-CoV-2 exposure reduction through physically distanced seating in aircraft cabins using bacteriophage aerosol - November 2020 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7016E1
2021-04-23 Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS10050509 33922476
2021-04-23 SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.65962 33890572
2021-04-23 Re-positive of SARS-CoV-2 test is common in COVID-19 patients after hospital discharge. Data from high standard post-discharge quarantined patients in Macao SAR, China (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.11170
2021-04-22 N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.167003 33895266
2021-04-22 Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-87254-3 33888738
2021-04-22 Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 (edit) SARS-CoV-2 (edit) 10.1056/NEJMOA2100433
2021-04-22 New framework for recombination and adaptive evolution analysis with application to the novel coronavirus SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAB107
2021-04-22 Misleading clinical evidence and systematic reviews on ivermectin for COVID-19 (edit) SARS-CoV-2 (edit) 10.1136/BMJEBM-2021-111678
2021-04-22 A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.146316 33720905
2021-04-22 Uncertainties around COVID-19 from the perspectives of oral health care workers during the first wave of SARS-CoV-2 infections in British Columbia, Canada (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0249186
2021-04-22 High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0250019 33886614
2021-04-22 Wastewater Surveillance for SARS-CoV-2 on College Campuses: Initial Efforts, Lessons Learned, and Research Needs (edit) SARS-CoV-2 (edit) 10.3390/IJERPH18094455 33922263
2021-04-21 Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100578 33898733
2021-04-21 Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPCB.1C00869 33881861
2021-04-21 Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-87703-Z 33883570
2021-04-21 SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02025-0 33883675
2021-04-21 Vaccine Breakthrough Infections with SARS-CoV-2 Variants (edit) SARS-CoV-2 (edit) 10.1056/NEJMOA2105000
2021-04-21 SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABF7872 33723017
2021-04-21 Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7017E1
2021-04-21 COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7017E2
2021-04-21 The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis (edit) SARS-CoV-2 (edit) 10.2196/20699 33729168
2021-04-20 Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.109020 33852916
2021-04-20 Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104383 33915361
2021-04-20 Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104390 33895459
2021-04-20 Identification of SARS-CoV-2 origin: Using Ngrams, principal component analysis and Random Forest algorithm (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100577 33898732
2021-04-20 C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia (edit) SARS-CoV-2 (edit) 10.1016/J.JACI.2021.03.038 33852936
2021-04-20 Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100255 33842902
2021-04-20 Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100275 33899033
2021-04-20 Sharing COVID data? Check these recommendations and guidelines (edit) SARS-CoV-2 (edit) 10.1038/D41586-021-01028-5
2021-04-20 SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination (edit) SARS-CoV-2 (edit) 10.1038/S41418-021-00782-3 33879858
2021-04-20 Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02011-6 33879833
2021-04-20 SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2022643118 33811184
2021-04-20 Origins of SARS-CoV-2: Focusing on Science (edit) SARS-CoV-2 (edit) 10.1097/ID9.0000000000000008
2021-04-20 Sentinel cells enable genetic detection of SARS-CoV-2 Spike protein (edit) SARS-CoV-2 (edit) 10.1101/2021.04.20.440678 33907743
2021-04-20 Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays (edit) SARS-CoV-2 (edit) 10.1128/JCM.02890-20 33602698
2021-04-20 Immunoinformatics Identification of B- and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1155/2021/6627141 33936347
2021-04-20 The SARS‐unique domain (SUD) of SARS‐CoV and SARS‐CoV‐2 interacts with human Paip1 to enhance viral RNA translation (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2019102277 33876849
2021-04-20 Differences in the concentration of anti-SARS-CoV-2 IgG antibodies as a result of post-covid or/and post-vaccination immunization (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-388040/V2
2021-04-20 SARS-CoV-2 Switches 'on' MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.631879 33995033
2021-04-20 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infecting Pregnant Women and the Fetus, Intrauterine Transmission, and Placental Pathology During the Coronavirus Disease 2019 (COVID-19) Pandemic: It's Complicated (edit) SARS-CoV-2 (edit) 10.5858/ARPA.2021-0164-ED
2021-04-19 Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine* (edit) SARS-CoV-2 (edit) 10.1002/ANIE.202015362 33464672
2021-04-19 Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104364 33895457
2021-04-19 Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2021.107920 33933885
2021-04-19 Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00147-X 33887209
2021-04-19 Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.1C00216 34075345
2021-04-19 Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-87713-X 33875719
2021-04-19 Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities (edit) SARS-CoV-2 (edit) 10.1101/2021.04.19.440086
2021-04-19 Low dose inocula of SARS-CoV-2 B.1.1.7 variant initiate more robust infections in the upper respiratory tract of hamsters than earlier D614G variants (edit) SARS-CoV-2 (edit) 10.1101/2021.04.19.440414
2021-04-19 Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export (edit) SARS-CoV-2 (edit) 10.1101/2021.04.19.440452 33907748
2021-04-19 Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies (edit) SARS-CoV-2 (edit) 10.1186/S13073-021-00882-2 33875001
2021-04-19 The Challenging Diagnosis of Pediatric Multisystem Inflammatory Syndrome Associated with Sars-Cov-2 Infection-Two Case Reports and Literature Review (edit) SARS-CoV-2 (edit) 10.3390/JPM11040318 33921718
2021-04-19 New Drug/Vaccine RNA-Peptide Named Melody Against SARS-CoV-2: Adapting Antiviral Pathways in Cell Culture WM-266 as Temporal Memory of “In Vitro Cell” (edit) SARS-CoV-2 (edit) 10.47485/2693-2504.1040
2021-04-17 COVID-19: What Does Confirmation of the Airborne Transmission of SARS-CoV-2 Virus Mean? (edit) SARS-CoV-2 (edit)
2021-04-17 Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2021.105075 33872675
2021-04-17 SARS-CoV-2 transmission in a Georgia school district — United States, December 2020–January 2021 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB332
2021-04-17 How do we can control SARS-CoV-2/ Covid -19 pandemic through various clinical and public health approaches? What are the agent (Covid-19 virus), host & environmental factors responsible for continuation & recurrence of SARS-CoV-2/ Covid -19 pandemic? (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/VDHG3
2021-04-16 Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics (edit) SARS-CoV-2 (edit) 10.1007/S10989-021-10205-Z 33897313
2021-04-16 Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104362 33894500
2021-04-16 The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2021.166875 33556408
2021-04-16 Development and performance characteristics evaluation of a new Bioelectric Recognition Assay (BERA) method for rapid Sars-CoV-2 detection in clinical samples (edit) SARS-CoV-2 (edit) 10.1016/J.JVIROMET.2021.114166 33872651
2021-04-16 Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22580-8 33863887
2021-04-16 Structural equation modeling to shed light on the controversial role of climate on the spread of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-87113-1 33863938
2021-04-16 SARS-CoV-2 within-host diversity and transmission (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG0821 33688063
2021-04-15 A COVID moonshot: assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy (edit) SARS-CoV-2 (edit) 10.1007/S10858-021-00365-X 33856612
2021-04-15 The antigenic anatomy of SARS-CoV-2 receptor binding domain (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.032 33756110
2021-04-15 Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.033 33743891
2021-04-15 A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.044 33691138
2021-04-15 Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.053 33713620
2021-04-15 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.04.005 33894127
2021-04-15 A unique view of SARS-COV-2 through the lens of ORF8 protein (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104380 33872970
2021-04-15 CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.04.009 33951417
2021-04-15 Coronavirus (SARS-CoV-2) in the environment: Occurrence, persistence, analysis in aquatic systems and possible management (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2020.142698 33097261
2021-04-15 The novel SARS-CoV-2 pandemic: Possible environmental transmission, detection, persistence and fate during wastewater and water treatment (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2020.142746 33092831
2021-04-15 Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198345 33631222
2021-04-15 Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir (edit) SARS-CoV-2 (edit) 10.1021/ACSCENTSCI.0C01186 34075346
2021-04-15 SARS-CoV-2 one year on: evidence for ongoing viral adaptation (edit) SARS-CoV-2 (edit) 10.1099/JGV.0.001584
2021-04-15 REACT-1 round 10 report: Level prevalence of SARS-CoV-2 swab-positivity in England during third national lockdown in March 2021 (edit) SARS-CoV-2 (edit) 10.1101/2021.04.08.21255100
2021-04-15 Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PNTD.0009327 33857136
2021-04-15 Assessing Public Interest Based on Wikipedia’s Most Visited Medical Articles During the SARS-CoV-2 Outbreak: Search Trends Analysis (edit) SARS-CoV-2 (edit) 10.2196/26331
2021-04-15 Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS10040479 33920814
2021-04-14 Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies (edit) SARS-CoV-2 (edit) 10.1002/PMIC.202100036 33811468
2021-04-14 Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.1C00096 33849267
2021-04-14 In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAB189 34109257
2021-04-14 SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 T cell activation in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABF7550 33853928
2021-04-14 Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity (edit) SARS-CoV-2 (edit) 10.1186/S40168-021-01008-X 33853691
2021-04-14 What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? How Covid-19 pande (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-414848/V2
2021-04-14 What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? How Covid-19 pande (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/5T3Z2
2021-04-14 L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/NU13041297 33919991
2021-04-14 Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.34067/KID.0002172021
2021-04-13 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.3071 33662102
2021-04-13 Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease (edit) SARS-CoV-2 (edit) 10.1007/S15010-021-01597-7 33851328
2021-04-13 CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.04.006 33945786
2021-04-13 Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane (edit) SARS-CoV-2 (edit) 10.1021/ACS.JCTC.0C01144 33689337
2021-04-13 Highly Accurate Chip-Based Resequencing of SARS-CoV-2 Clinical Samples (edit) SARS-CoV-2 (edit) 10.1021/ACS.LANGMUIR.0C02927 33848173
2021-04-13 The effect of in-person primary and secondary school instruction on county-level SARS-CoV-2 spread in Indiana (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB306 33846706
2021-04-13 SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98 (edit) SARS-CoV-2 (edit) 10.1128/MBIO.00065-21 33849972
2021-04-13 Does my patient have SARS-CoV-2 infection? A reminder of clinical probability formulas (edit) SARS-CoV-2 (edit) 10.1136/BMJEBM-2020-111633
2021-04-12 The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S11224-021-01776-0 33867777
2021-04-12 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03493-4
2021-04-12 A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-86134-0 33846375
2021-04-12 Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-02030-3 33846513
2021-04-12 SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation (edit) SARS-CoV-2 (edit) 10.1128/JVI.00002-21 33608407
2021-04-12 The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2 (edit) SARS-CoV-2 (edit) 10.1128/JVI.02422-20 33563656
2021-04-12 What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-414848/V1
2021-04-12 What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/7VGPX
2021-04-12 Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil (edit) SARS-CoV-2 (edit) 10.3201/EID2705.204912 33797393
2021-04-12 Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.633769 33912161
2021-04-12 Inhibition of SARS-CoV-2 3CL Mpro by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19 (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2021.640819 33912587
2021-04-12 Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FNEUR.2021.660087 33912129
2021-04-12 Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2021.602218 33986661
2021-04-10 Airborne spread of infectious SARS-CoV-2: Moving forward using lessons from SARS-CoV and MERS-CoV (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2020.142802 33071145
2021-04-10 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00628-0 33798499
2021-04-10 Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3390/V13040653
2021-04-10 In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor (edit) SARS-CoV-2 (edit) 10.7150/IJBS.59191 33907519
2021-04-09 Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1007/S00134-021-06392-4 33835207
2021-04-09 In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins (edit) SARS-CoV-2 (edit) 10.1007/S10989-021-10214-Y 33867899
2021-04-09 Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation (edit) SARS-CoV-2 (edit) 10.1007/S12250-021-00369-9 33835389
2021-04-09 The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial (edit) SARS-CoV-2 (edit) 10.1016/J.VACCINE.2021.04.006 33875266
2021-04-09 SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00675-9 33844963
2021-04-09 Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir (edit) SARS-CoV-2 (edit) 10.1021/ACSPTSCI.1C00022 33855277
2021-04-09 GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22297-8 33837182
2021-04-09 IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22449-W 33837219
2021-04-09 Seroprevalence of SARS-CoV-2 following the largest initial epidemic wave in the United States: Findings from New York City, May 13-July 21, 2020 (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAB200 33836067
2021-04-09 Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report (edit) SARS-CoV-2 (edit) 10.1097/MD.0000000000025352 33832113
2021-04-09 Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry (edit) SARS-CoV-2 (edit) 10.1101/2021.04.08.438924
2021-04-09 In Silico Analysis of High-Risk Missense Variants in Human ACE2 Gene and Susceptibility to SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1155/2021/6685840 33884270
2021-04-09 Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009501 33836016
2021-04-09 Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles (edit) SARS-CoV-2 (edit) 10.3390/CELLS10040853 33918600
2021-04-09 The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells (edit) SARS-CoV-2 (edit) 10.3390/V13040645 33918599
2021-04-09 Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs (edit) SARS-CoV-2 (edit) 10.3791/62379
2021-04-09 Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.66815 33835028
2021-04-08 Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain (edit) SARS-CoV-2 (edit) 10.1021/ACSMEDCHEMLETT.0C00684 33850605
2021-04-08 Inhibition of SARS-CoV-2 polymerase by nucleotide analogs: a single molecule perspective (edit) SARS-CoV-2 (edit) 10.1101/2020.08.06.240325 33851161
2021-04-08 Survival of SARS-CoV-2 on Clothing Materials (edit) SARS-CoV-2 (edit) 10.1155/2021/6623409 33927762
2021-04-08 High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009431 33831133
2021-04-08 Determining the communicable period of SARS-CoV-2: A rapid review of the literature, March to September 2020 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.14.2001506 33834961
2021-04-08 Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.11232 33889450
2021-04-07 Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19? (edit) SARS-CoV-2 (edit) 10.1007/S10067-021-05724-5 33826045
2021-04-07 Temperature effect on the SARS-CoV-2: A molecular dynamics study of the spike homotrimeric glycoprotein (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.03.037 33841750
2021-04-07 The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling (edit) SARS-CoV-2 (edit) 10.1101/2021.04.06.438552
2021-04-07 SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation (edit) SARS-CoV-2 (edit) 10.1126/SCIIMMUNOL.ABG0833 33827897
2021-04-07 Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009499 33826681
2021-04-06 SARS-CoV-2 Viral Variants—Tackling a Moving Target (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.2088
2021-04-06 ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility (edit) SARS-CoV-2 (edit) 10.1002/JMV.26953 33755203
2021-04-06 Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108940 33784499
2021-04-06 Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108950 33794145
2021-04-06 Optical Tracking of the Interfacial Dynamics of Single SARS-CoV-2 Pseudoviruses (edit) SARS-CoV-2 (edit) 10.1021/ACS.EST.0C06962 33566596
2021-04-06 Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00256-3 33824288
2021-04-06 Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2103022
2021-04-06 Circadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 Mpro for pharmacological interventions in COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1080/07420528.2021.1903027 33820462
2021-04-06 On the many advantages of using the VariantExperiment class to store, exchange and analyze SARS-CoV-2 genomic data and associated metadata (edit) SARS-CoV-2 (edit) 10.1101/2021.04.05.438328
2021-04-06 The Up state of the SARS-COV-2 Spike homotrimer favors an increased virulence for new variants (edit) SARS-CoV-2 (edit) 10.1101/2021.04.05.438465
2021-04-06 In silico investigation of the viroporin E as a vaccine target against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1152/AJPLUNG.00443.2020 33822639
2021-04-06 Sars-Cov-2 Wastewater Surveillance for Public Health Action: Connecting Perspectives From Wastewater Researchers and Public Health Officials During a Global Pandemic (edit) SARS-CoV-2 (edit) 10.20944/PREPRINTS202104.0167.V1
2021-04-06 Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/CELLS10040821 33917481
2021-04-05 In silico approach to understand the epigenetic mechanism of SARS-CoV-2 and its impact on the environment (edit) SARS-CoV-2 (edit) 10.1007/S13337-021-00655-W 33842674
2021-04-05 AutoVEM: An automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.04.002 33841748
2021-04-05 Repositioning of histamine H receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2 (edit) SARS-CoV-2 (edit) 10.1016/J.EJPHAR.2021.173897 33497607
2021-04-05 Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.PATTER.2021.100247 33842903
2021-04-05 SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4 (edit) SARS-CoV-2 (edit) 10.1084/JEM.20201387 33533916
2021-04-05 Persistent cellular immunity to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1084/JEM.20202515 33533915
2021-04-05 Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination (edit) SARS-CoV-2 (edit) 10.1101/2021.04.01.21252379
2021-04-05 Differences in the concentration of anti-SARS-CoV-2 IgG antibodies as a result of post-covid or/and post-vaccination immunization (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-388040/V1
2021-04-05 Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study (edit) SARS-CoV-2 (edit) 10.3329/IMCJMS.V14I2.52826
2021-04-05 Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.11117 33868814
2021-04-04 Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN (edit) SARS-CoV-2 (edit) 10.1101/2021.04.02.438274 33821277
2021-04-03 Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.061 33891875
2021-04-03 Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases (edit) SARS-CoV-2 (edit) 10.1016/J.EJPHAR.2021.174082 33823185
2021-04-03 A Public Health Antibody Screening Indicates a Marked Increase of SARS-CoV-2 Exposure Rate in Children during the Second Wave (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2021.03.019 33842906
2021-04-03 Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression (edit) SARS-CoV-2 (edit) 10.1016/J.YEXCR.2021.112594 33823179
2021-04-02 Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations (edit) SARS-CoV-2 (edit)
2021-04-02 Virtual Screening of Peptides with High Affinity for SARS-CoV-2 Main Protease (edit) SARS-CoV-2 (edit)
2021-04-02 Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein (edit) SARS-CoV-2 (edit)
2021-04-02 Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104823 33819681
2021-04-02 In silico characterization of mutations circulating in SARS-CoV-2 structural proteins (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1908170 33797336
2021-04-02 Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics (edit) SARS-CoV-2 (edit) 10.1186/S43141-021-00152-Z 33797663
2021-04-02 Can the SARS-CoV-2 virus damage human hearing and balance? (edit) SARS-CoV-2 (edit) 10.13075/MP.5893.01083
2021-04-02 Rapid Spread of SARS-CoV-2 in a State Prison After Introduction by Newly Transferred Incarcerated Persons — Wisconsin, August 14–October 22, 2020 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7013A4 33793462
2021-04-01 Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes (edit) SARS-CoV-2 (edit)
2021-04-01 Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.7746 33900399
2021-04-01 SARS-CoV-2 myopathy (edit) SARS-CoV-2 (edit) 10.1002/JMV.26550 32975824
2021-04-01 Crystallographic molecular replacement using an in silico-generated search model of SARS-CoV-2 ORF8 (edit) SARS-CoV-2 (edit) 10.1002/PRO.4050 33625752
2021-04-01 Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission (edit) SARS-CoV-2 (edit) 10.1002/VETR.247 33890314
2021-04-01 Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release (edit) SARS-CoV-2 (edit) 10.1007/S00018-020-03745-Y 33449149
2021-04-01 Sequencing of SARS-CoV-2 genome using different nanopore chemistries (edit) SARS-CoV-2 (edit) 10.1007/S00253-021-11250-W 33792750
2021-04-01 Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review (edit) SARS-CoV-2 (edit) 10.1007/S00296-021-04794-7 33543338
2021-04-01 Anticoagulant treatment in COVID-19: a narrative review (edit) SARS-CoV-2 (edit) 10.1007/S11239-020-02242-0 32809158
2021-04-01 Homeschooling during the SARS-CoV-2 pandemic: the role of students’ trait self-regulation and task attributes of daily learning tasks for students’ daily self-regulation (edit) SARS-CoV-2 (edit) 10.1007/S11618-021-01011-W
2021-04-01 H, C and N backbone chemical shift assignments of SARS-CoV-2 nsp3a (edit) SARS-CoV-2 (edit) 10.1007/S12104-020-10001-8 33475934
2021-04-01 The highly flexible disordered regions of the SARS-CoV-2 nucleocapsid N protein within the 1-248 residue construct: sequence-specific resonance assignments through NMR (edit) SARS-CoV-2 (edit) 10.1007/S12104-021-10009-8 33660218
2021-04-01 Epidemiology of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S15010-020-01531-3 33034020
2021-04-01 What we have to know about corticosteroids use during Sars-Cov-2 infection (edit) SARS-CoV-2 (edit) 10.1007/S40618-020-01384-5 32860209
2021-04-01 Use of Powered Air-Purifying Respirator(PAPR) as part of protective equipment against SARS-CoV-2-a narrative review and critical appraisal of evidence (edit) SARS-CoV-2 (edit) 10.1016/J.AJIC.2020.11.009 33186678
2021-04-01 SARS-CoV-2 transmission via aquatic food animal species or their products: A review (edit) SARS-CoV-2 (edit) 10.1016/J.AQUACULTURE.2021.736460
2021-04-01 The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators (edit) SARS-CoV-2 (edit) 10.1016/J.BIOPHA.2021.111228 33454595
2021-04-01 Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures (edit) SARS-CoV-2 (edit) 10.1016/J.BIOS.2021.112969 33434780
2021-04-01 Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis (edit) SARS-CoV-2 (edit) 10.1016/J.CBI.2021.109420 33609497
2021-04-01 In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.008 33636127
2021-04-01 Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.026 33691139
2021-04-01 N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.028 33761326
2021-04-01 Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.04.033 33974910
2021-04-01 Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108959 33811811
2021-04-01 Coronavirus entry: how we arrived at SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.COVIRO.2021.02.006 33744490
2021-04-01 Considerations for the Discovery and Development of 3-Chymotrypsin-Like Cysteine Protease Inhibitors Targeting SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1016/J.COVIRO.2021.04.006 34029993
2021-04-01 Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.CYTOGFR.2020.08.002 32948440
2021-04-01 SARS-CoV-2: Targeted managements and vaccine development (edit) SARS-CoV-2 (edit) 10.1016/J.CYTOGFR.2020.11.001 33293238
2021-04-01 Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors (edit) SARS-CoV-2 (edit) 10.1016/J.CYTOGFR.2021.01.003 33608189
2021-04-01 SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders (edit) SARS-CoV-2 (edit) 10.1016/J.CYTOGFR.2021.02.002
2021-04-01 Polyphenols as promising biologically active substances for preventing SARS-CoV-2: A review with research evidence and underlying mechanisms (edit) SARS-CoV-2 (edit) 10.1016/J.FBIO.2021.100891
2021-04-01 Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020 (edit) SARS-CoV-2 (edit) 10.1016/J.IJID.2021.02.026 33578010
2021-04-01 SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102295 33718825
2021-04-01 Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation (edit) SARS-CoV-2 (edit) 10.1016/J.IT.2021.02.003 33622601
2021-04-01 SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis (edit) SARS-CoV-2 (edit) 10.1016/J.JACBTS.2021.01.002 33681537
2021-04-01 Intraventricular Conundrum in a SARS-CoV-2–Positive Patient With Elevated Biomarkers of Myocardial Injury (edit) SARS-CoV-2 (edit) 10.1016/J.JACCAS.2021.01.030
2021-04-01 Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.1016/J.JHIN.2020.12.022 33453351
2021-04-01 Genotype and phenotype of COVID-19: Their roles in pathogenesis (edit) SARS-CoV-2 (edit) 10.1016/J.JMII.2020.03.022 32265180
2021-04-01 SARS-CoV-2 host diversity: An update of natural infections and experimental evidence (edit) SARS-CoV-2 (edit) 10.1016/J.JMII.2020.06.006 32624360
2021-04-01 SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis (edit) SARS-CoV-2 (edit) 10.1016/J.LFS.2021.119124 33508291
2021-04-01 Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2020.104490 32745811
2021-04-01 Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104736 33516969
2021-04-01 Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110529
2021-04-01 Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication (edit) SARS-CoV-2 (edit) 10.1016/J.MOLCEL.2021.01.035 33631104
2021-04-01 SARS-CoV-2 infection leading to ischemic and hemorrhagic brain lesions and acute respiratory distress syndrome (edit) SARS-CoV-2 (edit) 10.1016/J.RADCR.2021.01.025 33520045
2021-04-01 SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip (edit) SARS-CoV-2 (edit) 10.1016/J.SCIB.2020.11.015 33282445
2021-04-01 Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.02.019 33852884
2021-04-01 Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution (edit) SARS-CoV-2 (edit) 10.1016/J.VIROL.2020.12.018 33545556
2021-04-01 The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198350 33626380
2021-04-01 Ten scientific reasons in support of airborne transmission of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00869-2
2021-04-01 Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00146-8 33857405
2021-04-01 Coronavirus from cities to forests: mapping vulnerable interfaces and hotspots for SARS-CoV-2 spillover from humans to biodiversity (edit) SARS-CoV-2 (edit) 10.1016/S2542-5196(21)00099-1
2021-04-01 On the origin and evolution of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S12276-021-00604-Z 33864026
2021-04-01 The mA methylome of SARS-CoV-2 in host cells (edit) SARS-CoV-2 (edit) 10.1038/S41422-020-00465-7 33510385
2021-04-01 Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review (edit) SARS-CoV-2 (edit) 10.1038/S41440-020-00604-Y 33469197
2021-04-01 Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22362-2 33795671
2021-04-01 ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity (edit) SARS-CoV-2 (edit) 10.1038/S41564-021-00884-1 33727702
2021-04-01 Effects of pancreatic SARS-CoV-2 infection identified (edit) SARS-CoV-2 (edit) 10.1038/S41574-021-00481-6 33627835
2021-04-01 Potential intestinal infection and faecal-oral transmission of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41575-021-00416-6 33589829
2021-04-01 Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01294-W 33664494
2021-04-01 Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-86471-0 33795718
2021-04-01 G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19) (edit) SARS-CoV-2 (edit) 10.1080/10715762.2020.1866757 33401987
2021-04-01 SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19 (edit) SARS-CoV-2 (edit) 10.1080/13543776.2021.1880568 33475441
2021-04-01 Short Communication:Evidence of Novel SARS-CoV-2 Variants Circulation in Romania (edit) SARS-CoV-2 (edit) 10.1089/AID.2021.0009
2021-04-01 The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses (edit) SARS-CoV-2 (edit) 10.1089/VIM.2020.0174
2021-04-01 Estimating the strength of selection for new SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1101/2021.03.29.21254233 33821289
2021-04-01 SARS-CoV-2 immune evasion by variant B.1.427/B.1.429 (edit) SARS-CoV-2 (edit) 10.1101/2021.03.31.437925 33821281
2021-04-01 Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry (edit) SARS-CoV-2 (edit) 10.1101/2021.03.31.437960 33821268
2021-04-01 Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein (edit) SARS-CoV-2 (edit) 10.1101/2021.04.01.438120 33821278
2021-04-01 Infection control in dental health care during and after the SARS-CoV-2 outbreak (edit) SARS-CoV-2 (edit) 10.1111/ODI.13408 32391651
2021-04-01 Gastrointestinal and Renal Complications in SARS-CoV-2-Infected Patients: Role of Immune System (edit) SARS-CoV-2 (edit) 10.1111/SJI.12999 33190306
2021-04-01 Hearing disorders secondary to infection with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1121/10.0005350
2021-04-01 The SARS-CoV-2 Spike variant D614G favors an open conformational state (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABF3671 33863729
2021-04-01 Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABF8711 33853786
2021-04-01 Safety and Impact of Nasal Lavages During Viral Infections Such as SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1177/0145561320950491 32853040
2021-04-01 Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature (edit) SARS-CoV-2 (edit) 10.1177/0145561320953231 32865458
2021-04-01 Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins ‒ A new frontier (edit) SARS-CoV-2 (edit) 10.1177/1535370220986785 33467896
2021-04-01 Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing (edit) SARS-CoV-2 (edit) 10.1289/EHP7886 33793301
2021-04-01 Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001216 33914730
2021-04-01 Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001237 33914735
2021-04-01 Computational epitope map of SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1008790 33793546
2021-04-01 The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (edit) Human coronavirus 229E (edit) 10.1371/JOURNAL.PPAT.1009500 33886690
2021-04-01 The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (edit) MERS-CoV (edit) 10.1371/JOURNAL.PPAT.1009500 33886690
2021-04-01 The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009500 33886690
2021-04-01 SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review (edit) SARS-CoV-2 (edit) 10.18502/IJPH.V50I4.5991 34183916
2021-04-01 Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach (edit) SARS-CoV-2 (edit) 10.2217/FVL-2020-0342
2021-04-01 SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.15.2001695 33860747
2021-04-01 Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.16.2100348 33890566
2021-04-01 What are the agent (Covid-19 virus) factors responsible for continuation & recurrence of SARS-CoV-2/ Covid -19? How does environmental and host factors of epidemiological triad do influence ongoing pandemic? (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/T8NYX
2021-04-01 Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva (edit) SARS-CoV-2 (edit) 10.3201/EID2704.204199 33754989
2021-04-01 Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples (edit) SARS-CoV-2 (edit) 10.3201/EID2704.204200 33755009
2021-04-01 Characteristics of SARS-CoV-2 transmission among meat processing workers in Nebraska, USA, and effectiveness of risk mitigation measures (edit) SARS-CoV-2 (edit) 10.3201/EID2704.204800 33591249
2021-04-01 Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy (edit) SARS-CoV-2 (edit) 10.3201/EID2704.210183 33567246
2021-04-01 Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9040320
2021-04-01 Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation (edit) SARS-CoV-2 (edit) 10.4110/IN.2021.21.E16 33996172
2021-03-31 Simultaneous detection and mutation surveillance of SARS-CoV-2 and multiple respiratory viruses by rapid field-deployable sequencing (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2021.03.015 33821249
2021-03-31 Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients? (edit) SARS-CoV-2 (edit) 10.1111/TID.13602 33728702
2021-03-31 SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PNTD.0009254 33788840
2021-03-31 Structural basis for SARS-CoV-2 envelope protein in recognition of human cell junction protein PALS1 (edit) SARS-CoV-2 (edit) 10.2210/PDB7M4R/PDB
2021-03-31 A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2021.636647 33869283
2021-03-31 Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification (edit) SARS-CoV-2 (edit) 10.3791/62295
2021-03-30 WHO-convened Global Study of Origins of SARS-CoV-2: China Part (edit) SARS-CoV-2 (edit)
2021-03-30 An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (edit) SARS-CoV-2 (edit) 10.1002/MINF.202000187 33787066
2021-03-30 TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.051 33836156
2021-03-30 Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00248-3 33785729
2021-03-30 SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22210-3 33785765
2021-03-30 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2 Pandemic era does influence RCH Programme? Immunisa (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-348841/V4
2021-03-29 The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis (edit) SARS-CoV-2 (edit) 10.1007/S43440-021-00245-Z 33779964
2021-03-29 Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay (edit) SARS-CoV-2 (edit) 10.1016/J.BIOORG.2021.104862 33862474
2021-03-29 Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.03.023 33794152
2021-03-29 SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.03.024 33794150
2021-03-29 Exploring the effectiveness of the TSR-based protein 3-D structural comparison method for protein clustering, and structural motif identification and discovery of protein kinases, hydrolases, and SARS-CoV-2’s protein via the application of amino aci (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107479
2021-03-29 Network-based virus-host interaction prediction with application to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.PATTER.2021.100242 33817672
2021-03-29 The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21953-3 33782395
2021-03-29 A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22045-Y 33782398
2021-03-29 Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03471-W
2021-03-29 Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01316-7 33782619
2021-03-29 SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates (edit) SARS-CoV-2 (edit) 10.1101/2021.03.26.21254394
2021-03-29 Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001158 33780434
2021-03-29 Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19) (edit) SARS-CoV-2 (edit) 10.2215/CJN.16281020 33782033
2021-03-29 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2 Pandemic era does influence RCH Programme?  Immunisation? (edit) SARS-CoV-2 (edit) 10.22541/AU.161705127.75041334/V1
2021-03-29 Antiviral Essential Oil Components Against SARS-CoV-2 in Pre-procedural Mouth Rinses for Dental Settings During COVID-19: A Computational Study (edit) SARS-CoV-2 (edit) 10.3389/FCHEM.2021.642026 33855010
2021-03-28 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme (Immunisation, Maternal Health, Family Planning) of Andhra Pradesh in India over the 3 months after nationwide Lock down announcement in March 2020? Immunisa (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/DPHGA
2021-03-28 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Uttar Pradesh in India over the 3 months after nationwide Lock down announcement in March 2020? Immunisation? Maternal Health? Family Planning? (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/GS8Q2
2021-03-28 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2Pandemic era does influence RCH Programme? Immunisat (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/N45FR
2021-03-28 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2 Pandemic era does influence RCH Programme? (edit) SARS-CoV-2 (edit) 10.31219/OSF.IO/VJZHR
2021-03-27 Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00558-8 33774649
2021-03-27 The nucleotide addition cycle of the SARS-CoV-2 polymerase (edit) SARS-CoV-2 (edit) 10.1101/2021.03.27.437309 33791706
2021-03-26 Q106488914 (edit) SARS-CoV-2 (edit)
2021-03-26 Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S13238-021-00832-Z 33770364
2021-03-26 In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2) (edit) SARS-CoV-2 (edit) 10.1016/J.EJPS.2021.105820 33775827
2021-03-26 Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers (edit) SARS-CoV-2 (edit) 10.1016/J.JINF.2021.03.019 33775704
2021-03-26 SARS-CoV-2: Cross-scale Insights from Ecology and Evolution (edit) SARS-CoV-2 (edit) 10.1016/J.TIM.2021.03.013 33893024
2021-03-26 Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01318-5
2021-03-26 Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB263
2021-03-26 Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface (edit) SARS-CoV-2 (edit) 10.1101/2021.03.24.21253587
2021-03-26 D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1: An in silico Study (edit) SARS-CoV-2 (edit) 10.1101/2021.03.26.437194
2021-03-26 SARS-CoV-2 M inhibitors with antiviral activity in a transgenic mouse model (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF1611 33602867
2021-03-26 Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0243265 33770098
2021-03-26 Low SARS-CoV-2 transmission in elementary schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7012E3 33764967
2021-03-26 Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7012E4 33764961
2021-03-26 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-348841/V2
2021-03-26 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-348841/V3
2021-03-26 Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure (edit) SARS-CoV-2 (edit) 10.3390/V13040562 33810401
2021-03-25 In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV (edit) SARS-CoV-2 (edit) 10.1007/S13721-021-00299-2 33786291
2021-03-25 SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22166-4 33767183
2021-03-25 The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization (edit) SARS-CoV-2 (edit) 10.1038/S41541-021-00313-8 33767200
2021-03-25 Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03470-X
2021-03-25 In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-86380-2 33767306
2021-03-25 Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-86452-3 33767292
2021-03-25 Freely accessible ready to use global infrastructure for SARS-CoV-2 monitoring (edit) SARS-CoV-2 (edit) 10.1101/2021.03.25.437046 33791701
2021-03-25 Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses (edit) SARS-CoV-2 (edit) 10.1101/2021.03.25.437060 33791708
2021-03-25 The emerging plasticity of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG4493
2021-03-25 mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG9175 33766944
2021-03-25 Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.1186/S12865-021-00412-0 33765919
2021-03-25 Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment (edit) SARS-CoV-2 (edit) 10.1186/S13578-021-00567-8 33766136
2021-03-25 Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor (edit) SARS-CoV-2 (edit) 10.1186/S13578-021-00568-7 33766124
2021-03-25 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Uttar Pradesh in India over the 3 months after nationwide Lockdown announcement in March 2020 -A brief analysis (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-350287/V1
2021-03-25 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-360551/V1
2021-03-25 AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.602196 33841493
2021-03-25 Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data (edit) SARS-CoV-2 (edit) 10.3389/FRAI.2021.630955 33842877
2021-03-25 Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells (edit) SARS-CoV-2 (edit) 10.3390/V13040551 33806155
2021-03-24 Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104815 33774178
2021-03-24 Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions (edit) SARS-CoV-2 (edit) 10.1021/ACS.NANOLETT.0C04465 33474931
2021-03-24 Inhibition of HECT E3 ligases as potential therapy for COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41419-021-03513-1 33762578
2021-03-24 A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases (edit) SARS-CoV-2 (edit) 10.1039/D0RA10458B 35423778
2021-03-24 Dimeric form of SARS-CoV-2 polymerase (edit) SARS-CoV-2 (edit) 10.1101/2021.03.23.436644
2021-03-24 B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.03.24.436620 33791698
2021-03-24 Arginine Methylation Regulates SARS-CoV-2 Nucleocapsid Protein Function and Viral Replication (edit) SARS-CoV-2 (edit) 10.1101/2021.03.24.436822
2021-03-24 SARS-CoV-2 variants reveal features critical for replication in primary human cells (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001006 33760807
2021-03-23 Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review (edit) SARS-CoV-2 (edit) 33757133
2021-03-23 The effect of spike mutations on SARS-CoV-2 neutralization (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108890 33713594
2021-03-23 Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design (edit) SARS-CoV-2 (edit) 10.1016/J.CSBJ.2021.03.021 33777333
2021-03-23 SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin (edit) SARS-CoV-2 (edit) 10.1016/J.GENE.2021.145596 33766711
2021-03-23 Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study (edit) SARS-CoV-2 (edit) 10.1016/S2666-5247(21)00025-2 33778792
2021-03-23 SARS-CoV-2 cell tropism and multiorgan infection (edit) SARS-CoV-2 (edit) 10.1038/S41421-021-00249-2 33758165
2021-03-23 Double insult: flu bug enhances SARS-CoV-2 infectivity (edit) SARS-CoV-2 (edit) 10.1038/S41422-021-00498-6
2021-03-23 Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2019034118 33798095
2021-03-23 Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2025373118 33658332
2021-03-23 Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro (edit) SARS-CoV-2 (edit) 10.1101/2021.03.22.436379
2021-03-23 Characterization and functional interrogation of SARS-CoV-2 RNA interactome (edit) SARS-CoV-2 (edit) 10.1101/2021.03.23.436611
2021-03-23 Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases (edit) SARS-CoV-2 (edit) 10.1136/ANNRHEUMDIS-2021-220289
2021-03-23 What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-348841/V1
2021-03-23 SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.629185 33833755
2021-03-23 Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing (edit) SARS-CoV-2 (edit) 10.3390/V13030532 33807095
2021-03-22 Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays (edit) SARS-CoV-2 (edit) 10.1016/J.DIAGMICROBIO.2021.115382 33930691
2021-03-22 SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22034-1 33753738
2021-03-22 Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAA232 33147627
2021-03-22 Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAA419 33458747
2021-03-22 Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAB026 33611340
2021-03-22 Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1101/2021.03.19.21253964 33791719
2021-03-22 Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.03.22.436468 33791702
2021-03-22 Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area (edit) SARS-CoV-2 (edit) 10.1172/JCI.INSIGHT.144350 33749660
2021-03-22 A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.653189 33828563
2021-03-22 A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/GENES12030450 33809949
2021-03-22 Why Does SARS-CoV-2 Infection Induce Autoantibody Production? (edit) SARS-CoV-2 (edit) 10.3390/PATHOGENS10030380 33809954
2021-03-22 Stand on the Same Side Against Covid – 19: Ics-Containing Products in Treatment Covid-19 Patients with Asthma and COPD (edit) SARS-CoV-2 (edit) 10.36253/SUBSTANTIA-1234
2021-03-20 SARS-CoV-2 in hospital wastewater during outbreak of COVID-19: A review on detection, survival and disinfection technologies (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2020.143192 33153744
2021-03-20 Indels in SARS-CoV-2 occur at template-switching hotspots (edit) SARS-CoV-2 (edit) 10.1186/S13040-021-00251-0 33743803
2021-03-20 SARS-CoV-2 Detection in Fecal Sample from a Patient with Typical Findings of COVID-19 Pneumonia on CT but Negative to Multiple SARS-CoV-2 RT-PCR Tests on Oropharyngeal and Nasopharyngeal Swab Samples (edit) SARS-CoV-2 (edit) 10.3390/MEDICINA57030290 33804646
2021-03-19 Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis (edit) SARS-CoV-2 (edit) 10.1001/JAMANEUROL.2021.0688
2021-03-19 RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.01.013 33545635
2021-03-19 Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102151 33585804
2021-03-19 Expression and purification of tag-free SARS-CoV-2 RNA-dependent RNA polymerase in (edit) SARS-CoV-2 (edit) 10.1016/J.XPRO.2021.100357 33558863
2021-03-19 Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21972-0 33741941
2021-03-19 Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21992-W
2021-03-19 Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-22036-Z
2021-03-19 Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42004-021-00476-4 34189273
2021-03-19 Self-Collected Saline Gargle Samples as an Alternative to Health Care Worker-Collected Nasopharyngeal Swabs for COVID-19 Diagnosis in Outpatients (edit) SARS-CoV-2 (edit) 10.1128/JCM.02427-20 33514627
2021-03-19 Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay (edit) SARS-CoV-2 (edit) 10.1128/JCM.03077-20 33441395
2021-03-19 SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009374 33740028
2021-03-19 OverCOVID: an integrative web portal for SARS-CoV-2 bioinformatics resources (edit) SARS-CoV-2 (edit) 10.1515/JIB-2020-0046 33735949
2021-03-19 Minimal SARS-CoV-2 Transmission After Implementation of a Comprehensive Mitigation Strategy at a School - New Jersey, August 20-November 27, 2020 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7011A2 33735161
2021-03-19 TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells (edit) SARS-CoV-2 (edit) 10.18632/AGING.202718 33744846
2021-03-19 Exaptation of Retroviral Syncytin for Development of Syncytialized Placenta, Its Limited Homology to the SARS-CoV-2 Spike Protein and Arguments against Disturbing Narrative in the Context of COVID-19 Vaccination (edit) SARS-CoV-2 (edit) 10.3390/BIOLOGY10030238 33808658
2021-03-19 Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) (edit) SARS-CoV-2 (edit) 10.3390/BIOM11030460
2021-03-19 High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and Children (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS9030642 33808815
2021-03-18 Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83737-5 33737523
2021-03-18 Extracellular vimentin as a target against SARS-CoV-2 host cell invasion (edit) SARS-CoV-2 (edit) 10.1101/2021.01.08.425793 33442680
2021-03-18 Identification of guanylyltransferase activity in the SARS-CoV-2 RNA polymerase (edit) SARS-CoV-2 (edit) 10.1101/2021.03.17.435913
2021-03-18 The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice (edit) SARS-CoV-2 (edit) 10.1101/2021.03.18.436013
2021-03-18 Timing the SARS-CoV-2 index case in Hubei province (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF8003
2021-03-18 AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19 (edit) SARS-CoV-2 (edit) 10.1128/AAC.02479-20 33558299
2021-03-18 Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis (edit) SARS-CoV-2 (edit) 10.1159/000515342 33735872
2021-03-18 A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0248553 33735271
2021-03-18 Sialic acid-Dependent Binding and Viral Entry of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-318912/V1
2021-03-17 Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.146400 33794459
2021-03-17 Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00575-4
2021-03-17 Transmission dynamics and timing of key events for SARS-CoV-2 infection in healthcare workers (edit) SARS-CoV-2 (edit) 10.1080/23744235.2021.1900599
2021-03-17 The Effects of Social Distancing Policies on Non-SARS-CoV-2 Respiratory Pathogens (edit) SARS-CoV-2 (edit) 10.1093/OFID/OFAB133
2021-03-17 SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway (edit) SARS-CoV-2 (edit) 10.1101/2021.03.16.435700 33758854
2021-03-17 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection (edit) SARS-CoV-2 (edit) 10.1128/CMR.00133-20 33441314
2021-03-17 Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0248061 33730022
2021-03-17 Circular RNA-MicroRNA-MRNA interaction predictions in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1515/JIB-2020-0047 33725751
2021-03-17 Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19 (edit) SARS-CoV-2 (edit) 10.3389/FMICB.2021.637430 33815323
2021-03-17 Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence (edit) SARS-CoV-2 (edit) 10.3390/IJMS22063059 33802761
2021-03-17 SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity (edit) SARS-CoV-2 (edit) 10.3390/IJMS22063060 33802729
2021-03-17 SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study (edit) SARS-CoV-2 (edit) 10.3390/V13030494 33802857
2021-03-16 SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.2294
2021-03-16 Tackling SARS-CoV-2 Infections using Remdesivir and Favipiravir as Therapeutic Options (edit) SARS-CoV-2 (edit) 10.1002/CBIC.202000595 33031623
2021-03-16 Neuropsychiatric Complications of COVID-19 (edit) SARS-CoV-2 (edit) 10.1007/S11920-021-01237-9 33725218
2021-03-16 Ca-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.02.023 33631204
2021-03-16 BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.026 33811809
2021-03-16 Metabolic programs define dysfunctional immune responses in severe COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108863 33691089
2021-03-16 Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.1C00363 33748632
2021-03-16 Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03431-4
2021-03-16 Clinical Predictors of SARS-CoV-2 Testing Pressure on Clinical Laboratories: A Multinational Study Analyzing Google Trends and Over 100 Million Diagnostic Tests (edit) SARS-CoV-2 (edit) 10.1093/LABMED/LMAB013
2021-03-16 Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry (edit) SARS-CoV-2 (edit) 10.1177/24725552211000652
2021-03-16 Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids (edit) SARS-CoV-2 (edit) 10.1186/S40246-021-00316-5 33726831
2021-03-16 Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.599261 33796130
2021-03-16 Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.597399 33796097
2021-03-15 Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing (edit) SARS-CoV-2 (edit) 10.1007/S00705-021-04986-3 33723631
2021-03-15 The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.BIOS.2020.112905 33358285
2021-03-15 Global and local mutations in Bangladeshi SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1016/J.VIRUSRES.2021.198390 33737154
2021-03-15 Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00515-5 33723219
2021-03-15 SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21903-Z 33723254
2021-03-15 Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03426-1
2021-03-15 The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-85049-0 33723270
2021-03-15 The local and systemic response to SARS-CoV-2 infection in children and adults (edit) SARS-CoV-2 (edit) 10.1101/2021.03.09.21253012
2021-03-15 SARS-CoV-2 Nsp8 N-terminal domain dimerizes and harbors autonomously folded elements (edit) SARS-CoV-2 (edit) 10.1101/2021.03.12.435186
2021-03-15 A map of binary SARS-CoV-2 protein interactions implicates host immune regulation and ubiquitination (edit) SARS-CoV-2 (edit) 10.1101/2021.03.15.433877
2021-03-15 Structure, Mechanism and Crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase (edit) SARS-CoV-2 (edit) 10.1101/2021.03.15.435326
2021-03-15 Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data (edit) SARS-CoV-2 (edit) 10.1101/GR.268110.120 33722935
2021-03-15 Repurposing of thalidomide and its derivatives for the treatment of SARS-coV-2 infections: Hints on molecular action (edit) SARS-CoV-2 (edit) 10.1111/BCP.14792 33609410
2021-03-15 Disinfection of Contaminated Heritage Surfaces from SARS-CoV-2 Virus (edit) SARS-CoV-2 (edit) 10.5334/JCMS.209
2021-03-14 Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex (edit) SARS-CoV-2 (edit) 10.1101/2021.03.13.435256 33758867
2021-03-13 A SARS-CoV-2 -human metalloproteome interaction map (edit) SARS-CoV-2 (edit) 10.1016/J.JINORGBIO.2021.111423 33813307
2021-03-12 Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108915 33761319
2021-03-12 SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2020.12.010 33521748
2021-03-12 Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis (edit) SARS-CoV-2 (edit) 10.1038/S41419-021-03527-9 33712574
2021-03-12 Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21361-7 33712587
2021-03-12 SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21918-6 33712573
2021-03-12 Compounds of plants with activity against SARS-CoV-2 targets (edit) SARS-CoV-2 (edit) 10.1080/17512433.2021.1903317
2021-03-12 Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice (edit) SARS-CoV-2 (edit) 10.1101/2021.03.09.434696
2021-03-12 Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity (edit) SARS-CoV-2 (edit) 10.1101/2021.03.11.435037 33758838
2021-03-12 Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF6950 33536258
2021-03-12 Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG6105 33514629
2021-03-12 Immunity to SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG7404
2021-03-12 Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1158/1557-3265.COVID-19-21-S03-03
2021-03-12 Experimental Analysis of Structures for Trapping SARS-CoV-2-Related Floating Waste in Rivers (edit) SARS-CoV-2 (edit) 10.3390/W13060771
2021-03-12 Factors affecting SARS-CoV-2 (COVID-19) Pandemic, including Zoonotic, Human Transmission and Chain of Infection. Reducing Public health Risk by Serum Antibody Testing, Avoiding Screening in Unhygienic Places and False PCR Reporting. A Scientific Revi (edit) SARS-CoV-2 (edit) 10.53986/IBJM.2021.0023
2021-03-11 Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7 (edit) SARS-CoV-2 (edit) 33704818
2021-03-11 Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia (edit) SARS-CoV-2 (edit) 10.1016/J.INTIMP.2021.107522 33735712
2021-03-11 Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen (edit) SARS-CoV-2 (edit) 10.1021/ACSPTSCI.0C00216
2021-03-11 SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00509-3 33707416
2021-03-11 Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21767-3 33707453
2021-03-11 Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03412-7
2021-03-11 ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 (edit) SARS-CoV-2 (edit) 10.1101/2021.03.11.435000 33758847
2021-03-11 New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1111/FEBS.15815 33705595
2021-03-11 Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon (edit) SARS-CoV-2 (edit) 10.1128/MRA.00093-21
2021-03-11 Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model (edit) SARS-CoV-2 (edit) 10.2147/DDDT.S292805 33737804
2021-03-11 Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19 (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9030243 33799505
2021-03-10 Q106488918 (edit) SARS-CoV-2 (edit)
2021-03-10 Q106489168 (edit) SARS-CoV-2 (edit)
2021-03-10 Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus (edit) SARS-CoV-2 (edit) 10.1007/S13337-021-00665-8 33723515
2021-03-10 Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.01.015 33548198
2021-03-10 Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.02.003 33592168
2021-03-10 The great escape? SARS-CoV-2 variants evading neutralizing responses (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.02.010 33705702
2021-03-10 In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.OMTM.2021.03.003 33723514
2021-03-10 Wastewater surveillance for SARS-CoV-2: Lessons learnt from recent studies to define future applications (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2020.143493 33190883
2021-03-10 Living Donor Hepatectomy After Proven SARS-CoV-2 Infection: First Report of 9 Cases From 3 Centers (edit) SARS-CoV-2 (edit) 10.1097/TP.0000000000003750
2021-03-10 The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.03.09.434607
2021-03-10 Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology (edit) SARS-CoV-2 (edit) 10.3390/V13030447
2021-03-09 Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.1505 33566056
2021-03-09 Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity (edit) SARS-CoV-2 (edit) 10.1016/J.IMMUNI.2021.01.017 33577760
2021-03-09 Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.02.005 33631122
2021-03-09 Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.02.010 33636110
2021-03-09 Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21825-W 33750821
2021-03-09 Detection of a SARS-CoV-2 variant of concern in South Africa (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03402-9
2021-03-09 Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study (edit) SARS-CoV-2 (edit) 10.1039/D0RA10674G 35423530
2021-03-09 Bepridil is potent against SARS-CoV-2 in vitro (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2012201118 33597253
2021-03-09 Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation (edit) SARS-CoV-2 (edit) 10.1101/2021.03.07.21252647 33758899
2021-03-09 Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps (edit) SARS-CoV-2 (edit) 10.1101/2021.03.08.434433 33758858
2021-03-09 Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications (edit) SARS-CoV-2 (edit) 10.3390/V13030439 33803400
2021-03-08 Characterization of the bioaerosol in a natural thermal cave and assessment of the risk of transmission of SARS-CoV-2 virus (edit) SARS-CoV-2 (edit) 10.1007/S10653-021-00870-W 33683533
2021-03-08 Can shellfish be used to monitor SARS-CoV-2 in the coastal environment? (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.146270 33714825
2021-03-08 Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03398-2
2021-03-08 Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41588-021-00805-2 33686287
2021-03-08 The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-84782-W 33686143
2021-03-08 MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-84882-7 33686154
2021-03-08 Long-term monitoring of SARS-CoV-2 RNA in wastewater of the Frankfurt metropolitan area in Southern Germany (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-84914-2 33686189
2021-03-08 De novo3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures (edit) SARS-CoV-2 (edit) 10.1093/NAR/GKAB119 33693814
2021-03-08 SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release (edit) SARS-CoV-2 (edit) 10.1101/2021.03.06.21252796 33758872
2021-03-08 Sialic acid-Dependent Binding and Viral Entry of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.03.08.434228
2021-03-08 A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1008810 33684134
2021-03-08 SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.64330 33683204
2021-03-07 Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2 (edit) SARS-CoV-2 (edit) 10.1002/CTI2.1260 33732459
2021-03-07 Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CLpro through high-throughput virtual screening and molecular dynamics simulation (edit) SARS-CoV-2 (edit) 10.18632/AGING.202703 33678621
2021-03-06 A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOMED.2021.104315 33705994
2021-03-06 REACT-1 round 9 final report: Continued but slowing decline of prevalence of SARS-CoV-2 during national lockdown in England in February 2021 (edit) SARS-CoV-2 (edit) 10.1101/2021.03.03.21252856
2021-03-06 Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens: Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis (edit) SARS-CoV-2 (edit) 10.14302/ISSN.2692-1537.IJCV-21-3756
2021-03-06 COVID-19: A Hypothesis to Prevent SARS-CoV-2 From Entering Respiratory Cells (edit) SARS-CoV-2 (edit) 10.18502/PBR.V6I(S2).5657
2021-03-06 Interactions of SARS-CoV-2 with the Blood–Brain Barrier (edit) SARS-CoV-2 (edit) 10.3390/IJMS22052681 33800954
2021-03-05 The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2021.01.073 33515911
2021-03-05 RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.EJMECH.2021.113201 33524687
2021-03-05 Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E06435 33693066
2021-03-05 A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance (edit) SARS-CoV-2 (edit) 10.1016/J.JHAZMAT.2020.124043 33268203
2021-03-05 The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104800 33677109
2021-03-05 Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21627-0
2021-03-05 IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-01829-4 33674719
2021-03-05 Association between SARS-CoV-2 Transmissibility, Viral Load, and Age in Households (edit) SARS-CoV-2 (edit) 10.1101/2021.02.28.21252608
2021-03-05 Zoonotic spillover of SARS-CoV-2: mink-adapted virus in humans (edit) SARS-CoV-2 (edit) 10.1101/2021.03.05.433713
2021-03-05 Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.03.05.434000 33688654
2021-03-05 Community Transmission of SARS-CoV-2 at Three Fitness Facilities — Hawaii, June–July 2020 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7009E1 33661861
2021-03-05 CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands (edit) SARS-CoV-2 (edit) 10.3390/IJMS22052614 33807682
2021-03-05 Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing (edit) SARS-CoV-2 (edit) 10.5455/JAVAR.2021.H481 33860009
2021-03-04 Saliva for Detection of SARS-CoV-2. Reply (edit) SARS-CoV-2 (edit) 33534974
2021-03-04 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.01.037 33621484
2021-03-04 Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-84850-1 33664446
2021-03-04 Clinical Features of Emergency Department Patients from Early COVID-19 Pandemic that Predict SARS-CoV-2 Infection: Machine-learning Approach (edit) SARS-CoV-2 (edit) 10.5811/WESTJEM.2020.12.49370 33856307
2021-03-03 Q106488966 (edit) SARS-CoV-2 (edit)
2021-03-03 Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104796 33667722
2021-03-03 Viability of SARS-CoV-2 in river water and wastewater at different temperatures and solids content (edit) SARS-CoV-2 (edit) 10.1016/J.WATRES.2021.117002 33714910
2021-03-03 SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.0C05163 33748571
2021-03-03 Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry (edit) SARS-CoV-2 (edit) 10.1021/JACS.1C00353 33657316
2021-03-03 Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections (edit) SARS-CoV-2 (edit) 10.1101/2021.03.02.433156
2021-03-03 Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG3055
2021-03-03 The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A (edit) SARS-CoV-2 (edit) 10.1182/BLOODADVANCES.2020003259 33656534
2021-03-03 A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009328 33657135
2021-03-03 Epithelial response to IFN-γ promotes SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.15252/EMMM.202013191 33544398
2021-03-03 Monitoring of SARS-CoV-2 infection in mustelids (edit) SARS-CoV-2 (edit) 10.2903/J.EFSA.2021.6459 33717355
2021-03-02 SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.1114
2021-03-02 Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108790 33596407
2021-03-02 Risk factors and on-site simulation of environmental transmission of SARS-CoV-2 in the largest wholesale market of Beijing, China (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.146040 33711597
2021-03-02 Diffusion and Relaxation Edited Proton NMR Spectroscopy of Plasma Reveals a High-Fidelity Supramolecular Biomarker Signature of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1021/ACS.ANALCHEM.0C04952 33577736
2021-03-02 Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart (edit) SARS-CoV-2 (edit) 10.1021/ACS.BIOCHEM.1C00046 33569952
2021-03-02 SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01285-X
2021-03-02 Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB198 33675655
2021-03-02 Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02648-20 33653892
2021-03-02 High-Throughput Wastewater SARS-CoV-2 Detection Enables Forecasting of Community Infection Dynamics in San Diego County (edit) SARS-CoV-2 (edit) 10.1128/MSYSTEMS.00045-21 33653938
2021-03-02 New Acaciin-Loaded Self-Assembled Nanofibers as MPro Inhibitors Against BCV as a Surrogate Model for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.2147/IJN.S298900 33688191
2021-03-02 SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response (edit) SARS-CoV-2 (edit) 10.3390/CELLS10030530 33801464
2021-03-02 miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery (edit) SARS-CoV-2 (edit) 10.3390/NCRNA7010018 33801496
2021-03-02 Rapid review of the effects of cloth and medical masks for preventing transmission of SARS-CoV-2 in community and household settings (edit) SARS-CoV-2 (edit) 10.7196/SAMJ.2021.V111I3.15119
2021-03-01 Q106489324 (edit) SARS-CoV-2 (edit)
2021-03-01 Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development (edit) SARS-CoV-2 (edit)
2021-03-01 Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation (edit) SARS-CoV-2 (edit) 33718878
2021-03-01 Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020 (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.1552 33724387
2021-03-01 Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization (edit) SARS-CoV-2 (edit) 10.1002/BTPR.3096 33118327
2021-03-01 Genetic and epigenetic factors associated with increased severity of Covid‐19 (edit) SARS-CoV-2 (edit) 10.1002/CBIN.11572 33590936
2021-03-01 Videotherapy and Therapeutic Alliance in the Age of COVID-19 (edit) SARS-CoV-2 (edit) 10.1002/CPP.2521 33037682
2021-03-01 Management of SARS-CoV-2 Pneumonia (edit) SARS-CoV-2 (edit) 10.1002/JMV.26470 32856728
2021-03-01 Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement in the lethality of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1002/JMV.26570 33002209
2021-03-01 SARS-CoV-2 triggered Takotsubo in 38 patients (edit) SARS-CoV-2 (edit) 10.1002/JMV.26581 33022810
2021-03-01 SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights (edit) SARS-CoV-2 (edit) 10.1002/JOBM.202000537 33460172
2021-03-01 Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review (edit) SARS-CoV-2 (edit) 10.1002/RMV.2162 32964627
2021-03-01 The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus (edit) SARS-CoV-2 (edit) 10.1002/RMV.2171 33350025
2021-03-01 Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review (edit) SARS-CoV-2 (edit) 10.1002/VMS3.394 33210477
2021-03-01 Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis (edit) SARS-CoV-2 (edit) 10.1007/S00134-020-06326-6 33388837
2021-03-01 Fecal-oral transmission of SARS-CoV-2: review of laboratory-confirmed virus in gastrointestinal system (edit) SARS-CoV-2 (edit) 10.1007/S00384-020-03785-7 33057894
2021-03-01 SARS-CoV-2-induced SIADH: a novel cause of hyponatremia (edit) SARS-CoV-2 (edit) 10.1007/S00391-021-01863-1 33649867
2021-03-01 Micronutrients and bioactive compounds in the immunological pathways related to SARS-CoV-2 (adults and elderly) (edit) SARS-CoV-2 (edit) 10.1007/S00394-020-02410-1 33084959
2021-03-01 The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV (edit) SARS-CoV-2 (edit) 10.1007/S00705-021-04958-7 33462671
2021-03-01 Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review (edit) SARS-CoV-2 (edit) 10.1007/S10561-020-09869-6 33033963
2021-03-01 Pharmacotherapeutics of SARS-CoV-2 Infections (edit) SARS-CoV-2 (edit) 10.1007/S11481-020-09968-X 33403500
2021-03-01 Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S40272-020-00435-X 33479801
2021-03-01 Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI) (edit) SARS-CoV-2 (edit) 10.1016/J.AMJMS.2020.10.025 33358501
2021-03-01 Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development (edit) SARS-CoV-2 (edit) 10.1016/J.ANTIVIRAL.2021.105020 33515606
2021-03-01 Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature (edit) SARS-CoV-2 (edit) 10.1016/J.BBIH.2021.100210 33521691
2021-03-01 The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve (edit) SARS-CoV-2 (edit) 10.1016/J.BBREP.2021.100907 33521335
2021-03-01 3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting (edit) SARS-CoV-2 (edit) 10.1016/J.BJ.2020.11.009 33602633
2021-03-01 Recent trends in analytical and digital techniques for the detection of the SARS-Cov-2 (edit) SARS-CoV-2 (edit) 10.1016/J.BPC.2020.106538 33418105
2021-03-01 SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.03.027
2021-03-01 Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.01.014 33535027
2021-03-01 SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.03.002
2021-03-01 Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.03.009
2021-03-01 Current opinion in neurological manifestations of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.COTOX.2021.03.004 33817451
2021-03-01 Potential SARS-CoV-2 main protease inhibitors (edit) SARS-CoV-2 (edit) 10.1016/J.DRUDIS.2020.12.005 33309533
2021-03-01 Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103246 33647767
2021-03-01 Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103255 33676899
2021-03-01 Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins (edit) SARS-CoV-2 (edit) 10.1016/J.FCT.2021.112009 33503469
2021-03-01 The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E06387 33688584
2021-03-01 Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target (edit) SARS-CoV-2 (edit) 10.1016/J.INTIMP.2020.107336 33418248
2021-03-01 Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2021.102187 33615195
2021-03-01 Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JGAR.2020.12.018 33460844
2021-03-01 Relative Sensitivity of Saliva and Upper Airway Swabs for Initial Detection of SARS-CoV-2 in Ambulatory Patients: Rapid Review (edit) SARS-CoV-2 (edit) 10.1016/J.JMOLDX.2020.12.008 33395576
2021-03-01 Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.JSB.2020.107690 33383190
2021-03-01 Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity (edit) SARS-CoV-2 (edit) 10.1016/J.JSB.2021.107713 33662570
2021-03-01 Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104708 33421654
2021-03-01 SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome (edit) SARS-CoV-2 (edit) 10.1016/J.MEHY.2021.110509
2021-03-01 Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus (edit) SARS-CoV-2 (edit) 10.1016/J.OMTM.2020.12.007 33521163
2021-03-01 [Ethical issues in primary care during the coronavirus (SARS-CoV-2) pandemic] (edit) SARS-CoV-2 (edit) 10.1016/J.SEMERG.2020.11.002 33358090
2021-03-01 Genome composition and genetic characterization of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.SJBS.2020.12.053 33519278
2021-03-01 Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.02.001 33581053
2021-03-01 SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function (edit) SARS-CoV-2 (edit) 10.1016/J.STEMCR.2021.02.008 33657418
2021-03-01 Technical considerations to development of serological tests for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.TALANTA.2020.121883 33379092
2021-03-01 Dysregulation of Cell Signaling by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.TIM.2020.12.007 33451855
2021-03-01 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00501-8
2021-03-01 Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00070-0
2021-03-01 The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(21)00079-7
2021-03-01 Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study (edit) SARS-CoV-2 (edit) 10.1016/S2352-4642(21)00060-2
2021-03-01 Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study (edit) SARS-CoV-2 (edit) 10.1016/S2589-7500(20)30293-4 33483277
2021-03-01 Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks (edit) SARS-CoV-2 (edit) 10.1016/S2666-5247(21)00004-5
2021-03-01 The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1038/S41385-020-00359-2 33244161
2021-03-01 SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes (edit) SARS-CoV-2 (edit) 10.1038/S41420-021-00428-W 33649297
2021-03-01 Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response (edit) SARS-CoV-2 (edit) 10.1038/S41423-020-00603-6 33473190
2021-03-01 ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species (edit) SARS-CoV-2 (edit) 10.1038/S41559-021-01407-1
2021-03-01 The SARS-CoV-2 RNA-protein interactome in infected human cells (edit) SARS-CoV-2 (edit) 10.1038/S41564-020-00846-Z 33349665
2021-03-01 Author Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland (edit) SARS-CoV-2 (edit) 10.1038/S41564-021-00869-0 33504980
2021-03-01 Characteristics of SARS-CoV-2 and COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41579-020-00459-7 33024307
2021-03-01 Coronavirus biology and replication: implications for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41579-020-00468-6 33116300
2021-03-01 SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03312-W 33561864
2021-03-01 Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics (edit) SARS-CoV-2 (edit) 10.1038/S41591-020-01227-Z
2021-03-01 Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin (edit) SARS-CoV-2 (edit) 10.1038/S41594-021-00570-0
2021-03-01 Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts (edit) SARS-CoV-2 (edit) 10.1080/02813432.2021.1880101 33544016
2021-03-01 A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1889665 33645443
2021-03-01 Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients (edit) SARS-CoV-2 (edit) 10.1084/JEM.20201707 33231615
2021-03-01 Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo (edit) SARS-CoV-2 (edit) 10.1084/JEM.20201993 33211088
2021-03-01 Neuroinvasion of SARS-CoV-2 in human and mouse brain (edit) SARS-CoV-2 (edit) 10.1084/JEM.20202135 33433624
2021-03-01 An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAA437 33479725
2021-03-01 Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6 (edit) SARS-CoV-2 (edit) 10.1093/BIB/BBAB025 33725111
2021-03-01 A genetic element in the SARS-CoV-2 genome is shared with multiple insect species (edit) SARS-CoV-2 (edit) 10.1099/JGV.0.001551 33427605
2021-03-01 The localized rise of a B.1.526 SARS-CoV-2 variant containing an E484K mutation in New York State (edit) SARS-CoV-2 (edit) 10.1101/2021.02.26.21251868
2021-03-01 Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Native Top-Down Mass Spectrometry (edit) SARS-CoV-2 (edit) 10.1101/2021.02.28.433291 33688648
2021-03-01 SARS-CoV-2, COVID-19, skin and immunology - what do we know so far? (edit) SARS-CoV-2 (edit) 10.1111/ALL.14498 32658359
2021-03-01 A five-step risk management process for geriatric dental practice during SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1111/GER.12499 32978832
2021-03-01 Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review (edit) SARS-CoV-2 (edit) 10.1111/TBED.13707 32603505
2021-03-01 Hypothetical targets and plausible drugs of Coronavirus infection caused by SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1111/TBED.13734 32662203
2021-03-01 Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABE8065 33608249
2021-03-01 Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABF1004 33658206
2021-03-01 Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1128/AAC.02428-20 33649113
2021-03-01 Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil (edit) SARS-CoV-2 (edit) 10.1128/JVI.00119-21 33649194
2021-03-01 Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection (edit) SARS-CoV-2 (edit) 10.1134/S0006297921030032 33838638
2021-03-01 Onset of rheumatoid arthritis after COVID-19: coincidence or connected? (edit) SARS-CoV-2 (edit) 10.1136/ANNRHEUMDIS-2021-219859
2021-03-01 Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy (edit) SARS-CoV-2 (edit) 10.1212/NXI.0000000000000935 33361386
2021-03-01 Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001115 33711012
2021-03-01 Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001143 33730024
2021-03-01 A novel cell culture system modeling the SARS-CoV-2 life cycle (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009439 33711082
2021-03-01 Urological tumors treatment in Brazil during the SARS-Cov-2 outbrake (edit) SARS-CoV-2 (edit) 10.1590/S1677-5538.IBJU.2020.0479.1 33284540
2021-03-01 The networks of m6A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis (edit) SARS-CoV-2 (edit) 10.18632/AGING.202725 33647885
2021-03-01 Low secondary transmission rates of SARS-CoV-2 infection among contacts of construction laborers at open air environment (edit) SARS-CoV-2 (edit) 10.18683/GERMS.2021.1250 33898351
2021-03-01 Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.24272/J.ISSN.2095-8137.2020.301 33738989
2021-03-01 Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021 (edit) SARS-CoV-2 (edit) 10.2807/1560-7917.ES.2021.26.10.2100130 33706862
2021-03-01 Las zoonosis emergentes y la infección provocada por el SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.31434/RMS.V6I3.656
2021-03-01 Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis (edit) SARS-CoV-2 (edit) 10.3310/HTA25210
2021-03-01 SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations (edit) SARS-CoV-2 (edit) 10.3390/V13030392 33804556
2021-03-01 How we prepared our operating theatre for patients with SARS-CoV-2 virus (edit) SARS-CoV-2 (edit) 10.5114/WIITM.2020.95090 33786124
2021-02-28 A call for governments to pause Twitter censorship: using Twitter data as social-spatial sensors of COVID-19/SARS-CoV-2 research diffusion (edit) SARS-CoV-2 (edit) 10.1007/S11192-020-03843-5 33678927
2021-02-28 TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.3390/V13030384 33671076
2021-02-27 COVID-19 outbreak in Malaysia: Decoding D614G mutation of SARS-CoV-2 virus isolated from an asymptomatic case in Pahang (edit) SARS-CoV-2 (edit) 10.1016/J.MATPR.2021.02.387 33680867
2021-02-27 Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice (edit) SARS-CoV-2 (edit) 10.1186/S12985-021-01515-1 33639976
2021-02-27 Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration (edit) SARS-CoV-2 (edit) 10.3390/MPS4010018 33673589
2021-02-26 Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.110944 33647300
2021-02-26 SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00523-5 33637679
2021-02-26 SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation (edit) SARS-CoV-2 (edit) 10.1038/S41423-020-00619-Y 33637958
2021-02-26 SARS-CoV-2 spike D614G change enhances replication and transmission (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03361-1
2021-02-26 A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection (edit) SARS-CoV-2 (edit) 10.1038/S41597-021-00848-4 33637768
2021-02-26 Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-82850-9 33637820
2021-02-26 Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83641-Y 33637783
2021-02-26 SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction (edit) SARS-CoV-2 (edit) 10.1128/JVI.00110-21
2021-02-26 Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening (edit) SARS-CoV-2 (edit) 10.1155/2021/1596834 33728324
2021-02-26 Detection of B.1.351 SARS-CoV-2 Variant Strain — Zambia, December 2020 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7008E2
2021-02-26 Clusters of SARS-CoV-2 Infection Among Elementary School Educators and Students in One School District - Georgia, December 2020-January 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7008E4 33630823
2021-02-26 SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS9030494 33652815
2021-02-25 Nonstructural protein 7 and 8 complexes of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1002/PRO.4046 33594727
2021-02-25 Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.CHOM.2021.02.019 33657424
2021-02-25 In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease (edit) SARS-CoV-2 (edit) 10.1016/J.JAIM.2021.02.004 33654345
2021-02-25 Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100218 33649747
2021-02-25 A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01281-1 33633408
2021-02-25 Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-84053-8 33633229
2021-02-25 A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York (edit) SARS-CoV-2 (edit) 10.1101/2021.02.23.21252259 33655278
2021-02-25 A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.02.25.430130 33655247
2021-02-25 SARS-CoV-2 dependence on host pathways (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABG6837 33632832
2021-02-25 In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19 (edit) SARS-CoV-2 (edit) 10.1128/MRA.00137-21 33632859
2021-02-24 The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem (edit) SARS-CoV-2 (edit) 33377359
2021-02-24 A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2 (edit) SARS-CoV-2 (edit) 10.1007/S10930-021-09967-8 33629236
2021-02-24 SARS-CoV-2 genomic surveillance identifies naturally occurring truncations of ORF7a that limit immune suppression (edit) SARS-CoV-2 (edit) 10.1101/2021.02.22.21252253 33655280
2021-02-24 SARS-CoV-2 ORF6 disturbs nucleocytoplasmic trafficking to advance the viral replication (edit) SARS-CoV-2 (edit) 10.1101/2021.02.24.432656
2021-02-24 Implications of central carbon metabolism in SARS-CoV-2 replication and disease severity (edit) SARS-CoV-2 (edit) 10.1101/2021.02.24.432759
2021-02-24 Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup (edit) Human coronavirus 229E (edit) 10.1128/MSPHERE.00819-20
2021-02-24 Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0247366 33626098
2021-02-24 Evaluation of the Effectiveness and Safety of Adding Ivermectin to Treatment in Severe COVID-19 Patients (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-224203/V1
2021-02-24 Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2021.640093 33717193
2021-02-24 Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.3390/DISEASES9010017 33668325
2021-02-24 Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity (edit) SARS-CoV-2 (edit) 10.7717/PEERJ.11008 33665043
2021-02-23 Anxiety and depression due to 2019 SARS-CoV-2 among frontier healthcare workers in Kenya (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E06351 33644428
2021-02-23 Ensemble-based screening of natural products and FDA-approved drugs identified potent inhibitors of SARS-CoV-2 that work with two distinct mechanisms (edit) SARS-CoV-2 (edit) 10.1016/J.JMGM.2021.107871 33684603
2021-02-23 Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83969-5 33623101
2021-02-23 Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage (edit) SARS-CoV-2 (edit) 10.1093/JTM/TAAB009 33506252
2021-02-23 Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis (edit) SARS-CoV-2 (edit) 10.1093/JTM/TAAB011 33506254
2021-02-23 REACT-1 round 9 interim report: downward trend of SARS-CoV-2 in England in February 2021 but still at high prevalence (edit) SARS-CoV-2 (edit) 10.1101/2021.02.18.21251973
2021-02-23 Efficacy and safety of Ivermectin and Hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial (edit) SARS-CoV-2 (edit) 10.1101/2021.02.18.21252037
2021-02-23 Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (edit) SARS-CoV-2 (edit) 10.1101/2021.02.23.432424
2021-02-23 The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation (edit) SARS-CoV-2 (edit) 10.1101/2021.02.23.432450 33655243
2021-02-23 Use of masks in public places in Poland during SARS-Cov-2 epidemic: a covert observational study (edit) SARS-CoV-2 (edit) 10.1186/S12889-021-10418-3 33622279
2021-02-23 COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.63409 33620031
2021-02-23 Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.63537
2021-02-22 Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α (edit) SARS-CoV-2 (edit) 10.1007/S13205-021-02685-Z 33643762
2021-02-22 ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation (edit) SARS-CoV-2 (edit) 10.1016/J.DEVCEL.2020.12.010 33422265
2021-02-22 Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00519-1 33619245
2021-02-22 Genome-scale deconvolution of RNA structure ensembles (edit) SARS-CoV-2 (edit) 10.1038/S41592-021-01075-W 33619392
2021-02-22 In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83730-Y 33619344
2021-02-22 Air circulation in a gastrointestinal light source box and endoscope in the era of SARS-CoV-2 and airborne transmission of microorganisms (edit) SARS-CoV-2 (edit) 10.1055/A-1336-3280
2021-02-22 Lessons Learned From SARS-CoV-2 Pandemic in Donation and Tissue Banking Activities: Key Takeaways (edit) SARS-CoV-2 (edit) 10.1097/TP.0000000000003716
2021-02-22 Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant (edit) SARS-CoV-2 (edit) 10.1101/2021.02.20.432046 33655254
2021-02-22 Structural Basis for Accommodation of Emerging B.1.351 and B.1.1.7 Variants by Two Potent SARS-CoV-2 Neutralizing Antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.02.21.432168 33655245
2021-02-22 Identification and functional analysis of the SARS-COV-2 nucleocapsid protein (edit) SARS-CoV-2 (edit) 10.1186/S12866-021-02107-3 33618668
2021-02-22 Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1186/S13073-021-00847-5 33618765
2021-02-22 SARS-CoV-2 viral shedding characteristics and potential evidence for the priority for faecal specimen testing in diagnosis (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0247367 33617590
2021-02-22 Potential Role of Galectin-glycan Lattices in SARS-CoV-2 Infection and Pathogenesis: A Hypothesis (edit) SARS-CoV-2 (edit) 10.14218/ERHM.2020.00079
2021-02-20 Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 MPro by targeting the cysteine 145 (edit) SARS-CoV-2 (edit) 10.1016/J.COMPBIOLCHEM.2021.107463 33677227
2021-02-20 Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution (edit) SARS-CoV-2 (edit) 10.1093/MILMED/USAB031 33609027
2021-02-20 Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1101/2021.02.20.431155 33619488
2021-02-20 Next-generation diagnostics: virus capture facilitates a sensitive viral diagnosis for epizootic and zoonotic pathogens including SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1186/S40168-020-00973-Z 33610182
2021-02-19 SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.2392
2021-02-19 Importation of SARS‐CoV‐2 Variant B.1.1.7 in Pakistan (edit) SARS-CoV-2 (edit) 10.1002/JMV.26869 33570181
2021-02-19 Emulsion-based isothermal nucleic acid amplification for rapid SARS-CoV-2 detection via angle-dependent light scatter analysis (edit) SARS-CoV-2 (edit) 10.1016/J.BIOS.2021.113099 33640656
2021-02-19 In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach (edit) SARS-CoV-2 (edit) 10.1016/J.EJPS.2021.105771 33617948
2021-02-19 Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100539 33623816
2021-02-19 Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.0C00929
2021-02-19 Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83110-6 33608566
2021-02-19 Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated individuals (edit) SARS-CoV-2 (edit) 10.1101/2021.02.16.21251535
2021-02-19 Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.02.18.431897 33619484
2021-02-19 Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate Inhibitors (edit) SARS-CoV-2 (edit) 10.1101/2021.02.19.424337 33619486
2021-02-19 COVID-19: a review on SARS-CoV-2 origin, epidemiology, virology, clinical manifestations and complications with special emphasis on adverse outcome in Bhopal Gas Tragedy survivor (edit) SARS-CoV-2 (edit) 10.1515/HMBCI-2020-0070
2021-02-19 SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene (edit) SARS-CoV-2 (edit) 10.3389/FGENE.2021.622271 33679887
2021-02-18 Adaptive immunity to SARS-CoV-2 and COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.01.007 33497610
2021-02-18 Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 (edit) SARS-CoV-2 (edit) 10.1056/NEJMC2027040 33503337
2021-02-18 Maintaining Safety with SARS-CoV-2 Vaccines (edit) SARS-CoV-2 (edit) 10.1056/NEJMRA2035343 33378605
2021-02-18 Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Children’s Hospital in India (edit) SARS-CoV-2 (edit) 10.1093/TROPEJ/FMAB015
2021-02-18 Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (edit) SARS-CoV-2 (edit) 10.1101/2021.02.14.21251704
2021-02-18 Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin (edit) SARS-CoV-2 (edit) 10.1101/2021.02.14.431174 33594363
2021-02-18 SARS-CoV-2 nucleocapsid protein dually regulates innate immune responses (edit) SARS-CoV-2 (edit) 10.1101/2021.02.17.431755
2021-02-18 SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission (edit) SARS-CoV-2 (edit) 10.1101/GR.268961.120 33602693
2021-02-18 SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets (edit) SARS-CoV-2 (edit) 10.1186/S12864-021-07433-4 33602138
2021-02-18 High-throughput Wastewater SARS-CoV-2 Detection Pipeline v1 (edit) SARS-CoV-2 (edit) 10.17504/PROTOCOLS.IO.BSHVNB66
2021-02-17 SARS-CoV-2 spillover transmission due to recombination event (edit) SARS-CoV-2 (edit) 10.1016/J.GENREP.2021.101045
2021-02-17 A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses (edit) SARS-CoV-2 (edit) 10.1016/J.GENREP.2021.101055 33615042
2021-02-17 Dysregulated transcriptional responses to SARS-CoV-2 in the periphery (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21289-Y 33597532
2021-02-17 Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABF4896
2021-02-17 Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0246167
2021-02-17 High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0247115 33596239
2021-02-17 Histologic and Immunohistochemical Evaluation of 65 Placentas From Women With Polymerase Chain Reaction–Proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (edit) SARS-CoV-2 (edit) 10.5858/ARPA.2020-0793-SA
2021-02-16 Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.0202 33475701
2021-02-16 Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases (edit) SARS-CoV-2 (edit) 10.1016/J.XCRM.2021.100204 33521695
2021-02-16 Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83642-X 33594223
2021-02-16 Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2021946118 33526596
2021-02-16 Endothelial cells elicit a pro-inflammatory response to SARS-CoV-2 without productive viral infection (edit) SARS-CoV-2 (edit) 10.1101/2021.02.14.431177
2021-02-16 Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02492-20 33593976
2021-02-16 Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-179906/V1
2021-02-15 Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase (edit) SARS-CoV-2 (edit) 10.1016/J.APSB.2021.02.011 33614402
2021-02-15 Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21056-Z 33589624
2021-02-15 Discrete SARS-CoV-2 antibody titers track with functional humoral stability (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21336-8 33589636
2021-02-15 Diagnostics for SARS-CoV-2 infections (edit) SARS-CoV-2 (edit) 10.1038/S41563-020-00906-Z
2021-02-15 Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-01754-6 33589648
2021-02-15 Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M inhibitors (edit) SARS-CoV-2 (edit) 10.1039/D0CC06870E 33462575
2021-02-15 In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1886174
2021-02-15 SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.01.19.21249840 33619509
2021-02-14 SARS-CoV-2, Covid-19, and the debunking of conspiracy theories (edit) SARS-CoV-2 (edit) 10.1002/RMV.2222 33586302
2021-02-14 Mesenchymal Stem Cells: The Secret Children’s Weapons against the SARS-CoV-2 Lethal Infection (edit) SARS-CoV-2 (edit) 10.3390/APP11041696
2021-02-13 Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication (edit) SARS-CoV-2 (edit) 10.1007/S42485-021-00057-Y
2021-02-13 Variant analysis of SARS-CoV-2 genomes in the Middle East (edit) SARS-CoV-2 (edit) 10.1016/J.MICPATH.2021.104741 33588026
2021-02-13 Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1886175 33583326
2021-02-13 On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community (edit) SARS-CoV-2 (edit) 10.1093/INFDIS/JIAA691 33119738
2021-02-13 Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1093/JPIDS/PIAA115 32918548
2021-02-12 [Evaluation of a SARS-CoV-2 test strategy in a southwestern university hospital at the beginning of the COVID-19 pandemic] (edit) SARS-CoV-2 (edit) 10.1007/S00103-021-03287-Z 33580269
2021-02-12 Immunoinformatics prediction of overlapping CD8 T-cell, IFN-γ and IL-4 inducer CD4 T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.1016/J.VACCINE.2021.01.003 33478794
2021-02-12 Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin (edit) SARS-CoV-2 (edit) 10.1021/ACSINFECDIS.0C00701 33432808
2021-02-12 SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options (edit) SARS-CoV-2 (edit) 10.1021/ACSPTSCI.0C00219 33615190
2021-02-12 SARS-CoV-2 genomic surveillance in Rondônia, Brazilian Western Amazon (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83203-2 33580111
2021-02-12 Immunoreactive peptide maps of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-01743-9 33580175
2021-02-12 The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2022586118 33579792
2021-02-12 Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 (edit) SARS-CoV-2 (edit) 10.1101/2021.01.25.428137 33532778
2021-02-12 Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.02.12.430472
2021-02-12 Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape (edit) SARS-CoV-2 (edit) 10.1126/SCIENCE.ABE6230 33436526
2021-02-12 COVID-19–associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron (edit) SARS-CoV-2 (edit) 10.34067/KID.0006992020
2021-02-11 Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey (edit) SARS-CoV-2 (edit) 10.1016/S2666-7568(20)30065-9 33655236
2021-02-11 A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21213-4 33574281
2021-02-11 Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21239-8 33574228
2021-02-11 Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-83229-6 33574416
2021-02-11 Differential roles of RIG-I-like receptors in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1101/2021.02.10.430677 33594370
2021-02-11 Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009165 33571304
2021-02-11 SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters (edit) SARS-CoV-2 (edit) 10.26508/LSA.202000886 33574037
2021-02-11 The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis (edit) SARS-CoV-2 (edit) 10.3390/IJMS22041804 33670394
2021-02-11 Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro (edit) SARS-CoV-2 (edit) 10.3390/V13020282 33670363
2021-02-11 The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.65365
2021-02-10 Identification of potential antivirals against SARS-CoV-2 using virtual screening method (edit) SARS-CoV-2 (edit) 10.1016/J.IMU.2021.100531 33594342
2021-02-10 Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection (edit) SARS-CoV-2 (edit) 10.1016/J.MEDJ.2021.02.001 33589885
2021-02-10 mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03324-6
2021-02-10 Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-82852-7 33568700
2021-02-10 Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAB129 33566076
2021-02-10 Maximizing fit for cloth and medical procedure masks to improve performance and reduce SARS-COV-2 transmission and exposure, 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7007E1 33600386
2021-02-10 Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2? (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2020.608765 33643982
2021-02-10 Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coli (edit) SARS-CoV-2 (edit) 10.3390/DIAGNOSTICS11020271
2021-02-09 “COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment” (edit) SARS-CoV-2 (edit) 10.1007/S00403-021-02190-6
2021-02-09 Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108728 33516277
2021-02-09 COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.145608 33607430
2021-02-09 Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.0C04691 33585737
2021-02-09 Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21155-X 33563974
2021-02-09 Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21240-1 33563978
2021-02-09 Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-01735-9 33564093
2021-02-09 Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2017715118 33479166
2021-02-09 Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit (edit) Human coronavirus 229E (edit) 10.1073/PNAS.2022310118 33472860
2021-02-09 Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2022310118 33472860
2021-02-09 Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients (edit) SARS-CoV-2 (edit) 10.1101/2021.02.07.21251281
2021-02-09 Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids (edit) SARS-CoV-2 (edit) 10.1101/2021.02.08.430344 33594360
2021-02-09 Disruption of nuclear architecture as a cause of COVID-19 induced anosmia (edit) SARS-CoV-2 (edit) 10.1101/2021.02.09.430314 33594368
2021-02-09 CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1186/S13073-021-00839-5 33563320
2021-02-09 Fluoxetine Can Inhibit SARS-CoV-2 In Vitro (edit) SARS-CoV-2 (edit) 10.3390/MICROORGANISMS9020339 33572117
2021-02-08 Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.0C00808 33555895
2021-02-08 Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21111-9 33558507
2021-02-08 SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21118-2 33558493
2021-02-08 Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21171-X 33558541
2021-02-08 Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01270-4
2021-02-08 Decreased SARS-CoV-2 viral load following vaccination (edit) SARS-CoV-2 (edit) 10.1101/2021.02.06.21251283
2021-02-08 Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma (edit) SARS-CoV-2 (edit) 10.1111/ECI.13501 33512013
2021-02-08 In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface (edit) SARS-CoV-2 (edit) 10.3390/IJMS22041695 33567580
2021-02-08 SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets (edit) SARS-CoV-2 (edit) 10.7554/ELIFE.63646 33554856
2021-02-07 Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1101/2021.02.05.429959 33564769
2021-02-07 Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies (edit) SARS-CoV-2 (edit) 10.1101/2021.02.05.430003 33564768
2021-02-05 Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.BRAINRES.2021.147344 33556379
2021-02-05 Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.GENE.2020.145313 33220345
2021-02-05 Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.0C00815 33491459
2021-02-05 NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.0C00876 33426894
2021-02-05 SARS-CoV-2 evolution during treatment of chronic infection (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03291-Y
2021-02-05 PACIFIC: a lightweight deep-learning classifier of SARS-CoV-2 and co-infecting RNA viruses (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-82043-4 33547380
2021-02-05 Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant (edit) SARS-CoV-2 (edit) 10.1101/2021.02.02.21250799 33564782
2021-02-05 SARS-CoV-2 ORF7b: is a bat virus protein homologue a major cause of COVID-19 symptoms? (edit) SARS-CoV-2 (edit) 10.1101/2021.02.05.428650
2021-02-05 Protein glycosylation is essential for SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1101/2021.02.05.429940
2021-02-05 The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories (edit) SARS-CoV-2 (edit) 10.1186/S12916-020-01872-8 33541353
2021-02-05 COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) SARS-CoV-2 (edit) 10.21203/RS.3.PEX-1338/V1
2021-02-04 An Androsterone-H2 @C60 hybrid: Synthesis, Properties and Molecular Docking Simulations with SARS-Cov-2 (edit) SARS-CoV-2 (edit) 10.1002/CPLU.202000770 33540487
2021-02-04 Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review (edit) SARS-CoV-2 (edit) 10.1007/S10311-020-01151-1 33558807
2021-02-04 Multi-organ proteomic landscape of COVID-19 autopsies (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.01.004 33503446
2021-02-04 On the usefulness of the bioclimatic correlative models of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2021.110818 33548299
2021-02-04 Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India (edit) SARS-CoV-2 (edit) 10.1016/J.GENE.2021.145470 33549714
2021-02-04 Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.IJBIOMAC.2021.02.012 33548314
2021-02-04 Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00468-9 33542181
2021-02-04 Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-82662-X
2021-02-04 Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-82938-2 33542420
2021-02-04 Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH (edit) SARS-CoV-2 (edit) 10.1101/2021.02.04.429604
2021-02-04 Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of Nsp1, Nsp2, and Nucleocapsid proteins from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.02.04.429751
2021-02-04 Chemokine Regulation During Epidemic Coronavirus Infection (edit) SARS-CoV-2 (edit) 10.3389/FPHAR.2020.600369 33613280
2021-02-04 Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week (edit) SARS-CoV-2 (edit) 10.3390/V13020243 33557213
2021-02-03 Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1007/S12602-021-09748-W 33537958
2021-02-03 Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.EBIOM.2021.103228 33548839
2021-02-03 Toolkit for Quickly Generating and Characterizing Molecular Probes Specific for SARS-CoV-2 Nucleocapsid as a Primer for Future Coronavirus Pandemic Preparedness (edit) SARS-CoV-2 (edit) 10.1021/ACSSYNBIO.0C00566 33534552
2021-02-03 Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents (edit) SARS-CoV-2 (edit) 10.1038/S41587-021-00822-W
2021-02-03 Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01 (edit) SARS-CoV-2 (edit) 10.1101/2021.02.01.21250959 33564794
2021-02-03 Bacterial expression and purification of functional recombinant SARS-CoV-2 spike receptor binding domain (edit) SARS-CoV-2 (edit) 10.1101/2021.02.03.429601
2021-02-03 ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PCBI.1008685 33534793
2021-02-03 Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0246647
2021-02-03 Urban Rail Transportation and SARS-Cov-2 Infections: An Ecological Study in the Lisbon Metropolitan Area (edit) SARS-CoV-2 (edit) 10.3389/FPUBH.2021.611565 33614581
2021-02-02 Maturation and persistence of the anti-SARS-CoV-2 memory B cell response (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.01.050 33571429
2021-02-02 Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108699 33485405
2021-02-02 Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-21060-3 33531496
2021-02-02 Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity (edit) SARS-CoV-2 (edit) 10.1038/S41590-021-00870-Z
2021-02-02 Sixteen novel lineages of SARS-CoV-2 in South Africa (edit) SARS-CoV-2 (edit) 10.1038/S41591-021-01255-3
2021-02-02 High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling (edit) SARS-CoV-2 (edit) 10.1039/D1SC00145K 34168762
2021-02-02 Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1073/PNAS.2021579118 33452205
2021-02-02 De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning (edit) SARS-CoV-2 (edit) 10.1186/S13065-021-00737-2 33531083
2021-02-02 Clinical and whole genome characterization of SARS-CoV-2 in India (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0246173 33529260
2021-02-02 Ivermectin in mild and moderate COVID-19 (RIVET-COV): a randomized, placebo-controlled trial (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-191648/V1
2021-02-02 Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression (edit) SARS-CoV-2 (edit) 10.3390/CELLS10020300 33540583
2021-02-01 Immunoinformatics based prediction of recombinant multi-epitope vaccine for the control and prevention of SARS-CoV-2 (edit) SARS-CoV-2 (edit)
2021-02-01 Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial (edit) SARS-CoV-2 (edit) 10.1001/JAMANETWORKOPEN.2021.0369 33576820
2021-02-01 CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections (edit) SARS-CoV-2 (edit) 10.1002/DDR.21752 33190277
2021-02-01 HIV/SARS-CoV-2 coinfection: a global perspective (edit) SARS-CoV-2 (edit) 10.1002/JMV.26321 32692406
2021-02-01 Placental SARS-CoV-2 in a Pregnant Woman with Mild COVID-19 Disease (edit) SARS-CoV-2 (edit) 10.1002/JMV.26386 32749712
2021-02-01 Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract (edit) SARS-CoV-2 (edit) 10.1002/PRP2.698 33369210
2021-02-01 Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2) (edit) SARS-CoV-2 (edit) 10.1002/PTR.6872 32945590
2021-02-01 [Recommendations from the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on perimetry during the SARS-CoV-2 pandemic : Status: 30 November 2020] (edit) SARS-CoV-2 (edit) 10.1007/S00347-020-01299-9 33394093
2021-02-01 Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach (edit) SARS-CoV-2 (edit) 10.1007/S00431-020-03766-6 32803422
2021-02-01 Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications (edit) SARS-CoV-2 (edit) 10.1007/S10753-020-01337-3 33029758
2021-02-01 SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions (edit) SARS-CoV-2 (edit) 10.1007/S11010-020-03935-Z 33064288
2021-02-01 Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2? (edit) SARS-CoV-2 (edit) 10.1007/S11259-021-09787-2 33464439
2021-02-01 Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible? (edit) SARS-CoV-2 (edit) 10.1007/S12015-020-10101-X 33403489
2021-02-01 Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1007/S12035-020-02134-7 32978729
2021-02-01 SARS-CoV-2 infection and its association with thrombosis and ischemic stroke: a review (edit) SARS-CoV-2 (edit) 10.1016/J.AJEM.2020.09.072 33036853
2021-02-01 763 Hemostasis changes among COVID-19 gravidas during SARS-CoV-2 pandemic on rotational thromboelastography (edit) SARS-CoV-2 (edit) 10.1016/J.AJOG.2020.12.786
2021-02-01 Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS) (edit) SARS-CoV-2 (edit) 10.1016/J.ANPEDI.2020.09.005 33132066
2021-02-01 Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection (edit) SARS-CoV-2 (edit) 10.1016/J.ARCMED.2020.10.014 33160751
2021-02-01 Force-Dependent Stimulation of RNA Unwinding by SARS-CoV-2 NSP13 Helicase (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2020.11.772
2021-02-01 Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.02.037
2021-02-01 SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108761 33567255
2021-02-01 The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial (edit) SARS-CoV-2 (edit) 10.1016/J.ECLINM.2020.100720 33495752
2021-02-01 Panic and pandemic: Narrative review of the literature on the links and risks of panic disorder as a consequence of the SARS-CoV-2 pandemic (edit) SARS-CoV-2 (edit) 10.1016/J.ENCEP.2020.08.001 33221039
2021-02-01 SARS-CoV-2 coronavirus in water and wastewater: A critical review about presence and concern (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2020.110265 33011225
2021-02-01 Contamination of inert surfaces by SARS-CoV-2: persistence, stability and infectivity. A review (edit) SARS-CoV-2 (edit) 10.1016/J.ENVRES.2020.110559 33275925
2021-02-01 SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E06187 33644468
2021-02-01 The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.INTIMP.2020.107325 33401205
2021-02-01 An effective approach for recombinant production of select SARS-CoV-2 proteins in Escherichia coli (edit) SARS-CoV-2 (edit) 10.1016/J.JACI.2020.12.264
2021-02-01 Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.JAUT.2021.102595 33453462
2021-02-01 Containing SARS-CoV-2 in hospitals facing finite PPE, limited testing, and physical space variability: Navigating resource constrained enhanced traffic control bundling (edit) SARS-CoV-2 (edit) 10.1016/J.JMII.2020.07.009 32773286
2021-02-01 Potential of pulsed light technology for control of SARS-CoV-2 in hospital environments (edit) SARS-CoV-2 (edit) 10.1016/J.JPHOTOBIOL.2020.112106 33383557
2021-02-01 Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms (edit) SARS-CoV-2 (edit) 10.1016/J.MOLCEL.2020.12.041 33444546
2021-02-01 Increased placental expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin anemia-polycythemia sequence (TAPS) (edit) SARS-CoV-2 (edit) 10.1016/J.PLACENTA.2021.01.008 33497931
2021-02-01 Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease (edit) SARS-CoV-2 (edit) 10.1016/J.PROSTAGLANDINS.2020.106504 33147503
2021-02-01 Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive math (edit) SARS-CoV-2 (edit) 10.1016/J.SCITOTENV.2021.145530
2021-02-01 Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir (edit) SARS-CoV-2 (edit) 10.1016/J.XINN.2021.100080 33521757
2021-02-01 SARS-CoV-2 variants and ending the COVID-19 pandemic (edit) SARS-CoV-2 (edit) 10.1016/S0140-6736(21)00370-6
2021-02-01 The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries (edit) SARS-CoV-2 (edit) 10.1016/S1473-3099(20)30785-4 33729915
2021-02-01 New variant of SARS-CoV-2 in UK causes surge of COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/S2213-2600(21)00005-9 33417829
2021-02-01 The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/S2666-7568(20)30068-4 33665645
2021-02-01 Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models (edit) SARS-CoV-2 (edit) 10.1021/ACS.JMEDCHEM.0C01929 33523654
2021-02-01 Publisher Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland (edit) SARS-CoV-2 (edit) 10.1038/S41564-021-00865-4 33462438
2021-02-01 Neurological infection with SARS-CoV-2 - the story so far (edit) SARS-CoV-2 (edit) 10.1038/S41582-020-00453-W 33414554
2021-02-01 Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia (edit) SARS-CoV-2 (edit) 10.1038/S41586-020-03148-W 33429418
2021-02-01 BNT162b vaccines protect rhesus macaques from SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03275-Y
2021-02-01 Cold sensitivity of the SARS-CoV-2 spike ectodomain (edit) SARS-CoV-2 (edit) 10.1038/S41594-020-00547-5 33402708
2021-02-01 SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas (edit) SARS-CoV-2 (edit) 10.1038/S42255-021-00347-1 33536639
2021-02-01 Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses (edit) SARS-CoV-2 (edit) 10.1080/03007995.2020.1862532 33306409
2021-02-01 Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1871863 33526003
2021-02-01 Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children (edit) SARS-CoV-2 (edit) 10.1097/PG9.0000000000000040 34192291
2021-02-01 PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern (edit) SARS-CoV-2 (edit) 10.1101/2021.01.28.21250486
2021-02-01 Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16 (edit) SARS-CoV-2 (edit) 10.1101/2021.01.31.429023
2021-02-01 Potential mechanisms of SARS-CoV-2 action on male gonadal function and fertility: Current status and future prospects (edit) SARS-CoV-2 (edit) 10.1111/AND.13883 33108833
2021-02-01 Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues (edit) SARS-CoV-2 (edit) 10.1111/HIS.14264 32981112
2021-02-01 SARS-CoV-2 infection, COVID-19 pathogenesis, and exposure to air pollution: What is the connection? (edit) SARS-CoV-2 (edit) 10.1111/NYAS.14512 33022781
2021-02-01 Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABE7386 33547084
2021-02-01 An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants (edit) SARS-CoV-2 (edit) 10.1126/SCIADV.ABF1738 33597251
2021-02-01 Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1177/0022034520967933 33089717
2021-02-01 A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PBIO.3001091 33630831
2021-02-01 SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009225 33596266
2021-02-01 Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009282 33556147
2021-02-01 Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PPAT.1009373 33635912
2021-02-01 SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection (edit) SARS-CoV-2 (edit) 10.14814/PHY2.14761 33625796
2021-02-01 Syncytia formation by SARS-CoV-2-infected cells (edit) SARS-CoV-2 (edit) 10.15252/EMBJ.2020107405 33522642
2021-02-01 SARS-CoV-2 infection remodels the host protein thermal stability landscape (edit) SARS-CoV-2 (edit) 10.15252/MSB.202010188 33590968
2021-02-01 SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals (edit) SARS-CoV-2 (edit) 10.4110/IN.2021.21.E2 33728095
2021-01-31 Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1101/2021.01.27.21250637
2021-01-31 REACT-1 round 8 final report: high average prevalence with regional heterogeneity of trends in SARS-CoV-2 infection in the community in England during January 2021 (edit) SARS-CoV-2 (edit) 10.1101/2021.01.28.21250606
2021-01-29 Apoptosis induced by SARS-CoV-2: can we target it? (edit) SARS-CoV-2 (edit) 10.1007/S10495-021-01656-2 33512610
2021-01-29 Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations (edit) SARS-CoV-2 (edit) 10.1007/S12010-020-03475-8 33512650
2021-01-29 Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.012 33069360
2021-01-29 The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ? (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.042 33341233
2021-01-29 T cell immunity to SARS-CoV-2 following natural infection and vaccination (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.060 33190827
2021-01-29 The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.080 33303190
2021-01-29 The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.091 33288200
2021-01-29 Host-directed editing of the SARS-CoV-2 genome (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.092 33234239
2021-01-29 Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.108 33187644
2021-01-29 The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.10.109 33199022
2021-01-29 A nidovirus perspective on SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.11.015 33413979
2021-01-29 Functional importance of the D614G mutation in the SARS-CoV-2 spike protein (edit) SARS-CoV-2 (edit) 10.1016/J.BBRC.2020.11.026 33220921
2021-01-29 Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection (edit) SARS-CoV-2 (edit) 10.1038/S41392-021-00470-1 33514685
2021-01-29 Engineering SARS-CoV-2 using a reverse genetic system (edit) SARS-CoV-2 (edit) 10.1038/S41596-021-00491-8 33514944
2021-01-29 SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus (edit) SARS-CoV-2 (edit) 10.1038/S42003-021-01649-6 33514825
2021-01-29 Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1876774 33509045
2021-01-29 New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19 (edit) SARS-CoV-2 (edit) 10.1101/2021.01.27.21250559 33532787
2021-01-29 SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells (edit) SARS-CoV-2 (edit) 10.1128/JVI.02415-20 33514628
2021-01-29 ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues (edit) SARS-CoV-2 (edit) 10.1186/S40246-021-00304-9 33514423
2021-01-29 High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0246396 33513195
2021-01-29 Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2020.621735 33584720
2021-01-29 Severe SARS-CoV-2 Infection: A Multisystem Inflammatory Syndrome in Moroccan Children (edit) SARS-CoV-2 (edit) 10.7759/CUREUS.12991 33659125
2021-01-28 ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19 (edit) SARS-CoV-2 (edit) 10.1016/J.HELIYON.2021.E06133 33532652
2021-01-28 Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia (edit) SARS-CoV-2 (edit) 10.1038/S41467-020-20880-Z 33510171
2021-01-28 A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication (edit) SARS-CoV-2 (edit) 10.1038/S41467-021-20900-6 33510133
2021-01-28 Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020 (edit) SARS-CoV-2 (edit) 10.1093/CID/CIAA1880 33506256
2021-01-28 Effect of SARS-CoV-2 spike mutations on animal ACE2 usage and in vitro neutralization sensitivity (edit) SARS-CoV-2 (edit) 10.1101/2021.01.27.428353
2021-01-28 D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Viral Transmission via Enhanced Furin-mediated Spike Cleavage (edit) SARS-CoV-2 (edit) 10.1101/2021.01.27.428541
2021-01-28 SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19 (edit) SARS-CoV-2 (edit) 10.1111/BJD.19833 33511657
2021-01-28 Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals (edit) SARS-CoV-2 (edit) 10.3389/FIMMU.2020.618685 33584712
2021-01-28 The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis (edit) SARS-CoV-2 (edit) 10.3390/IJMS22031308 33525632
2021-01-27 Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations (edit) SARS-CoV-2 (edit) 10.1016/J.SJBS.2021.01.040 33526965
2021-01-27 Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics (edit) SARS-CoV-2 (edit) 10.1038/S41467-020-20608-Z 33504779
2021-01-27 Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis (edit) SARS-CoV-2 (edit) 10.1101/2021.01.26.21250420
2021-01-27 Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys (edit) SARS-CoV-2 (edit) 10.1126/SCITRANSLMED.ABE8146 33431511
2021-01-27 Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1186/S40164-021-00199-1 33504359
2021-01-26 Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection (edit) SARS-CoV-2 (edit) 10.1001/JAMA.2021.0374
2021-01-26 Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1016/J.CELL.2021.01.035 33577765
2021-01-26 The immunodominant and neutralization linear epitopes for SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2020.108666 33503420
2021-01-26 Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1016/J.CELREP.2021.108737 33545052
2021-01-26 Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes (edit) SARS-CoV-2 (edit) 10.1016/J.GENREP.2021.101020 33521382
2021-01-26 Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104730 33513449
2021-01-26 Quantitative Assessment of SARS-CoV-2 Virus in Nasopharyngeal Swabs Stored in Transport Medium by a Straightforward LC-MS/MS Assay Targeting Nucleocapsid, Membrane, and Spike Proteins (edit) SARS-CoV-2 (edit) 10.1021/ACS.JPROTEOME.0C00887
2021-01-26 A new SYBR Green real-time PCR to detect SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-81245-0 33500453
2021-01-26 Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19) (edit) SARS-CoV-2 (edit) 10.1080/08998280.2021.1874231 33664552
2021-01-26 Complete aortic thrombosis in SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.1093/EURHEARTJ/EHAB011
2021-01-26 Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma (edit) SARS-CoV-2 (edit) 10.1101/2021.01.26.21250224
2021-01-26 Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains (edit) SARS-CoV-2 (edit) 10.1371/JOURNAL.PONE.0238665 33497392
2021-01-26 One Year of SARS-CoV-2: How Much Has the Virus Changed? (edit) SARS-CoV-2 (edit) 10.3390/BIOLOGY10020091 33530355
2021-01-26 Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets (edit) SARS-CoV-2 (edit) 10.3390/MOLECULES26030632
2021-01-25 Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis (edit) SARS-CoV-2 (edit) 10.1038/S41586-021-03237-4 33494095
2021-01-25 Detection of SARS-CoV-2 infection by rapid antigen test in comparison with RT-PCR in a public setting (edit) SARS-CoV-2 (edit) 10.1101/2021.01.22.21250042
2021-01-25 mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants (edit) SARS-CoV-2 (edit) 10.1101/2021.01.25.427948 33501442
2021-01-25 Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing (edit) SARS-CoV-2 (edit) 10.1111/TRF.16268 33491194
2021-01-25 Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases (edit) SARS-CoV-2 (edit) 10.1146/ANNUREV-MICRO-110520-023212 33492978
2021-01-25 2019 Novel Human Coronavirus Sars-Cov-2 And Covid-19: A Brief Review (edit) SARS-CoV-2 (edit) 10.22376/IJPBS/LPR.2021.11.1.L273-283
2021-01-25 Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic (edit) SARS-CoV-2 (edit) 10.3389/FMOLB.2020.628551 33569392
2021-01-25 Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188 (edit) SARS-CoV-2 (edit) 10.3390/V13020174 33503819
2021-01-25 Ultrasonography of the larynx: Novel use during the SARS‑CoV‑2 pandemic (Review) (edit) SARS-CoV-2 (edit) 10.3892/ETM.2021.9704 33603880
2021-01-24 Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach (edit) SARS-CoV-2 (edit) 10.1007/S13205-020-02610-W 33520579
2021-01-23 SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics (edit) SARS-CoV-2 (edit) 10.1016/J.MEEGID.2021.104729 33497837
2021-01-23 Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.12688/F1000RESEARCH.36371.1 33841800
2021-01-22 Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods (edit) SARS-CoV-2 (edit) 10.1016/J.CMPB.2021.105951 33513487
2021-01-22 Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2020.101947 33437935
2021-01-22 High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance (edit) SARS-CoV-2 (edit) 10.1016/J.ISCI.2020.101992 33490902
2021-01-22 Structural insights into SARS-CoV-2 proteins (edit) SARS-CoV-2 (edit) 10.1016/J.JMB.2020.11.024 33245961
2021-01-22 Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins (edit) SARS-CoV-2 (edit) 10.1016/J.JTCME.2021.01.006 33520682
2021-01-22 Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1021/ACS.JNATPROD.0C00968 33352046
2021-01-22 SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques (edit) SARS-CoV-2 (edit) 10.1038/S41467-020-20642-X 33483492
2021-01-22 In silico evaluation of lapachol derivatives binding to the Nsp9 of SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1875050
2021-01-22 REACT-1 round 8 interim report: SARS-CoV-2 prevalence during the initial stages of the third national lockdown in England (edit) SARS-CoV-2 (edit) 10.1101/2021.01.20.21250158
2021-01-22 A protocol for adding knowledge to Wikidata: aligning resources on human coronaviruses (edit) SARS-CoV-2 (edit) 10.1186/S12915-020-00940-Y 33482803
2021-01-22 Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021 (edit) SARS-CoV-2 (edit) 10.15585/MMWR.MM7003E2 33476315
2021-01-22 Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis (edit) SARS-CoV-2 (edit) 10.2196/25995 33497425
2021-01-22 ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data (edit) SARS-CoV-2 (edit) 10.3390/V13020160 33499228
2021-01-21 Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein (edit) SARS-CoV-2 (edit) 10.1016/J.BPJ.2021.01.012 33484712
2021-01-21 SARSCOVIDB-A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection (edit) SARS-CoV-2 (edit) 10.1021/ACSOMEGA.0C05701 33553941
2021-01-21 SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region (edit) SARS-CoV-2 (edit) 10.1038/S41421-020-00240-3 33479219
2021-01-21 The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein (edit) SARS-CoV-2 (edit) 10.1038/S41467-020-20768-Y 33479198
2021-01-21 Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19 (edit) SARS-CoV-2 (edit) 10.1038/S41598-021-81451-W 33479353
2021-01-21 Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study (edit) SARS-CoV-2 (edit) 10.1080/07391102.2021.1872418
2021-01-21 SARS-CoV-2 and Zoonotic Preparedness: Unknown Knowns? (edit) SARS-CoV-2 (edit) 10.1097/IM9.0000000000000051
2021-01-21 P251 The induction of early, dynamic airway mucosal and systemic immune responses following recent SARS-CoV-2 household exposure (edit) SARS-CoV-2 (edit) 10.1136/THORAX-2020-BTSABSTRACTS.395
2021-01-21 Horizontal gene transfer and recombination analysis of SARS-CoV-2 genes helps discover its close relatives and shed light on its origin (edit) SARS-CoV-2 (edit) 10.1186/S12862-020-01732-2
2021-01-21 Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses (edit) SARS-CoV-2 (edit) 10.3390/VACCINES9020073 33494381
2021-01-20 The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery (edit) SARS-CoV-2 (edit) 10.1038/S41467-020-20718-8 33473130
2021-01-20 Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape (edit) SARS-CoV-2 (edit) 10.1038/S41467-020-20789-7 33473140
2021-01-20 Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents (edit) SARS-CoV-2 (edit) 10.1038/S42003-020-01577-X 33473151
2021-01-20 Epidemic waves of COVID-19 in Scotland: a genomic perspective on the impact of the introduction and relaxation of lockdown on SARS-CoV-2 (edit) SARS-CoV-2 (edit) 10.1101/2021.01.08.20248677
2021-01-20 Emergence of a novel SARS-CoV-2 strain in Southern California, USA (edit) SARS-CoV-2 (edit) 10.1101/2021.01.18.21249786
2021-01-20 The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera (edit) SARS-CoV-2 (edit) 10.1101/2021.01.19.21249592 33501468
2021-01-20 Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? (edit) SARS-CoV-2 (edit) 10.3390/IJMS22030992 33498183
2021-01-20 Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein (edit) SARS-CoV-2 (edit) 10.3390/V13020146 33498225
2021-01-19 Genome‐wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID‐19 (edit) SARS-CoV-2 (edit) 10.1002/JLB.5HI0720-466R 33464637
2021-01-19 mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (edit) SARS-CoV-2 (edit) 10.1101/2021.01.15.426911 33501451
2021-01-19 Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera (edit) SARS-CoV-2 (edit) 10.1101/2021.01.18.426984
2021-01-19 Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors (edit) SARS-CoV-2 (edit) 10.1128/MBIO.02754-20 33468688
2021-01-19 Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion (edit) SARS-CoV-2 (edit) 10.1128/MBIO.03014-20 33468697
2021-01-19 Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection (edit) SARS-CoV-2 (edit) 10.21203/RS.3.RS-148845/V1
2021-01-19 Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies (edit) SARS-CoV-2 (edit) 10.3390/V13010134 33477902
2021-01-19 Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e (edit) Human coronavirus OC43 (edit) 10.7554/ELIFE.64509 33463525

Ejemplos de código

curl

curl -s https://raw.githubusercontent.com/egonw/SARS-CoV-2-Queries/master/sparql/litHumanCoronaviruses.rq | sed 's+<lang/>+es+' > litHumanCoronaviruses.rq

curl -H "Accept: text/tab-separated-values" -G https://query.wikidata.org/bigdata/namespace/wdq/sparql --data-urlencode query@litHumanCoronaviruses.rq

Esta consulta SPARQL está disponible en CCZero.